Add Pathways KG PARTIAL BUILD: 138,725 nodes / 601,322 edges — known gaps documented, not a v1.0 release
0c528ef verified Download nodes/pathway.csv from VaidhyaMegha/pathways-kg: direct link, hf CLI and curl.
- Browser
- Download file 314 kB
-
https://huggingface.co/datasets/VaidhyaMegha/pathways-kg/resolve/main/nodes/pathway.csv
- Command line
-
hf download hf://datasets/VaidhyaMegha/pathways-kg/nodes/pathway.csv
-
curl -L -o pathway.csv https://huggingface.co/datasets/VaidhyaMegha/pathways-kg/resolve/main/nodes/pathway.csv
314 kB
| id,reactome_id,wp_id,name,organism,source | |
| 1,R-HSA-164843,,2-LTR circle formation,Homo sapiens,reactome | |
| 2,R-HSA-9909438,,3-Methylcrotonyl-CoA carboxylase deficiency,Homo sapiens,reactome | |
| 3,R-HSA-9916722,,3-hydroxyisobutyryl-CoA hydrolase deficiency,Homo sapiens,reactome | |
| 4,R-HSA-9914274,,3-methylglutaconic aciduria,Homo sapiens,reactome | |
| 5,R-HSA-73843,,5-Phosphoribose 1-diphosphate biosynthesis,Homo sapiens,reactome | |
| 6,R-HSA-5619084,,ABC transporter disorders,Homo sapiens,reactome | |
| 7,R-HSA-1369062,,ABC transporters in lipid homeostasis,Homo sapiens,reactome | |
| 8,R-HSA-382556,,ABC-family protein mediated transport,Homo sapiens,reactome | |
| 9,R-HSA-9033807,,ABO blood group biosynthesis,Homo sapiens,reactome | |
| 10,R-HSA-9660821,,ADORA2B mediated anti-inflammatory cytokines production,Homo sapiens,reactome | |
| 11,R-HSA-418592,,ADP signalling through P2Y purinoceptor 1,Homo sapiens,reactome | |
| 12,R-HSA-392170,,ADP signalling through P2Y purinoceptor 12,Homo sapiens,reactome | |
| 13,R-HSA-198323,,AKT phosphorylates targets in the cytosol,Homo sapiens,reactome | |
| 14,R-HSA-198693,,AKT phosphorylates targets in the nucleus,Homo sapiens,reactome | |
| 15,R-HSA-211163,,AKT-mediated inactivation of FOXO1A,Homo sapiens,reactome | |
| 16,R-HSA-9700645,,ALK mutants bind TKIs,Homo sapiens,reactome | |
| 17,R-HSA-112122,,ALKBH2 mediated reversal of alkylation damage,Homo sapiens,reactome | |
| 18,R-HSA-112126,,ALKBH3 mediated reversal of alkylation damage,Homo sapiens,reactome | |
| 19,R-HSA-163680,,AMPK inhibits chREBP transcriptional activation activity,Homo sapiens,reactome | |
| 20,R-HSA-9931269,,AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274),Homo sapiens,reactome | |
| 21,R-HSA-5467333,,APC truncation mutants are not K63 polyubiquitinated,Homo sapiens,reactome | |
| 22,R-HSA-5467337,,APC truncation mutants have impaired AXIN binding,Homo sapiens,reactome | |
| 23,R-HSA-179409,,APC-Cdc20 mediated degradation of Nek2A,Homo sapiens,reactome | |
| 24,R-HSA-174143,,APC/C-mediated degradation of cell cycle proteins,Homo sapiens,reactome | |
| 25,R-HSA-174048,,APC/C:Cdc20 mediated degradation of Cyclin B,Homo sapiens,reactome | |
| 26,R-HSA-174154,,APC/C:Cdc20 mediated degradation of Securin,Homo sapiens,reactome | |
| 27,R-HSA-176409,,APC/C:Cdc20 mediated degradation of mitotic proteins,Homo sapiens,reactome | |
| 28,R-HSA-174178,,APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1,Homo sapiens,reactome | |
| 29,R-HSA-179419,,APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint,Homo sapiens,reactome | |
| 30,R-HSA-5649702,,APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway,Homo sapiens,reactome | |
| 31,R-HSA-180689,,APOBEC3G mediated resistance to HIV-1 infection,Homo sapiens,reactome | |
| 32,R-HSA-9956514,,ARG1 variants cause hyperargininemia,Homo sapiens,reactome | |
| 33,R-HSA-5624958,,ARL13B-mediated ciliary trafficking of INPP5E,Homo sapiens,reactome | |
| 34,R-HSA-170984,,ARMS-mediated activation,Homo sapiens,reactome | |
| 35,R-HSA-9956529,,ASL variants cause argininosuccinate aciduria,Homo sapiens,reactome | |
| 36,R-HSA-9717264,,ASP-3026-resistant ALK mutants,Homo sapiens,reactome | |
| 37,R-HSA-9956520,,ASS1 variants cause citrullinemia,Homo sapiens,reactome | |
| 38,R-HSA-380994,,ATF4 activates genes in response to endoplasmic reticulum stress,Homo sapiens,reactome | |
| 39,R-HSA-381183,,ATF6 (ATF6-alpha) activates chaperone genes,Homo sapiens,reactome | |
| 40,R-HSA-381033,,ATF6 (ATF6-alpha) activates chaperones,Homo sapiens,reactome | |
| 41,R-HSA-8874177,,ATF6B (ATF6-beta) activates chaperones,Homo sapiens,reactome | |
| 42,R-HSA-1296025,,ATP sensitive Potassium channels,Homo sapiens,reactome | |
| 43,R-HSA-9932444,,ATP-dependent chromatin remodelers,Homo sapiens,reactome | |
| 44,R-HSA-450408,,AUF1 (hnRNP D0) binds and destabilizes mRNA,Homo sapiens,reactome | |
| 45,R-HSA-8854518,,AURKA Activation by TPX2,Homo sapiens,reactome | |
| 46,R-HSA-5467340,,AXIN missense mutants destabilize the destruction complex,Homo sapiens,reactome | |
| 47,R-HSA-2161522,,Abacavir ADME,Homo sapiens,reactome | |
| 48,R-HSA-2161541,,Abacavir metabolism,Homo sapiens,reactome | |
| 49,R-HSA-2161517,,Abacavir transmembrane transport,Homo sapiens,reactome | |
| 50,R-HSA-73930,,Abasic sugar-phosphate removal via the single-nucleotide replacement pathway,Homo sapiens,reactome | |
| 51,R-HSA-9659787,,Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects,Homo sapiens,reactome | |
| 52,R-HSA-9687139,,Aberrant regulation of mitotic cell cycle due to RB1 defects,Homo sapiens,reactome | |
| 53,R-HSA-9687136,,Aberrant regulation of mitotic exit in cancer due to RB1 defects,Homo sapiens,reactome | |
| 54,R-HSA-2978092,,Abnormal conversion of 2-oxoglutarate to 2-hydroxyglutarate,Homo sapiens,reactome | |
| 55,R-HSA-167242,,Abortive elongation of HIV-1 transcript in the absence of Tat,Homo sapiens,reactome | |
| 56,R-HSA-156582,,Acetylation,Homo sapiens,reactome | |
| 57,R-HSA-264642,,Acetylcholine Neurotransmitter Release Cycle,Homo sapiens,reactome | |
| 58,R-HSA-181431,,Acetylcholine binding and downstream events,Homo sapiens,reactome | |
| 59,R-HSA-9667769,,Acetylcholine inhibits contraction of outer hair cells,Homo sapiens,reactome | |
| 60,R-HSA-399997,,Acetylcholine regulates insulin secretion,Homo sapiens,reactome | |
| 61,R-HSA-1300645,,Acrosome Reaction and Sperm:Oocyte Membrane Binding,Homo sapiens,reactome | |
| 62,R-HSA-9638771,,Action of antimicrobials,Homo sapiens,reactome | |
| 63,R-HSA-9638737,,Action of antimicrobials and antimicrobial resistance,Homo sapiens,reactome | |
| 64,R-HSA-2122948,,Activated NOTCH1 Transmits Signal to the Nucleus,Homo sapiens,reactome | |
| 65,R-HSA-9032845,,Activated NTRK2 signals through CDK5,Homo sapiens,reactome | |
| 66,R-HSA-9028731,,Activated NTRK2 signals through FRS2 and FRS3,Homo sapiens,reactome | |
| 67,R-HSA-9032500,,Activated NTRK2 signals through FYN,Homo sapiens,reactome | |
| 68,R-HSA-9028335,,Activated NTRK2 signals through PI3K,Homo sapiens,reactome | |
| 69,R-HSA-9026527,,Activated NTRK2 signals through PLCG1,Homo sapiens,reactome | |
| 70,R-HSA-9026519,,Activated NTRK2 signals through RAS,Homo sapiens,reactome | |
| 71,R-HSA-9603381,,Activated NTRK3 signals through PI3K,Homo sapiens,reactome | |
| 72,R-HSA-9034793,,Activated NTRK3 signals through PLCG1,Homo sapiens,reactome | |
| 73,R-HSA-9034864,,Activated NTRK3 signals through RAS,Homo sapiens,reactome | |
| 74,R-HSA-5625886,,Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3,Homo sapiens,reactome | |
| 75,R-HSA-2033519,,Activated point mutants of FGFR2,Homo sapiens,reactome | |
| 76,R-HSA-111452,,Activation and oligomerization of BAK protein,Homo sapiens,reactome | |
| 77,R-HSA-165158,,Activation of AKT2,Homo sapiens,reactome | |
| 78,R-HSA-399710,,Activation of AMPA receptors,Homo sapiens,reactome | |
| 79,R-HSA-9619483,,Activation of AMPK downstream of NMDARs,Homo sapiens,reactome | |
| 80,R-HSA-176814,,Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins,Homo sapiens,reactome | |
| 81,R-HSA-176187,,Activation of ATR in response to replication stress,Homo sapiens,reactome | |
| 82,R-HSA-111447,,Activation of BAD and translocation to mitochondria,Homo sapiens,reactome | |
| 83,R-HSA-114452,,Activation of BH3-only proteins,Homo sapiens,reactome | |
| 84,R-HSA-111446,,Activation of BIM and translocation to mitochondria,Homo sapiens,reactome | |
| 85,R-HSA-139910,,Activation of BMF and translocation to mitochondria,Homo sapiens,reactome | |
| 86,R-HSA-174577,,Activation of C3 and C5,Homo sapiens,reactome | |
| 87,R-HSA-451308,,Activation of Ca-permeable Kainate Receptor,Homo sapiens,reactome | |
| 88,R-HSA-1296041,,Activation of G protein gated Potassium channels,Homo sapiens,reactome | |
| 89,R-HSA-991365,,Activation of GABAB receptors,Homo sapiens,reactome | |
| 90,R-HSA-5619507,,Activation of HOX genes during differentiation,Homo sapiens,reactome | |
| 91,R-HSA-936964,,"Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE)",Homo sapiens,reactome | |
| 92,R-HSA-1592389,,Activation of Matrix Metalloproteinases,Homo sapiens,reactome | |
| 93,R-HSA-1169091,,Activation of NF-kappaB in B cells,Homo sapiens,reactome | |
| 94,R-HSA-2980767,,"Activation of NIMA Kinases NEK9, NEK6, NEK7",Homo sapiens,reactome | |
| 95,R-HSA-442755,,Activation of NMDA receptors and postsynaptic events,Homo sapiens,reactome | |
| 96,R-HSA-111448,,Activation of NOXA and translocation to mitochondria,Homo sapiens,reactome | |
| 97,R-HSA-451307,,Activation of Na-permeable kainate receptors,Homo sapiens,reactome | |
| 98,R-HSA-2151209,,Activation of PPARGC1A (PGC-1alpha) by phosphorylation,Homo sapiens,reactome | |
| 99,R-HSA-139915,,Activation of PUMA and translocation to mitochondria,Homo sapiens,reactome | |
| 100,R-HSA-428540,,Activation of RAC1,Homo sapiens,reactome | |
| 101,R-HSA-9619229,,Activation of RAC1 downstream of NMDARs,Homo sapiens,reactome | |
| 102,R-HSA-1169092,,Activation of RAS in B cells,Homo sapiens,reactome | |
| 103,R-HSA-5635838,,Activation of SMO,Homo sapiens,reactome | |
| 104,R-HSA-9958825,,Activation of STAT3 by cadherin engagement,Homo sapiens,reactome | |
| 105,R-HSA-187015,,Activation of TRKA receptors,Homo sapiens,reactome | |
| 106,R-HSA-5617472,,Activation of anterior HOX genes in hindbrain development during early embryogenesis,Homo sapiens,reactome | |
| 107,R-HSA-111459,,Activation of caspases through apoptosome-mediated cleavage,Homo sapiens,reactome | |
| 108,R-HSA-2426168,,Activation of gene expression by SREBF (SREBP),Homo sapiens,reactome | |
| 109,R-HSA-451326,,Activation of kainate receptors upon glutamate binding,Homo sapiens,reactome | |
| 110,R-HSA-450341,,Activation of the AP-1 family of transcription factors,Homo sapiens,reactome | |
| 111,R-HSA-8866907,,Activation of the TFAP2 (AP-2) family of transcription factors,Homo sapiens,reactome | |
| 112,R-HSA-72662,,"Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S",Homo sapiens,reactome | |
| 113,R-HSA-2485179,,Activation of the phototransduction cascade,Homo sapiens,reactome | |
| 114,R-HSA-68962,,Activation of the pre-replicative complex,Homo sapiens,reactome | |
| 115,R-HSA-75108,,"Activation, myristolyation of BID and translocation to mitochondria",Homo sapiens,reactome | |
| 116,R-HSA-114294,,"Activation, translocation and oligomerization of BAX",Homo sapiens,reactome | |
| 117,R-HSA-1482798,,Acyl chain remodeling of CL,Homo sapiens,reactome | |
| 118,R-HSA-1482883,,Acyl chain remodeling of DAG and TAG,Homo sapiens,reactome | |
| 119,R-HSA-1482788,,Acyl chain remodelling of PC,Homo sapiens,reactome | |
| 120,R-HSA-1482839,,Acyl chain remodelling of PE,Homo sapiens,reactome | |
| 121,R-HSA-1482925,,Acyl chain remodelling of PG,Homo sapiens,reactome | |
| 122,R-HSA-1482922,,Acyl chain remodelling of PI,Homo sapiens,reactome | |
| 123,R-HSA-1482801,,Acyl chain remodelling of PS,Homo sapiens,reactome | |
| 124,R-HSA-1280218,,Adaptive Immune System,Homo sapiens,reactome | |
| 125,R-HSA-417973,,Adenosine P1 receptors,Homo sapiens,reactome | |
| 126,R-HSA-170660,,Adenylate cyclase activating pathway,Homo sapiens,reactome | |
| 127,R-HSA-170670,,Adenylate cyclase inhibitory pathway,Homo sapiens,reactome | |
| 128,R-HSA-418990,,Adherens junctions interactions,Homo sapiens,reactome | |
| 129,R-HSA-9843745,,Adipogenesis,Homo sapiens,reactome | |
| 130,R-HSA-392023,,Adrenaline signalling through Alpha-2 adrenergic receptor,Homo sapiens,reactome | |
| 131,R-HSA-400042,,"Adrenaline,noradrenaline inhibits insulin secretion",Homo sapiens,reactome | |
| 132,R-HSA-390696,,Adrenoceptors,Homo sapiens,reactome | |
| 133,R-HSA-879415,,Advanced glycosylation endproduct receptor signaling,Homo sapiens,reactome | |
| 134,R-HSA-1428517,,Aerobic respiration and respiratory electron transport,Homo sapiens,reactome | |
| 135,R-HSA-9938027,,Affinity selection of immunoglobulins,Homo sapiens,reactome | |
| 136,R-HSA-5423646,,Aflatoxin activation and detoxification,Homo sapiens,reactome | |
| 137,R-HSA-9936900,,Aggregated β-amyloid induces FXII autocatalysis,Homo sapiens,reactome | |
| 138,R-HSA-9936686,,Aggregated β-amyloid interacts with fibrinogen,Homo sapiens,reactome | |
| 139,R-HSA-9646399,,Aggrephagy,Homo sapiens,reactome | |
| 140,R-HSA-351143,,Agmatine biosynthesis,Homo sapiens,reactome | |
| 141,R-HSA-8964540,,Alanine metabolism,Homo sapiens,reactome | |
| 142,R-HSA-9730737,,Alkylating DNA damage induced by chemotherapeutic drugs,Homo sapiens,reactome | |
| 143,R-HSA-1462054,,Alpha-defensins,Homo sapiens,reactome | |
| 144,R-HSA-389599,,Alpha-oxidation of phytanate,Homo sapiens,reactome | |
| 145,R-HSA-9645460,,Alpha-protein kinase 1 signaling pathway,Homo sapiens,reactome | |
| 146,R-HSA-9006821,,Alternative Lengthening of Telomeres (ALT),Homo sapiens,reactome | |
| 147,R-HSA-173736,,Alternative complement activation,Homo sapiens,reactome | |
| 148,R-HSA-140179,,Amine Oxidase reactions,Homo sapiens,reactome | |
| 149,R-HSA-375280,,Amine ligand-binding receptors,Homo sapiens,reactome | |
| 150,R-HSA-156587,,Amino Acid conjugation,Homo sapiens,reactome | |
| 151,R-HSA-352230,,Amino acid transport across the plasma membrane,Homo sapiens,reactome | |
| 152,R-HSA-9639288,,Amino acids regulate mTORC1,Homo sapiens,reactome | |
| 153,R-HSA-141444,,Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal,Homo sapiens,reactome | |
| 154,R-HSA-9769743,,Amplification and propagation of coagulation cascade,Homo sapiens,reactome | |
| 155,R-HSA-141424,,Amplification of signal from the kinetochores,Homo sapiens,reactome | |
| 156,R-HSA-977225,,Amyloid fiber formation,Homo sapiens,reactome | |
| 157,R-HSA-2214320,,Anchoring fibril formation,Homo sapiens,reactome | |
| 158,R-HSA-5620912,,Anchoring of the basal body to the plasma membrane,Homo sapiens,reactome | |
| 159,R-HSA-193048,,Androgen biosynthesis,Homo sapiens,reactome | |
| 160,R-HSA-2473224,,Antagonism of Activin by Follistatin,Homo sapiens,reactome | |
| 161,R-HSA-9662851,,Anti-inflammatory response favouring Leishmania parasite infection,Homo sapiens,reactome | |
| 162,R-HSA-983170,,"Antigen Presentation: Folding, assembly and peptide loading of class I MHC",Homo sapiens,reactome | |
| 163,R-HSA-983695,,Antigen activates B Cell Receptor (BCR) leading to generation of second messengers,Homo sapiens,reactome | |
| 164,R-HSA-1236975,,Antigen processing-Cross presentation,Homo sapiens,reactome | |
| 165,R-HSA-9912633,,"Antigen processing: Ub, ATP-independent proteasomal degradation",Homo sapiens,reactome | |
| 166,R-HSA-983168,,Antigen processing: Ubiquitination & Proteasome degradation,Homo sapiens,reactome | |
| 167,R-HSA-9639775,,Antimicrobial action and antimicrobial resistance in Mtb,Homo sapiens,reactome | |
| 168,R-HSA-1169410,,Antimicrobial mechanism of IFN-stimulated genes,Homo sapiens,reactome | |
| 169,R-HSA-6803157,,Antimicrobial peptides,Homo sapiens,reactome | |
| 170,R-HSA-9913143,,Antimicrobial resistance,Homo sapiens,reactome | |
| 171,R-HSA-109581,,Apoptosis,Homo sapiens,reactome | |
| 172,R-HSA-140342,,Apoptosis induced DNA fragmentation,Homo sapiens,reactome | |
| 173,R-HSA-351906,,Apoptotic cleavage of cell adhesion proteins,Homo sapiens,reactome | |
| 174,R-HSA-111465,,Apoptotic cleavage of cellular proteins,Homo sapiens,reactome | |
| 175,R-HSA-75153,,Apoptotic execution phase,Homo sapiens,reactome | |
| 176,R-HSA-111471,,Apoptotic factor-mediated response,Homo sapiens,reactome | |
| 177,R-HSA-445717,,Aquaporin-mediated transport,Homo sapiens,reactome | |
| 178,R-HSA-2142753,,Arachidonate metabolism,Homo sapiens,reactome | |
| 179,R-HSA-426048,,Arachidonate production from DAG,Homo sapiens,reactome | |
| 180,R-HSA-211957,,Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2,Homo sapiens,reactome | |
| 181,R-HSA-8937144,,Aryl hydrocarbon receptor signalling,Homo sapiens,reactome | |
| 182,R-HSA-446203,,Asparagine N-linked glycosylation,Homo sapiens,reactome | |
| 183,R-HSA-8963693,,Aspartate and asparagine metabolism,Homo sapiens,reactome | |
| 184,R-HSA-9749641,,Aspirin ADME,Homo sapiens,reactome | |
| 185,R-HSA-175474,,Assembly Of The HIV Virion,Homo sapiens,reactome | |
| 186,R-HSA-9918476,,Assembly and Release of Dengue Virus Virions,Homo sapiens,reactome | |
| 187,R-HSA-9609736,,Assembly and cell surface presentation of NMDA receptors,Homo sapiens,reactome | |
| 188,R-HSA-9820962,,Assembly and release of respiratory syncytial virus (RSV) virions,Homo sapiens,reactome | |
| 189,R-HSA-168316,,Assembly of Viral Components at the Budding Site,Homo sapiens,reactome | |
| 190,R-HSA-8963889,,Assembly of active LPL and LIPC lipase complexes,Homo sapiens,reactome | |
| 191,R-HSA-2022090,,Assembly of collagen fibrils and other multimeric structures,Homo sapiens,reactome | |
| 192,R-HSA-9975921,,Assembly of the 9+0 primary cilium,Homo sapiens,reactome | |
| 193,R-HSA-9975924,,Assembly of the 9+2 motile cilia,Homo sapiens,reactome | |
| 194,R-HSA-68616,,Assembly of the ORC complex at the origin of replication,Homo sapiens,reactome | |
| 195,R-HSA-9683439,,Assembly of the SARS-CoV-1 Replication-Transcription Complex (RTC),Homo sapiens,reactome | |
| 196,R-HSA-9694271,,Assembly of the SARS-CoV-2 Replication-Transcription Complex (RTC),Homo sapiens,reactome | |
| 197,R-HSA-68867,,Assembly of the pre-replicative complex,Homo sapiens,reactome | |
| 198,R-HSA-390471,,Association of TriC/CCT with target proteins during biosynthesis,Homo sapiens,reactome | |
| 199,R-HSA-210455,,Astrocytic Glutamate-Glutamine Uptake And Metabolism,Homo sapiens,reactome | |
| 200,R-HSA-4608870,,Asymmetric localization of PCP proteins,Homo sapiens,reactome | |
| 201,R-HSA-9754706,,Atorvastatin ADME,Homo sapiens,reactome | |
| 202,R-HSA-9678110,,Attachment and Entry,Homo sapiens,reactome | |
| 203,R-HSA-9694614,,Attachment and Entry,Homo sapiens,reactome | |
| 204,R-HSA-162791,,Attachment of GPI anchor to uPAR,Homo sapiens,reactome | |
| 205,R-HSA-9638630,,Attachment of bacteria to epithelial cells,Homo sapiens,reactome | |
| 206,R-HSA-3371568,,Attenuation phase,Homo sapiens,reactome | |
| 207,R-HSA-174084,,Autodegradation of Cdh1 by Cdh1:APC/C,Homo sapiens,reactome | |
| 208,R-HSA-349425,,Autodegradation of the E3 ubiquitin ligase COP1,Homo sapiens,reactome | |
| 209,R-HSA-177539,,Autointegration results in viral DNA circles,Homo sapiens,reactome | |
| 210,R-HSA-9612973,,Autophagy,Homo sapiens,reactome | |
| 211,R-HSA-422475,,Axon guidance,Homo sapiens,reactome | |
| 212,R-HSA-193634,,Axonal growth inhibition (RHOA activation),Homo sapiens,reactome | |
| 213,R-HSA-209563,,Axonal growth stimulation,Homo sapiens,reactome | |
| 214,R-HSA-9748787,,Azathioprine ADME,Homo sapiens,reactome | |
| 215,R-HSA-5250924,,B-WICH complex positively regulates rRNA expression,Homo sapiens,reactome | |
| 216,R-HSA-5620922,,BBSome-mediated cargo-targeting to cilium,Homo sapiens,reactome | |
| 217,R-HSA-9859138,,"BCKDH synthesizes BCAA-CoA from KIC, KMVA, KIV",Homo sapiens,reactome | |
| 218,R-HSA-9024909,,BDNF activates NTRK2 (TRKB) signaling,Homo sapiens,reactome | |
| 219,R-HSA-111453,,BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members,Homo sapiens,reactome | |
| 220,R-HSA-1368108,,"BMAL1:CLOCK,NPAS2 activates circadian expression",Homo sapiens,reactome | |
| 221,R-HSA-9824439,,Bacterial Infection Pathways,Homo sapiens,reactome | |
| 222,R-HSA-73884,,Base Excision Repair,Homo sapiens,reactome | |
| 223,R-HSA-73929,,"Base-Excision Repair, AP Site Formation",Homo sapiens,reactome | |
| 224,R-HSA-210991,,Basigin interactions,Homo sapiens,reactome | |
| 225,R-HSA-1461957,,Beta defensins,Homo sapiens,reactome | |
| 226,R-HSA-77352,,Beta oxidation of butanoyl-CoA to acetyl-CoA,Homo sapiens,reactome | |
| 227,R-HSA-77346,,Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA,Homo sapiens,reactome | |
| 228,R-HSA-77350,,Beta oxidation of hexanoyl-CoA to butanoyl-CoA,Homo sapiens,reactome | |
| 229,R-HSA-77310,,Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA,Homo sapiens,reactome | |
| 230,R-HSA-77285,,Beta oxidation of myristoyl-CoA to lauroyl-CoA,Homo sapiens,reactome | |
| 231,R-HSA-77348,,Beta oxidation of octanoyl-CoA to hexanoyl-CoA,Homo sapiens,reactome | |
| 232,R-HSA-77305,,Beta oxidation of palmitoyl-CoA to myristoyl-CoA,Homo sapiens,reactome | |
| 233,R-HSA-3858494,,Beta-catenin independent WNT signaling,Homo sapiens,reactome | |
| 234,R-HSA-196299,,Beta-catenin phosphorylation cascade,Homo sapiens,reactome | |
| 235,R-HSA-9915355,,Beta-ketothiolase deficiency,Homo sapiens,reactome | |
| 236,R-HSA-389887,,Beta-oxidation of pristanoyl-CoA,Homo sapiens,reactome | |
| 237,R-HSA-390247,,Beta-oxidation of very long chain fatty acids,Homo sapiens,reactome | |
| 238,R-HSA-425381,,Bicarbonate transporters,Homo sapiens,reactome | |
| 239,R-HSA-194068,,Bile acid and bile salt metabolism,Homo sapiens,reactome | |
| 240,R-HSA-2173782,,Binding and Uptake of Ligands by Scavenger Receptors,Homo sapiens,reactome | |
| 241,R-HSA-173107,,Binding and entry of HIV virion,Homo sapiens,reactome | |
| 242,R-HSA-4411364,,Binding of TCF/LEF:CTNNB1 to target gene promoters,Homo sapiens,reactome | |
| 243,R-HSA-9931953,,Biofilm formation,Homo sapiens,reactome | |
| 244,R-HSA-141333,,Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB,Homo sapiens,reactome | |
| 245,R-HSA-211859,,Biological oxidations,Homo sapiens,reactome | |
| 246,R-HSA-2466712,,"Biosynthesis of A2E, implicated in retinal degradation",Homo sapiens,reactome | |
| 247,R-HSA-9018676,,Biosynthesis of D-series resolvins,Homo sapiens,reactome | |
| 248,R-HSA-9018677,,Biosynthesis of DHA-derived SPMs,Homo sapiens,reactome | |
| 249,R-HSA-9026395,,Biosynthesis of DHA-derived sulfido conjugates,Homo sapiens,reactome | |
| 250,R-HSA-9018683,,Biosynthesis of DPA-derived SPMs,Homo sapiens,reactome | |
| 251,R-HSA-9025094,,Biosynthesis of DPAn-3 SPMs,Homo sapiens,reactome | |
| 252,R-HSA-9026403,,Biosynthesis of DPAn-3-derived 13-series resolvins,Homo sapiens,reactome | |
| 253,R-HSA-9026290,,Biosynthesis of DPAn-3-derived maresins,Homo sapiens,reactome | |
| 254,R-HSA-9026286,,Biosynthesis of DPAn-3-derived protectins and resolvins,Homo sapiens,reactome | |
| 255,R-HSA-9025106,,Biosynthesis of DPAn-6 SPMs,Homo sapiens,reactome | |
| 256,R-HSA-9023661,,Biosynthesis of E-series 18(R)-resolvins,Homo sapiens,reactome | |
| 257,R-HSA-9018896,,Biosynthesis of E-series 18(S)-resolvins,Homo sapiens,reactome | |
| 258,R-HSA-9018679,,Biosynthesis of EPA-derived SPMs,Homo sapiens,reactome | |
| 259,R-HSA-2142700,,Biosynthesis of Lipoxins (LX),Homo sapiens,reactome | |
| 260,R-HSA-9020265,,Biosynthesis of aspirin-triggered D-series resolvins,Homo sapiens,reactome | |
| 261,R-HSA-9027604,,Biosynthesis of electrophilic ω-3 PUFA oxo-derivatives,Homo sapiens,reactome | |
| 262,R-HSA-9026762,,Biosynthesis of maresin conjugates in tissue regeneration (MCTR),Homo sapiens,reactome | |
| 263,R-HSA-9027307,,Biosynthesis of maresin-like SPMs,Homo sapiens,reactome | |
| 264,R-HSA-9018682,,Biosynthesis of maresins,Homo sapiens,reactome | |
| 265,R-HSA-9026766,,Biosynthesis of protectin and resolvin conjugates in tissue regeneration (PCTR and RCTR),Homo sapiens,reactome | |
| 266,R-HSA-9018681,,Biosynthesis of protectins,Homo sapiens,reactome | |
| 267,R-HSA-9018678,,Biosynthesis of specialized proresolving mediators (SPMs),Homo sapiens,reactome | |
| 268,R-HSA-446193,,"Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein",Homo sapiens,reactome | |
| 269,R-HSA-196780,,Biotin transport and metabolism,Homo sapiens,reactome | |
| 270,R-HSA-9636467,,Blockage of phagosome acidification,Homo sapiens,reactome | |
| 271,R-HSA-9033658,,Blood group systems biosynthesis,Homo sapiens,reactome | |
| 272,R-HSA-70895,,Branched-chain amino acid catabolism,Homo sapiens,reactome | |
| 273,R-HSA-9912481,,Branched-chain ketoacid dehydrogenase kinase deficiency,Homo sapiens,reactome | |
| 274,R-HSA-352238,,Breakdown of the nuclear lamina,Homo sapiens,reactome | |
| 275,R-HSA-168302,,Budding,Homo sapiens,reactome | |
| 276,R-HSA-162588,,Budding and maturation of HIV virion,Homo sapiens,reactome | |
| 277,R-HSA-450385,,Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA,Homo sapiens,reactome | |
| 278,R-HSA-8851680,,Butyrophilin (BTN) family interactions,Homo sapiens,reactome | |
| 279,R-HSA-5621481,,C-type lectin receptors (CLRs),Homo sapiens,reactome | |
| 280,R-HSA-75102,,C6 deamination of adenosine,Homo sapiens,reactome | |
| 281,R-HSA-9948001,,CASP4 inflammasome assembly,Homo sapiens,reactome | |
| 282,R-HSA-9960519,,CASP4-mediated substrate cleavage,Homo sapiens,reactome | |
| 283,R-HSA-9948011,,CASP5 inflammasome assembly,Homo sapiens,reactome | |
| 284,R-HSA-9960525,,CASP5-mediated substrate cleavage,Homo sapiens,reactome | |
| 285,R-HSA-5218900,,CASP8 activity is inhibited,Homo sapiens,reactome | |
| 286,R-HSA-9662834,,CD163 mediating an anti-inflammatory response,Homo sapiens,reactome | |
| 287,R-HSA-5621575,,CD209 (DC-SIGN) signaling,Homo sapiens,reactome | |
| 288,R-HSA-5690714,,CD22 mediated BCR regulation,Homo sapiens,reactome | |
| 289,R-HSA-389357,,CD28 dependent PI3K/Akt signaling,Homo sapiens,reactome | |
| 290,R-HSA-389359,,CD28 dependent Vav1 pathway,Homo sapiens,reactome | |
| 291,R-HSA-9013148,,CDC42 GTPase cycle,Homo sapiens,reactome | |
| 292,R-HSA-68689,,CDC6 association with the ORC:origin complex,Homo sapiens,reactome | |
| 293,R-HSA-9833576,,CDH11 homotypic and heterotypic interactions,Homo sapiens,reactome | |
| 294,R-HSA-69017,,CDK-mediated phosphorylation and removal of Cdc6,Homo sapiens,reactome | |
| 295,R-HSA-9937848,,CHD chromatin remodelers,Homo sapiens,reactome | |
| 296,R-HSA-9943411,,CHD1 and CHD2 subfamily,Homo sapiens,reactome | |
| 297,R-HSA-9943965,,"CHD3, CHD4, CHD5 subfamily",Homo sapiens,reactome | |
| 298,R-HSA-9943962,,"CHD6, CHD7, CHD8, CHD9 subfamily",Homo sapiens,reactome | |
| 299,R-HSA-447041,,CHL1 interactions,Homo sapiens,reactome | |
| 300,R-HSA-5607763,,CLEC7A (Dectin-1) induces NFAT activation,Homo sapiens,reactome | |
| 301,R-HSA-5607764,,CLEC7A (Dectin-1) signaling,Homo sapiens,reactome | |
| 302,R-HSA-5660668,,CLEC7A/inflammasome pathway,Homo sapiens,reactome | |
| 303,R-HSA-6811434,,COPI-dependent Golgi-to-ER retrograde traffic,Homo sapiens,reactome | |
| 304,R-HSA-6811436,,COPI-independent Golgi-to-ER retrograde traffic,Homo sapiens,reactome | |
| 305,R-HSA-6807878,,COPI-mediated anterograde transport,Homo sapiens,reactome | |
| 306,R-HSA-204005,,COPII-mediated vesicle transport,Homo sapiens,reactome | |
| 307,R-HSA-140180,,COX reactions,Homo sapiens,reactome | |
| 308,R-HSA-9955542,,CPS1 variants cause CPS1 deficiency,Homo sapiens,reactome | |
| 309,R-HSA-199920,,CREB phosphorylation,Homo sapiens,reactome | |
| 310,R-HSA-442742,,CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling,Homo sapiens,reactome | |
| 311,R-HSA-442720,,CREB1 phosphorylation through the activation of Adenylate Cyclase,Homo sapiens,reactome | |
| 312,R-HSA-442729,,CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde,Homo sapiens,reactome | |
| 313,R-HSA-8874211,,CREB3 factors activate genes,Homo sapiens,reactome | |
| 314,R-HSA-399956,,CRMPs in Sema3A signaling,Homo sapiens,reactome | |
| 315,R-HSA-2022870,,CS-GAG biosynthesis,Homo sapiens,reactome | |
| 316,R-HSA-2024101,,CS/DS degradation,Homo sapiens,reactome | |
| 317,R-HSA-5358747,,CTNNB1 S33 mutants aren't phosphorylated,Homo sapiens,reactome | |
| 318,R-HSA-5358749,,CTNNB1 S37 mutants aren't phosphorylated,Homo sapiens,reactome | |
| 319,R-HSA-5358751,,CTNNB1 S45 mutants aren't phosphorylated,Homo sapiens,reactome | |
| 320,R-HSA-5358752,,CTNNB1 T41 mutants aren't phosphorylated,Homo sapiens,reactome | |
| 321,R-HSA-211999,,CYP2E1 reactions,Homo sapiens,reactome | |
| 322,R-HSA-111996,,Ca-dependent events,Homo sapiens,reactome | |
| 323,R-HSA-1296052,,Ca2+ activated K+ channels,Homo sapiens,reactome | |
| 324,R-HSA-4086398,,Ca2+ pathway,Homo sapiens,reactome | |
| 325,R-HSA-111997,,CaM pathway,Homo sapiens,reactome | |
| 326,R-HSA-111932,,CaMK IV-mediated phosphorylation of CREB,Homo sapiens,reactome | |
| 327,R-HSA-2025928,,Calcineurin activates NFAT,Homo sapiens,reactome | |
| 328,R-HSA-419812,,Calcitonin-like ligand receptors,Homo sapiens,reactome | |
| 329,R-HSA-111933,,Calmodulin induced events,Homo sapiens,reactome | |
| 330,R-HSA-901042,,Calnexin/calreticulin cycle,Homo sapiens,reactome | |
| 331,R-HSA-111957,,Cam-PDE 1 activation,Homo sapiens,reactome | |
| 332,R-HSA-72737,,Cap-dependent Translation Initiation,Homo sapiens,reactome | |
| 333,R-HSA-8955332,,Carboxyterminal post-translational modifications of tubulin,Homo sapiens,reactome | |
| 334,R-HSA-5576891,,Cardiac conduction,Homo sapiens,reactome | |
| 335,R-HSA-9733709,,Cardiogenesis,Homo sapiens,reactome | |
| 336,R-HSA-5694530,,Cargo concentration in the ER,Homo sapiens,reactome | |
| 337,R-HSA-8856825,,Cargo recognition for clathrin-mediated endocytosis,Homo sapiens,reactome | |
| 338,R-HSA-5620920,,Cargo trafficking to the periciliary membrane,Homo sapiens,reactome | |
| 339,R-HSA-200425,,Carnitine shuttle,Homo sapiens,reactome | |
| 340,R-HSA-71262,,Carnitine synthesis,Homo sapiens,reactome | |
| 341,R-HSA-140534,,Caspase activation via Death Receptors in the presence of ligand,Homo sapiens,reactome | |
| 342,R-HSA-418889,,Caspase activation via Dependence Receptors in the absence of ligand,Homo sapiens,reactome | |
| 343,R-HSA-5357769,,Caspase activation via extrinsic apoptotic signalling pathway,Homo sapiens,reactome | |
| 344,R-HSA-264870,,Caspase-mediated cleavage of cytoskeletal proteins,Homo sapiens,reactome | |
| 345,R-HSA-209905,,Catecholamine biosynthesis,Homo sapiens,reactome | |
| 346,R-HSA-426117,,Cation-coupled Chloride cotransporters,Homo sapiens,reactome | |
| 347,R-HSA-174184,,Cdc20:Phospho-APC/C mediated degradation of Cyclin A,Homo sapiens,reactome | |
| 348,R-HSA-1640170,,Cell Cycle,Homo sapiens,reactome | |
| 349,R-HSA-69620,,Cell Cycle Checkpoints,Homo sapiens,reactome | |
| 350,R-HSA-69278,,"Cell Cycle, Mitotic",Homo sapiens,reactome | |
| 351,R-HSA-204998,,"Cell death signalling via NRAGE, NRIF and NADE",Homo sapiens,reactome | |
| 352,R-HSA-446728,,Cell junction organization,Homo sapiens,reactome | |
| 353,R-HSA-9664424,,Cell recruitment (pro-inflammatory response),Homo sapiens,reactome | |
| 354,R-HSA-1222541,,Cell redox homeostasis,Homo sapiens,reactome | |
| 355,R-HSA-202733,,Cell surface interactions at the vascular wall,Homo sapiens,reactome | |
| 356,R-HSA-1500931,,Cell-Cell communication,Homo sapiens,reactome | |
| 357,R-HSA-421270,,Cell-cell junction organization,Homo sapiens,reactome | |
| 358,R-HSA-446353,,Cell-extracellular matrix interactions,Homo sapiens,reactome | |
| 359,R-HSA-2559583,,Cellular Senescence,Homo sapiens,reactome | |
| 360,R-HSA-189200,,Cellular hexose transport,Homo sapiens,reactome | |
| 361,R-HSA-9711123,,Cellular response to chemical stress,Homo sapiens,reactome | |
| 362,R-HSA-3371556,,Cellular response to heat stress,Homo sapiens,reactome | |
| 363,R-HSA-1234174,,Cellular response to hypoxia,Homo sapiens,reactome | |
| 364,R-HSA-9840373,,Cellular response to mitochondrial stress,Homo sapiens,reactome | |
| 365,R-HSA-9711097,,Cellular response to starvation,Homo sapiens,reactome | |
| 366,R-HSA-9855142,,Cellular responses to mechanical stimuli,Homo sapiens,reactome | |
| 367,R-HSA-8953897,,Cellular responses to stimuli,Homo sapiens,reactome | |
| 368,R-HSA-2262752,,Cellular responses to stress,Homo sapiens,reactome | |
| 369,R-HSA-380287,,Centrosome maturation,Homo sapiens,reactome | |
| 370,R-HSA-193681,,Ceramide signalling,Homo sapiens,reactome | |
| 371,R-HSA-9940465,,ChAHP complex assembly,Homo sapiens,reactome | |
| 372,R-HSA-163765,,ChREBP activates metabolic gene expression,Homo sapiens,reactome | |
| 373,R-HSA-9613829,,Chaperone Mediated Autophagy,Homo sapiens,reactome | |
| 374,R-HSA-390466,,Chaperonin-mediated protein folding,Homo sapiens,reactome | |
| 375,R-HSA-380108,,Chemokine receptors bind chemokines,Homo sapiens,reactome | |
| 376,R-HSA-75035,,Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex,Homo sapiens,reactome | |
| 377,R-HSA-191273,,Cholesterol biosynthesis,Homo sapiens,reactome | |
| 378,R-HSA-9969901,,Cholesterol biosynthesis from zymosterol (modified Kandutsch-Russell pathway),Homo sapiens,reactome | |
| 379,R-HSA-6807047,,Cholesterol biosynthesis via desmosterol (Bloch pathway),Homo sapiens,reactome | |
| 380,R-HSA-6798163,,Choline catabolism,Homo sapiens,reactome | |
| 381,R-HSA-1793185,,Chondroitin sulfate/dermatan sulfate metabolism,Homo sapiens,reactome | |
| 382,R-HSA-9821002,,Chromatin modifications during the maternal to zygotic transition (MZT),Homo sapiens,reactome | |
| 383,R-HSA-3247509,,Chromatin modifying enzymes,Homo sapiens,reactome | |
| 384,R-HSA-4839726,,Chromatin organization,Homo sapiens,reactome | |
| 385,R-HSA-73886,,Chromosome Maintenance,Homo sapiens,reactome | |
| 386,R-HSA-8963888,,Chylomicron assembly,Homo sapiens,reactome | |
| 387,R-HSA-8964026,,Chylomicron clearance,Homo sapiens,reactome | |
| 388,R-HSA-8963901,,Chylomicron remodeling,Homo sapiens,reactome | |
| 389,R-HSA-5617833,,Cilium Assembly,Homo sapiens,reactome | |
| 390,R-HSA-9793528,,Ciprofloxacin ADME,Homo sapiens,reactome | |
| 391,R-HSA-9909396,,Circadian clock,Homo sapiens,reactome | |
| 392,R-HSA-71403,,Citric acid cycle (TCA cycle),Homo sapiens,reactome | |
| 393,R-HSA-373076,,Class A/1 (Rhodopsin-like receptors),Homo sapiens,reactome | |
| 394,R-HSA-373080,,Class B/2 (Secretin family receptors),Homo sapiens,reactome | |
| 395,R-HSA-420499,,Class C/3 (Metabotropic glutamate/pheromone receptors),Homo sapiens,reactome | |
| 396,R-HSA-983169,,Class I MHC mediated antigen processing & presentation,Homo sapiens,reactome | |
| 397,R-HSA-9603798,,Class I peroxisomal membrane protein import,Homo sapiens,reactome | |
| 398,R-HSA-1296053,,Classical Kir channels,Homo sapiens,reactome | |
| 399,R-HSA-173623,,Classical antibody-mediated complement activation,Homo sapiens,reactome | |
| 400,R-HSA-8856828,,Clathrin-mediated endocytosis,Homo sapiens,reactome | |
| 401,R-HSA-110331,,Cleavage of the damaged purine,Homo sapiens,reactome | |
| 402,R-HSA-110329,,Cleavage of the damaged pyrimidine,Homo sapiens,reactome | |
| 403,R-HSA-9927353,,Co-inhibition by BTLA,Homo sapiens,reactome | |
| 404,R-HSA-389513,,Co-inhibition by CTLA4,Homo sapiens,reactome | |
| 405,R-HSA-389948,,Co-inhibition by PD-1,Homo sapiens,reactome | |
| 406,R-HSA-389356,,Co-stimulation by CD28,Homo sapiens,reactome | |
| 407,R-HSA-9927354,,Co-stimulation by ICOS,Homo sapiens,reactome | |
| 408,R-HSA-9769740,,Coagulation pathway,Homo sapiens,reactome | |
| 409,R-HSA-9759218,,Cobalamin (Cbl) metabolism,Homo sapiens,reactome | |
| 410,R-HSA-196741,,"Cobalamin (Cbl, vitamin B12) transport and metabolism",Homo sapiens,reactome | |
| 411,R-HSA-196783,,Coenzyme A biosynthesis,Homo sapiens,reactome | |
| 412,R-HSA-2470946,,Cohesin Loading onto Chromatin,Homo sapiens,reactome | |
| 413,R-HSA-1650814,,Collagen biosynthesis and modifying enzymes,Homo sapiens,reactome | |
| 414,R-HSA-8948216,,Collagen chain trimerization,Homo sapiens,reactome | |
| 415,R-HSA-1442490,,Collagen degradation,Homo sapiens,reactome | |
| 416,R-HSA-1474290,,Collagen formation,Homo sapiens,reactome | |
| 417,R-HSA-8948700,,Competing endogenous RNAs (ceRNAs) regulate PTEN translation,Homo sapiens,reactome | |
| 418,R-HSA-166658,,Complement cascade,Homo sapiens,reactome | |
| 419,R-HSA-6799198,,Complex I biogenesis,Homo sapiens,reactome | |
| 420,R-HSA-9865881,,Complex III assembly,Homo sapiens,reactome | |
| 421,R-HSA-9864848,,Complex IV assembly,Homo sapiens,reactome | |
| 422,R-HSA-2514853,,Condensation of Prometaphase Chromosomes,Homo sapiens,reactome | |
| 423,R-HSA-2299718,,Condensation of Prophase Chromosomes,Homo sapiens,reactome | |
| 424,R-HSA-177135,,Conjugation of benzoate with glycine,Homo sapiens,reactome | |
| 425,R-HSA-159424,,Conjugation of carboxylic acids,Homo sapiens,reactome | |
| 426,R-HSA-177162,,Conjugation of phenylacetate with glutamine,Homo sapiens,reactome | |
| 427,R-HSA-177128,,Conjugation of salicylate with glycine,Homo sapiens,reactome | |
| 428,R-HSA-5674400,,Constitutive Signaling by AKT1 E17K in Cancer,Homo sapiens,reactome | |
| 429,R-HSA-2219530,,Constitutive Signaling by Aberrant PI3K in Cancer,Homo sapiens,reactome | |
| 430,R-HSA-5637810,,Constitutive Signaling by EGFRvIII,Homo sapiens,reactome | |
| 431,R-HSA-1236382,,Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants,Homo sapiens,reactome | |
| 432,R-HSA-2691232,,Constitutive Signaling by NOTCH1 HD Domain Mutants,Homo sapiens,reactome | |
| 433,R-HSA-2894862,,Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants,Homo sapiens,reactome | |
| 434,R-HSA-2644606,,Constitutive Signaling by NOTCH1 PEST Domain Mutants,Homo sapiens,reactome | |
| 435,R-HSA-2660826,,Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant,Homo sapiens,reactome | |
| 436,R-HSA-9634285,,Constitutive Signaling by Overexpressed ERBB2,Homo sapiens,reactome | |
| 437,R-HSA-176407,,Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase,Homo sapiens,reactome | |
| 438,R-HSA-6814122,,Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding,Homo sapiens,reactome | |
| 439,R-HSA-389958,,Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding,Homo sapiens,reactome | |
| 440,R-HSA-71288,,Creatine metabolism,Homo sapiens,reactome | |
| 441,R-HSA-166786,,Creation of C4 and C2 activators,Homo sapiens,reactome | |
| 442,R-HSA-8949613,,Cristae formation,Homo sapiens,reactome | |
| 443,R-HSA-1236973,,Cross-presentation of particulate exogenous antigens (phagosomes),Homo sapiens,reactome | |
| 444,R-HSA-1236978,,Cross-presentation of soluble exogenous antigens (endosomes),Homo sapiens,reactome | |
| 445,R-HSA-2243919,,Crosslinking of collagen fibrils,Homo sapiens,reactome | |
| 446,R-HSA-69273,,Cyclin A/B1/B2 associated events during G2/M transition,Homo sapiens,reactome | |
| 447,R-HSA-69656,,Cyclin A:Cdk2-associated events at S phase entry,Homo sapiens,reactome | |
| 448,R-HSA-69231,,Cyclin D associated events in G1,Homo sapiens,reactome | |
| 449,R-HSA-69202,,Cyclin E associated events during G1/S transition,Homo sapiens,reactome | |
| 450,R-HSA-1614603,,Cysteine formation from homocysteine,Homo sapiens,reactome | |
| 451,R-HSA-211897,,Cytochrome P450 - arranged by substrate type,Homo sapiens,reactome | |
| 452,R-HSA-111461,,Cytochrome c-mediated apoptotic response,Homo sapiens,reactome | |
| 453,R-HSA-1280215,,Cytokine Signaling in Immune system,Homo sapiens,reactome | |
| 454,R-HSA-9707564,,Cytoprotection by HMOX1,Homo sapiens,reactome | |
| 455,R-HSA-2564830,,Cytosolic iron-sulfur cluster assembly,Homo sapiens,reactome | |
| 456,R-HSA-1834949,,Cytosolic sensors of pathogen-associated DNA,Homo sapiens,reactome | |
| 457,R-HSA-156584,,Cytosolic sulfonation of small molecules,Homo sapiens,reactome | |
| 458,R-HSA-379716,,Cytosolic tRNA aminoacylation,Homo sapiens,reactome | |
| 459,R-HSA-1489509,,DAG and IP3 signaling,Homo sapiens,reactome | |
| 460,R-HSA-8932506,,DAG1 core M1 glycosylations,Homo sapiens,reactome | |
| 461,R-HSA-8932504,,DAG1 core M2 glycosylations,Homo sapiens,reactome | |
| 462,R-HSA-8932505,,DAG1 core M3 glycosylations,Homo sapiens,reactome | |
| 463,R-HSA-8931838,,DAG1 glycosylations,Homo sapiens,reactome | |
| 464,R-HSA-2172127,,DAP12 interactions,Homo sapiens,reactome | |
| 465,R-HSA-2424491,,DAP12 signaling,Homo sapiens,reactome | |
| 466,R-HSA-180024,,DARPP-32 events,Homo sapiens,reactome | |
| 467,R-HSA-418885,,DCC mediated attractive signaling,Homo sapiens,reactome | |
| 468,R-HSA-168928,,DDX58/IFIH1-mediated induction of interferon-alpha/beta,Homo sapiens,reactome | |
| 469,R-HSA-3134963,,DEx/H-box helicases activate type I IFN and inflammatory cytokines production,Homo sapiens,reactome | |
| 470,R-HSA-73893,,DNA Damage Bypass,Homo sapiens,reactome | |
| 471,R-HSA-5696394,,DNA Damage Recognition in GG-NER,Homo sapiens,reactome | |
| 472,R-HSA-73942,,DNA Damage Reversal,Homo sapiens,reactome | |
| 473,R-HSA-2559586,,DNA Damage/Telomere Stress Induced Senescence,Homo sapiens,reactome | |
| 474,R-HSA-5693606,,DNA Double Strand Break Response,Homo sapiens,reactome | |
| 475,R-HSA-5693532,,DNA Double-Strand Break Repair,Homo sapiens,reactome | |
| 476,R-HSA-73894,,DNA Repair,Homo sapiens,reactome | |
| 477,R-HSA-69306,,DNA Replication,Homo sapiens,reactome | |
| 478,R-HSA-69002,,DNA Replication Pre-Initiation,Homo sapiens,reactome | |
| 479,R-HSA-5334118,,DNA methylation,Homo sapiens,reactome | |
| 480,R-HSA-68952,,DNA replication initiation,Homo sapiens,reactome | |
| 481,R-HSA-69190,,DNA strand elongation,Homo sapiens,reactome | |
| 482,R-HSA-2022923,,DS-GAG biosynthesis,Homo sapiens,reactome | |
| 483,R-HSA-376172,,DSCAM interactions,Homo sapiens,reactome | |
| 484,R-HSA-9669914,,Dasatinib-resistant KIT mutants,Homo sapiens,reactome | |
| 485,R-HSA-3769402,,Deactivation of the beta-catenin transactivating complex,Homo sapiens,reactome | |
| 486,R-HSA-429947,,Deadenylation of mRNA,Homo sapiens,reactome | |
| 487,R-HSA-429914,,Deadenylation-dependent mRNA decay,Homo sapiens,reactome | |
| 488,R-HSA-73887,,Death Receptor Signaling,Homo sapiens,reactome | |
| 489,R-HSA-5607761,,Dectin-1 mediated noncanonical NF-kB signaling,Homo sapiens,reactome | |
| 490,R-HSA-5621480,,Dectin-2 family,Homo sapiens,reactome | |
| 491,R-HSA-5682113,,Defective ABCA1 causes TGD,Homo sapiens,reactome | |
| 492,R-HSA-5682294,,Defective ABCA12 causes ARCI4B,Homo sapiens,reactome | |
| 493,R-HSA-5688399,,Defective ABCA3 causes SMDP3,Homo sapiens,reactome | |
| 494,R-HSA-5683678,,Defective ABCA3 causes SMDP3,Homo sapiens,reactome | |
| 495,R-HSA-5678520,,Defective ABCB11 causes PFIC2 and BRIC2,Homo sapiens,reactome | |
| 496,R-HSA-5678771,,"Defective ABCB4 causes PFIC3, ICP3 and GBD1",Homo sapiens,reactome | |
| 497,R-HSA-5683371,,Defective ABCB6 causes MCOPCB7,Homo sapiens,reactome | |
| 498,R-HSA-5679001,,Defective ABCC2 causes DJS,Homo sapiens,reactome | |
| 499,R-HSA-5690338,,Defective ABCC6 causes PXE,Homo sapiens,reactome | |
| 500,R-HSA-5683177,,Defective ABCC8 can cause hypo- and hyper-glycemias,Homo sapiens,reactome | |
| 501,R-HSA-5678420,,"Defective ABCC9 causes CMD10, ATFB12 and Cantu syndrome",Homo sapiens,reactome | |
| 502,R-HSA-5684045,,Defective ABCD1 causes ALD,Homo sapiens,reactome | |
| 503,R-HSA-5683329,,Defective ABCD4 causes MAHCJ,Homo sapiens,reactome | |
| 504,R-HSA-5679096,,Defective ABCG5 causes sitosterolemia,Homo sapiens,reactome | |
| 505,R-HSA-5679090,,Defective ABCG8 causes GBD4 and sitosterolemia,Homo sapiens,reactome | |
| 506,R-HSA-5579031,,Defective ACTH causes obesity and POMCD,Homo sapiens,reactome | |
| 507,R-HSA-5579007,,Defective ACY1 causes encephalopathy,Homo sapiens,reactome | |
| 508,R-HSA-9734735,,Defective ADA disrupts (deoxy)adenosine deamination,Homo sapiens,reactome | |
| 509,R-HSA-5578997,,Defective AHCY causes HMAHCHD,Homo sapiens,reactome | |
| 510,R-HSA-4549380,,Defective ALG1 causes CDG-1k,Homo sapiens,reactome | |
| 511,R-HSA-4551295,,Defective ALG11 causes CDG-1p,Homo sapiens,reactome | |
| 512,R-HSA-4720489,,Defective ALG12 causes CDG-1g,Homo sapiens,reactome | |
| 513,R-HSA-5633231,,Defective ALG14 causes ALG14-CMS,Homo sapiens,reactome | |
| 514,R-HSA-4549349,,Defective ALG2 causes CDG-1i,Homo sapiens,reactome | |
| 515,R-HSA-4720475,,Defective ALG3 causes CDG-1d,Homo sapiens,reactome | |
| 516,R-HSA-4724289,,Defective ALG6 causes CDG-1c,Homo sapiens,reactome | |
| 517,R-HSA-4724325,,Defective ALG8 causes CDG-1h,Homo sapiens,reactome | |
| 518,R-HSA-4720454,,Defective ALG9 causes CDG-1l,Homo sapiens,reactome | |
| 519,R-HSA-3359462,,Defective AMN causes MGA1,Homo sapiens,reactome | |
| 520,R-HSA-9853846,,"Defective ANO6 does not expose PS, PE on the platelet membrane",Homo sapiens,reactome | |
| 521,R-HSA-9734195,,Defective APRT disrupts adenine salvage,Homo sapiens,reactome | |
| 522,R-HSA-5619099,,"Defective AVP does not bind AVPR1A,B and causes neurohypophyseal diabetes insipidus (NDI)",Homo sapiens,reactome | |
| 523,R-HSA-9036092,,Defective AVP does not bind AVPR2 and causes neurohypophyseal diabetes insipidus (NDI),Homo sapiens,reactome | |
| 524,R-HSA-4420332,,Defective B3GALT6 causes EDSP2 and SEMDJL1,Homo sapiens,reactome | |
| 525,R-HSA-5083635,,Defective B3GALTL causes PpS,Homo sapiens,reactome | |
| 526,R-HSA-3560801,,Defective B3GAT3 causes JDSSDHD,Homo sapiens,reactome | |
| 527,R-HSA-3656244,,Defective B4GALT1 causes B4GALT1-CDG (CDG-2d),Homo sapiens,reactome | |
| 528,R-HSA-4793953,,Defective B4GALT1 causes CDG-2d,Homo sapiens,reactome | |
| 529,R-HSA-3560783,,"Defective B4GALT7 causes EDS, progeroid type",Homo sapiens,reactome | |
| 530,R-HSA-3371598,,Defective BTD causes biotidinase deficiency,Homo sapiens,reactome | |
| 531,R-HSA-9605310,,Defective Base Excision Repair Associated with MUTYH,Homo sapiens,reactome | |
| 532,R-HSA-9616334,,Defective Base Excision Repair Associated with NEIL1,Homo sapiens,reactome | |
| 533,R-HSA-9629232,,Defective Base Excision Repair Associated with NEIL3,Homo sapiens,reactome | |
| 534,R-HSA-9616333,,Defective Base Excision Repair Associated with NTHL1,Homo sapiens,reactome | |
| 535,R-HSA-9656249,,Defective Base Excision Repair Associated with OGG1,Homo sapiens,reactome | |
| 536,R-HSA-5083632,,Defective C1GALT1C1 causes TNPS,Homo sapiens,reactome | |
| 537,R-HSA-3359457,,Defective CBLIF causes IFD,Homo sapiens,reactome | |
| 538,R-HSA-3359485,,Defective CD320 causes MMATC,Homo sapiens,reactome | |
| 539,R-HSA-5678895,,Defective CFTR causes cystic fibrosis,Homo sapiens,reactome | |
| 540,R-HSA-3595174,,"Defective CHST14 causes EDS, musculocontractural type",Homo sapiens,reactome | |
| 541,R-HSA-3595172,,Defective CHST3 causes SEDCJD,Homo sapiens,reactome | |
| 542,R-HSA-3656225,,Defective CHST6 causes MCDC1,Homo sapiens,reactome | |
| 543,R-HSA-3595177,,Defective CHSY1 causes TPBS,Homo sapiens,reactome | |
| 544,R-HSA-5619060,,Defective CP causes aceruloplasminemia (ACERULOP),Homo sapiens,reactome | |
| 545,R-HSA-5688890,,Defective CSF2RA causes SMDP4,Homo sapiens,reactome | |
| 546,R-HSA-5688849,,Defective CSF2RB causes SMDP5,Homo sapiens,reactome | |
| 547,R-HSA-3359463,,Defective CUBN causes MGA1,Homo sapiens,reactome | |
| 548,R-HSA-5579026,,Defective CYP11A1 causes AICSR,Homo sapiens,reactome | |
| 549,R-HSA-5579017,,Defective CYP11B1 causes AH4,Homo sapiens,reactome | |
| 550,R-HSA-5579009,,Defective CYP11B2 causes CMO-1 deficiency,Homo sapiens,reactome | |
| 551,R-HSA-5579028,,Defective CYP17A1 causes AH5,Homo sapiens,reactome | |
| 552,R-HSA-5579030,,Defective CYP19A1 causes AEXS,Homo sapiens,reactome | |
| 553,R-HSA-5579000,,Defective CYP1B1 causes Glaucoma,Homo sapiens,reactome | |
| 554,R-HSA-5579021,,Defective CYP21A2 causes AH3,Homo sapiens,reactome | |
| 555,R-HSA-5579010,,Defective CYP24A1 causes HCAI,Homo sapiens,reactome | |
| 556,R-HSA-5579015,,Defective CYP26B1 causes RHFCA,Homo sapiens,reactome | |
| 557,R-HSA-5579004,,Defective CYP26C1 causes FFDD4,Homo sapiens,reactome | |
| 558,R-HSA-5578996,,Defective CYP27A1 causes CTX,Homo sapiens,reactome | |
| 559,R-HSA-5579014,,Defective CYP27B1 causes VDDR1A,Homo sapiens,reactome | |
| 560,R-HSA-5579027,,Defective CYP27B1 causes VDDR1B,Homo sapiens,reactome | |
| 561,R-HSA-5579011,,Defective CYP2U1 causes SPG56,Homo sapiens,reactome | |
| 562,R-HSA-5579005,,Defective CYP4F22 causes ARCI5,Homo sapiens,reactome | |
| 563,R-HSA-5579013,,Defective CYP7B1 causes SPG5A and CBAS3,Homo sapiens,reactome | |
| 564,R-HSA-4755609,,Defective DHDDS causes RP59,Homo sapiens,reactome | |
| 565,R-HSA-9699150,,Defective DNA double strand break response due to BARD1 loss of function,Homo sapiens,reactome | |
| 566,R-HSA-9663199,,Defective DNA double strand break response due to BRCA1 loss of function,Homo sapiens,reactome | |
| 567,R-HSA-4755583,,Defective DOLK causes DOLK-CDG,Homo sapiens,reactome | |
| 568,R-HSA-4549356,,"Defective DPAGT1 causes CDG-1j, CMSTA2",Homo sapiens,reactome | |
| 569,R-HSA-4717374,,Defective DPM1 causes DPM1-CDG,Homo sapiens,reactome | |
| 570,R-HSA-4719377,,Defective DPM2 causes DPM2-CDG,Homo sapiens,reactome | |
| 571,R-HSA-4719360,,Defective DPM3 causes DPM3-CDG,Homo sapiens,reactome | |
| 572,R-HSA-3656253,,"Defective EXT1 causes exostoses 1, TRPS2 and CHDS",Homo sapiens,reactome | |
| 573,R-HSA-3656237,,Defective EXT2 causes exostoses 2,Homo sapiens,reactome | |
| 574,R-HSA-9672387,,Defective F8 accelerates dissociation of the A2 domain,Homo sapiens,reactome | |
| 575,R-HSA-9672395,,Defective F8 binding to the cell membrane,Homo sapiens,reactome | |
| 576,R-HSA-9672393,,Defective F8 binding to von Willebrand factor,Homo sapiens,reactome | |
| 577,R-HSA-9672391,,Defective F8 cleavage by thrombin,Homo sapiens,reactome | |
| 578,R-HSA-9672397,,Defective F8 secretion,Homo sapiens,reactome | |
| 579,R-HSA-9674519,,Defective F8 sulfation at Y1699,Homo sapiens,reactome | |
| 580,R-HSA-9673221,,Defective F9 activation,Homo sapiens,reactome | |
| 581,R-HSA-9673218,,Defective F9 secretion,Homo sapiens,reactome | |
| 582,R-HSA-9673202,,Defective F9 variant does not activate FX,Homo sapiens,reactome | |
| 583,R-HSA-5579019,,Defective FMO3 causes TMAU,Homo sapiens,reactome | |
| 584,R-HSA-9930483,,Defective FV causes thrombophilia,Homo sapiens,reactome | |
| 585,R-HSA-5609977,,Defective GALE causes EDG,Homo sapiens,reactome | |
| 586,R-HSA-5609976,,Defective GALK1 causes GALCT2,Homo sapiens,reactome | |
| 587,R-HSA-9931929,,Defective GALM causes GALAC4,Homo sapiens,reactome | |
| 588,R-HSA-5083636,,Defective GALNT12 causes CRCS1,Homo sapiens,reactome | |
| 589,R-HSA-5083625,,Defective GALNT3 causes HFTC,Homo sapiens,reactome | |
| 590,R-HSA-5609978,,Defective GALT can cause GALCT,Homo sapiens,reactome | |
| 591,R-HSA-5619073,,Defective GCK causes maturity-onset diabetes of the young 2 (MODY2),Homo sapiens,reactome | |
| 592,R-HSA-5578999,,Defective GCLC causes HAGGSD,Homo sapiens,reactome | |
| 593,R-HSA-4085023,,Defective GFPT1 causes CMSTA1,Homo sapiens,reactome | |
| 594,R-HSA-5579022,,Defective GGT1 causes GLUTH,Homo sapiens,reactome | |
| 595,R-HSA-9035968,,Defective GGT1 in aflatoxin detoxification causes GLUTH,Homo sapiens,reactome | |
| 596,R-HSA-4085011,,"Defective GNE causes sialuria, NK and IBM2",Homo sapiens,reactome | |
| 597,R-HSA-5579006,,Defective GSS causes GSS deficiency,Homo sapiens,reactome | |
| 598,R-HSA-9704331,,Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function,Homo sapiens,reactome | |
| 599,R-HSA-9704646,,Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function,Homo sapiens,reactome | |
| 600,R-HSA-3656234,,Defective HEXA causes GM2G1 (Hyaluronan metabolism),Homo sapiens,reactome | |
| 601,R-HSA-3656248,,Defective HEXB causes GM2G2 (Hyaluronan metabolism),Homo sapiens,reactome | |
| 602,R-HSA-5619056,,Defective HK1 causes hexokinase deficiency (HK deficiency),Homo sapiens,reactome | |
| 603,R-HSA-3371599,,Defective HLCS causes multiple carboxylase deficiency,Homo sapiens,reactome | |
| 604,R-HSA-9734281,,Defective HPRT1 disrupts guanine and hypoxanthine salvage,Homo sapiens,reactome | |
| 605,R-HSA-9670621,,Defective Inhibition of DNA Recombination at Telomere,Homo sapiens,reactome | |
| 606,R-HSA-9670615,,Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations,Homo sapiens,reactome | |
| 607,R-HSA-9670613,,Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations,Homo sapiens,reactome | |
| 608,R-HSA-9734009,,Defective Intrinsic Pathway for Apoptosis,Homo sapiens,reactome | |
| 609,R-HSA-9645722,,Defective Intrinsic Pathway for Apoptosis Due to p14ARF Loss of Function,Homo sapiens,reactome | |
| 610,R-HSA-5083627,,Defective LARGE causes MDDGA6 and MDDGB6,Homo sapiens,reactome | |
| 611,R-HSA-5083630,,Defective LFNG causes SCDO3,Homo sapiens,reactome | |
| 612,R-HSA-4793950,,Defective MAN1B1 causes MRT15,Homo sapiens,reactome | |
| 613,R-HSA-5579012,,Defective MAOA causes BRUNS,Homo sapiens,reactome | |
| 614,R-HSA-5579024,,Defective MAT1A causes MATD,Homo sapiens,reactome | |
| 615,R-HSA-4793952,,Defective MGAT2 causes CDG-2a,Homo sapiens,reactome | |
| 616,R-HSA-3359475,,"Defective MMAA causes MMA, cblA type",Homo sapiens,reactome | |
| 617,R-HSA-3359471,,"Defective MMAB causes MMA, cblB type",Homo sapiens,reactome | |
| 618,R-HSA-3359474,,Defective MMACHC causes MAHCC,Homo sapiens,reactome | |
| 619,R-HSA-3359473,,Defective MMADHC causes MMAHCD,Homo sapiens,reactome | |
| 620,R-HSA-4793954,,Defective MOGS causes CDG-2b,Homo sapiens,reactome | |
| 621,R-HSA-4687000,,Defective MPDU1 causes CDG-1f,Homo sapiens,reactome | |
| 622,R-HSA-4043916,,Defective MPI causes MPI-CDG,Homo sapiens,reactome | |
| 623,R-HSA-3359469,,Defective MTR causes HMAG,Homo sapiens,reactome | |
| 624,R-HSA-3359467,,Defective MTRR causes HMAE,Homo sapiens,reactome | |
| 625,R-HSA-3359478,,Defective MUT causes MMAM,Homo sapiens,reactome | |
| 626,R-HSA-9608287,,Defective MUTYH substrate binding,Homo sapiens,reactome | |
| 627,R-HSA-9608290,,Defective MUTYH substrate processing,Homo sapiens,reactome | |
| 628,R-HSA-5545483,,Defective Mismatch Repair Associated With MLH1,Homo sapiens,reactome | |
| 629,R-HSA-5632928,,Defective Mismatch Repair Associated With MSH2,Homo sapiens,reactome | |
| 630,R-HSA-5632927,,Defective Mismatch Repair Associated With MSH3,Homo sapiens,reactome | |
| 631,R-HSA-5632968,,Defective Mismatch Repair Associated With MSH6,Homo sapiens,reactome | |
| 632,R-HSA-5632987,,Defective Mismatch Repair Associated With PMS2,Homo sapiens,reactome | |
| 633,R-HSA-4341670,,Defective NEU1 causes sialidosis,Homo sapiens,reactome | |
| 634,R-HSA-9630222,,Defective NTHL1 substrate binding,Homo sapiens,reactome | |
| 635,R-HSA-9630221,,Defective NTHL1 substrate processing,Homo sapiens,reactome | |
| 636,R-HSA-9657050,,Defective OGG1 Localization,Homo sapiens,reactome | |
| 637,R-HSA-9656255,,Defective OGG1 Substrate Binding,Homo sapiens,reactome | |
| 638,R-HSA-9656256,,Defective OGG1 Substrate Processing,Homo sapiens,reactome | |
| 639,R-HSA-5578998,,Defective OPLAH causes OPLAHD,Homo sapiens,reactome | |
| 640,R-HSA-3560796,,Defective PAPSS2 causes SEMD-PA,Homo sapiens,reactome | |
| 641,R-HSA-5609974,,Defective PGM1 causes PGM1-CDG,Homo sapiens,reactome | |
| 642,R-HSA-4043911,,Defective PMM2 causes PMM2-CDG,Homo sapiens,reactome | |
| 643,R-HSA-9735763,,Defective PNP disrupts phosphorolysis of (deoxy)guanosine and (deoxy)inosine,Homo sapiens,reactome | |
| 644,R-HSA-5083628,,"Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3",Homo sapiens,reactome | |
| 645,R-HSA-5083633,,"Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1",Homo sapiens,reactome | |
| 646,R-HSA-5083629,,"Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2",Homo sapiens,reactome | |
| 647,R-HSA-4570571,,Defective RFT1 causes CDG-1n,Homo sapiens,reactome | |
| 648,R-HSA-5619042,,Defective RHAG causes regulator type Rh-null hemolytic anemia (RHN),Homo sapiens,reactome | |
| 649,R-HSA-9693928,,Defective RIPK1-mediated regulated necrosis,Homo sapiens,reactome | |
| 650,R-HSA-9657689,,Defective SERPING1 causes hereditary angioedema,Homo sapiens,reactome | |
| 651,R-HSA-5687868,,Defective SFTPA2 causes IPF,Homo sapiens,reactome | |
| 652,R-HSA-5619048,,"Defective SLC11A2 causes hypochromic microcytic anemia, with iron overload 1 (AHMIO1)",Homo sapiens,reactome | |
| 653,R-HSA-5619104,,Defective SLC12A1 causes Bartter syndrome 1 (BS1),Homo sapiens,reactome | |
| 654,R-HSA-5619087,,Defective SLC12A3 causes Gitelman syndrome (GS),Homo sapiens,reactome | |
| 655,R-HSA-5619039,,"Defective SLC12A6 causes agenesis of the corpus callosum, with peripheral neuropathy (ACCPN)",Homo sapiens,reactome | |
| 656,R-HSA-5619070,,Defective SLC16A1 causes symptomatic deficiency in lactate transport (SDLT),Homo sapiens,reactome | |
| 657,R-HSA-5619035,,Defective SLC17A5 causes Salla disease (SD) and ISSD,Homo sapiens,reactome | |
| 658,R-HSA-5619076,,Defective SLC17A8 causes autosomal dominant deafness 25 (DFNA25),Homo sapiens,reactome | |
| 659,R-HSA-5619067,,Defective SLC1A1 is implicated in schizophrenia 18 (SCZD18) and dicarboxylic aminoaciduria (DCBXA),Homo sapiens,reactome | |
| 660,R-HSA-5619062,,Defective SLC1A3 causes episodic ataxia 6 (EA6),Homo sapiens,reactome | |
| 661,R-HSA-5619111,,Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1),Homo sapiens,reactome | |
| 662,R-HSA-5619071,,Defective SLC22A12 causes renal hypouricemia 1 (RHUC1),Homo sapiens,reactome | |
| 663,R-HSA-5619066,,Defective SLC22A18 causes lung cancer (LNCR) and embryonal rhabdomyosarcoma 1 (RMSE1),Homo sapiens,reactome | |
| 664,R-HSA-5619053,,Defective SLC22A5 causes systemic primary carnitine deficiency (CDSP),Homo sapiens,reactome | |
| 665,R-HSA-5619077,,Defective SLC24A1 causes congenital stationary night blindness 1D (CSNB1D),Homo sapiens,reactome | |
| 666,R-HSA-5619055,,Defective SLC24A4 causes hypomineralized amelogenesis imperfecta (AI),Homo sapiens,reactome | |
| 667,R-HSA-5619036,,Defective SLC24A5 causes oculocutaneous albinism 6 (OCA6),Homo sapiens,reactome | |
| 668,R-HSA-3560792,,Defective SLC26A2 causes chondrodysplasias,Homo sapiens,reactome | |
| 669,R-HSA-5619085,,Defective SLC26A3 causes congenital secretory chloride diarrhea 1 (DIAR1),Homo sapiens,reactome | |
| 670,R-HSA-5619046,,Defective SLC26A4 causes Pendred syndrome (PDS),Homo sapiens,reactome | |
| 671,R-HSA-5619108,,Defective SLC27A4 causes ichthyosis prematurity syndrome (IPS),Homo sapiens,reactome | |
| 672,R-HSA-5619063,,Defective SLC29A3 causes histiocytosis-lymphadenopathy plus syndrome (HLAS),Homo sapiens,reactome | |
| 673,R-HSA-5619043,,Defective SLC2A1 causes GLUT1 deficiency syndrome 1 (GLUT1DS1),Homo sapiens,reactome | |
| 674,R-HSA-5619068,,Defective SLC2A10 causes arterial tortuosity syndrome (ATS),Homo sapiens,reactome | |
| 675,R-HSA-5619098,,Defective SLC2A2 causes Fanconi-Bickel syndrome (FBS),Homo sapiens,reactome | |
| 676,R-HSA-5619047,,Defective SLC2A9 causes hypouricemia renal 2 (RHUC2),Homo sapiens,reactome | |
| 677,R-HSA-5619061,,Defective SLC33A1 causes spastic paraplegia 42 (SPG42),Homo sapiens,reactome | |
| 678,R-HSA-5619040,,Defective SLC34A1 causes hypophosphatemic nephrolithiasis/osteoporosis 1 (NPHLOP1),Homo sapiens,reactome | |
| 679,R-HSA-5687583,,Defective SLC34A2 causes PALM,Homo sapiens,reactome | |
| 680,R-HSA-5619045,,Defective SLC34A2 causes pulmonary alveolar microlithiasis (PALM),Homo sapiens,reactome | |
| 681,R-HSA-5619097,,Defective SLC34A3 causes Hereditary hypophosphatemic rickets with hypercalciuria (HHRH),Homo sapiens,reactome | |
| 682,R-HSA-5663020,,Defective SLC35A1 in sialic acid metabolism causes congenital disorder of glycosylation 2F (CDG2F),Homo sapiens,reactome | |
| 683,R-HSA-5619072,,Defective SLC35A2 causes congenital disorder of glycosylation 2M (CDG2M),Homo sapiens,reactome | |
| 684,R-HSA-5619083,,"Defective SLC35A3 causes arthrogryposis, mental retardation, and seizures (AMRS)",Homo sapiens,reactome | |
| 685,R-HSA-5619078,,Defective SLC35C1 causes congenital disorder of glycosylation 2C (CDG2C),Homo sapiens,reactome | |
| 686,R-HSA-5579020,,Defective SLC35D1 causes SCHBCKD,Homo sapiens,reactome | |
| 687,R-HSA-5619041,,Defective SLC36A2 causes iminoglycinuria (IG) and hyperglycinuria (HG),Homo sapiens,reactome | |
| 688,R-HSA-5619088,,"Defective SLC39A4 causes acrodermatitis enteropathica, zinc-deficiency type (AEZ)",Homo sapiens,reactome | |
| 689,R-HSA-5619113,,Defective SLC3A1 causes cystinuria (CSNU),Homo sapiens,reactome | |
| 690,R-HSA-5655799,,Defective SLC40A1 causes hemochromatosis 4 (HFE4) (duodenum),Homo sapiens,reactome | |
| 691,R-HSA-5619049,,Defective SLC40A1 causes hemochromatosis 4 (HFE4) (macrophages),Homo sapiens,reactome | |
| 692,R-HSA-5619050,,"Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA)",Homo sapiens,reactome | |
| 693,R-HSA-5619054,,"Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA)",Homo sapiens,reactome | |
| 694,R-HSA-5656364,,Defective SLC5A1 causes congenital glucose/galactose malabsorption (GGM),Homo sapiens,reactome | |
| 695,R-HSA-5658208,,Defective SLC5A2 causes renal glucosuria (GLYS1),Homo sapiens,reactome | |
| 696,R-HSA-5619096,,Defective SLC5A5 causes thyroid dyshormonogenesis 1 (TDH1),Homo sapiens,reactome | |
| 697,R-HSA-5619114,,Defective SLC5A7 in the neurotransmitter release cycle causes distal hereditary motor neuronopathy 7A (HMN7A),Homo sapiens,reactome | |
| 698,R-HSA-5619109,,Defective SLC6A2 causes orthostatic intolerance (OI),Homo sapiens,reactome | |
| 699,R-HSA-5619089,,Defective SLC6A5 causes hyperekplexia 3 (HKPX3),Homo sapiens,reactome | |
| 700,R-HSA-5619092,,"Defective SLC9A6 causes X-linked, syndromic mental retardation,, Christianson type (MRXSCH)",Homo sapiens,reactome | |
| 701,R-HSA-5619052,,Defective SLC9A9 causes autism 16 (AUTS16),Homo sapiens,reactome | |
| 702,R-HSA-5619110,,"Defective SLCO1B1 causes hyperbilirubinemia, Rotor type (HBLRR)",Homo sapiens,reactome | |
| 703,R-HSA-5619058,,"Defective SLCO1B3 causes hyperbilirubinemia, Rotor type (HBLRR)",Homo sapiens,reactome | |
| 704,R-HSA-5619095,,"Defective SLCO2A1 causes primary, autosomal recessive hypertrophic osteoarthropathy 2 (PHOAR2)",Homo sapiens,reactome | |
| 705,R-HSA-4755579,,"Defective SRD5A3 causes SRD5A3-CDG, KHRZ",Homo sapiens,reactome | |
| 706,R-HSA-3656243,,Defective ST3GAL3 causes MCT12 and EIEE15,Homo sapiens,reactome | |
| 707,R-HSA-5579032,,Defective TBXAS1 causes GHDD,Homo sapiens,reactome | |
| 708,R-HSA-3359454,,Defective TCN2 causes TCN2 deficiency,Homo sapiens,reactome | |
| 709,R-HSA-5578995,,Defective TPMT causes TPMT deficiency,Homo sapiens,reactome | |
| 710,R-HSA-5619107,,Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC),Homo sapiens,reactome | |
| 711,R-HSA-5579002,,Defective UGT1A1 causes hyperbilirubinemia,Homo sapiens,reactome | |
| 712,R-HSA-5579016,,Defective UGT1A4 causes hyperbilirubinemia,Homo sapiens,reactome | |
| 713,R-HSA-9845622,,Defective VWF binding to collagen type I,Homo sapiens,reactome | |
| 714,R-HSA-9845621,,Defective VWF cleavage by ADAMTS13 variant,Homo sapiens,reactome | |
| 715,R-HSA-5660862,,Defective amino acid transport by SLC7A7 causes lysinuric protein intolerance (LPI),Homo sapiens,reactome | |
| 716,R-HSA-5660883,,Defective amino acid transport by SLC7A9 causes cystinuria (CSNU),Homo sapiens,reactome | |
| 717,R-HSA-9661069,,"Defective binding of RB1 mutants to E2F1,(E2F2, E2F3)",Homo sapiens,reactome | |
| 718,R-HSA-9846298,,Defective binding of VWF variant to GPIb:IX:V,Homo sapiens,reactome | |
| 719,R-HSA-9930479,,Defective cleavage of FV variant at R334,Homo sapiens,reactome | |
| 720,R-HSA-9930449,,Defective cleavage of FV variant at a.a.534,Homo sapiens,reactome | |
| 721,R-HSA-9672396,,Defective cofactor function of FVIIIa variant,Homo sapiens,reactome | |
| 722,R-HSA-9668250,,Defective factor IX causes hemophilia B,Homo sapiens,reactome | |
| 723,R-HSA-9672383,,Defective factor IX causes thrombophilia,Homo sapiens,reactome | |
| 724,R-HSA-9662001,,Defective factor VIII causes hemophilia A,Homo sapiens,reactome | |
| 725,R-HSA-9657688,,Defective factor XII causes hereditary angioedema,Homo sapiens,reactome | |
| 726,R-HSA-9673240,,Defective gamma-carboxylation of F9,Homo sapiens,reactome | |
| 727,R-HSA-9701192,,Defective homologous recombination repair (HRR) due to BRCA1 loss of function,Homo sapiens,reactome | |
| 728,R-HSA-9701190,,Defective homologous recombination repair (HRR) due to BRCA2 loss of function,Homo sapiens,reactome | |
| 729,R-HSA-9701193,,Defective homologous recombination repair (HRR) due to PALB2 loss of function,Homo sapiens,reactome | |
| 730,R-HSA-5619081,,Defective neurotransmitter clearance by SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS),Homo sapiens,reactome | |
| 731,R-HSA-5688031,,Defective pro-SFTPB causes SMDP1 and RDS,Homo sapiens,reactome | |
| 732,R-HSA-5688354,,Defective pro-SFTPC causes SMDP2 and RDS,Homo sapiens,reactome | |
| 733,R-HSA-9710421,,Defective pyroptosis,Homo sapiens,reactome | |
| 734,R-HSA-9824856,,Defective regulation of TLR7 by endogenous ligand,Homo sapiens,reactome | |
| 735,R-HSA-9661070,,Defective translocation of RB1 mutants to the nucleus,Homo sapiens,reactome | |
| 736,R-HSA-5619037,,Defective transport by SLC35A1 causes congenital disorder of glycosylation 2F (CDG2F),Homo sapiens,reactome | |
| 737,R-HSA-5658471,,Defective transport by SLC5A7 causes distal hereditary motor neuronopathy 7A (HMN7A),Homo sapiens,reactome | |
| 738,R-HSA-5659735,,Defective transport of amino acids by SLC6A19 causes Hartnup disorder (HND),Homo sapiens,reactome | |
| 739,R-HSA-5619044,,Defective transport of neurotransmitters by SLC6A19 causes Hartnup disorder (HND),Homo sapiens,reactome | |
| 740,R-HSA-5660724,,Defective transport of neurotransmitters by SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS),Homo sapiens,reactome | |
| 741,R-HSA-9918454,,Defective visual phototransduction due to ABCA4 loss of function,Homo sapiens,reactome | |
| 742,R-HSA-9918442,,Defective visual phototransduction due to LRAT loss of function,Homo sapiens,reactome | |
| 743,R-HSA-9918450,,Defective visual phototransduction due to OPN1LW loss of function,Homo sapiens,reactome | |
| 744,R-HSA-9918436,,Defective visual phototransduction due to OPN1MW loss of function,Homo sapiens,reactome | |
| 745,R-HSA-9918443,,Defective visual phototransduction due to OPN1SW loss of function,Homo sapiens,reactome | |
| 746,R-HSA-9918440,,Defective visual phototransduction due to RDH12 loss of function,Homo sapiens,reactome | |
| 747,R-HSA-9918438,,Defective visual phototransduction due to RDH5 loss of function,Homo sapiens,reactome | |
| 748,R-HSA-9918449,,Defective visual phototransduction due to STRA6 loss of function,Homo sapiens,reactome | |
| 749,R-HSA-3323169,,Defects in biotin (Btn) metabolism,Homo sapiens,reactome | |
| 750,R-HSA-3296469,,Defects in cobalamin (B12) metabolism,Homo sapiens,reactome | |
| 751,R-HSA-3296482,,Defects in vitamin and cofactor metabolism,Homo sapiens,reactome | |
| 752,R-HSA-9769726,,Defects of Coagulation cascade,Homo sapiens,reactome | |
| 753,R-HSA-9946127,,Defects of contact activation system and kallikrein-kinin system,Homo sapiens,reactome | |
| 754,R-HSA-9823587,,Defects of platelet adhesion to exposed collagen,Homo sapiens,reactome | |
| 755,R-HSA-1461973,,Defensins,Homo sapiens,reactome | |
| 756,R-HSA-4641257,,Degradation of AXIN,Homo sapiens,reactome | |
| 757,R-HSA-9766229,,Degradation of CDH1,Homo sapiens,reactome | |
| 758,R-HSA-9932298,,Degradation of CRY and PER proteins,Homo sapiens,reactome | |
| 759,R-HSA-4641258,,Degradation of DVL,Homo sapiens,reactome | |
| 760,R-HSA-916853,,Degradation of GABA,Homo sapiens,reactome | |
| 761,R-HSA-5610780,,Degradation of GLI1 by the proteasome,Homo sapiens,reactome | |
| 762,R-HSA-5610783,,Degradation of GLI2 by the proteasome,Homo sapiens,reactome | |
| 763,R-HSA-195253,,Degradation of beta-catenin by the destruction complex,Homo sapiens,reactome | |
| 764,R-HSA-1614558,,Degradation of cysteine and homocysteine,Homo sapiens,reactome | |
| 765,R-HSA-1474228,,Degradation of the extracellular matrix,Homo sapiens,reactome | |
| 766,R-HSA-5467343,,Deletions in the AMER1 gene destabilize the destruction complex,Homo sapiens,reactome | |
| 767,R-HSA-5467345,,Deletions in the AXIN1 gene destabilize the destruction complex,Homo sapiens,reactome | |
| 768,R-HSA-9918485,,Dengue Virus Attachment and Entry,Homo sapiens,reactome | |
| 769,R-HSA-9918487,,Dengue Virus Genome Translation and Replication,Homo sapiens,reactome | |
| 770,R-HSA-9839923,,Dengue Virus Infection,Homo sapiens,reactome | |
| 771,R-HSA-9918481,,Dengue Virus-Host Interactions,Homo sapiens,reactome | |
| 772,R-HSA-9920588,,Dengue virus activates/modulates innate and adaptive immune responses,Homo sapiens,reactome | |
| 773,R-HSA-9920951,,Dengue virus modulates apoptosis,Homo sapiens,reactome | |
| 774,R-HSA-4419969,,Depolymerization of the Nuclear Lamina,Homo sapiens,reactome | |
| 775,R-HSA-606279,,Deposition of new CENPA-containing nucleosomes at the centromere,Homo sapiens,reactome | |
| 776,R-HSA-73927,,Depurination,Homo sapiens,reactome | |
| 777,R-HSA-73928,,Depyrimidination,Homo sapiens,reactome | |
| 778,R-HSA-8862803,,Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models,Homo sapiens,reactome | |
| 779,R-HSA-3299685,,Detoxification of Reactive Oxygen Species,Homo sapiens,reactome | |
| 780,R-HSA-5688426,,Deubiquitination,Homo sapiens,reactome | |
| 781,R-HSA-1266738,,Developmental Biology,Homo sapiens,reactome | |
| 782,R-HSA-9734767,,Developmental Cell Lineages,Homo sapiens,reactome | |
| 783,R-HSA-9820448,,Developmental Cell Lineages of the Exocrine Pancreas,Homo sapiens,reactome | |
| 784,R-HSA-9734779,,Developmental Cell Lineages of the Integumentary System,Homo sapiens,reactome | |
| 785,R-HSA-9927426,,Developmental Lineage of Mammary Gland Alveolar Cells,Homo sapiens,reactome | |
| 786,R-HSA-9927418,,Developmental Lineage of Mammary Gland Luminal Epithelial Cells,Homo sapiens,reactome | |
| 787,R-HSA-9927432,,Developmental Lineage of Mammary Gland Myoepithelial Cells,Homo sapiens,reactome | |
| 788,R-HSA-9938206,,Developmental Lineage of Mammary Stem Cells,Homo sapiens,reactome | |
| 789,R-HSA-9937080,,Developmental Lineage of Multipotent Pancreatic Progenitor Cells,Homo sapiens,reactome | |
| 790,R-HSA-9925561,,Developmental Lineage of Pancreatic Acinar Cells,Homo sapiens,reactome | |
| 791,R-HSA-9925563,,Developmental Lineage of Pancreatic Ductal Cells,Homo sapiens,reactome | |
| 792,R-HSA-9981148,,Developmental Lineage of Pancreatic Endocrine Mid Progenitor Cells,Homo sapiens,reactome | |
| 793,R-HSA-9924644,,Developmental Lineages of the Mammary Gland,Homo sapiens,reactome | |
| 794,R-HSA-9968734,,Differentiation of Circulating Monocytes,Homo sapiens,reactome | |
| 795,R-HSA-9725554,,Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin,Homo sapiens,reactome | |
| 796,R-HSA-9945266,,Differentiation of T cells,Homo sapiens,reactome | |
| 797,R-HSA-9942503,,Differentiation of naive CD4+ T cells to T helper 1 cells (Th1 cells),Homo sapiens,reactome | |
| 798,R-HSA-9976102,,Differentiation of naive CD4+ T cells to T helper 2 cells (Th2 cells),Homo sapiens,reactome | |
| 799,R-HSA-8935690,,Digestion,Homo sapiens,reactome | |
| 800,R-HSA-8963743,,Digestion and absorption,Homo sapiens,reactome | |
| 801,R-HSA-189085,,Digestion of dietary carbohydrate,Homo sapiens,reactome | |
| 802,R-HSA-192456,,Digestion of dietary lipid,Homo sapiens,reactome | |
| 803,R-HSA-69416,,Dimerization of procaspase-8,Homo sapiens,reactome | |
| 804,R-HSA-4641262,,Disassembly of the destruction complex and recruitment of AXIN to the membrane,Homo sapiens,reactome | |
| 805,R-HSA-1643685,,Disease,Homo sapiens,reactome | |
| 806,R-HSA-3781860,,Diseases associated with N-glycosylation of proteins,Homo sapiens,reactome | |
| 807,R-HSA-3906995,,Diseases associated with O-glycosylation of proteins,Homo sapiens,reactome | |
| 808,R-HSA-3560782,,Diseases associated with glycosaminoglycan metabolism,Homo sapiens,reactome | |
| 809,R-HSA-5609975,,Diseases associated with glycosylation precursor biosynthesis,Homo sapiens,reactome | |
| 810,R-HSA-5687613,,Diseases associated with surfactant metabolism,Homo sapiens,reactome | |
| 811,R-HSA-5602358,,Diseases associated with the TLR signaling cascade,Homo sapiens,reactome | |
| 812,R-HSA-2474795,,Diseases associated with visual transduction,Homo sapiens,reactome | |
| 813,R-HSA-9605308,,Diseases of Base Excision Repair,Homo sapiens,reactome | |
| 814,R-HSA-9630747,,Diseases of Cellular Senescence,Homo sapiens,reactome | |
| 815,R-HSA-9675136,,Diseases of DNA Double-Strand Break Repair,Homo sapiens,reactome | |
| 816,R-HSA-9675135,,Diseases of DNA repair,Homo sapiens,reactome | |
| 817,R-HSA-5260271,,Diseases of Immune System,Homo sapiens,reactome | |
| 818,R-HSA-5423599,,Diseases of Mismatch Repair (MMR),Homo sapiens,reactome | |
| 819,R-HSA-9673013,,Diseases of Telomere Maintenance,Homo sapiens,reactome | |
| 820,R-HSA-9865118,,Diseases of branched-chain amino acid catabolism,Homo sapiens,reactome | |
| 821,R-HSA-5663084,,Diseases of carbohydrate metabolism,Homo sapiens,reactome | |
| 822,R-HSA-9675132,,Diseases of cellular response to stress,Homo sapiens,reactome | |
| 823,R-HSA-3781865,,Diseases of glycosylation,Homo sapiens,reactome | |
| 824,R-HSA-9671793,,Diseases of hemostasis,Homo sapiens,reactome | |
| 825,R-HSA-5668914,,Diseases of metabolism,Homo sapiens,reactome | |
| 826,R-HSA-9759774,,Diseases of mitochondrial beta oxidation,Homo sapiens,reactome | |
| 827,R-HSA-9675126,,Diseases of mitotic cell cycle,Homo sapiens,reactome | |
| 828,R-HSA-9735804,,Diseases of nucleotide metabolism,Homo sapiens,reactome | |
| 829,R-HSA-9645723,,Diseases of programmed cell death,Homo sapiens,reactome | |
| 830,R-HSA-9759785,,Diseases of propionyl-CoA catabolism,Homo sapiens,reactome | |
| 831,R-HSA-5663202,,Diseases of signal transduction by growth factor receptors and second messengers,Homo sapiens,reactome | |
| 832,R-HSA-9675143,,Diseases of the neuronal system,Homo sapiens,reactome | |
| 833,R-HSA-9955698,,Diseases of the urea cycle,Homo sapiens,reactome | |
| 834,R-HSA-114516,,Disinhibition of SNARE formation,Homo sapiens,reactome | |
| 835,R-HSA-9675151,,Disorders of Developmental Biology,Homo sapiens,reactome | |
| 836,R-HSA-9697154,,Disorders of Nervous System Development,Homo sapiens,reactome | |
| 837,R-HSA-5619115,,Disorders of transmembrane transporters,Homo sapiens,reactome | |
| 838,R-HSA-110357,,Displacement of DNA glycosylase by APEX1,Homo sapiens,reactome | |
| 839,R-HSA-75205,,Dissolution of Fibrin Clot,Homo sapiens,reactome | |
| 840,R-HSA-212676,,Dopamine Neurotransmitter Release Cycle,Homo sapiens,reactome | |
| 841,R-HSA-379401,,Dopamine clearance from the synaptic cleft,Homo sapiens,reactome | |
| 842,R-HSA-390651,,Dopamine receptors,Homo sapiens,reactome | |
| 843,R-HSA-8863795,,Downregulation of ERBB2 signaling,Homo sapiens,reactome | |
| 844,R-HSA-1358803,,Downregulation of ERBB2:ERBB3 signaling,Homo sapiens,reactome | |
| 845,R-HSA-1253288,,Downregulation of ERBB4 signaling,Homo sapiens,reactome | |
| 846,R-HSA-2173795,,Downregulation of SMAD2/3:SMAD4 transcriptional activity,Homo sapiens,reactome | |
| 847,R-HSA-2173788,,Downregulation of TGF-beta receptor signaling,Homo sapiens,reactome | |
| 848,R-HSA-202424,,Downstream TCR signaling,Homo sapiens,reactome | |
| 849,R-HSA-186763,,Downstream signal transduction,Homo sapiens,reactome | |
| 850,R-HSA-1168372,,Downstream signaling events of B Cell Receptor (BCR),Homo sapiens,reactome | |
| 851,R-HSA-5654687,,Downstream signaling of activated FGFR1,Homo sapiens,reactome | |
| 852,R-HSA-5654696,,Downstream signaling of activated FGFR2,Homo sapiens,reactome | |
| 853,R-HSA-5654708,,Downstream signaling of activated FGFR3,Homo sapiens,reactome | |
| 854,R-HSA-5654716,,Downstream signaling of activated FGFR4,Homo sapiens,reactome | |
| 855,R-HSA-9748784,,Drug ADME,Homo sapiens,reactome | |
| 856,R-HSA-9665230,,Drug resistance in ERBB2 KD mutants,Homo sapiens,reactome | |
| 857,R-HSA-9665737,,Drug resistance in ERBB2 TMD/JMD mutants,Homo sapiens,reactome | |
| 858,R-HSA-9700649,,Drug resistance of ALK mutants,Homo sapiens,reactome | |
| 859,R-HSA-9702506,,Drug resistance of FLT3 mutants,Homo sapiens,reactome | |
| 860,R-HSA-9669937,,Drug resistance of KIT mutants,Homo sapiens,reactome | |
| 861,R-HSA-9674415,,Drug resistance of PDGFR mutants,Homo sapiens,reactome | |
| 862,R-HSA-9750126,,Drug-induced formation of DNA interstrand crosslinks,Homo sapiens,reactome | |
| 863,R-HSA-9754119,,Drug-mediated inhibition of CDK4/CDK6 activity,Homo sapiens,reactome | |
| 864,R-HSA-9652282,,Drug-mediated inhibition of ERBB2 signaling,Homo sapiens,reactome | |
| 865,R-HSA-9734091,,Drug-mediated inhibition of MET activation,Homo sapiens,reactome | |
| 866,R-HSA-5696400,,Dual Incision in GG-NER,Homo sapiens,reactome | |
| 867,R-HSA-6782135,,Dual incision in TC-NER,Homo sapiens,reactome | |
| 868,R-HSA-113510,,E2F mediated regulation of DNA replication,Homo sapiens,reactome | |
| 869,R-HSA-113507,,E2F-enabled inhibition of pre-replication complex formation,Homo sapiens,reactome | |
| 870,R-HSA-8866654,,E3 ubiquitin ligases ubiquitinate target proteins,Homo sapiens,reactome | |
| 871,R-HSA-3000178,,ECM proteoglycans,Homo sapiens,reactome | |
| 872,R-HSA-2179392,,EGFR Transactivation by Gastrin,Homo sapiens,reactome | |
| 873,R-HSA-182971,,EGFR downregulation,Homo sapiens,reactome | |
| 874,R-HSA-212718,,EGFR interacts with phospholipase C-gamma,Homo sapiens,reactome | |
| 875,R-HSA-9619665,,EGR2 and SOX10-mediated initiation of Schwann cell myelination,Homo sapiens,reactome | |
| 876,R-HSA-9648025,,EML4 and NUDC in mitotic spindle formation,Homo sapiens,reactome | |
| 877,R-HSA-2682334,,EPH-Ephrin signaling,Homo sapiens,reactome | |
| 878,R-HSA-3928665,,EPH-ephrin mediated repulsion of cells,Homo sapiens,reactome | |
| 879,R-HSA-3928663,,EPHA-mediated growth cone collapse,Homo sapiens,reactome | |
| 880,R-HSA-3928662,,EPHB-mediated forward signaling,Homo sapiens,reactome | |
| 881,R-HSA-901032,,ER Quality Control Compartment (ERQC),Homo sapiens,reactome | |
| 882,R-HSA-199977,,ER to Golgi Anterograde Transport,Homo sapiens,reactome | |
| 883,R-HSA-1236974,,ER-Phagosome pathway,Homo sapiens,reactome | |
| 884,R-HSA-8847993,,ERBB2 Activates PTK6 Signaling,Homo sapiens,reactome | |
| 885,R-HSA-6785631,,ERBB2 Regulates Cell Motility,Homo sapiens,reactome | |
| 886,R-HSA-427389,,ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression,Homo sapiens,reactome | |
| 887,R-HSA-198753,,ERK/MAPK targets,Homo sapiens,reactome | |
| 888,R-HSA-202670,,ERKs are inactivated,Homo sapiens,reactome | |
| 889,R-HSA-8939211,,ESR-mediated signaling,Homo sapiens,reactome | |
| 890,R-HSA-162594,,Early Phase of HIV Life Cycle,Homo sapiens,reactome | |
| 891,R-HSA-9772572,,Early SARS-CoV-2 Infection Events,Homo sapiens,reactome | |
| 892,R-HSA-114508,,Effects of PIP2 hydrolysis,Homo sapiens,reactome | |
| 893,R-HSA-391903,,Eicosanoid ligand-binding receptors,Homo sapiens,reactome | |
| 894,R-HSA-211979,,Eicosanoids,Homo sapiens,reactome | |
| 895,R-HSA-1566948,,Elastic fibre formation,Homo sapiens,reactome | |
| 896,R-HSA-112303,,Electric Transmission Across Gap Junctions,Homo sapiens,reactome | |
| 897,R-HSA-2395516,,Electron transport from NADPH to Ferredoxin,Homo sapiens,reactome | |
| 898,R-HSA-139853,,Elevation of cytosolic Ca2+ levels,Homo sapiens,reactome | |
| 899,R-HSA-211976,,Endogenous sterols,Homo sapiens,reactome | |
| 900,R-HSA-917729,,Endosomal Sorting Complex Required For Transport (ESCRT),Homo sapiens,reactome | |
| 901,R-HSA-1236977,,Endosomal/Vacuolar pathway,Homo sapiens,reactome | |
| 902,R-HSA-380972,,Energy dependent regulation of mTOR by LKB1-AMPK,Homo sapiens,reactome | |
| 903,R-HSA-9845620,,Enhanced binding of GP1BA variant to VWF multimer:collagen,Homo sapiens,reactome | |
| 904,R-HSA-9845619,,Enhanced cleavage of VWF variant by ADAMTS13,Homo sapiens,reactome | |
| 905,R-HSA-9956593,,Enterobacterial factors antagonize host defense,Homo sapiens,reactome | |
| 906,R-HSA-168275,,Entry of Influenza Virion into Host Cell via Endocytosis,Homo sapiens,reactome | |
| 907,R-HSA-379398,,Enzymatic degradation of Dopamine by monoamine oxidase,Homo sapiens,reactome | |
| 908,R-HSA-379397,,Enzymatic degradation of dopamine by COMT,Homo sapiens,reactome | |
| 909,R-HSA-3928664,,Ephrin signaling,Homo sapiens,reactome | |
| 910,R-HSA-9917777,,Epigenetic regulation by WDR5-containing histone modifying complexes,Homo sapiens,reactome | |
| 911,R-HSA-9851695,,Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes,Homo sapiens,reactome | |
| 912,R-HSA-212165,,Epigenetic regulation of gene expression,Homo sapiens,reactome | |
| 913,R-HSA-9818564,,Epigenetic regulation of gene expression by MLL3 and MLL4 complexes,Homo sapiens,reactome | |
| 914,R-HSA-9758919,,Epithelial-Mesenchymal Transition (EMT) during gastrulation,Homo sapiens,reactome | |
| 915,R-HSA-1237044,,Erythrocytes take up carbon dioxide and release oxygen,Homo sapiens,reactome | |
| 916,R-HSA-1247673,,Erythrocytes take up oxygen and release carbon dioxide,Homo sapiens,reactome | |
| 917,R-HSA-9027276,,Erythropoietin activates Phosphoinositide-3-kinase (PI3K),Homo sapiens,reactome | |
| 918,R-HSA-9027277,,Erythropoietin activates Phospholipase C gamma (PLCG),Homo sapiens,reactome | |
| 919,R-HSA-9027284,,Erythropoietin activates RAS,Homo sapiens,reactome | |
| 920,R-HSA-9027283,,Erythropoietin activates STAT5,Homo sapiens,reactome | |
| 921,R-HSA-9637679,,Escape of Mtb from the phagocyte,Homo sapiens,reactome | |
| 922,R-HSA-5657562,,Essential fructosuria,Homo sapiens,reactome | |
| 923,R-HSA-5662853,,Essential pentosuria,Homo sapiens,reactome | |
| 924,R-HSA-2468052,,Establishment of Sister Chromatid Cohesion,Homo sapiens,reactome | |
| 925,R-HSA-193144,,Estrogen biosynthesis,Homo sapiens,reactome | |
| 926,R-HSA-9018519,,Estrogen-dependent gene expression,Homo sapiens,reactome | |
| 927,R-HSA-9634638,,Estrogen-dependent nuclear events downstream of ESR-membrane signaling,Homo sapiens,reactome | |
| 928,R-HSA-9634635,,Estrogen-stimulated signaling through PRKCZ,Homo sapiens,reactome | |
| 929,R-HSA-71384,,Ethanol oxidation,Homo sapiens,reactome | |
| 930,R-HSA-156842,,Eukaryotic Translation Elongation,Homo sapiens,reactome | |
| 931,R-HSA-72613,,Eukaryotic Translation Initiation,Homo sapiens,reactome | |
| 932,R-HSA-72764,,Eukaryotic Translation Termination,Homo sapiens,reactome | |
| 933,R-HSA-9833109,,Evasion by RSV of host interferon responses,Homo sapiens,reactome | |
| 934,R-HSA-9630791,,Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4,Homo sapiens,reactome | |
| 935,R-HSA-9630794,,Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6,Homo sapiens,reactome | |
| 936,R-HSA-9646303,,Evasion of Oncogene Induced Senescence Due to p14ARF Defects,Homo sapiens,reactome | |
| 937,R-HSA-9630750,,Evasion of Oncogene Induced Senescence Due to p16INK4A Defects,Homo sapiens,reactome | |
| 938,R-HSA-9632697,,Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4,Homo sapiens,reactome | |
| 939,R-HSA-9632700,,Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6,Homo sapiens,reactome | |
| 940,R-HSA-9646304,,Evasion of Oxidative Stress Induced Senescence Due to p14ARF Defects,Homo sapiens,reactome | |
| 941,R-HSA-9632693,,Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects,Homo sapiens,reactome | |
| 942,R-HSA-8941413,,Events associated with phagocytolytic activity of PMN cells,Homo sapiens,reactome | |
| 943,R-HSA-168274,,Export of Viral Ribonucleoproteins from Nucleus,Homo sapiens,reactome | |
| 944,R-HSA-9036866,,Expression and Processing of Neurotrophins,Homo sapiens,reactome | |
| 945,R-HSA-9752946,,Expression and translocation of olfactory receptors,Homo sapiens,reactome | |
| 946,R-HSA-9931509,,"Expression of BMAL (ARNTL), CLOCK, and NPAS2",Homo sapiens,reactome | |
| 947,R-HSA-9911233,,Expression of NOTCH2NL genes,Homo sapiens,reactome | |
| 948,R-HSA-180786,,Extension of Telomeres,Homo sapiens,reactome | |
| 949,R-HSA-9009391,,Extra-nuclear estrogen signaling,Homo sapiens,reactome | |
| 950,R-HSA-1474244,,Extracellular matrix organization,Homo sapiens,reactome | |
| 951,R-HSA-9837092,,FASTK family proteins regulate processing and stability of mitochondrial RNAs,Homo sapiens,reactome | |
| 952,R-HSA-8854050,,FBXL7 down-regulates AURKA during mitotic entry and in early mitosis,Homo sapiens,reactome | |
| 953,R-HSA-2644605,,FBXW7 Mutants and NOTCH1 in Cancer,Homo sapiens,reactome | |
| 954,R-HSA-2871809,,FCERI mediated Ca+2 mobilization,Homo sapiens,reactome | |
| 955,R-HSA-2871796,,FCERI mediated MAPK activation,Homo sapiens,reactome | |
| 956,R-HSA-2871837,,FCERI mediated NF-kB activation,Homo sapiens,reactome | |
| 957,R-HSA-2029481,,FCGR activation,Homo sapiens,reactome | |
| 958,R-HSA-9664323,,FCGR3A-mediated IL10 synthesis,Homo sapiens,reactome | |
| 959,R-HSA-9664422,,FCGR3A-mediated phagocytosis,Homo sapiens,reactome | |
| 960,R-HSA-190242,,FGFR1 ligand binding and activation,Homo sapiens,reactome | |
| 961,R-HSA-1839124,,FGFR1 mutant receptor activation,Homo sapiens,reactome | |
| 962,R-HSA-190370,,FGFR1b ligand binding and activation,Homo sapiens,reactome | |
| 963,R-HSA-190374,,FGFR1c and Klotho ligand binding and activation,Homo sapiens,reactome | |
| 964,R-HSA-190373,,FGFR1c ligand binding and activation,Homo sapiens,reactome | |
| 965,R-HSA-6803529,,FGFR2 alternative splicing,Homo sapiens,reactome | |
| 966,R-HSA-190241,,FGFR2 ligand binding and activation,Homo sapiens,reactome | |
| 967,R-HSA-1839126,,FGFR2 mutant receptor activation,Homo sapiens,reactome | |
| 968,R-HSA-190377,,FGFR2b ligand binding and activation,Homo sapiens,reactome | |
| 969,R-HSA-190375,,FGFR2c ligand binding and activation,Homo sapiens,reactome | |
| 970,R-HSA-190239,,FGFR3 ligand binding and activation,Homo sapiens,reactome | |
| 971,R-HSA-2033514,,FGFR3 mutant receptor activation,Homo sapiens,reactome | |
| 972,R-HSA-190371,,FGFR3b ligand binding and activation,Homo sapiens,reactome | |
| 973,R-HSA-190372,,FGFR3c ligand binding and activation,Homo sapiens,reactome | |
| 974,R-HSA-190322,,FGFR4 ligand binding and activation,Homo sapiens,reactome | |
| 975,R-HSA-1839128,,FGFR4 mutant receptor activation,Homo sapiens,reactome | |
| 976,R-HSA-5658623,,FGFRL1 modulation of FGFR1 signaling,Homo sapiens,reactome | |
| 977,R-HSA-9607240,,FLT3 Signaling,Homo sapiens,reactome | |
| 978,R-HSA-9702509,,FLT3 mutants bind TKIs,Homo sapiens,reactome | |
| 979,R-HSA-9706377,,FLT3 signaling by CBL mutants,Homo sapiens,reactome | |
| 980,R-HSA-9682385,,FLT3 signaling in disease,Homo sapiens,reactome | |
| 981,R-HSA-9706374,,FLT3 signaling through SRC family kinases,Homo sapiens,reactome | |
| 982,R-HSA-217271,,FMO oxidises nucleophiles,Homo sapiens,reactome | |
| 983,R-HSA-9614085,,FOXO-mediated transcription,Homo sapiens,reactome | |
| 984,R-HSA-9617828,,FOXO-mediated transcription of cell cycle genes,Homo sapiens,reactome | |
| 985,R-HSA-9614657,,FOXO-mediated transcription of cell death genes,Homo sapiens,reactome | |
| 986,R-HSA-9615017,,"FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes",Homo sapiens,reactome | |
| 987,R-HSA-5654693,,FRS-mediated FGFR1 signaling,Homo sapiens,reactome | |
| 988,R-HSA-5654700,,FRS-mediated FGFR2 signaling,Homo sapiens,reactome | |
| 989,R-HSA-5654706,,FRS-mediated FGFR3 signaling,Homo sapiens,reactome | |
| 990,R-HSA-5654712,,FRS-mediated FGFR4 signaling,Homo sapiens,reactome | |
| 991,R-HSA-9970672,,FXIIa activates plasma kallikrein-kinin system,Homo sapiens,reactome | |
| 992,R-HSA-9935598,,"FXIIa, PKa-dependent activation of coagulation pathway",Homo sapiens,reactome | |
| 993,R-HSA-983231,,Factors involved in megakaryocyte development and platelet production,Homo sapiens,reactome | |
| 994,R-HSA-6783310,,Fanconi Anemia Pathway,Homo sapiens,reactome | |
| 995,R-HSA-75157,,FasL/ CD95L signaling,Homo sapiens,reactome | |
| 996,R-HSA-434316,,Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion,Homo sapiens,reactome | |
| 997,R-HSA-8978868,,Fatty acid metabolism,Homo sapiens,reactome | |
| 998,R-HSA-211935,,Fatty acids,Homo sapiens,reactome | |
| 999,R-HSA-75105,,Fatty acyl-CoA biosynthesis,Homo sapiens,reactome | |
| 1000,R-HSA-2454202,,Fc epsilon receptor (FCERI) signaling,Homo sapiens,reactome | |
| 1001,R-HSA-2029480,,Fcgamma receptor (FCGR) dependent phagocytosis,Homo sapiens,reactome | |
| 1002,R-HSA-1187000,,Fertilization,Homo sapiens,reactome | |
| 1003,R-HSA-9769733,,Fibrin formation,Homo sapiens,reactome | |
| 1004,R-HSA-1566977,,Fibronectin matrix formation,Homo sapiens,reactome | |
| 1005,R-HSA-2855086,,Ficolins bind to repetitive carbohydrate structures on the target cell surface,Homo sapiens,reactome | |
| 1006,R-HSA-390450,,Folding of actin by CCT/TriC,Homo sapiens,reactome | |
| 1007,R-HSA-163210,,Formation of ATP by chemiosmotic coupling,Homo sapiens,reactome | |
| 1008,R-HSA-167152,,Formation of HIV elongation complex in the absence of HIV Tat,Homo sapiens,reactome | |
| 1009,R-HSA-167200,,Formation of HIV-1 elongation complex containing HIV-1 Tat,Homo sapiens,reactome | |
| 1010,R-HSA-5696395,,Formation of Incision Complex in GG-NER,Homo sapiens,reactome | |
| 1011,R-HSA-112382,,Formation of RNA Pol II elongation complex,Homo sapiens,reactome | |
| 1012,R-HSA-2559584,,Formation of Senescence-Associated Heterochromatin Foci (SAHF),Homo sapiens,reactome | |
| 1013,R-HSA-6781823,,Formation of TC-NER Pre-Incision Complex,Homo sapiens,reactome | |
| 1014,R-HSA-9772755,,Formation of WDR5-containing histone-modifying complexes,Homo sapiens,reactome | |
| 1015,R-HSA-72689,,Formation of a pool of free 40S subunits,Homo sapiens,reactome | |
| 1016,R-HSA-196025,,Formation of annular gap junctions,Homo sapiens,reactome | |
| 1017,R-HSA-111458,,Formation of apoptosome,Homo sapiens,reactome | |
| 1018,R-HSA-9796292,,Formation of axial mesoderm,Homo sapiens,reactome | |
| 1019,R-HSA-9823730,,Formation of definitive endoderm,Homo sapiens,reactome | |
| 1020,R-HSA-77042,,Formation of editosomes by ADAR proteins,Homo sapiens,reactome | |
| 1021,R-HSA-9761174,,Formation of intermediate mesoderm,Homo sapiens,reactome | |
| 1022,R-HSA-9758920,,Formation of lateral plate mesoderm,Homo sapiens,reactome | |
| 1023,R-HSA-9934037,,Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF),Homo sapiens,reactome | |
| 1024,R-HSA-9793380,,Formation of paraxial mesoderm,Homo sapiens,reactome | |
| 1025,R-HSA-2408499,,Formation of selenosugars for excretion,Homo sapiens,reactome | |
| 1026,R-HSA-113418,,Formation of the Early Elongation Complex,Homo sapiens,reactome | |
| 1027,R-HSA-75094,,Formation of the Editosome,Homo sapiens,reactome | |
| 1028,R-HSA-167158,,Formation of the HIV-1 Early Elongation Complex,Homo sapiens,reactome | |
| 1029,R-HSA-173599,,"Formation of the active cofactor, UDP-glucuronate",Homo sapiens,reactome | |
| 1030,R-HSA-9823739,,Formation of the anterior neural plate,Homo sapiens,reactome | |
| 1031,R-HSA-201722,,Formation of the beta-catenin:TCF transactivating complex,Homo sapiens,reactome | |
| 1032,R-HSA-9933937,,Formation of the canonical BAF (cBAF) complex,Homo sapiens,reactome | |
| 1033,R-HSA-6809371,,Formation of the cornified envelope,Homo sapiens,reactome | |
| 1034,R-HSA-9913351,,Formation of the dystrophin-glycoprotein complex (DGC),Homo sapiens,reactome | |
| 1035,R-HSA-9933946,,Formation of the embryonic stem cell BAF (esBAF) complex,Homo sapiens,reactome | |
| 1036,R-HSA-9830364,,Formation of the nephric duct,Homo sapiens,reactome | |
| 1037,R-HSA-9933947,,Formation of the non-canonical BAF (ncBAF) complex,Homo sapiens,reactome | |
| 1038,R-HSA-9933939,,Formation of the polybromo-BAF (pBAF) complex,Homo sapiens,reactome | |
| 1039,R-HSA-9832991,,Formation of the posterior neural plate,Homo sapiens,reactome | |
| 1040,R-HSA-72695,,"Formation of the ternary complex, and subsequently, the 43S complex",Homo sapiens,reactome | |
| 1041,R-HSA-9830674,,Formation of the ureteric bud,Homo sapiens,reactome | |
| 1042,R-HSA-389960,,Formation of tubulin folding intermediates by CCT/TriC,Homo sapiens,reactome | |
| 1043,R-HSA-5661270,,Formation of xylulose-5-phosphate,Homo sapiens,reactome | |
| 1044,R-HSA-444473,,Formyl peptide receptors bind formyl peptides and many other ligands,Homo sapiens,reactome | |
| 1045,R-HSA-444209,,Free fatty acid receptors,Homo sapiens,reactome | |
| 1046,R-HSA-400451,,Free fatty acids regulate insulin secretion,Homo sapiens,reactome | |
| 1047,R-HSA-170968,,Frs2-mediated activation,Homo sapiens,reactome | |
| 1048,R-HSA-5652227,,Fructose biosynthesis,Homo sapiens,reactome | |
| 1049,R-HSA-70350,,Fructose catabolism,Homo sapiens,reactome | |
| 1050,R-HSA-5652084,,Fructose metabolism,Homo sapiens,reactome | |
| 1051,R-HSA-168270,,Fusion and Uncoating of the Influenza Virion,Homo sapiens,reactome | |
| 1052,R-HSA-168288,,Fusion of the Influenza Virion to the Host Cell Endosome,Homo sapiens,reactome | |
| 1053,R-HSA-416482,,G alpha (12/13) signalling events,Homo sapiens,reactome | |
| 1054,R-HSA-418594,,G alpha (i) signalling events,Homo sapiens,reactome | |
| 1055,R-HSA-416476,,G alpha (q) signalling events,Homo sapiens,reactome | |
| 1056,R-HSA-418555,,G alpha (s) signalling events,Homo sapiens,reactome | |
| 1057,R-HSA-418597,,G alpha (z) signalling events,Homo sapiens,reactome | |
| 1058,R-HSA-8964315,,G beta:gamma signalling through BTK,Homo sapiens,reactome | |
| 1059,R-HSA-8964616,,G beta:gamma signalling through CDC42,Homo sapiens,reactome | |
| 1060,R-HSA-392451,,G beta:gamma signalling through PI3Kgamma,Homo sapiens,reactome | |
| 1061,R-HSA-418217,,G beta:gamma signalling through PLC beta,Homo sapiens,reactome | |
| 1062,R-HSA-1296059,,G protein gated Potassium channels,Homo sapiens,reactome | |
| 1063,R-HSA-202040,,G-protein activation,Homo sapiens,reactome | |
| 1064,R-HSA-397795,,G-protein beta:gamma signalling,Homo sapiens,reactome | |
| 1065,R-HSA-112040,,G-protein mediated events,Homo sapiens,reactome | |
| 1066,R-HSA-1538133,,G0 and Early G1,Homo sapiens,reactome | |
| 1067,R-HSA-69236,,G1 Phase,Homo sapiens,reactome | |
| 1068,R-HSA-69615,,G1/S DNA Damage Checkpoints,Homo sapiens,reactome | |
| 1069,R-HSA-69206,,G1/S Transition,Homo sapiens,reactome | |
| 1070,R-HSA-69205,,G1/S-Specific Transcription,Homo sapiens,reactome | |
| 1071,R-HSA-68911,,G2 Phase,Homo sapiens,reactome | |
| 1072,R-HSA-69481,,G2/M Checkpoints,Homo sapiens,reactome | |
| 1073,R-HSA-69473,,G2/M DNA damage checkpoint,Homo sapiens,reactome | |
| 1074,R-HSA-69478,,G2/M DNA replication checkpoint,Homo sapiens,reactome | |
| 1075,R-HSA-69275,,G2/M Transition,Homo sapiens,reactome | |
| 1076,R-HSA-180292,,GAB1 signalosome,Homo sapiens,reactome | |
| 1077,R-HSA-977444,,GABA B receptor activation,Homo sapiens,reactome | |
| 1078,R-HSA-977443,,GABA receptor activation,Homo sapiens,reactome | |
| 1079,R-HSA-888568,,GABA synthesis,Homo sapiens,reactome | |
| 1080,R-HSA-888590,,"GABA synthesis, release, reuptake and degradation",Homo sapiens,reactome | |
| 1081,R-HSA-9953170,,GBP-mediated host defense,Homo sapiens,reactome | |
| 1082,R-HSA-6787639,,GDP-fucose biosynthesis,Homo sapiens,reactome | |
| 1083,R-HSA-5635851,,GLI proteins bind promoters of Hh responsive genes to promote transcription,Homo sapiens,reactome | |
| 1084,R-HSA-5610785,,GLI3 is processed to GLI3R by the proteasome,Homo sapiens,reactome | |
| 1085,R-HSA-430116,,GP1b-IX-V activation signalling,Homo sapiens,reactome | |
| 1086,R-HSA-388396,,GPCR downstream signalling,Homo sapiens,reactome | |
| 1087,R-HSA-500792,,GPCR ligand binding,Homo sapiens,reactome | |
| 1088,R-HSA-9634597,,GPER1 signaling,Homo sapiens,reactome | |
| 1089,R-HSA-114604,,GPVI-mediated activation cascade,Homo sapiens,reactome | |
| 1090,R-HSA-179812,,GRB2 events in EGFR signaling,Homo sapiens,reactome | |
| 1091,R-HSA-1963640,,GRB2 events in ERBB2 signaling,Homo sapiens,reactome | |
| 1092,R-HSA-354194,,GRB2:SOS provides linkage to MAPK signaling for Integrins,Homo sapiens,reactome | |
| 1093,R-HSA-1306955,,GRB7 events in ERBB2 signaling,Homo sapiens,reactome | |
| 1094,R-HSA-9762114,,GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2,Homo sapiens,reactome | |
| 1095,R-HSA-9929356,,GSK3B-mediated proteasomal degradation of PD-L1(CD274),Homo sapiens,reactome | |
| 1096,R-HSA-72706,,GTP hydrolysis and joining of the 60S ribosomal subunit,Homo sapiens,reactome | |
| 1097,R-HSA-9726842,,Gain-of-function MRAS complexes activate RAF signaling,Homo sapiens,reactome | |
| 1098,R-HSA-70370,,Galactose catabolism,Homo sapiens,reactome | |
| 1099,R-HSA-163841,,"Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation",Homo sapiens,reactome | |
| 1100,R-HSA-159740,,Gamma-carboxylation of protein precursors,Homo sapiens,reactome | |
| 1101,R-HSA-159854,,"Gamma-carboxylation, transport, and amino-terminal cleavage of proteins",Homo sapiens,reactome | |
| 1102,R-HSA-190861,,Gap junction assembly,Homo sapiens,reactome | |
| 1103,R-HSA-190873,,Gap junction degradation,Homo sapiens,reactome | |
| 1104,R-HSA-190828,,Gap junction trafficking,Homo sapiens,reactome | |
| 1105,R-HSA-157858,,Gap junction trafficking and regulation,Homo sapiens,reactome | |
| 1106,R-HSA-5696397,,Gap-filling DNA repair synthesis and ligation in GG-NER,Homo sapiens,reactome | |
| 1107,R-HSA-6782210,,Gap-filling DNA repair synthesis and ligation in TC-NER,Homo sapiens,reactome | |
| 1108,R-HSA-881907,,Gastrin-CREB signalling pathway via PKC and MAPK,Homo sapiens,reactome | |
| 1109,R-HSA-9758941,,Gastrulation,Homo sapiens,reactome | |
| 1110,R-HSA-211000,,Gene Silencing by RNA,Homo sapiens,reactome | |
| 1111,R-HSA-8950505,,Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation,Homo sapiens,reactome | |
| 1112,R-HSA-74160,,Gene expression (Transcription),Homo sapiens,reactome | |
| 1113,R-HSA-202433,,Generation of second messenger molecules,Homo sapiens,reactome | |
| 1114,R-HSA-212436,,Generic Transcription Pathway,Homo sapiens,reactome | |
| 1115,R-HSA-9754189,,Germ layer formation at gastrulation,Homo sapiens,reactome | |
| 1116,R-HSA-5696399,,Global Genome Nucleotide Excision Repair (GG-NER),Homo sapiens,reactome | |
| 1117,R-HSA-163359,,Glucagon signaling in metabolic regulation,Homo sapiens,reactome | |
| 1118,R-HSA-381676,,Glucagon-like Peptide-1 (GLP1) regulates insulin secretion,Homo sapiens,reactome | |
| 1119,R-HSA-420092,,Glucagon-type ligand receptors,Homo sapiens,reactome | |
| 1120,R-HSA-194002,,Glucocorticoid biosynthesis,Homo sapiens,reactome | |
| 1121,R-HSA-70263,,Gluconeogenesis,Homo sapiens,reactome | |
| 1122,R-HSA-70326,,Glucose metabolism,Homo sapiens,reactome | |
| 1123,R-HSA-156588,,Glucuronidation,Homo sapiens,reactome | |
| 1124,R-HSA-210500,,Glutamate Neurotransmitter Release Cycle,Homo sapiens,reactome | |
| 1125,R-HSA-8964539,,Glutamate and glutamine metabolism,Homo sapiens,reactome | |
| 1126,R-HSA-399721,,"Glutamate binding, activation of AMPA receptors and synaptic plasticity",Homo sapiens,reactome | |
| 1127,R-HSA-156590,,Glutathione conjugation,Homo sapiens,reactome | |
| 1128,R-HSA-174403,,Glutathione synthesis and recycling,Homo sapiens,reactome | |
| 1129,R-HSA-1483206,,Glycerophospholipid biosynthesis,Homo sapiens,reactome | |
| 1130,R-HSA-6814848,,Glycerophospholipid catabolism,Homo sapiens,reactome | |
| 1131,R-HSA-6783984,,Glycine degradation,Homo sapiens,reactome | |
| 1132,R-HSA-70221,,Glycogen breakdown (glycogenolysis),Homo sapiens,reactome | |
| 1133,R-HSA-8982491,,Glycogen metabolism,Homo sapiens,reactome | |
| 1134,R-HSA-3858516,,Glycogen storage disease type 0 (liver GYS2),Homo sapiens,reactome | |
| 1135,R-HSA-3828062,,Glycogen storage disease type 0 (muscle GYS1),Homo sapiens,reactome | |
| 1136,R-HSA-5357609,,Glycogen storage disease type II (GAA),Homo sapiens,reactome | |
| 1137,R-HSA-3878781,,Glycogen storage disease type IV (GBE1),Homo sapiens,reactome | |
| 1138,R-HSA-3274531,,Glycogen storage disease type Ia (G6PC),Homo sapiens,reactome | |
| 1139,R-HSA-3229133,,Glycogen storage disease type Ib (SLC37A4),Homo sapiens,reactome | |
| 1140,R-HSA-3814836,,Glycogen storage disease type XV (GYG1),Homo sapiens,reactome | |
| 1141,R-HSA-3229121,,Glycogen storage diseases,Homo sapiens,reactome | |
| 1142,R-HSA-3322077,,Glycogen synthesis,Homo sapiens,reactome | |
| 1143,R-HSA-70171,,Glycolysis,Homo sapiens,reactome | |
| 1144,R-HSA-209822,,Glycoprotein hormones,Homo sapiens,reactome | |
| 1145,R-HSA-1630316,,Glycosaminoglycan metabolism,Homo sapiens,reactome | |
| 1146,R-HSA-1971475,,Glycosaminoglycan-protein linkage region biosynthesis,Homo sapiens,reactome | |
| 1147,R-HSA-9840309,,Glycosphingolipid biosynthesis,Homo sapiens,reactome | |
| 1148,R-HSA-9840310,,Glycosphingolipid catabolism,Homo sapiens,reactome | |
| 1149,R-HSA-1660662,,Glycosphingolipid metabolism,Homo sapiens,reactome | |
| 1150,R-HSA-9845576,,Glycosphingolipid transport,Homo sapiens,reactome | |
| 1151,R-HSA-389661,,Glyoxylate metabolism and glycine degradation,Homo sapiens,reactome | |
| 1152,R-HSA-432722,,Golgi Associated Vesicle Biogenesis,Homo sapiens,reactome | |
| 1153,R-HSA-162658,,Golgi Cisternae Pericentriolar Stack Reorganization,Homo sapiens,reactome | |
| 1154,R-HSA-8856688,,Golgi-to-ER retrograde transport,Homo sapiens,reactome | |
| 1155,R-HSA-982772,,Growth hormone receptor signaling,Homo sapiens,reactome | |
| 1156,R-HSA-9912529,,H139Hfs13* PPM1K causes a mild variant of MSUD,Homo sapiens,reactome | |
| 1157,R-HSA-3214847,,HATs acetylate histones,Homo sapiens,reactome | |
| 1158,R-HSA-9609690,,HCMV Early Events,Homo sapiens,reactome | |
| 1159,R-HSA-9609646,,HCMV Infection,Homo sapiens,reactome | |
| 1160,R-HSA-9610379,,HCMV Late Events,Homo sapiens,reactome | |
| 1161,R-HSA-1296061,,HCN channels,Homo sapiens,reactome | |
| 1162,R-HSA-3214815,,HDACs deacetylate histones,Homo sapiens,reactome | |
| 1163,R-HSA-8963896,,HDL assembly,Homo sapiens,reactome | |
| 1164,R-HSA-8964011,,HDL clearance,Homo sapiens,reactome | |
| 1165,R-HSA-8964058,,HDL remodeling,Homo sapiens,reactome | |
| 1166,R-HSA-3214842,,HDMs demethylate histones,Homo sapiens,reactome | |
| 1167,R-HSA-5685942,,HDR through Homologous Recombination (HRR),Homo sapiens,reactome | |
| 1168,R-HSA-5693567,,HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA),Homo sapiens,reactome | |
| 1169,R-HSA-5685939,,HDR through MMEJ (alt-NHEJ),Homo sapiens,reactome | |
| 1170,R-HSA-5685938,,HDR through Single Strand Annealing (SSA),Homo sapiens,reactome | |
| 1171,R-HSA-5658034,,HHAT G278V doesn't palmitoylate Hh-Np,Homo sapiens,reactome | |
| 1172,R-HSA-162906,,HIV Infection,Homo sapiens,reactome | |
| 1173,R-HSA-162587,,HIV Life Cycle,Homo sapiens,reactome | |
| 1174,R-HSA-167169,,HIV Transcription Elongation,Homo sapiens,reactome | |
| 1175,R-HSA-167161,,HIV Transcription Initiation,Homo sapiens,reactome | |
| 1176,R-HSA-167287,,HIV elongation arrest and recovery,Homo sapiens,reactome | |
| 1177,R-HSA-2022928,,HS-GAG biosynthesis,Homo sapiens,reactome | |
| 1178,R-HSA-2024096,,HS-GAG degradation,Homo sapiens,reactome | |
| 1179,R-HSA-3371511,,HSF1 activation,Homo sapiens,reactome | |
| 1180,R-HSA-3371571,,HSF1-dependent transactivation,Homo sapiens,reactome | |
| 1181,R-HSA-3371497,,HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand,Homo sapiens,reactome | |
| 1182,R-HSA-5610787,,Hedgehog 'off' state,Homo sapiens,reactome | |
| 1183,R-HSA-5632684,,Hedgehog 'on' state,Homo sapiens,reactome | |
| 1184,R-HSA-5358346,,Hedgehog ligand biogenesis,Homo sapiens,reactome | |
| 1185,R-HSA-9927020,,Heme assimilation,Homo sapiens,reactome | |
| 1186,R-HSA-189451,,Heme biosynthesis,Homo sapiens,reactome | |
| 1187,R-HSA-189483,,Heme degradation,Homo sapiens,reactome | |
| 1188,R-HSA-9707616,,Heme signaling,Homo sapiens,reactome | |
| 1189,R-HSA-109582,,Hemostasis,Homo sapiens,reactome | |
| 1190,R-HSA-1638091,,Heparan sulfate/heparin (HS-GAG) metabolism,Homo sapiens,reactome | |
| 1191,R-HSA-5657560,,Hereditary fructose intolerance,Homo sapiens,reactome | |
| 1192,R-HSA-5387390,,Hh mutants abrogate ligand secretion,Homo sapiens,reactome | |
| 1193,R-HSA-5362768,,Hh mutants are degraded by ERAD,Homo sapiens,reactome | |
| 1194,R-HSA-9856530,,High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells,Homo sapiens,reactome | |
| 1195,R-HSA-629597,,Highly calcium permeable nicotinic acetylcholine receptors,Homo sapiens,reactome | |
| 1196,R-HSA-629594,,Highly calcium permeable postsynaptic nicotinic acetylcholine receptors,Homo sapiens,reactome | |
| 1197,R-HSA-629587,,Highly sodium permeable postsynaptic acetylcholine nicotinic receptors,Homo sapiens,reactome | |
| 1198,R-HSA-390650,,Histamine receptors,Homo sapiens,reactome | |
| 1199,R-HSA-70921,,Histidine catabolism,Homo sapiens,reactome | |
| 1200,R-HSA-5693579,,Homologous DNA Pairing and Strand Exchange,Homo sapiens,reactome | |
| 1201,R-HSA-5693538,,Homology Directed Repair,Homo sapiens,reactome | |
| 1202,R-HSA-375281,,Hormone ligand-binding receptors,Homo sapiens,reactome | |
| 1203,R-HSA-162909,,Host Interactions of HIV factors,Homo sapiens,reactome | |
| 1204,R-HSA-450520,,HuR (ELAVL1) binds and stabilizes mRNA,Homo sapiens,reactome | |
| 1205,R-HSA-2160916,,Hyaluronan degradation,Homo sapiens,reactome | |
| 1206,R-HSA-2142845,,Hyaluronan metabolism,Homo sapiens,reactome | |
| 1207,R-HSA-1483115,,Hydrolysis of LPC,Homo sapiens,reactome | |
| 1208,R-HSA-1483152,,Hydrolysis of LPE,Homo sapiens,reactome | |
| 1209,R-HSA-3296197,,Hydroxycarboxylic acid-binding receptors,Homo sapiens,reactome | |
| 1210,R-HSA-204626,,Hypusine synthesis from eIF5A-lysine,Homo sapiens,reactome | |
| 1211,R-HSA-9684482,,IFIT antiviral response,Homo sapiens,reactome | |
| 1212,R-HSA-9732724,,IFNG signaling activates MAPKs,Homo sapiens,reactome | |
| 1213,R-HSA-2428924,,IGF1R signaling cascade,Homo sapiens,reactome | |
| 1214,R-HSA-5602636,,IKBKB deficiency causes SCID,Homo sapiens,reactome | |
| 1215,R-HSA-5603027,,IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR),Homo sapiens,reactome | |
| 1216,R-HSA-937041,,IKK complex recruitment mediated by RIP1,Homo sapiens,reactome | |
| 1217,R-HSA-6788467,,IL-6-type cytokine receptor ligand interactions,Homo sapiens,reactome | |
| 1218,R-HSA-1855196,,IP3 and IP4 transport between cytosol and nucleus,Homo sapiens,reactome | |
| 1219,R-HSA-1855229,,IP6 and IP7 transport between cytosol and nucleus,Homo sapiens,reactome | |
| 1220,R-HSA-1855215,,IPs transport between ER lumen and cytosol,Homo sapiens,reactome | |
| 1221,R-HSA-1855156,,IPs transport between ER lumen and nucleus,Homo sapiens,reactome | |
| 1222,R-HSA-1855184,,IPs transport between cytosol and ER lumen,Homo sapiens,reactome | |
| 1223,R-HSA-1855192,,IPs transport between nucleus and ER lumen,Homo sapiens,reactome | |
| 1224,R-HSA-1855170,,IPs transport between nucleus and cytosol,Homo sapiens,reactome | |
| 1225,R-HSA-937039,,IRAK1 recruits IKK complex,Homo sapiens,reactome | |
| 1226,R-HSA-975144,,IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation,Homo sapiens,reactome | |
| 1227,R-HSA-937042,,IRAK2 mediated activation of TAK1 complex,Homo sapiens,reactome | |
| 1228,R-HSA-975163,,IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation,Homo sapiens,reactome | |
| 1229,R-HSA-5603041,,IRAK4 deficiency (TLR2/4),Homo sapiens,reactome | |
| 1230,R-HSA-5603037,,IRAK4 deficiency (TLR5),Homo sapiens,reactome | |
| 1231,R-HSA-381070,,IRE1alpha activates chaperones,Homo sapiens,reactome | |
| 1232,R-HSA-1606341,,IRF3 mediated activation of type 1 IFN,Homo sapiens,reactome | |
| 1233,R-HSA-3270619,,IRF3-mediated induction of type I IFN,Homo sapiens,reactome | |
| 1234,R-HSA-74713,,IRS activation,Homo sapiens,reactome | |
| 1235,R-HSA-112399,,IRS-mediated signalling,Homo sapiens,reactome | |
| 1236,R-HSA-2428928,,IRS-related events triggered by IGF1R,Homo sapiens,reactome | |
| 1237,R-HSA-1169408,,ISG15 antiviral mechanism,Homo sapiens,reactome | |
| 1238,R-HSA-5603029,,IkBA variant leads to EDA-ID,Homo sapiens,reactome | |
| 1239,R-HSA-9669917,,Imatinib-resistant KIT mutants,Homo sapiens,reactome | |
| 1240,R-HSA-9674396,,Imatinib-resistant PDGFR mutants,Homo sapiens,reactome | |
| 1241,R-HSA-168256,,Immune System,Homo sapiens,reactome | |
| 1242,R-HSA-9938026,,Immunoglobulin maturation,Homo sapiens,reactome | |
| 1243,R-HSA-198933,,Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell,Homo sapiens,reactome | |
| 1244,R-HSA-9709603,,Impaired BRCA2 binding to PALB2,Homo sapiens,reactome | |
| 1245,R-HSA-9709570,,Impaired BRCA2 binding to RAD51,Homo sapiens,reactome | |
| 1246,R-HSA-9763198,,Impaired BRCA2 binding to SEM1 (DSS1),Homo sapiens,reactome | |
| 1247,R-HSA-9709275,,Impaired BRCA2 translocation to the nucleus,Homo sapiens,reactome | |
| 1248,R-HSA-141430,,Inactivation of APC/C via direct inhibition of the APC/C complex,Homo sapiens,reactome | |
| 1249,R-HSA-428543,,Inactivation of CDC42 and RAC1,Homo sapiens,reactome | |
| 1250,R-HSA-9705462,,Inactivation of CSF3 (G-CSF) signaling,Homo sapiens,reactome | |
| 1251,R-HSA-2514859,,"Inactivation, recovery and regulation of the phototransduction cascade",Homo sapiens,reactome | |
| 1252,R-HSA-400508,,"Incretin synthesis, secretion, and inactivation",Homo sapiens,reactome | |
| 1253,R-HSA-9733458,,Induction of Cell-Cell Fusion,Homo sapiens,reactome | |
| 1254,R-HSA-9640148,,Infection with Enterobacteria,Homo sapiens,reactome | |
| 1255,R-HSA-9635486,,Infection with Mycobacterium tuberculosis,Homo sapiens,reactome | |
| 1256,R-HSA-5663205,,Infectious disease,Homo sapiens,reactome | |
| 1257,R-HSA-622312,,Inflammasomes,Homo sapiens,reactome | |
| 1258,R-HSA-168255,,Influenza Infection,Homo sapiens,reactome | |
| 1259,R-HSA-168273,,Influenza Viral RNA Transcription and Replication,Homo sapiens,reactome | |
| 1260,R-HSA-168277,,Influenza Virus Induced Apoptosis,Homo sapiens,reactome | |
| 1261,R-HSA-997272,,Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits,Homo sapiens,reactome | |
| 1262,R-HSA-9670095,,Inhibition of DNA recombination at telomere,Homo sapiens,reactome | |
| 1263,R-HSA-168315,,Inhibition of Host mRNA Processing and RNA Silencing,Homo sapiens,reactome | |
| 1264,R-HSA-168888,,Inhibition of IFN-beta,Homo sapiens,reactome | |
| 1265,R-HSA-168305,,Inhibition of Interferon Synthesis,Homo sapiens,reactome | |
| 1266,R-HSA-169131,,Inhibition of PKR,Homo sapiens,reactome | |
| 1267,R-HSA-5638303,,Inhibition of Signaling by Overexpressed EGFR,Homo sapiens,reactome | |
| 1268,R-HSA-165181,,Inhibition of TSC complex formation by AKT (PKB),Homo sapiens,reactome | |
| 1269,R-HSA-9635644,,Inhibition of membrane repair,Homo sapiens,reactome | |
| 1270,R-HSA-9636249,,Inhibition of nitric oxide production,Homo sapiens,reactome | |
| 1271,R-HSA-113501,,Inhibition of replication initiation of damaged DNA by RB1/E2F1,Homo sapiens,reactome | |
| 1272,R-HSA-141405,,Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components,Homo sapiens,reactome | |
| 1273,R-HSA-166663,,Initial triggering of complement,Homo sapiens,reactome | |
| 1274,R-HSA-2995383,,Initiation of Nuclear Envelope (NE) Reformation,Homo sapiens,reactome | |
| 1275,R-HSA-9769735,,Initiation of coagulation cascade,Homo sapiens,reactome | |
| 1276,R-HSA-8876493,,InlA-mediated entry of Listeria monocytogenes into host cells,Homo sapiens,reactome | |
| 1277,R-HSA-8875360,,InlB-mediated entry of Listeria monocytogenes into host cell,Homo sapiens,reactome | |
| 1278,R-HSA-168249,,Innate Immune System,Homo sapiens,reactome | |
| 1279,R-HSA-427601,,Inorganic anion exchange by SLC26 transporters,Homo sapiens,reactome | |
| 1280,R-HSA-1483249,,Inositol phosphate metabolism,Homo sapiens,reactome | |
| 1281,R-HSA-429593,,Inositol transporters,Homo sapiens,reactome | |
| 1282,R-HSA-9609523,,Insertion of tail-anchored proteins into the endoplasmic reticulum membrane,Homo sapiens,reactome | |
| 1283,R-HSA-163754,,Insulin effects increased synthesis of Xylulose-5-Phosphate,Homo sapiens,reactome | |
| 1284,R-HSA-264876,,Insulin processing,Homo sapiens,reactome | |
| 1285,R-HSA-77387,,Insulin receptor recycling,Homo sapiens,reactome | |
| 1286,R-HSA-74751,,Insulin receptor signalling cascade,Homo sapiens,reactome | |
| 1287,R-HSA-428359,,Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA,Homo sapiens,reactome | |
| 1288,R-HSA-163685,,Integration of energy metabolism,Homo sapiens,reactome | |
| 1289,R-HSA-162592,,Integration of provirus,Homo sapiens,reactome | |
| 1290,R-HSA-175567,,Integration of viral DNA into host genomic DNA,Homo sapiens,reactome | |
| 1291,R-HSA-216083,,Integrin cell surface interactions,Homo sapiens,reactome | |
| 1292,R-HSA-354192,,Integrin signaling,Homo sapiens,reactome | |
| 1293,R-HSA-2534343,,Interaction With Cumulus Cells And The Zona Pellucida,Homo sapiens,reactome | |
| 1294,R-HSA-445095,,Interaction between L1 and Ankyrins,Homo sapiens,reactome | |
| 1295,R-HSA-8854521,,Interaction between PHLDA1 and AURKA,Homo sapiens,reactome | |
| 1296,R-HSA-9940951,,Interaction of NuRD complexes with transcription factors,Homo sapiens,reactome | |
| 1297,R-HSA-177243,,Interactions of Rev with host cellular proteins,Homo sapiens,reactome | |
| 1298,R-HSA-176034,,Interactions of Tat with host cellular proteins,Homo sapiens,reactome | |
| 1299,R-HSA-176033,,Interactions of Vpr with host cellular proteins,Homo sapiens,reactome | |
| 1300,R-HSA-880009,,Interconversion of 2-oxoglutarate and 2-hydroxyglutarate,Homo sapiens,reactome | |
| 1301,R-HSA-499943,,Interconversion of nucleotide di- and triphosphates,Homo sapiens,reactome | |
| 1302,R-HSA-351200,,Interconversion of polyamines,Homo sapiens,reactome | |
| 1303,R-HSA-913531,,Interferon Signaling,Homo sapiens,reactome | |
| 1304,R-HSA-909733,,Interferon alpha/beta signaling,Homo sapiens,reactome | |
| 1305,R-HSA-877300,,Interferon gamma signaling,Homo sapiens,reactome | |
| 1306,R-HSA-912526,,Interleukin receptor SHC signaling,Homo sapiens,reactome | |
| 1307,R-HSA-446652,,Interleukin-1 family signaling,Homo sapiens,reactome | |
| 1308,R-HSA-448706,,Interleukin-1 processing,Homo sapiens,reactome | |
| 1309,R-HSA-9020702,,Interleukin-1 signaling,Homo sapiens,reactome | |
| 1310,R-HSA-6783783,,Interleukin-10 signaling,Homo sapiens,reactome | |
| 1311,R-HSA-447115,,Interleukin-12 family signaling,Homo sapiens,reactome | |
| 1312,R-HSA-9020591,,Interleukin-12 signaling,Homo sapiens,reactome | |
| 1313,R-HSA-8983432,,Interleukin-15 signaling,Homo sapiens,reactome | |
| 1314,R-HSA-448424,,Interleukin-17 signaling,Homo sapiens,reactome | |
| 1315,R-HSA-9012546,,Interleukin-18 signaling,Homo sapiens,reactome | |
| 1316,R-HSA-451927,,Interleukin-2 family signaling,Homo sapiens,reactome | |
| 1317,R-HSA-9020558,,Interleukin-2 signaling,Homo sapiens,reactome | |
| 1318,R-HSA-8854691,,Interleukin-20 family signaling,Homo sapiens,reactome | |
| 1319,R-HSA-9020958,,Interleukin-21 signaling,Homo sapiens,reactome | |
| 1320,R-HSA-9020933,,Interleukin-23 signaling,Homo sapiens,reactome | |
| 1321,R-HSA-9020956,,Interleukin-27 signaling,Homo sapiens,reactome | |
| 1322,R-HSA-512988,,"Interleukin-3, Interleukin-5 and GM-CSF signaling",Homo sapiens,reactome | |
| 1323,R-HSA-9014843,,Interleukin-33 signaling,Homo sapiens,reactome | |
| 1324,R-HSA-8984722,,Interleukin-35 Signalling,Homo sapiens,reactome | |
| 1325,R-HSA-9014826,,Interleukin-36 pathway,Homo sapiens,reactome | |
| 1326,R-HSA-9008059,,Interleukin-37 signaling,Homo sapiens,reactome | |
| 1327,R-HSA-9007892,,Interleukin-38 signaling,Homo sapiens,reactome | |
| 1328,R-HSA-6785807,,Interleukin-4 and Interleukin-13 signaling,Homo sapiens,reactome | |
| 1329,R-HSA-6783589,,Interleukin-6 family signaling,Homo sapiens,reactome | |
| 1330,R-HSA-1059683,,Interleukin-6 signaling,Homo sapiens,reactome | |
| 1331,R-HSA-1266695,,Interleukin-7 signaling,Homo sapiens,reactome | |
| 1332,R-HSA-8985947,,Interleukin-9 signaling,Homo sapiens,reactome | |
| 1333,R-HSA-8963676,,Intestinal absorption,Homo sapiens,reactome | |
| 1334,R-HSA-8981373,,Intestinal hexose absorption,Homo sapiens,reactome | |
| 1335,R-HSA-8942233,,Intestinal infectious diseases,Homo sapiens,reactome | |
| 1336,R-HSA-8963678,,Intestinal lipid absorption,Homo sapiens,reactome | |
| 1337,R-HSA-5659898,,Intestinal saccharidase deficiencies,Homo sapiens,reactome | |
| 1338,R-HSA-6811442,,Intra-Golgi and retrograde Golgi-to-ER traffic,Homo sapiens,reactome | |
| 1339,R-HSA-6811438,,Intra-Golgi traffic,Homo sapiens,reactome | |
| 1340,R-HSA-434313,,Intracellular metabolism of fatty acids regulates insulin secretion,Homo sapiens,reactome | |
| 1341,R-HSA-8981607,,Intracellular oxygen transport,Homo sapiens,reactome | |
| 1342,R-HSA-9006925,,Intracellular signaling by second messengers,Homo sapiens,reactome | |
| 1343,R-HSA-5620924,,Intraflagellar transport,Homo sapiens,reactome | |
| 1344,R-HSA-109606,,Intrinsic Pathway for Apoptosis,Homo sapiens,reactome | |
| 1345,R-HSA-8941237,,Invadopodia formation,Homo sapiens,reactome | |
| 1346,R-HSA-1296065,,Inwardly rectifying K+ channels,Homo sapiens,reactome | |
| 1347,R-HSA-983712,,Ion channel transport,Homo sapiens,reactome | |
| 1348,R-HSA-5578775,,Ion homeostasis,Homo sapiens,reactome | |
| 1349,R-HSA-6803544,,Ion influx/efflux at host-pathogen interface,Homo sapiens,reactome | |
| 1350,R-HSA-936837,,Ion transport by P-type ATPases,Homo sapiens,reactome | |
| 1351,R-HSA-451306,,Ionotropic activity of kainate receptors,Homo sapiens,reactome | |
| 1352,R-HSA-9638334,,Iron assimilation using enterobactin,Homo sapiens,reactome | |
| 1353,R-HSA-917937,,Iron uptake and transport,Homo sapiens,reactome | |
| 1354,R-HSA-9914355,,Isovaleric acidemia,Homo sapiens,reactome | |
| 1355,R-HSA-450321,,JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1,Homo sapiens,reactome | |
| 1356,R-HSA-5689877,,Josephin domain DUBs,Homo sapiens,reactome | |
| 1357,R-HSA-9755511,,KEAP1-NFE2L2 pathway,Homo sapiens,reactome | |
| 1358,R-HSA-9669921,,KIT mutants bind TKIs,Homo sapiens,reactome | |
| 1359,R-HSA-450604,,KSRP (KHSRP) binds and destabilizes mRNA,Homo sapiens,reactome | |
| 1360,R-HSA-9702569,,KW2449-resistant FLT3 mutants,Homo sapiens,reactome | |
| 1361,R-HSA-2022854,,Keratan sulfate biosynthesis,Homo sapiens,reactome | |
| 1362,R-HSA-2022857,,Keratan sulfate degradation,Homo sapiens,reactome | |
| 1363,R-HSA-1638074,,Keratan sulfate/keratin metabolism,Homo sapiens,reactome | |
| 1364,R-HSA-6805567,,Keratinization,Homo sapiens,reactome | |
| 1365,R-HSA-74182,,Ketone body metabolism,Homo sapiens,reactome | |
| 1366,R-HSA-9830369,,Kidney development,Homo sapiens,reactome | |
| 1367,R-HSA-9664420,,Killing mechanisms,Homo sapiens,reactome | |
| 1368,R-HSA-983189,,Kinesins,Homo sapiens,reactome | |
| 1369,R-HSA-156827,,L13a-mediated translational silencing of Ceruloplasmin expression,Homo sapiens,reactome | |
| 1370,R-HSA-373760,,L1CAM interactions,Homo sapiens,reactome | |
| 1371,R-HSA-8964038,,LDL clearance,Homo sapiens,reactome | |
| 1372,R-HSA-8964041,,LDL remodeling,Homo sapiens,reactome | |
| 1373,R-HSA-5682910,,LGI-ADAM interactions,Homo sapiens,reactome | |
| 1374,R-HSA-5340573,,LGK974 inhibits PORCN,Homo sapiens,reactome | |
| 1375,R-HSA-3134973,,LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production,Homo sapiens,reactome | |
| 1376,R-HSA-9664535,,LTC4-CYSLTR mediated IL4 production,Homo sapiens,reactome | |
| 1377,R-HSA-5653890,,Lactose synthesis,Homo sapiens,reactome | |
| 1378,R-HSA-69186,,Lagging Strand Synthesis,Homo sapiens,reactome | |
| 1379,R-HSA-3000157,,Laminin interactions,Homo sapiens,reactome | |
| 1380,R-HSA-9969896,,Lanosterol biosynthesis,Homo sapiens,reactome | |
| 1381,R-HSA-162599,,Late Phase of HIV Life Cycle,Homo sapiens,reactome | |
| 1382,R-HSA-9772573,,Late SARS-CoV-2 Infection Events,Homo sapiens,reactome | |
| 1383,R-HSA-9615710,,Late endosomal microautophagy,Homo sapiens,reactome | |
| 1384,R-HSA-1222499,,Latent infection - Other responses of Mtb to phagocytosis,Homo sapiens,reactome | |
| 1385,R-HSA-69109,,Leading Strand Synthesis,Homo sapiens,reactome | |
| 1386,R-HSA-166662,,Lectin pathway of complement activation,Homo sapiens,reactome | |
| 1387,R-HSA-9658195,,Leishmania infection,Homo sapiens,reactome | |
| 1388,R-HSA-9664433,,Leishmania parasite growth and survival,Homo sapiens,reactome | |
| 1389,R-HSA-9664417,,Leishmania phagocytosis,Homo sapiens,reactome | |
| 1390,R-HSA-391906,,Leukotriene receptors,Homo sapiens,reactome | |
| 1391,R-HSA-9037629,,Lewis blood group biosynthesis,Homo sapiens,reactome | |
| 1392,R-HSA-5632681,,Ligand-receptor interactions,Homo sapiens,reactome | |
| 1393,R-HSA-2046105,,Linoleic acid (LA) metabolism,Homo sapiens,reactome | |
| 1394,R-HSA-8964572,,Lipid particle organization,Homo sapiens,reactome | |
| 1395,R-HSA-9613354,,Lipophagy,Homo sapiens,reactome | |
| 1396,R-HSA-8876384,,Listeria monocytogenes entry into host cells,Homo sapiens,reactome | |
| 1397,R-HSA-446343,,Localization of the PINCH-ILK-PARVIN complex to focal adhesions,Homo sapiens,reactome | |
| 1398,R-HSA-9620244,,Long-term potentiation,Homo sapiens,reactome | |
| 1399,R-HSA-2644607,,Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling,Homo sapiens,reactome | |
| 1400,R-HSA-9944971,,Loss of Function of KMT2D in Kabuki Syndrome,Homo sapiens,reactome | |
| 1401,R-HSA-9944997,,Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome,Homo sapiens,reactome | |
| 1402,R-HSA-3304349,,Loss of Function of SMAD2/3 in Cancer,Homo sapiens,reactome | |
| 1403,R-HSA-3304347,,Loss of Function of SMAD4 in Cancer,Homo sapiens,reactome | |
| 1404,R-HSA-3656534,,Loss of Function of TGFBR1 in Cancer,Homo sapiens,reactome | |
| 1405,R-HSA-3642278,,Loss of Function of TGFBR2 in Cancer,Homo sapiens,reactome | |
| 1406,R-HSA-9723907,,Loss of Function of TP53 in Cancer,Homo sapiens,reactome | |
| 1407,R-HSA-9022534,,Loss of MECP2 binding ability to 5hmC-DNA,Homo sapiens,reactome | |
| 1408,R-HSA-9022538,,Loss of MECP2 binding ability to 5mC-DNA,Homo sapiens,reactome | |
| 1409,R-HSA-9022537,,Loss of MECP2 binding ability to the NCoR/SMRT complex,Homo sapiens,reactome | |
| 1410,R-HSA-380259,,Loss of Nlp from mitotic centrosomes,Homo sapiens,reactome | |
| 1411,R-HSA-9005891,,Loss of function of MECP2 in Rett syndrome,Homo sapiens,reactome | |
| 1412,R-HSA-9723905,,Loss of function of TP53 in cancer due to loss of tetramerization ability,Homo sapiens,reactome | |
| 1413,R-HSA-9022535,,Loss of phosphorylation of MECP2 at T308,Homo sapiens,reactome | |
| 1414,R-HSA-380284,,Loss of proteins required for interphase microtubule organization from the centrosome,Homo sapiens,reactome | |
| 1415,R-HSA-9865125,,Loss-of-function mutations in BCKDHA or BCKDHB cause MSUD,Homo sapiens,reactome | |
| 1416,R-HSA-9865113,,Loss-of-function mutations in DBT cause MSUD2,Homo sapiens,reactome | |
| 1417,R-HSA-9907570,,Loss-of-function mutations in DLD cause MSUD3/DLDD,Homo sapiens,reactome | |
| 1418,R-HSA-71064,,Lysine catabolism,Homo sapiens,reactome | |
| 1419,R-HSA-8853383,,Lysosomal oligosaccharide catabolism,Homo sapiens,reactome | |
| 1420,R-HSA-432720,,Lysosome Vesicle Biogenesis,Homo sapiens,reactome | |
| 1421,R-HSA-419408,,Lysosphingolipid and LPA receptors,Homo sapiens,reactome | |
| 1422,R-HSA-68886,,M Phase,Homo sapiens,reactome | |
| 1423,R-HSA-9820841,,M-decay: degradation of maternal mRNAs by maternally stored factors,Homo sapiens,reactome | |
| 1424,R-HSA-450294,,MAP kinase activation,Homo sapiens,reactome | |
| 1425,R-HSA-5674135,,MAP2K and MAPK activation,Homo sapiens,reactome | |
| 1426,R-HSA-5684264,,MAP3K8 (TPL2)-dependent MAPK1/3 activation,Homo sapiens,reactome | |
| 1427,R-HSA-5683057,,MAPK family signaling cascades,Homo sapiens,reactome | |
| 1428,R-HSA-450282,,MAPK targets/ Nuclear events mediated by MAP kinases,Homo sapiens,reactome | |
| 1429,R-HSA-112411,,MAPK1 (ERK2) activation,Homo sapiens,reactome | |
| 1430,R-HSA-5684996,,MAPK1/MAPK3 signaling,Homo sapiens,reactome | |
| 1431,R-HSA-110056,,MAPK3 (ERK1) activation,Homo sapiens,reactome | |
| 1432,R-HSA-5687128,,MAPK6/MAPK4 signaling,Homo sapiens,reactome | |
| 1433,R-HSA-2465910,,MASTL Facilitates Mitotic Progression,Homo sapiens,reactome | |
| 1434,R-HSA-9851151,,MDK and PTN in ALK signaling,Homo sapiens,reactome | |
| 1435,R-HSA-9022699,,MECP2 regulates neuronal receptors and channels,Homo sapiens,reactome | |
| 1436,R-HSA-9022707,,MECP2 regulates transcription factors,Homo sapiens,reactome | |
| 1437,R-HSA-9022927,,MECP2 regulates transcription of genes involved in GABA signaling,Homo sapiens,reactome | |
| 1438,R-HSA-9022702,,MECP2 regulates transcription of neuronal ligands,Homo sapiens,reactome | |
| 1439,R-HSA-6806942,,MET Receptor Activation,Homo sapiens,reactome | |
| 1440,R-HSA-8851907,,MET activates PI3K/AKT signaling,Homo sapiens,reactome | |
| 1441,R-HSA-8874081,,MET activates PTK2 signaling,Homo sapiens,reactome | |
| 1442,R-HSA-8865999,,MET activates PTPN11,Homo sapiens,reactome | |
| 1443,R-HSA-8875555,,MET activates RAP1 and RAC1,Homo sapiens,reactome | |
| 1444,R-HSA-8851805,,MET activates RAS signaling,Homo sapiens,reactome | |
| 1445,R-HSA-8875791,,MET activates STAT3,Homo sapiens,reactome | |
| 1446,R-HSA-8875513,,MET interacts with TNS proteins,Homo sapiens,reactome | |
| 1447,R-HSA-8875878,,MET promotes cell motility,Homo sapiens,reactome | |
| 1448,R-HSA-8875656,,MET receptor recycling,Homo sapiens,reactome | |
| 1449,R-HSA-5657655,,MGMT-mediated DNA damage reversal,Homo sapiens,reactome | |
| 1450,R-HSA-2132295,,MHC class II antigen presentation,Homo sapiens,reactome | |
| 1451,R-HSA-9856651,,MITF-M-dependent gene expression,Homo sapiens,reactome | |
| 1452,R-HSA-9730414,,MITF-M-regulated melanocyte development,Homo sapiens,reactome | |
| 1453,R-HSA-9841922,,MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis,Homo sapiens,reactome | |
| 1454,R-HSA-9953038,,MPS I - Hurler syndrome (CS/DS degradation),Homo sapiens,reactome | |
| 1455,R-HSA-2206302,,MPS I - Hurler syndrome (HS-GAG degradation),Homo sapiens,reactome | |
| 1456,R-HSA-9953078,,MPS II - Hunter syndrome (CS/DS degradation),Homo sapiens,reactome | |
| 1457,R-HSA-2206296,,MPS II - Hunter syndrome (HS-GAG degradation),Homo sapiens,reactome | |
| 1458,R-HSA-2206307,,MPS IIIA - Sanfilippo syndrome A,Homo sapiens,reactome | |
| 1459,R-HSA-2206282,,MPS IIIB - Sanfilippo syndrome B,Homo sapiens,reactome | |
| 1460,R-HSA-2206291,,MPS IIIC - Sanfilippo syndrome C,Homo sapiens,reactome | |
| 1461,R-HSA-2206305,,MPS IIID - Sanfilippo syndrome D,Homo sapiens,reactome | |
| 1462,R-HSA-2206290,,MPS IV - Morquio syndrome A,Homo sapiens,reactome | |
| 1463,R-HSA-9953111,,MPS IV - Morquio syndrome B (CS/DS degradation),Homo sapiens,reactome | |
| 1464,R-HSA-2206308,,MPS IV - Morquio syndrome B (Keratin metabolism),Homo sapiens,reactome | |
| 1465,R-HSA-9953097,,MPS IX - Natowicz syndrome (CS/DS degradation),Homo sapiens,reactome | |
| 1466,R-HSA-2206280,,MPS IX - Natowicz syndrome (Hyaluronan metabolism),Homo sapiens,reactome | |
| 1467,R-HSA-2206285,,MPS VI - Maroteaux-Lamy syndrome,Homo sapiens,reactome | |
| 1468,R-HSA-9953080,,MPS VII - Sly syndrome (CS/DS degradation),Homo sapiens,reactome | |
| 1469,R-HSA-2206292,,MPS VII - Sly syndrome (Hyaluronan metabolism),Homo sapiens,reactome | |
| 1470,R-HSA-5660489,,MTF1 activates gene expression,Homo sapiens,reactome | |
| 1471,R-HSA-165159,,MTOR signalling,Homo sapiens,reactome | |
| 1472,R-HSA-1632852,,Macroautophagy,Homo sapiens,reactome | |
| 1473,R-HSA-6791226,,Major pathway of rRNA processing in the nucleolus and cytosol,Homo sapiens,reactome | |
| 1474,R-HSA-9856872,,Malate-aspartate shuttle,Homo sapiens,reactome | |
| 1475,R-HSA-9636667,,Manipulation of host energy metabolism,Homo sapiens,reactome | |
| 1476,R-HSA-9865114,,Maple Syrup Urine Disease,Homo sapiens,reactome | |
| 1477,R-HSA-9669924,,Masitinib-resistant KIT mutants,Homo sapiens,reactome | |
| 1478,R-HSA-9816359,,Maternal to zygotic transition (MZT),Homo sapiens,reactome | |
| 1479,R-HSA-9939291,,Matriglycan biosynthesis on DAG1,Homo sapiens,reactome | |
| 1480,R-HSA-9918432,,Maturation of DENV proteins,Homo sapiens,reactome | |
| 1481,R-HSA-9854311,,Maturation of TCA enzymes and regulation of TCA cycle,Homo sapiens,reactome | |
| 1482,R-HSA-9828806,,Maturation of hRSV A proteins,Homo sapiens,reactome | |
| 1483,R-HSA-9683610,,Maturation of nucleoprotein,Homo sapiens,reactome | |
| 1484,R-HSA-9694631,,Maturation of nucleoprotein,Homo sapiens,reactome | |
| 1485,R-HSA-9683673,,Maturation of protein 3a,Homo sapiens,reactome | |
| 1486,R-HSA-9694719,,Maturation of protein 3a,Homo sapiens,reactome | |
| 1487,R-HSA-9683683,,Maturation of protein E,Homo sapiens,reactome | |
| 1488,R-HSA-9694493,,Maturation of protein E,Homo sapiens,reactome | |
| 1489,R-HSA-9683612,,Maturation of protein M,Homo sapiens,reactome | |
| 1490,R-HSA-9694594,,Maturation of protein M,Homo sapiens,reactome | |
| 1491,R-HSA-9684325,,Maturation of replicase proteins,Homo sapiens,reactome | |
| 1492,R-HSA-9694301,,Maturation of replicase proteins,Homo sapiens,reactome | |
| 1493,R-HSA-9683686,,Maturation of spike protein,Homo sapiens,reactome | |
| 1494,R-HSA-9694548,,Maturation of spike protein,Homo sapiens,reactome | |
| 1495,R-HSA-9856532,,Mechanical load activates signaling by PIEZO1 and integrins in osteocytes,Homo sapiens,reactome | |
| 1496,R-HSA-1500620,,Meiosis,Homo sapiens,reactome | |
| 1497,R-HSA-912446,,Meiotic recombination,Homo sapiens,reactome | |
| 1498,R-HSA-1221632,,Meiotic synapsis,Homo sapiens,reactome | |
| 1499,R-HSA-5662702,,Melanin biosynthesis,Homo sapiens,reactome | |
| 1500,R-HSA-199991,,Membrane Trafficking,Homo sapiens,reactome | |
| 1501,R-HSA-174490,,Membrane binding and targetting of GAG proteins,Homo sapiens,reactome | |
| 1502,R-HSA-5579029,,Metabolic disorders of biological oxidation enzymes,Homo sapiens,reactome | |
| 1503,R-HSA-1430728,,Metabolism,Homo sapiens,reactome | |
| 1504,R-HSA-2022377,,Metabolism of Angiotensinogen to Angiotensins,Homo sapiens,reactome | |
| 1505,R-HSA-8953854,,Metabolism of RNA,Homo sapiens,reactome | |
| 1506,R-HSA-209776,,Metabolism of amine-derived hormones,Homo sapiens,reactome | |
| 1507,R-HSA-71291,,Metabolism of amino acids and derivatives,Homo sapiens,reactome | |
| 1508,R-HSA-71387,,Metabolism of carbohydrates and carbohydrate derivatives,Homo sapiens,reactome | |
| 1509,R-HSA-8978934,,Metabolism of cofactors,Homo sapiens,reactome | |
| 1510,R-HSA-6806667,,Metabolism of fat-soluble vitamins,Homo sapiens,reactome | |
| 1511,R-HSA-196757,,Metabolism of folate and pterines,Homo sapiens,reactome | |
| 1512,R-HSA-2408550,,Metabolism of ingested H2SeO4 and H2SeO3 into H2Se,Homo sapiens,reactome | |
| 1513,R-HSA-5263617,,Metabolism of ingested MeSeO2H into MeSeH,Homo sapiens,reactome | |
| 1514,R-HSA-2408508,,"Metabolism of ingested SeMet, Sec, MeSec into H2Se",Homo sapiens,reactome | |
| 1515,R-HSA-556833,,Metabolism of lipids,Homo sapiens,reactome | |
| 1516,R-HSA-202131,,Metabolism of nitric oxide: NOS3 activation and regulation,Homo sapiens,reactome | |
| 1517,R-HSA-194441,,Metabolism of non-coding RNA,Homo sapiens,reactome | |
| 1518,R-HSA-15869,,Metabolism of nucleotides,Homo sapiens,reactome | |
| 1519,R-HSA-351202,,Metabolism of polyamines,Homo sapiens,reactome | |
| 1520,R-HSA-189445,,Metabolism of porphyrins,Homo sapiens,reactome | |
| 1521,R-HSA-392499,,Metabolism of proteins,Homo sapiens,reactome | |
| 1522,R-HSA-380612,,Metabolism of serotonin,Homo sapiens,reactome | |
| 1523,R-HSA-196071,,Metabolism of steroid hormones,Homo sapiens,reactome | |
| 1524,R-HSA-8957322,,Metabolism of steroids,Homo sapiens,reactome | |
| 1525,R-HSA-6806664,,Metabolism of vitamin K,Homo sapiens,reactome | |
| 1526,R-HSA-196854,,Metabolism of vitamins and cofactors,Homo sapiens,reactome | |
| 1527,R-HSA-196849,,Metabolism of water-soluble vitamins and cofactors,Homo sapiens,reactome | |
| 1528,R-HSA-425410,,Metal ion SLC transporters,Homo sapiens,reactome | |
| 1529,R-HSA-9638482,,Metal ion assimilation from the host,Homo sapiens,reactome | |
| 1530,R-HSA-6799990,,Metal sequestration by antimicrobial proteins,Homo sapiens,reactome | |
| 1531,R-HSA-5689901,,Metalloprotease DUBs,Homo sapiens,reactome | |
| 1532,R-HSA-5661231,,Metallothioneins bind metals,Homo sapiens,reactome | |
| 1533,R-HSA-1237112,,Methionine salvage pathway,Homo sapiens,reactome | |
| 1534,R-HSA-156581,,Methylation,Homo sapiens,reactome | |
| 1535,R-HSA-2408552,,Methylation of MeSeH for excretion,Homo sapiens,reactome | |
| 1536,R-HSA-203927,,MicroRNA (miRNA) biogenesis,Homo sapiens,reactome | |
| 1537,R-HSA-9686347,,Microbial modulation of RIPK1-mediated regulated necrosis,Homo sapiens,reactome | |
| 1538,R-HSA-190840,,Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane,Homo sapiens,reactome | |
| 1539,R-HSA-193993,,Mineralocorticoid biosynthesis,Homo sapiens,reactome | |
| 1540,R-HSA-164516,,Minus-strand DNA synthesis,Homo sapiens,reactome | |
| 1541,R-HSA-9715370,,Miro GTPase Cycle,Homo sapiens,reactome | |
| 1542,R-HSA-211958,,Miscellaneous substrates,Homo sapiens,reactome | |
| 1543,R-HSA-5223345,,Miscellaneous transport and binding events,Homo sapiens,reactome | |
| 1544,R-HSA-5358508,,Mismatch Repair,Homo sapiens,reactome | |
| 1545,R-HSA-5358606,,Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta),Homo sapiens,reactome | |
| 1546,R-HSA-5358565,,Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha),Homo sapiens,reactome | |
| 1547,R-HSA-1369007,,Mitochondrial ABC transporters,Homo sapiens,reactome | |
| 1548,R-HSA-77289,,Mitochondrial Fatty Acid Beta-Oxidation,Homo sapiens,reactome | |
| 1549,R-HSA-9836573,,Mitochondrial RNA degradation,Homo sapiens,reactome | |
| 1550,R-HSA-166187,,Mitochondrial Uncoupling,Homo sapiens,reactome | |
| 1551,R-HSA-1592230,,Mitochondrial biogenesis,Homo sapiens,reactome | |
| 1552,R-HSA-8949215,,Mitochondrial calcium ion transport,Homo sapiens,reactome | |
| 1553,R-HSA-1362409,,Mitochondrial iron-sulfur cluster biogenesis,Homo sapiens,reactome | |
| 1554,R-HSA-9937008,,Mitochondrial mRNA modification,Homo sapiens,reactome | |
| 1555,R-HSA-9837999,,Mitochondrial protein degradation,Homo sapiens,reactome | |
| 1556,R-HSA-1268020,,Mitochondrial protein import,Homo sapiens,reactome | |
| 1557,R-HSA-9937383,,Mitochondrial ribosome-associated quality control,Homo sapiens,reactome | |
| 1558,R-HSA-9916720,,Mitochondrial short-chain enoyl-CoA hydratase deficiency 1,Homo sapiens,reactome | |
| 1559,R-HSA-379726,,Mitochondrial tRNA aminoacylation,Homo sapiens,reactome | |
| 1560,R-HSA-163282,,Mitochondrial transcription initiation,Homo sapiens,reactome | |
| 1561,R-HSA-163316,,Mitochondrial transcription termination,Homo sapiens,reactome | |
| 1562,R-HSA-5368287,,Mitochondrial translation,Homo sapiens,reactome | |
| 1563,R-HSA-5389840,,Mitochondrial translation elongation,Homo sapiens,reactome | |
| 1564,R-HSA-5368286,,Mitochondrial translation initiation,Homo sapiens,reactome | |
| 1565,R-HSA-5419276,,Mitochondrial translation termination,Homo sapiens,reactome | |
| 1566,R-HSA-9841251,,Mitochondrial unfolded protein response (UPRmt),Homo sapiens,reactome | |
| 1567,R-HSA-5205647,,Mitophagy,Homo sapiens,reactome | |
| 1568,R-HSA-68882,,Mitotic Anaphase,Homo sapiens,reactome | |
| 1569,R-HSA-453279,,Mitotic G1 phase and G1/S transition,Homo sapiens,reactome | |
| 1570,R-HSA-453274,,Mitotic G2-G2/M phases,Homo sapiens,reactome | |
| 1571,R-HSA-2555396,,Mitotic Metaphase and Anaphase,Homo sapiens,reactome | |
| 1572,R-HSA-68881,,Mitotic Metaphase/Anaphase Transition,Homo sapiens,reactome | |
| 1573,R-HSA-68877,,Mitotic Prometaphase,Homo sapiens,reactome | |
| 1574,R-HSA-68875,,Mitotic Prophase,Homo sapiens,reactome | |
| 1575,R-HSA-69618,,Mitotic Spindle Checkpoint,Homo sapiens,reactome | |
| 1576,R-HSA-68884,,Mitotic Telophase/Cytokinesis,Homo sapiens,reactome | |
| 1577,R-HSA-9637628,,Modulation by Mtb of host immune system,Homo sapiens,reactome | |
| 1578,R-HSA-9909505,,Modulation of host responses by IFN-stimulated genes,Homo sapiens,reactome | |
| 1579,R-HSA-2129379,,Molecules associated with elastic fibres,Homo sapiens,reactome | |
| 1580,R-HSA-947581,,Molybdenum cofactor biosynthesis,Homo sapiens,reactome | |
| 1581,R-HSA-1222449,,Mtb iron assimilation by chelation,Homo sapiens,reactome | |
| 1582,R-HSA-2206281,,Mucopolysaccharidoses,Homo sapiens,reactome | |
| 1583,R-HSA-390648,,Muscarinic acetylcholine receptors,Homo sapiens,reactome | |
| 1584,R-HSA-397014,,Muscle contraction,Homo sapiens,reactome | |
| 1585,R-HSA-975871,,MyD88 cascade initiated on plasma membrane,Homo sapiens,reactome | |
| 1586,R-HSA-5602498,,MyD88 deficiency (TLR2/4),Homo sapiens,reactome | |
| 1587,R-HSA-5602680,,MyD88 deficiency (TLR5),Homo sapiens,reactome | |
| 1588,R-HSA-975155,,MyD88 dependent cascade initiated on endosome,Homo sapiens,reactome | |
| 1589,R-HSA-166166,,MyD88-independent TLR4 cascade,Homo sapiens,reactome | |
| 1590,R-HSA-166058,,MyD88:MAL(TIRAP) cascade initiated on plasma membrane,Homo sapiens,reactome | |
| 1591,R-HSA-3785653,,Myoclonic epilepsy of Lafora,Homo sapiens,reactome | |
| 1592,R-HSA-525793,,Myogenesis,Homo sapiens,reactome | |
| 1593,R-HSA-975577,,N-Glycan antennae elongation,Homo sapiens,reactome | |
| 1594,R-HSA-975576,,N-glycan antennae elongation in the medial/trans-Golgi,Homo sapiens,reactome | |
| 1595,R-HSA-964739,,N-glycan trimming and elongation in the cis-Golgi,Homo sapiens,reactome | |
| 1596,R-HSA-532668,,N-glycan trimming in the ER and Calnexin/Calreticulin cycle,Homo sapiens,reactome | |
| 1597,R-HSA-205025,,NADE modulates death signalling,Homo sapiens,reactome | |
| 1598,R-HSA-389542,,NADPH regeneration,Homo sapiens,reactome | |
| 1599,R-HSA-9955693,,NAGS variants cause NAGS deficiency,Homo sapiens,reactome | |
| 1600,R-HSA-375165,,NCAM signaling for neurite out-growth,Homo sapiens,reactome | |
| 1601,R-HSA-419037,,NCAM1 interactions,Homo sapiens,reactome | |
| 1602,R-HSA-9636003,,NEIL3-mediated resolution of ICLs,Homo sapiens,reactome | |
| 1603,R-HSA-168333,,NEP/NS2 Interacts with the Cellular Export Machinery,Homo sapiens,reactome | |
| 1604,R-HSA-933543,,NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10,Homo sapiens,reactome | |
| 1605,R-HSA-209560,,NF-kB is activated and signals survival,Homo sapiens,reactome | |
| 1606,R-HSA-9818028,,NFE2L2 regulates pentose phosphate pathway genes,Homo sapiens,reactome | |
| 1607,R-HSA-9818035,,NFE2L2 regulating ER-stress associated genes,Homo sapiens,reactome | |
| 1608,R-HSA-9818032,,NFE2L2 regulating MDR associated enzymes,Homo sapiens,reactome | |
| 1609,R-HSA-9818025,,NFE2L2 regulating TCA cycle genes,Homo sapiens,reactome | |
| 1610,R-HSA-9818027,,NFE2L2 regulating anti-oxidant/detoxification enzymes,Homo sapiens,reactome | |
| 1611,R-HSA-9818026,,NFE2L2 regulating inflammation associated genes,Homo sapiens,reactome | |
| 1612,R-HSA-9818030,,NFE2L2 regulating tumorigenic genes,Homo sapiens,reactome | |
| 1613,R-HSA-205017,,NFG and proNGF binds to p75NTR,Homo sapiens,reactome | |
| 1614,R-HSA-167060,,NGF processing,Homo sapiens,reactome | |
| 1615,R-HSA-187024,,NGF-independant TRKA activation,Homo sapiens,reactome | |
| 1616,R-HSA-9031628,,NGF-stimulated transcription,Homo sapiens,reactome | |
| 1617,R-HSA-5676590,,NIK-->noncanonical NF-kB signaling,Homo sapiens,reactome | |
| 1618,R-HSA-168638,,NOD1/2 Signaling Pathway,Homo sapiens,reactome | |
| 1619,R-HSA-203754,,NOSIP mediated eNOS trafficking,Homo sapiens,reactome | |
| 1620,R-HSA-203641,,NOSTRIN mediated eNOS trafficking,Homo sapiens,reactome | |
| 1621,R-HSA-2122947,,NOTCH1 Intracellular Domain Regulates Transcription,Homo sapiens,reactome | |
| 1622,R-HSA-2979096,,NOTCH2 Activation and Transmission of Signal to the Nucleus,Homo sapiens,reactome | |
| 1623,R-HSA-2197563,,NOTCH2 intracellular domain regulates transcription,Homo sapiens,reactome | |
| 1624,R-HSA-9013507,,NOTCH3 Activation and Transmission of Signal to the Nucleus,Homo sapiens,reactome | |
| 1625,R-HSA-9013508,,NOTCH3 Intracellular Domain Regulates Transcription,Homo sapiens,reactome | |
| 1626,R-HSA-9013700,,NOTCH4 Activation and Transmission of Signal to the Nucleus,Homo sapiens,reactome | |
| 1627,R-HSA-9013695,,NOTCH4 Intracellular Domain Regulates Transcription,Homo sapiens,reactome | |
| 1628,R-HSA-9768919,,NPAS4 regulates expression of target genes,Homo sapiens,reactome | |
| 1629,R-HSA-9632974,,NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis,Homo sapiens,reactome | |
| 1630,R-HSA-9029558,,NR1H2 & NR1H3 regulate gene expression linked to lipogenesis,Homo sapiens,reactome | |
| 1631,R-HSA-9031528,,NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose,Homo sapiens,reactome | |
| 1632,R-HSA-9623433,,NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis,Homo sapiens,reactome | |
| 1633,R-HSA-9031525,,NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake,Homo sapiens,reactome | |
| 1634,R-HSA-9024446,,NR1H2 and NR1H3-mediated signaling,Homo sapiens,reactome | |
| 1635,R-HSA-9029569,,NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux,Homo sapiens,reactome | |
| 1636,R-HSA-193648,,NRAGE signals death through JNK,Homo sapiens,reactome | |
| 1637,R-HSA-205043,,NRIF signals cell death from the nucleus,Homo sapiens,reactome | |
| 1638,R-HSA-168276,,NS1 Mediated Effects on Host Pathways,Homo sapiens,reactome | |
| 1639,R-HSA-9025046,,NTF3 activates NTRK2 (TRKB) signaling,Homo sapiens,reactome | |
| 1640,R-HSA-9034013,,NTF3 activates NTRK3 signaling,Homo sapiens,reactome | |
| 1641,R-HSA-9026357,,NTF4 activates NTRK2 (TRKB) signaling,Homo sapiens,reactome | |
| 1642,R-HSA-9032759,,NTRK2 activates RAC1,Homo sapiens,reactome | |
| 1643,R-HSA-9603505,,NTRK3 as a dependence receptor,Homo sapiens,reactome | |
| 1644,R-HSA-9717301,,NVP-TAE684-resistant ALK mutants,Homo sapiens,reactome | |
| 1645,R-HSA-420597,,Nectin/Necl trans heterodimerization,Homo sapiens,reactome | |
| 1646,R-HSA-8951664,,Neddylation,Homo sapiens,reactome | |
| 1647,R-HSA-167590,,Nef Mediated CD4 Down-regulation,Homo sapiens,reactome | |
| 1648,R-HSA-182218,,Nef Mediated CD8 Down-regulation,Homo sapiens,reactome | |
| 1649,R-HSA-164944,,Nef and signal transduction,Homo sapiens,reactome | |
| 1650,R-HSA-164939,,Nef mediated downregulation of CD28 cell surface expression,Homo sapiens,reactome | |
| 1651,R-HSA-164940,,Nef mediated downregulation of MHC class I complex cell surface expression,Homo sapiens,reactome | |
| 1652,R-HSA-164938,,Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters,Homo sapiens,reactome | |
| 1653,R-HSA-9764725,,Negative Regulation of CDH1 Gene Transcription,Homo sapiens,reactome | |
| 1654,R-HSA-9974237,,Negative Regulation of DNA Double Strand Break Response,Homo sapiens,reactome | |
| 1655,R-HSA-5250941,,Negative epigenetic regulation of rRNA expression,Homo sapiens,reactome | |
| 1656,R-HSA-5674499,,Negative feedback regulation of MAPK pathway,Homo sapiens,reactome | |
| 1657,R-HSA-5654726,,Negative regulation of FGFR1 signaling,Homo sapiens,reactome | |
| 1658,R-HSA-5654727,,Negative regulation of FGFR2 signaling,Homo sapiens,reactome | |
| 1659,R-HSA-5654732,,Negative regulation of FGFR3 signaling,Homo sapiens,reactome | |
| 1660,R-HSA-5654733,,Negative regulation of FGFR4 signaling,Homo sapiens,reactome | |
| 1661,R-HSA-9706369,,Negative regulation of FLT3,Homo sapiens,reactome | |
| 1662,R-HSA-5675221,,Negative regulation of MAPK pathway,Homo sapiens,reactome | |
| 1663,R-HSA-6807004,,Negative regulation of MET activity,Homo sapiens,reactome | |
| 1664,R-HSA-9617324,,Negative regulation of NMDA receptor-mediated neuronal transmission,Homo sapiens,reactome | |
| 1665,R-HSA-9604323,,Negative regulation of NOTCH4 signaling,Homo sapiens,reactome | |
| 1666,R-HSA-5368598,,Negative regulation of TCF-dependent signaling by DVL-interacting proteins,Homo sapiens,reactome | |
| 1667,R-HSA-3772470,,Negative regulation of TCF-dependent signaling by WNT ligand antagonists,Homo sapiens,reactome | |
| 1668,R-HSA-8866904,,Negative regulation of activity of TFAP2 (AP-2) family transcription factors,Homo sapiens,reactome | |
| 1669,R-HSA-199418,,Negative regulation of the PI3K/AKT network,Homo sapiens,reactome | |
| 1670,R-HSA-936440,,Negative regulators of DDX58/IFIH1 signaling,Homo sapiens,reactome | |
| 1671,R-HSA-9988426,,Negative transcriptional regulation of urea cycle enzymes,Homo sapiens,reactome | |
| 1672,R-HSA-373753,,Nephrin family interactions,Homo sapiens,reactome | |
| 1673,R-HSA-9831926,,Nephron development,Homo sapiens,reactome | |
| 1674,R-HSA-9675108,,Nervous system development,Homo sapiens,reactome | |
| 1675,R-HSA-418886,,Netrin mediated repulsion signals,Homo sapiens,reactome | |
| 1676,R-HSA-373752,,Netrin-1 signaling,Homo sapiens,reactome | |
| 1677,R-HSA-6794361,,Neurexins and neuroligins,Homo sapiens,reactome | |
| 1678,R-HSA-8863678,,Neurodegenerative Diseases,Homo sapiens,reactome | |
| 1679,R-HSA-447043,,Neurofascin interactions,Homo sapiens,reactome | |
| 1680,R-HSA-112316,,Neuronal System,Homo sapiens,reactome | |
| 1681,R-HSA-194306,,Neuropilin interactions with VEGF and VEGFR,Homo sapiens,reactome | |
| 1682,R-HSA-168799,,Neurotoxicity of clostridium toxins,Homo sapiens,reactome | |
| 1683,R-HSA-112311,,Neurotransmitter clearance,Homo sapiens,reactome | |
| 1684,R-HSA-112314,,Neurotransmitter receptors and postsynaptic signal transmission,Homo sapiens,reactome | |
| 1685,R-HSA-112310,,Neurotransmitter release cycle,Homo sapiens,reactome | |
| 1686,R-HSA-112313,,Neurotransmitter uptake and metabolism In glial cells,Homo sapiens,reactome | |
| 1687,R-HSA-6798695,,Neutrophil degranulation,Homo sapiens,reactome | |
| 1688,R-HSA-196807,,Nicotinate metabolism,Homo sapiens,reactome | |
| 1689,R-HSA-9669926,,Nilotinib-resistant KIT mutants,Homo sapiens,reactome | |
| 1690,R-HSA-392154,,Nitric oxide stimulates guanylate cyclase,Homo sapiens,reactome | |
| 1691,R-HSA-427413,,NoRC negatively regulates rRNA expression,Homo sapiens,reactome | |
| 1692,R-HSA-9686114,,Non-canonical inflammasome activation,Homo sapiens,reactome | |
| 1693,R-HSA-3000171,,Non-integrin membrane-ECM interactions,Homo sapiens,reactome | |
| 1694,R-HSA-9017802,,Noncanonical activation of NOTCH3,Homo sapiens,reactome | |
| 1695,R-HSA-5693571,,Nonhomologous End-Joining (NHEJ),Homo sapiens,reactome | |
| 1696,R-HSA-975957,,Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC),Homo sapiens,reactome | |
| 1697,R-HSA-975956,,Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),Homo sapiens,reactome | |
| 1698,R-HSA-927802,,Nonsense-Mediated Decay (NMD),Homo sapiens,reactome | |
| 1699,R-HSA-181430,,Norepinephrine Neurotransmitter Release Cycle,Homo sapiens,reactome | |
| 1700,R-HSA-350054,,Notch-HLH transcription pathway,Homo sapiens,reactome | |
| 1701,R-HSA-447038,,NrCAM interactions,Homo sapiens,reactome | |
| 1702,R-HSA-9937850,,NuRD complex assembly,Homo sapiens,reactome | |
| 1703,R-HSA-2995410,,Nuclear Envelope (NE) Reassembly,Homo sapiens,reactome | |
| 1704,R-HSA-2980766,,Nuclear Envelope Breakdown,Homo sapiens,reactome | |
| 1705,R-HSA-198725,,Nuclear Events (kinase and transcription factor activation),Homo sapiens,reactome | |
| 1706,R-HSA-3301854,,Nuclear Pore Complex (NPC) Disassembly,Homo sapiens,reactome | |
| 1707,R-HSA-9930044,,Nuclear RNA decay,Homo sapiens,reactome | |
| 1708,R-HSA-383280,,Nuclear Receptor transcription pathway,Homo sapiens,reactome | |
| 1709,R-HSA-9759194,,Nuclear events mediated by NFE2L2,Homo sapiens,reactome | |
| 1710,R-HSA-9725371,,Nuclear events stimulated by ALK signaling in cancer,Homo sapiens,reactome | |
| 1711,R-HSA-180746,,Nuclear import of Rev protein,Homo sapiens,reactome | |
| 1712,R-HSA-1251985,,Nuclear signaling by ERBB4,Homo sapiens,reactome | |
| 1713,R-HSA-774815,,Nucleosome assembly,Homo sapiens,reactome | |
| 1714,R-HSA-5696398,,Nucleotide Excision Repair,Homo sapiens,reactome | |
| 1715,R-HSA-8956320,,Nucleotide biosynthesis,Homo sapiens,reactome | |
| 1716,R-HSA-8956319,,Nucleotide catabolism,Homo sapiens,reactome | |
| 1717,R-HSA-9735786,,Nucleotide catabolism defects,Homo sapiens,reactome | |
| 1718,R-HSA-8956321,,Nucleotide salvage,Homo sapiens,reactome | |
| 1719,R-HSA-9734207,,Nucleotide salvage defects,Homo sapiens,reactome | |
| 1720,R-HSA-168643,,"Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways",Homo sapiens,reactome | |
| 1721,R-HSA-418038,,Nucleotide-like (purinergic) receptors,Homo sapiens,reactome | |
| 1722,R-HSA-5173214,,O-glycosylation of TSR domain-containing proteins,Homo sapiens,reactome | |
| 1723,R-HSA-5173105,,O-linked glycosylation,Homo sapiens,reactome | |
| 1724,R-HSA-913709,,O-linked glycosylation of mucins,Homo sapiens,reactome | |
| 1725,R-HSA-1480926,,O2/CO2 exchange in erythrocytes,Homo sapiens,reactome | |
| 1726,R-HSA-9858328,,OADH complex synthesizes glutaryl-CoA from 2-OA,Homo sapiens,reactome | |
| 1727,R-HSA-8983711,,OAS antiviral response,Homo sapiens,reactome | |
| 1728,R-HSA-9853506,,OGDH complex synthesizes succinyl-CoA from 2-OG,Homo sapiens,reactome | |
| 1729,R-HSA-9956551,,OTC leader sequence variants cause OTC deficiency,Homo sapiens,reactome | |
| 1730,R-HSA-9956553,,OTC main chain variants cause OTC deficiency,Homo sapiens,reactome | |
| 1731,R-HSA-9956522,,OTC variants cause OTC deficiency,Homo sapiens,reactome | |
| 1732,R-HSA-9673163,,Oleoyl-phe metabolism,Homo sapiens,reactome | |
| 1733,R-HSA-381753,,Olfactory Signaling Pathway,Homo sapiens,reactome | |
| 1734,R-HSA-190704,,Oligomerization of connexins into connexons,Homo sapiens,reactome | |
| 1735,R-HSA-2559585,,Oncogene Induced Senescence,Homo sapiens,reactome | |
| 1736,R-HSA-6802957,,Oncogenic MAPK signaling,Homo sapiens,reactome | |
| 1737,R-HSA-111885,,Opioid Signalling,Homo sapiens,reactome | |
| 1738,R-HSA-419771,,Opsins,Homo sapiens,reactome | |
| 1739,R-HSA-68949,,Orc1 removal from chromatin,Homo sapiens,reactome | |
| 1740,R-HSA-389397,,Orexin and neuropeptides FF and QRFP bind to their respective receptors,Homo sapiens,reactome | |
| 1741,R-HSA-1852241,,Organelle biogenesis and maintenance,Homo sapiens,reactome | |
| 1742,R-HSA-561048,,Organic anion transport by SLC22 transporters,Homo sapiens,reactome | |
| 1743,R-HSA-428643,,Organic anion transport by SLC5/17/25 transporters,Homo sapiens,reactome | |
| 1744,R-HSA-879518,,Organic anion transport by SLCO transporters,Homo sapiens,reactome | |
| 1745,R-HSA-449836,,Other interleukin signaling,Homo sapiens,reactome | |
| 1746,R-HSA-416700,,Other semaphorin interactions,Homo sapiens,reactome | |
| 1747,R-HSA-5689896,,Ovarian tumor domain proteases,Homo sapiens,reactome | |
| 1748,R-HSA-2559580,,Oxidative Stress Induced Senescence,Homo sapiens,reactome | |
| 1749,R-HSA-1234176,,Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha,Homo sapiens,reactome | |
| 1750,R-HSA-417957,,P2Y receptors,Homo sapiens,reactome | |
| 1751,R-HSA-141334,,PAOs oxidise polyamines to amines,Homo sapiens,reactome | |
| 1752,R-HSA-5651801,,PCNA-Dependent Long Patch Base Excision Repair,Homo sapiens,reactome | |
| 1753,R-HSA-4086400,,PCP/CE pathway,Homo sapiens,reactome | |
| 1754,R-HSA-9931295,,PD-L1(CD274) glycosylation and translocation to plasma membrane,Homo sapiens,reactome | |
| 1755,R-HSA-165160,,PDE3B signalling,Homo sapiens,reactome | |
| 1756,R-HSA-9674428,,PDGFR mutants bind TKIs,Homo sapiens,reactome | |
| 1757,R-HSA-9861559,,PDH complex synthesizes acetyl-CoA from PYR,Homo sapiens,reactome | |
| 1758,R-HSA-210990,,PECAM1 interactions,Homo sapiens,reactome | |
| 1759,R-HSA-9954714,,PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA,Homo sapiens,reactome | |
| 1760,R-HSA-381042,,PERK regulates gene expression,Homo sapiens,reactome | |
| 1761,R-HSA-1483255,,PI Metabolism,Homo sapiens,reactome | |
| 1762,R-HSA-1483196,,PI and PC transport between ER and Golgi membranes,Homo sapiens,reactome | |
| 1763,R-HSA-5654689,,PI-3K cascade:FGFR1,Homo sapiens,reactome | |
| 1764,R-HSA-5654695,,PI-3K cascade:FGFR2,Homo sapiens,reactome | |
| 1765,R-HSA-5654710,,PI-3K cascade:FGFR3,Homo sapiens,reactome | |
| 1766,R-HSA-5654720,,PI-3K cascade:FGFR4,Homo sapiens,reactome | |
| 1767,R-HSA-109704,,PI3K Cascade,Homo sapiens,reactome | |
| 1768,R-HSA-1963642,,PI3K events in ERBB2 signaling,Homo sapiens,reactome | |
| 1769,R-HSA-1250342,,PI3K events in ERBB4 signaling,Homo sapiens,reactome | |
| 1770,R-HSA-2219528,,PI3K/AKT Signaling in Cancer,Homo sapiens,reactome | |
| 1771,R-HSA-198203,,PI3K/AKT activation,Homo sapiens,reactome | |
| 1772,R-HSA-6811555,,PI5P Regulates TP53 Acetylation,Homo sapiens,reactome | |
| 1773,R-HSA-6811558,,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling",Homo sapiens,reactome | |
| 1774,R-HSA-5205685,,PINK1-PRKN Mediated Mitophagy,Homo sapiens,reactome | |
| 1775,R-HSA-1257604,,PIP3 activates AKT signaling,Homo sapiens,reactome | |
| 1776,R-HSA-1660510,,PIPs transport between Golgi and plasma membranes,Homo sapiens,reactome | |
| 1777,R-HSA-1660502,,PIPs transport between early and late endosome membranes,Homo sapiens,reactome | |
| 1778,R-HSA-1660537,,PIPs transport between early endosome and Golgi membranes,Homo sapiens,reactome | |
| 1779,R-HSA-1660508,,PIPs transport between late endosome and Golgi membranes,Homo sapiens,reactome | |
| 1780,R-HSA-1660524,,PIPs transport between plasma and early endosome membranes,Homo sapiens,reactome | |
| 1781,R-HSA-5601884,,PIWI-interacting RNA (piRNA) biogenesis,Homo sapiens,reactome | |
| 1782,R-HSA-163615,,PKA activation,Homo sapiens,reactome | |
| 1783,R-HSA-164378,,PKA activation in glucagon signalling,Homo sapiens,reactome | |
| 1784,R-HSA-111931,,PKA-mediated phosphorylation of CREB,Homo sapiens,reactome | |
| 1785,R-HSA-163358,,PKA-mediated phosphorylation of key metabolic factors,Homo sapiens,reactome | |
| 1786,R-HSA-109703,,PKB-mediated events,Homo sapiens,reactome | |
| 1787,R-HSA-3214841,,PKMTs methylate histone lysines,Homo sapiens,reactome | |
| 1788,R-HSA-9833482,,PKR-mediated signaling,Homo sapiens,reactome | |
| 1789,R-HSA-112043,,PLC beta mediated events,Homo sapiens,reactome | |
| 1790,R-HSA-167021,,PLC-gamma1 signalling,Homo sapiens,reactome | |
| 1791,R-HSA-1251932,,PLCG1 events in ERBB2 signaling,Homo sapiens,reactome | |
| 1792,R-HSA-110362,,POLB-Dependent Long Patch Base Excision Repair,Homo sapiens,reactome | |
| 1793,R-HSA-2892247,,"POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation",Homo sapiens,reactome | |
| 1794,R-HSA-2892245,,"POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation",Homo sapiens,reactome | |
| 1795,R-HSA-163767,,PP2A-mediated dephosphorylation of key metabolic factors,Homo sapiens,reactome | |
| 1796,R-HSA-1989781,,PPARA activates gene expression,Homo sapiens,reactome | |
| 1797,R-HSA-212300,,PRC2 methylates histones and DNA,Homo sapiens,reactome | |
| 1798,R-HSA-5674404,,PTEN Loss of Function in Cancer,Homo sapiens,reactome | |
| 1799,R-HSA-6807070,,PTEN Regulation,Homo sapiens,reactome | |
| 1800,R-HSA-8849474,,PTK6 Activates STAT3,Homo sapiens,reactome | |
| 1801,R-HSA-8849472,,PTK6 Down-Regulation,Homo sapiens,reactome | |
| 1802,R-HSA-8849473,,PTK6 Expression,Homo sapiens,reactome | |
| 1803,R-HSA-8849470,,PTK6 Regulates Cell Cycle,Homo sapiens,reactome | |
| 1804,R-HSA-8849468,,PTK6 Regulates Proteins Involved in RNA Processing,Homo sapiens,reactome | |
| 1805,R-HSA-8849471,,"PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases",Homo sapiens,reactome | |
| 1806,R-HSA-8849469,,PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1,Homo sapiens,reactome | |
| 1807,R-HSA-8857538,,PTK6 promotes HIF1A stabilization,Homo sapiens,reactome | |
| 1808,R-HSA-171306,,Packaging Of Telomere Ends,Homo sapiens,reactome | |
| 1809,R-HSA-168303,,Packaging of Eight RNA Segments,Homo sapiens,reactome | |
| 1810,R-HSA-9753281,,Paracetamol ADME,Homo sapiens,reactome | |
| 1811,R-HSA-6802955,,Paradoxical activation of RAF signaling by kinase inactive BRAF,Homo sapiens,reactome | |
| 1812,R-HSA-9664407,,Parasite infection,Homo sapiens,reactome | |
| 1813,R-HSA-9824443,,Parasitic Infection Pathways,Homo sapiens,reactome | |
| 1814,R-HSA-432047,,Passive transport by Aquaporins,Homo sapiens,reactome | |
| 1815,R-HSA-167290,,Pausing and recovery of HIV elongation,Homo sapiens,reactome | |
| 1816,R-HSA-167238,,Pausing and recovery of Tat-mediated HIV elongation,Homo sapiens,reactome | |
| 1817,R-HSA-71336,,Pentose phosphate pathway,Homo sapiens,reactome | |
| 1818,R-HSA-6791465,,Pentose phosphate pathway disease,Homo sapiens,reactome | |
| 1819,R-HSA-156902,,Peptide chain elongation,Homo sapiens,reactome | |
| 1820,R-HSA-209952,,Peptide hormone biosynthesis,Homo sapiens,reactome | |
| 1821,R-HSA-2980736,,Peptide hormone metabolism,Homo sapiens,reactome | |
| 1822,R-HSA-375276,,Peptide ligand-binding receptors,Homo sapiens,reactome | |
| 1823,R-HSA-390918,,Peroxisomal lipid metabolism,Homo sapiens,reactome | |
| 1824,R-HSA-9033241,,Peroxisomal protein import,Homo sapiens,reactome | |
| 1825,R-HSA-9005895,,Pervasive developmental disorders,Homo sapiens,reactome | |
| 1826,R-HSA-9664873,,Pexophagy,Homo sapiens,reactome | |
| 1827,R-HSA-9637698,,Phagocyte cell death caused by cytosolic Mtb,Homo sapiens,reactome | |
| 1828,R-HSA-5576892,,Phase 0 - rapid depolarisation,Homo sapiens,reactome | |
| 1829,R-HSA-5576894,,Phase 1 - inactivation of fast Na+ channels,Homo sapiens,reactome | |
| 1830,R-HSA-5576893,,Phase 2 - plateau phase,Homo sapiens,reactome | |
| 1831,R-HSA-5576890,,Phase 3 - rapid repolarisation,Homo sapiens,reactome | |
| 1832,R-HSA-5576886,,Phase 4 - resting membrane potential,Homo sapiens,reactome | |
| 1833,R-HSA-211945,,Phase I - Functionalization of compounds,Homo sapiens,reactome | |
| 1834,R-HSA-156580,,Phase II - Conjugation of compounds,Homo sapiens,reactome | |
| 1835,R-HSA-8963691,,Phenylalanine and tyrosine metabolism,Homo sapiens,reactome | |
| 1836,R-HSA-8964208,,Phenylalanine metabolism,Homo sapiens,reactome | |
| 1837,R-HSA-2160456,,Phenylketonuria,Homo sapiens,reactome | |
| 1838,R-HSA-8850843,,Phosphate bond hydrolysis by NTPDase proteins,Homo sapiens,reactome | |
| 1839,R-HSA-2393930,,Phosphate bond hydrolysis by NUDT proteins,Homo sapiens,reactome | |
| 1840,R-HSA-5654219,,Phospholipase C-mediated cascade: FGFR1,Homo sapiens,reactome | |
| 1841,R-HSA-5654221,,Phospholipase C-mediated cascade; FGFR2,Homo sapiens,reactome | |
| 1842,R-HSA-5654227,,Phospholipase C-mediated cascade; FGFR3,Homo sapiens,reactome | |
| 1843,R-HSA-5654228,,Phospholipase C-mediated cascade; FGFR4,Homo sapiens,reactome | |
| 1844,R-HSA-1483257,,Phospholipid metabolism,Homo sapiens,reactome | |
| 1845,R-HSA-9931510,,Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes,Homo sapiens,reactome | |
| 1846,R-HSA-9931529,,Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK,Homo sapiens,reactome | |
| 1847,R-HSA-9931530,,Phosphorylation and nuclear translocation of the CRY:PER:kinase complex,Homo sapiens,reactome | |
| 1848,R-HSA-202427,,Phosphorylation of CD3 and TCR zeta chains,Homo sapiens,reactome | |
| 1849,R-HSA-9931512,,"Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters",Homo sapiens,reactome | |
| 1850,R-HSA-176417,,Phosphorylation of Emi1,Homo sapiens,reactome | |
| 1851,R-HSA-69200,,Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes,Homo sapiens,reactome | |
| 1852,R-HSA-176412,,Phosphorylation of the APC/C,Homo sapiens,reactome | |
| 1853,R-HSA-5578768,,Physiological factors,Homo sapiens,reactome | |
| 1854,R-HSA-8963898,,Plasma lipoprotein assembly,Homo sapiens,reactome | |
| 1855,R-HSA-174824,,"Plasma lipoprotein assembly, remodeling, and clearance",Homo sapiens,reactome | |
| 1856,R-HSA-8964043,,Plasma lipoprotein clearance,Homo sapiens,reactome | |
| 1857,R-HSA-8963899,,Plasma lipoprotein remodeling,Homo sapiens,reactome | |
| 1858,R-HSA-75896,,Plasmalogen biosynthesis,Homo sapiens,reactome | |
| 1859,R-HSA-75892,,Platelet Adhesion to exposed collagen,Homo sapiens,reactome | |
| 1860,R-HSA-76009,,Platelet Aggregation (Plug Formation),Homo sapiens,reactome | |
| 1861,R-HSA-76002,,"Platelet activation, signaling and aggregation",Homo sapiens,reactome | |
| 1862,R-HSA-418360,,Platelet calcium homeostasis,Homo sapiens,reactome | |
| 1863,R-HSA-114608,,Platelet degranulation,Homo sapiens,reactome | |
| 1864,R-HSA-418346,,Platelet homeostasis,Homo sapiens,reactome | |
| 1865,R-HSA-432142,,Platelet sensitization by LDL,Homo sapiens,reactome | |
| 1866,R-HSA-164525,,Plus-strand DNA synthesis,Homo sapiens,reactome | |
| 1867,R-HSA-156711,,Polo-like kinase mediated events,Homo sapiens,reactome | |
| 1868,R-HSA-69091,,Polymerase switching,Homo sapiens,reactome | |
| 1869,R-HSA-174411,,Polymerase switching on the C-strand of the telomere,Homo sapiens,reactome | |
| 1870,R-HSA-9764790,,Positive Regulation of CDH1 Gene Transcription,Homo sapiens,reactome | |
| 1871,R-HSA-5250913,,Positive epigenetic regulation of rRNA expression,Homo sapiens,reactome | |
| 1872,R-HSA-438064,,Post NMDA receptor activation events,Homo sapiens,reactome | |
| 1873,R-HSA-389977,,Post-chaperonin tubulin folding pathway,Homo sapiens,reactome | |
| 1874,R-HSA-426496,,Post-transcriptional silencing by small RNAs,Homo sapiens,reactome | |
| 1875,R-HSA-163125,,Post-translational modification: synthesis of GPI-anchored proteins,Homo sapiens,reactome | |
| 1876,R-HSA-597592,,Post-translational protein modification,Homo sapiens,reactome | |
| 1877,R-HSA-8957275,,Post-translational protein phosphorylation,Homo sapiens,reactome | |
| 1878,R-HSA-9615933,,Postmitotic nuclear pore complex (NPC) reformation,Homo sapiens,reactome | |
| 1879,R-HSA-622327,,Postsynaptic nicotinic acetylcholine receptors,Homo sapiens,reactome | |
| 1880,R-HSA-1296071,,Potassium Channels,Homo sapiens,reactome | |
| 1881,R-HSA-1296067,,Potassium transport channels,Homo sapiens,reactome | |
| 1882,R-HSA-9679191,,Potential therapeutics for SARS,Homo sapiens,reactome | |
| 1883,R-HSA-1912422,,Pre-NOTCH Expression and Processing,Homo sapiens,reactome | |
| 1884,R-HSA-1912420,,Pre-NOTCH Processing in Golgi,Homo sapiens,reactome | |
| 1885,R-HSA-1912399,,Pre-NOTCH Processing in the Endoplasmic Reticulum,Homo sapiens,reactome | |
| 1886,R-HSA-1912408,,Pre-NOTCH Transcription and Translation,Homo sapiens,reactome | |
| 1887,R-HSA-9757110,,Prednisone ADME,Homo sapiens,reactome | |
| 1888,R-HSA-389957,,Prefoldin mediated transfer of substrate to CCT/TriC,Homo sapiens,reactome | |
| 1889,R-HSA-196108,,Pregnenolone biosynthesis,Homo sapiens,reactome | |
| 1890,R-HSA-112308,,Presynaptic depolarization and calcium channel opening,Homo sapiens,reactome | |
| 1891,R-HSA-500657,,Presynaptic function of Kainate receptors,Homo sapiens,reactome | |
| 1892,R-HSA-622323,,Presynaptic nicotinic acetylcholine receptors,Homo sapiens,reactome | |
| 1893,R-HSA-5693616,,Presynaptic phase of homologous DNA pairing and strand exchange,Homo sapiens,reactome | |
| 1894,R-HSA-9636383,,Prevention of phagosomal-lysosomal fusion,Homo sapiens,reactome | |
| 1895,R-HSA-3215018,,Processing and activation of SUMO,Homo sapiens,reactome | |
| 1896,R-HSA-72203,,Processing of Capped Intron-Containing Pre-mRNA,Homo sapiens,reactome | |
| 1897,R-HSA-75067,,Processing of Capped Intronless Pre-mRNA,Homo sapiens,reactome | |
| 1898,R-HSA-5693607,,Processing of DNA double-strand break ends,Homo sapiens,reactome | |
| 1899,R-HSA-77595,,Processing of Intronless Pre-mRNAs,Homo sapiens,reactome | |
| 1900,R-HSA-8949664,,Processing of SMDT1,Homo sapiens,reactome | |
| 1901,R-HSA-9979719,,Processing of antigen in germinal center B cells,Homo sapiens,reactome | |
| 1902,R-HSA-174414,,Processive synthesis on the C-strand of the telomere,Homo sapiens,reactome | |
| 1903,R-HSA-69183,,Processive synthesis on the lagging strand,Homo sapiens,reactome | |
| 1904,R-HSA-5357801,,Programmed Cell Death,Homo sapiens,reactome | |
| 1905,R-HSA-964827,,"Progressive trimming of alpha-1,2-linked mannose residues from Man9/8/7GlcNAc2 to produce Man5GlcNAc2",Homo sapiens,reactome | |
| 1906,R-HSA-1170546,,Prolactin receptor signaling,Homo sapiens,reactome | |
| 1907,R-HSA-70688,,Proline catabolism,Homo sapiens,reactome | |
| 1908,R-HSA-169893,,Prolonged ERK activation events,Homo sapiens,reactome | |
| 1909,R-HSA-71032,,Propionyl-CoA catabolism,Homo sapiens,reactome | |
| 1910,R-HSA-392851,,Prostacyclin signalling through prostacyclin receptor,Homo sapiens,reactome | |
| 1911,R-HSA-391908,,Prostanoid ligand receptors,Homo sapiens,reactome | |
| 1912,R-HSA-9907900,,Proteasome assembly,Homo sapiens,reactome | |
| 1913,R-HSA-391251,,Protein folding,Homo sapiens,reactome | |
| 1914,R-HSA-9629569,,Protein hydroxylation,Homo sapiens,reactome | |
| 1915,R-HSA-9857492,,Protein lipoylation,Homo sapiens,reactome | |
| 1916,R-HSA-9609507,,Protein localization,Homo sapiens,reactome | |
| 1917,R-HSA-8876725,,Protein methylation,Homo sapiens,reactome | |
| 1918,R-HSA-5676934,,Protein repair,Homo sapiens,reactome | |
| 1919,R-HSA-8852135,,Protein ubiquitination,Homo sapiens,reactome | |
| 1920,R-HSA-6794362,,Protein-protein interactions at synapses,Homo sapiens,reactome | |
| 1921,R-HSA-433692,,Proton-coupled monocarboxylate transport,Homo sapiens,reactome | |
| 1922,R-HSA-428559,,Proton-coupled neutral amino acid transporters,Homo sapiens,reactome | |
| 1923,R-HSA-427975,,Proton/oligopeptide cotransporters,Homo sapiens,reactome | |
| 1924,R-HSA-74259,,Purine catabolism,Homo sapiens,reactome | |
| 1925,R-HSA-73817,,Purine ribonucleoside monophosphate biosynthesis,Homo sapiens,reactome | |
| 1926,R-HSA-74217,,Purine salvage,Homo sapiens,reactome | |
| 1927,R-HSA-9660826,,Purinergic signaling in leishmaniasis infection,Homo sapiens,reactome | |
| 1928,R-HSA-500753,,Pyrimidine biosynthesis,Homo sapiens,reactome | |
| 1929,R-HSA-73621,,Pyrimidine catabolism,Homo sapiens,reactome | |
| 1930,R-HSA-73614,,Pyrimidine salvage,Homo sapiens,reactome | |
| 1931,R-HSA-71737,,Pyrophosphate hydrolysis,Homo sapiens,reactome | |
| 1932,R-HSA-5620971,,Pyroptosis,Homo sapiens,reactome | |
| 1933,R-HSA-70268,,Pyruvate metabolism,Homo sapiens,reactome | |
| 1934,R-HSA-5365859,,RA biosynthesis pathway,Homo sapiens,reactome | |
| 1935,R-HSA-8876198,,RAB GEFs exchange GTP for GDP on RABs,Homo sapiens,reactome | |
| 1936,R-HSA-8873719,,RAB geranylgeranylation,Homo sapiens,reactome | |
| 1937,R-HSA-9013149,,RAC1 GTPase cycle,Homo sapiens,reactome | |
| 1938,R-HSA-9013404,,RAC2 GTPase cycle,Homo sapiens,reactome | |
| 1939,R-HSA-9013423,,RAC3 GTPase cycle,Homo sapiens,reactome | |
| 1940,R-HSA-5673000,,RAF activation,Homo sapiens,reactome | |
| 1941,R-HSA-112409,,RAF-independent MAPK1/3 activation,Homo sapiens,reactome | |
| 1942,R-HSA-5673001,,RAF/MAP kinase cascade,Homo sapiens,reactome | |
| 1943,R-HSA-9649913,,RAS GTPase cycle mutants,Homo sapiens,reactome | |
| 1944,R-HSA-9648002,,RAS processing,Homo sapiens,reactome | |
| 1945,R-HSA-6802953,,RAS signaling downstream of NF1 loss-of-function variants,Homo sapiens,reactome | |
| 1946,R-HSA-8853659,,RET signaling,Homo sapiens,reactome | |
| 1947,R-HSA-195258,,RHO GTPase Effectors,Homo sapiens,reactome | |
| 1948,R-HSA-9012999,,RHO GTPase cycle,Homo sapiens,reactome | |
| 1949,R-HSA-5663220,,RHO GTPases Activate Formins,Homo sapiens,reactome | |
| 1950,R-HSA-5668599,,RHO GTPases Activate NADPH Oxidases,Homo sapiens,reactome | |
| 1951,R-HSA-5627117,,RHO GTPases Activate ROCKs,Homo sapiens,reactome | |
| 1952,R-HSA-5666185,,RHO GTPases Activate Rhotekin and Rhophilins,Homo sapiens,reactome | |
| 1953,R-HSA-5663213,,RHO GTPases Activate WASPs and WAVEs,Homo sapiens,reactome | |
| 1954,R-HSA-5625900,,RHO GTPases activate CIT,Homo sapiens,reactome | |
| 1955,R-HSA-5626467,,RHO GTPases activate IQGAPs,Homo sapiens,reactome | |
| 1956,R-HSA-5625970,,RHO GTPases activate KTN1,Homo sapiens,reactome | |
| 1957,R-HSA-5627123,,RHO GTPases activate PAKs,Homo sapiens,reactome | |
| 1958,R-HSA-5625740,,RHO GTPases activate PKNs,Homo sapiens,reactome | |
| 1959,R-HSA-5627083,,RHO GTPases regulate CFTR trafficking,Homo sapiens,reactome | |
| 1960,R-HSA-8980692,,RHOA GTPase cycle,Homo sapiens,reactome | |
| 1961,R-HSA-9013026,,RHOB GTPase cycle,Homo sapiens,reactome | |
| 1962,R-HSA-9706574,,RHOBTB GTPase Cycle,Homo sapiens,reactome | |
| 1963,R-HSA-9013422,,RHOBTB1 GTPase cycle,Homo sapiens,reactome | |
| 1964,R-HSA-9013418,,RHOBTB2 GTPase cycle,Homo sapiens,reactome | |
| 1965,R-HSA-9706019,,RHOBTB3 ATPase cycle,Homo sapiens,reactome | |
| 1966,R-HSA-9013106,,RHOC GTPase cycle,Homo sapiens,reactome | |
| 1967,R-HSA-9013405,,RHOD GTPase cycle,Homo sapiens,reactome | |
| 1968,R-HSA-9035034,,RHOF GTPase cycle,Homo sapiens,reactome | |
| 1969,R-HSA-9013408,,RHOG GTPase cycle,Homo sapiens,reactome | |
| 1970,R-HSA-9013407,,RHOH GTPase cycle,Homo sapiens,reactome | |
| 1971,R-HSA-9013409,,RHOJ GTPase cycle,Homo sapiens,reactome | |
| 1972,R-HSA-9013406,,RHOQ GTPase cycle,Homo sapiens,reactome | |
| 1973,R-HSA-9013425,,RHOT1 GTPase cycle,Homo sapiens,reactome | |
| 1974,R-HSA-9013419,,RHOT2 GTPase cycle,Homo sapiens,reactome | |
| 1975,R-HSA-9013420,,RHOU GTPase cycle,Homo sapiens,reactome | |
| 1976,R-HSA-9013424,,RHOV GTPase cycle,Homo sapiens,reactome | |
| 1977,R-HSA-1810476,,RIP-mediated NFkB activation via ZBP1,Homo sapiens,reactome | |
| 1978,R-HSA-5213460,,RIPK1-mediated regulated necrosis,Homo sapiens,reactome | |
| 1979,R-HSA-3214858,,RMTs methylate histone arginines,Homo sapiens,reactome | |
| 1980,R-HSA-77075,,RNA Pol II CTD phosphorylation and interaction with CE,Homo sapiens,reactome | |
| 1981,R-HSA-167160,,RNA Pol II CTD phosphorylation and interaction with CE during HIV infection,Homo sapiens,reactome | |
| 1982,R-HSA-73772,,RNA Polymerase I Promoter Escape,Homo sapiens,reactome | |
| 1983,R-HSA-73728,,RNA Polymerase I Promoter Opening,Homo sapiens,reactome | |
| 1984,R-HSA-73864,,RNA Polymerase I Transcription,Homo sapiens,reactome | |
| 1985,R-HSA-73762,,RNA Polymerase I Transcription Initiation,Homo sapiens,reactome | |
| 1986,R-HSA-73863,,RNA Polymerase I Transcription Termination,Homo sapiens,reactome | |
| 1987,R-HSA-167162,,RNA Polymerase II HIV Promoter Escape,Homo sapiens,reactome | |
| 1988,R-HSA-674695,,RNA Polymerase II Pre-transcription Events,Homo sapiens,reactome | |
| 1989,R-HSA-73776,,RNA Polymerase II Promoter Escape,Homo sapiens,reactome | |
| 1990,R-HSA-73857,,RNA Polymerase II Transcription,Homo sapiens,reactome | |
| 1991,R-HSA-75955,,RNA Polymerase II Transcription Elongation,Homo sapiens,reactome | |
| 1992,R-HSA-75953,,RNA Polymerase II Transcription Initiation,Homo sapiens,reactome | |
| 1993,R-HSA-76042,,RNA Polymerase II Transcription Initiation And Promoter Clearance,Homo sapiens,reactome | |
| 1994,R-HSA-73779,,RNA Polymerase II Transcription Pre-Initiation And Promoter Opening,Homo sapiens,reactome | |
| 1995,R-HSA-73856,,RNA Polymerase II Transcription Termination,Homo sapiens,reactome | |
| 1996,R-HSA-749476,,RNA Polymerase III Abortive And Retractive Initiation,Homo sapiens,reactome | |
| 1997,R-HSA-73780,,RNA Polymerase III Chain Elongation,Homo sapiens,reactome | |
| 1998,R-HSA-74158,,RNA Polymerase III Transcription,Homo sapiens,reactome | |
| 1999,R-HSA-76046,,RNA Polymerase III Transcription Initiation,Homo sapiens,reactome | |
| 2000,R-HSA-76061,,RNA Polymerase III Transcription Initiation From Type 1 Promoter,Homo sapiens,reactome | |
| 2001,R-HSA-76066,,RNA Polymerase III Transcription Initiation From Type 2 Promoter,Homo sapiens,reactome | |
| 2002,R-HSA-76071,,RNA Polymerase III Transcription Initiation From Type 3 Promoter,Homo sapiens,reactome | |
| 2003,R-HSA-73980,,RNA Polymerase III Transcription Termination,Homo sapiens,reactome | |
| 2004,R-HSA-6807505,,RNA polymerase II transcribes snRNA genes,Homo sapiens,reactome | |
| 2005,R-HSA-9696273,,RND1 GTPase cycle,Homo sapiens,reactome | |
| 2006,R-HSA-9696270,,RND2 GTPase cycle,Homo sapiens,reactome | |
| 2007,R-HSA-9696264,,RND3 GTPase cycle,Homo sapiens,reactome | |
| 2008,R-HSA-9010642,,ROBO receptors bind AKAP5,Homo sapiens,reactome | |
| 2009,R-HSA-9933387,,"RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression",Homo sapiens,reactome | |
| 2010,R-HSA-1222556,,ROS and RNS production in phagocytes,Homo sapiens,reactome | |
| 2011,R-HSA-5659996,,RPIA deficiency: failed conversion of R5P to RU5P,Homo sapiens,reactome | |
| 2012,R-HSA-6791461,,RPIA deficiency: failed conversion of RU5P to R5P,Homo sapiens,reactome | |
| 2013,R-HSA-444257,,RSK activation,Homo sapiens,reactome | |
| 2014,R-HSA-9833110,,RSV-host interactions,Homo sapiens,reactome | |
| 2015,R-HSA-8877330,,RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs),Homo sapiens,reactome | |
| 2016,R-HSA-8939243,,RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known,Homo sapiens,reactome | |
| 2017,R-HSA-8931987,,RUNX1 regulates estrogen receptor mediated transcription,Homo sapiens,reactome | |
| 2018,R-HSA-8935964,,RUNX1 regulates expression of components of tight junctions,Homo sapiens,reactome | |
| 2019,R-HSA-8936459,,RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function,Homo sapiens,reactome | |
| 2020,R-HSA-8939245,,RUNX1 regulates transcription of genes involved in BCR signaling,Homo sapiens,reactome | |
| 2021,R-HSA-8939256,,RUNX1 regulates transcription of genes involved in WNT signaling,Homo sapiens,reactome | |
| 2022,R-HSA-8939236,,RUNX1 regulates transcription of genes involved in differentiation of HSCs,Homo sapiens,reactome | |
| 2023,R-HSA-8939242,,RUNX1 regulates transcription of genes involved in differentiation of keratinocytes,Homo sapiens,reactome | |
| 2024,R-HSA-8939246,,RUNX1 regulates transcription of genes involved in differentiation of myeloid cells,Homo sapiens,reactome | |
| 2025,R-HSA-8939247,,RUNX1 regulates transcription of genes involved in interleukin signaling,Homo sapiens,reactome | |
| 2026,R-HSA-8941326,,RUNX2 regulates bone development,Homo sapiens,reactome | |
| 2027,R-HSA-8941284,,RUNX2 regulates chondrocyte maturation,Homo sapiens,reactome | |
| 2028,R-HSA-8941332,,RUNX2 regulates genes involved in cell migration,Homo sapiens,reactome | |
| 2029,R-HSA-8941333,,RUNX2 regulates genes involved in differentiation of myeloid cells,Homo sapiens,reactome | |
| 2030,R-HSA-8940973,,RUNX2 regulates osteoblast differentiation,Homo sapiens,reactome | |
| 2031,R-HSA-8949275,,RUNX3 Regulates Immune Response and Cell Migration,Homo sapiens,reactome | |
| 2032,R-HSA-8952158,,RUNX3 regulates BCL2L11 (BIM) transcription,Homo sapiens,reactome | |
| 2033,R-HSA-8941855,,RUNX3 regulates CDKN1A transcription,Homo sapiens,reactome | |
| 2034,R-HSA-8941856,,RUNX3 regulates NOTCH signaling,Homo sapiens,reactome | |
| 2035,R-HSA-8951911,,RUNX3 regulates RUNX1-mediated transcription,Homo sapiens,reactome | |
| 2036,R-HSA-8951430,,RUNX3 regulates WNT signaling,Homo sapiens,reactome | |
| 2037,R-HSA-8951671,,RUNX3 regulates YAP1-mediated transcription,Homo sapiens,reactome | |
| 2038,R-HSA-8951936,,RUNX3 regulates p14-ARF,Homo sapiens,reactome | |
| 2039,R-HSA-9007101,,Rab regulation of trafficking,Homo sapiens,reactome | |
| 2040,R-HSA-392517,,Rap1 signalling,Homo sapiens,reactome | |
| 2041,R-HSA-442982,,Ras activation upon Ca2+ influx through NMDA receptor,Homo sapiens,reactome | |
| 2042,R-HSA-975578,,Reactions specific to the complex N-glycan synthesis pathway,Homo sapiens,reactome | |
| 2043,R-HSA-975574,,Reactions specific to the hybrid N-glycan synthesis pathway,Homo sapiens,reactome | |
| 2044,R-HSA-8934903,,Receptor Mediated Mitophagy,Homo sapiens,reactome | |
| 2045,R-HSA-388844,,Receptor-type tyrosine-protein phosphatases,Homo sapiens,reactome | |
| 2046,R-HSA-110330,,Recognition and association of DNA glycosylase with site containing an affected purine,Homo sapiens,reactome | |
| 2047,R-HSA-110328,,Recognition and association of DNA glycosylase with site containing an affected pyrimidine,Homo sapiens,reactome | |
| 2048,R-HSA-110314,,Recognition of DNA damage by PCNA-containing replication complex,Homo sapiens,reactome | |
| 2049,R-HSA-5693565,,Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks,Homo sapiens,reactome | |
| 2050,R-HSA-380320,,Recruitment of NuMA to mitotic centrosomes,Homo sapiens,reactome | |
| 2051,R-HSA-380270,,Recruitment of mitotic centrosome proteins and complexes,Homo sapiens,reactome | |
| 2052,R-HSA-159418,,Recycling of bile acids and salts,Homo sapiens,reactome | |
| 2053,R-HSA-72731,,Recycling of eIF2:GDP,Homo sapiens,reactome | |
| 2054,R-HSA-437239,,Recycling pathway of L1,Homo sapiens,reactome | |
| 2055,R-HSA-418359,,Reduction of cytosolic Ca++ levels,Homo sapiens,reactome | |
| 2056,R-HSA-8866376,,Reelin signalling pathway,Homo sapiens,reactome | |
| 2057,R-HSA-9669929,,Regorafenib-resistant KIT mutants,Homo sapiens,reactome | |
| 2058,R-HSA-9674403,,Regorafenib-resistant PDGFR mutants,Homo sapiens,reactome | |
| 2059,R-HSA-5218859,,Regulated Necrosis,Homo sapiens,reactome | |
| 2060,R-HSA-193692,,Regulated proteolysis of p75NTR,Homo sapiens,reactome | |
| 2061,R-HSA-3248023,,Regulation by TREX1,Homo sapiens,reactome | |
| 2062,R-HSA-3371378,,Regulation by c-FLIP,Homo sapiens,reactome | |
| 2063,R-HSA-176408,,Regulation of APC/C activators between G1/S and early anaphase,Homo sapiens,reactome | |
| 2064,R-HSA-169911,,Regulation of Apoptosis,Homo sapiens,reactome | |
| 2065,R-HSA-9708530,,Regulation of BACH1 activity,Homo sapiens,reactome | |
| 2066,R-HSA-9764265,,Regulation of CDH1 Expression and Function,Homo sapiens,reactome | |
| 2067,R-HSA-9764561,,Regulation of CDH1 Function,Homo sapiens,reactome | |
| 2068,R-HSA-9764560,,Regulation of CDH1 Gene Transcription,Homo sapiens,reactome | |
| 2069,R-HSA-9764562,,Regulation of CDH1 mRNA translation by microRNAs,Homo sapiens,reactome | |
| 2070,R-HSA-9768727,,Regulation of CDH1 posttranslational processing and trafficking to plasma membrane,Homo sapiens,reactome | |
| 2071,R-HSA-9759475,,Regulation of CDH11 Expression and Function,Homo sapiens,reactome | |
| 2072,R-HSA-9762292,,Regulation of CDH11 function,Homo sapiens,reactome | |
| 2073,R-HSA-9762293,,Regulation of CDH11 gene transcription,Homo sapiens,reactome | |
| 2074,R-HSA-9759811,,Regulation of CDH11 mRNA translation by microRNAs,Homo sapiens,reactome | |
| 2075,R-HSA-9764302,,Regulation of CDH19 Expression and Function,Homo sapiens,reactome | |
| 2076,R-HSA-977606,,Regulation of Complement cascade,Homo sapiens,reactome | |
| 2077,R-HSA-9764274,,Regulation of Expression and Function of Type I Classical Cadherins,Homo sapiens,reactome | |
| 2078,R-HSA-9764260,,Regulation of Expression and Function of Type II Classical Cadherins,Homo sapiens,reactome | |
| 2079,R-HSA-9617629,,Regulation of FOXO transcriptional activity by acetylation,Homo sapiens,reactome | |
| 2080,R-HSA-9855719,,Regulation of FXIIa and plasma kallikrein activity,Homo sapiens,reactome | |
| 2081,R-HSA-4641263,,Regulation of FZD by ubiquitination,Homo sapiens,reactome | |
| 2082,R-HSA-9968551,,Regulation of GBP-mediated host defense,Homo sapiens,reactome | |
| 2083,R-HSA-170822,,Regulation of Glucokinase by Glucokinase Regulatory Protein,Homo sapiens,reactome | |
| 2084,R-HSA-9707587,,Regulation of HMOX1 expression and activity,Homo sapiens,reactome | |
| 2085,R-HSA-3371453,,Regulation of HSF1-mediated heat shock response,Homo sapiens,reactome | |
| 2086,R-HSA-9759476,,Regulation of Homotypic Cell-Cell Adhesion,Homo sapiens,reactome | |
| 2087,R-HSA-912694,,Regulation of IFNA/IFNB signaling,Homo sapiens,reactome | |
| 2088,R-HSA-877312,,Regulation of IFNG signaling,Homo sapiens,reactome | |
| 2089,R-HSA-381426,,Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs),Homo sapiens,reactome | |
| 2090,R-HSA-1433559,,Regulation of KIT signaling,Homo sapiens,reactome | |
| 2091,R-HSA-9022692,,Regulation of MECP2 expression and activity,Homo sapiens,reactome | |
| 2092,R-HSA-9854909,,Regulation of MITF-M dependent genes involved in invasion,Homo sapiens,reactome | |
| 2093,R-HSA-9854907,,Regulation of MITF-M dependent genes involved in metabolism,Homo sapiens,reactome | |
| 2094,R-HSA-9825895,,"Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence",Homo sapiens,reactome | |
| 2095,R-HSA-9824594,,Regulation of MITF-M-dependent genes involved in apoptosis,Homo sapiens,reactome | |
| 2096,R-HSA-9825892,,Regulation of MITF-M-dependent genes involved in cell cycle and proliferation,Homo sapiens,reactome | |
| 2097,R-HSA-9926550,,"Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition",Homo sapiens,reactome | |
| 2098,R-HSA-9857377,,Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy,Homo sapiens,reactome | |
| 2099,R-HSA-9824585,,Regulation of MITF-M-dependent genes involved in pigmentation,Homo sapiens,reactome | |
| 2100,R-HSA-9758274,,Regulation of NF-kappa B signaling,Homo sapiens,reactome | |
| 2101,R-HSA-9818749,,Regulation of NFE2L2 gene expression,Homo sapiens,reactome | |
| 2102,R-HSA-9768759,,Regulation of NPAS4 gene expression,Homo sapiens,reactome | |
| 2103,R-HSA-9768777,,Regulation of NPAS4 gene transcription,Homo sapiens,reactome | |
| 2104,R-HSA-9768778,,Regulation of NPAS4 mRNA translation,Homo sapiens,reactome | |
| 2105,R-HSA-211728,,Regulation of PAK-2p34 activity by PS-GAP/RHG10,Homo sapiens,reactome | |
| 2106,R-HSA-9909615,,Regulation of PD-L1(CD274) Post-translational modification,Homo sapiens,reactome | |
| 2107,R-HSA-9909648,,Regulation of PD-L1(CD274) expression,Homo sapiens,reactome | |
| 2108,R-HSA-9909649,,Regulation of PD-L1(CD274) transcription,Homo sapiens,reactome | |
| 2109,R-HSA-9909620,,Regulation of PD-L1(CD274) translation,Homo sapiens,reactome | |
| 2110,R-HSA-2565942,,Regulation of PLK1 Activity at G2/M Transition,Homo sapiens,reactome | |
| 2111,R-HSA-8943724,,Regulation of PTEN gene transcription,Homo sapiens,reactome | |
| 2112,R-HSA-8948747,,Regulation of PTEN localization,Homo sapiens,reactome | |
| 2113,R-HSA-8943723,,Regulation of PTEN mRNA translation,Homo sapiens,reactome | |
| 2114,R-HSA-8948751,,Regulation of PTEN stability and activity,Homo sapiens,reactome | |
| 2115,R-HSA-5658442,,Regulation of RAS by GAPs,Homo sapiens,reactome | |
| 2116,R-HSA-8934593,,Regulation of RUNX1 Expression and Activity,Homo sapiens,reactome | |
| 2117,R-HSA-8939902,,Regulation of RUNX2 expression and activity,Homo sapiens,reactome | |
| 2118,R-HSA-8941858,,Regulation of RUNX3 expression and activity,Homo sapiens,reactome | |
| 2119,R-HSA-388841,,Regulation of T cell activation by CD28 family,Homo sapiens,reactome | |
| 2120,R-HSA-9824878,,"Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7",Homo sapiens,reactome | |
| 2121,R-HSA-9828211,,"Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation",Homo sapiens,reactome | |
| 2122,R-HSA-5686938,,Regulation of TLR by endogenous ligand,Homo sapiens,reactome | |
| 2123,R-HSA-5357905,,Regulation of TNFR1 signaling,Homo sapiens,reactome | |
| 2124,R-HSA-5633007,,Regulation of TP53 Activity,Homo sapiens,reactome | |
| 2125,R-HSA-6804758,,Regulation of TP53 Activity through Acetylation,Homo sapiens,reactome | |
| 2126,R-HSA-6804759,,Regulation of TP53 Activity through Association with Co-factors,Homo sapiens,reactome | |
| 2127,R-HSA-6804760,,Regulation of TP53 Activity through Methylation,Homo sapiens,reactome | |
| 2128,R-HSA-6804756,,Regulation of TP53 Activity through Phosphorylation,Homo sapiens,reactome | |
| 2129,R-HSA-6804757,,Regulation of TP53 Degradation,Homo sapiens,reactome | |
| 2130,R-HSA-6804754,,Regulation of TP53 Expression,Homo sapiens,reactome | |
| 2131,R-HSA-6806003,,Regulation of TP53 Expression and Degradation,Homo sapiens,reactome | |
| 2132,R-HSA-2029482,,Regulation of actin dynamics for phagocytic cup formation,Homo sapiens,reactome | |
| 2133,R-HSA-211733,,Regulation of activated PAK-2p34 by proteasome mediated degradation,Homo sapiens,reactome | |
| 2134,R-HSA-186712,,Regulation of beta-cell development,Homo sapiens,reactome | |
| 2135,R-HSA-1655829,,Regulation of cholesterol biosynthesis by SREBP (SREBF),Homo sapiens,reactome | |
| 2136,R-HSA-9769739,,Regulation of clotting cascade,Homo sapiens,reactome | |
| 2137,R-HSA-428542,,Regulation of commissural axon pathfinding by SLIT and ROBO,Homo sapiens,reactome | |
| 2138,R-HSA-8985801,,Regulation of cortical dendrite branching,Homo sapiens,reactome | |
| 2139,R-HSA-446388,,Regulation of cytoskeletal remodeling and cell spreading by IPP complex components,Homo sapiens,reactome | |
| 2140,R-HSA-9842860,,Regulation of endogenous retroelements,Homo sapiens,reactome | |
| 2141,R-HSA-9843940,,Regulation of endogenous retroelements by KRAB-ZFP proteins,Homo sapiens,reactome | |
| 2142,R-HSA-9845323,,Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs),Homo sapiens,reactome | |
| 2143,R-HSA-9843970,,Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex,Homo sapiens,reactome | |
| 2144,R-HSA-9010553,,Regulation of expression of SLITs and ROBOs,Homo sapiens,reactome | |
| 2145,R-HSA-191650,,Regulation of gap junction activity,Homo sapiens,reactome | |
| 2146,R-HSA-1234158,,Regulation of gene expression by Hypoxia-inducible Factor,Homo sapiens,reactome | |
| 2147,R-HSA-210745,,Regulation of gene expression in beta cells,Homo sapiens,reactome | |
| 2148,R-HSA-210747,,Regulation of gene expression in early pancreatic precursor cells,Homo sapiens,reactome | |
| 2149,R-HSA-210746,,Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells,Homo sapiens,reactome | |
| 2150,R-HSA-210744,,Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells,Homo sapiens,reactome | |
| 2151,R-HSA-9634600,,"Regulation of glycolysis by fructose 2,6-bisphosphate metabolism",Homo sapiens,reactome | |
| 2152,R-HSA-3134975,,Regulation of innate immune responses to cytosolic DNA,Homo sapiens,reactome | |
| 2153,R-HSA-422356,,Regulation of insulin secretion,Homo sapiens,reactome | |
| 2154,R-HSA-400206,,Regulation of lipid metabolism by PPARalpha,Homo sapiens,reactome | |
| 2155,R-HSA-9614399,,Regulation of localization of FOXO transcription factors,Homo sapiens,reactome | |
| 2156,R-HSA-450531,,Regulation of mRNA stability by proteins that bind AU-rich elements,Homo sapiens,reactome | |
| 2157,R-HSA-453276,,Regulation of mitotic cell cycle,Homo sapiens,reactome | |
| 2158,R-HSA-5675482,,Regulation of necroptotic cell death,Homo sapiens,reactome | |
| 2159,R-HSA-350562,,Regulation of ornithine decarboxylase (ODC),Homo sapiens,reactome | |
| 2160,R-HSA-204174,,Regulation of pyruvate dehydrogenase (PDH) complex,Homo sapiens,reactome | |
| 2161,R-HSA-9861718,,Regulation of pyruvate metabolism,Homo sapiens,reactome | |
| 2162,R-HSA-912631,,Regulation of signaling by CBL,Homo sapiens,reactome | |
| 2163,R-HSA-1433617,,Regulation of signaling by NODAL,Homo sapiens,reactome | |
| 2164,R-HSA-9627069,,Regulation of the apoptosome activity,Homo sapiens,reactome | |
| 2165,R-HSA-350864,,Regulation of thyroid hormone activity,Homo sapiens,reactome | |
| 2166,R-HSA-444821,,Relaxin receptors,Homo sapiens,reactome | |
| 2167,R-HSA-168298,,Release,Homo sapiens,reactome | |
| 2168,R-HSA-5362798,,Release of Hh-Np from the secreting cell,Homo sapiens,reactome | |
| 2169,R-HSA-111457,,Release of apoptotic factors from the mitochondria,Homo sapiens,reactome | |
| 2170,R-HSA-159782,,Removal of aminoterminal propeptides from gamma-carboxylated proteins,Homo sapiens,reactome | |
| 2171,R-HSA-69166,,Removal of the Flap Intermediate,Homo sapiens,reactome | |
| 2172,R-HSA-174437,,Removal of the Flap Intermediate from the C-strand,Homo sapiens,reactome | |
| 2173,R-HSA-9821993,,Replacement of protamines by nucleosomes in the male pronucleus,Homo sapiens,reactome | |
| 2174,R-HSA-9682706,,Replication of the SARS-CoV-1 genome,Homo sapiens,reactome | |
| 2175,R-HSA-9694686,,Replication of the SARS-CoV-2 genome,Homo sapiens,reactome | |
| 2176,R-HSA-4641265,,Repression of WNT target genes,Homo sapiens,reactome | |
| 2177,R-HSA-1474165,,Reproduction,Homo sapiens,reactome | |
| 2178,R-HSA-9665250,,Resistance of ERBB2 KD mutants to AEE788,Homo sapiens,reactome | |
| 2179,R-HSA-9665249,,Resistance of ERBB2 KD mutants to afatinib,Homo sapiens,reactome | |
| 2180,R-HSA-9665251,,Resistance of ERBB2 KD mutants to lapatinib,Homo sapiens,reactome | |
| 2181,R-HSA-9665246,,Resistance of ERBB2 KD mutants to neratinib,Homo sapiens,reactome | |
| 2182,R-HSA-9665247,,Resistance of ERBB2 KD mutants to osimertinib,Homo sapiens,reactome | |
| 2183,R-HSA-9665244,,Resistance of ERBB2 KD mutants to sapitinib,Homo sapiens,reactome | |
| 2184,R-HSA-9665245,,Resistance of ERBB2 KD mutants to tesevatinib,Homo sapiens,reactome | |
| 2185,R-HSA-9665233,,Resistance of ERBB2 KD mutants to trastuzumab,Homo sapiens,reactome | |
| 2186,R-HSA-110373,,Resolution of AP sites via the multiple-nucleotide patch replacement pathway,Homo sapiens,reactome | |
| 2187,R-HSA-110381,,Resolution of AP sites via the single-nucleotide replacement pathway,Homo sapiens,reactome | |
| 2188,R-HSA-73933,,Resolution of Abasic Sites (AP sites),Homo sapiens,reactome | |
| 2189,R-HSA-5693537,,Resolution of D-Loop Structures,Homo sapiens,reactome | |
| 2190,R-HSA-5693568,,Resolution of D-loop Structures through Holliday Junction Intermediates,Homo sapiens,reactome | |
| 2191,R-HSA-5693554,,Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA),Homo sapiens,reactome | |
| 2192,R-HSA-2500257,,Resolution of Sister Chromatid Cohesion,Homo sapiens,reactome | |
| 2193,R-HSA-9820952,,Respiratory Syncytial Virus Infection Pathway,Homo sapiens,reactome | |
| 2194,R-HSA-611105,,Respiratory electron transport,Homo sapiens,reactome | |
| 2195,R-HSA-9820960,,Respiratory syncytial virus (RSV) attachment and entry,Homo sapiens,reactome | |
| 2196,R-HSA-9820965,,"Respiratory syncytial virus (RSV) genome replication, transcription and translation",Homo sapiens,reactome | |
| 2197,R-HSA-9834752,,Respiratory syncytial virus genome replication,Homo sapiens,reactome | |
| 2198,R-HSA-9828642,,Respiratory syncytial virus genome transcription,Homo sapiens,reactome | |
| 2199,R-HSA-9648895,,Response of EIF2AK1 (HRI) to heme deficiency,Homo sapiens,reactome | |
| 2200,R-HSA-9633012,,Response of EIF2AK4 (GCN2) to amino acid deficiency,Homo sapiens,reactome | |
| 2201,R-HSA-9637690,,Response of Mtb to phagocytosis,Homo sapiens,reactome | |
| 2202,R-HSA-9860931,,Response of endothelial cells to shear stress,Homo sapiens,reactome | |
| 2203,R-HSA-76005,,Response to elevated platelet cytosolic Ca2+,Homo sapiens,reactome | |
| 2204,R-HSA-5660526,,Response to metal ions,Homo sapiens,reactome | |
| 2205,R-HSA-2453864,,Retinoid cycle disease events,Homo sapiens,reactome | |
| 2206,R-HSA-975634,,Retinoid metabolism and transport,Homo sapiens,reactome | |
| 2207,R-HSA-6809583,,Retinoid metabolism disease events,Homo sapiens,reactome | |
| 2208,R-HSA-177504,,Retrograde neurotrophin signalling,Homo sapiens,reactome | |
| 2209,R-HSA-6811440,,Retrograde transport at the Trans-Golgi-Network,Homo sapiens,reactome | |
| 2210,R-HSA-888593,,Reuptake of GABA,Homo sapiens,reactome | |
| 2211,R-HSA-165054,,Rev-mediated nuclear export of HIV RNA,Homo sapiens,reactome | |
| 2212,R-HSA-73943,,Reversal of alkylation damage by DNA dioxygenases,Homo sapiens,reactome | |
| 2213,R-HSA-162589,,Reverse Transcription of HIV RNA,Homo sapiens,reactome | |
| 2214,R-HSA-9729902,,Reversible DNA damage induced by alkylating chemotherapeutic drugs,Homo sapiens,reactome | |
| 2215,R-HSA-1475029,,Reversible hydration of carbon dioxide,Homo sapiens,reactome | |
| 2216,R-HSA-9037628,,Rhesus blood group biosynthesis,Homo sapiens,reactome | |
| 2217,R-HSA-444411,,Rhesus glycoproteins mediate ammonium transport,Homo sapiens,reactome | |
| 2218,R-HSA-9755088,,Ribavirin ADME,Homo sapiens,reactome | |
| 2219,R-HSA-72702,,Ribosomal scanning and start codon recognition,Homo sapiens,reactome | |
| 2220,R-HSA-9954709,,Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide,Homo sapiens,reactome | |
| 2221,R-HSA-9948299,,Ribosome-associated quality control,Homo sapiens,reactome | |
| 2222,R-HSA-428890,,Role of ABL in ROBO-SLIT signaling,Homo sapiens,reactome | |
| 2223,R-HSA-2730905,,Role of LAT2/NTAL/LAB on calcium mobilization,Homo sapiens,reactome | |
| 2224,R-HSA-2029485,,Role of phospholipids in phagocytosis,Homo sapiens,reactome | |
| 2225,R-HSA-418890,,Role of second messengers in netrin-1 signaling,Homo sapiens,reactome | |
| 2226,R-HSA-69242,,S Phase,Homo sapiens,reactome | |
| 2227,R-HSA-9679506,,SARS-CoV Infections,Homo sapiens,reactome | |
| 2228,R-HSA-9679514,,SARS-CoV-1 Genome Replication and Transcription,Homo sapiens,reactome | |
| 2229,R-HSA-9678108,,SARS-CoV-1 Infection,Homo sapiens,reactome | |
| 2230,R-HSA-9692916,,SARS-CoV-1 activates/modulates innate immune responses,Homo sapiens,reactome | |
| 2231,R-HSA-9735869,,SARS-CoV-1 modulates host translation machinery,Homo sapiens,reactome | |
| 2232,R-HSA-9692912,,SARS-CoV-1 targets PDZ proteins in cell-cell junction,Homo sapiens,reactome | |
| 2233,R-HSA-9735871,,SARS-CoV-1 targets host intracellular signalling and regulatory pathways,Homo sapiens,reactome | |
| 2234,R-HSA-9692914,,SARS-CoV-1-host interactions,Homo sapiens,reactome | |
| 2235,R-HSA-9692913,,SARS-CoV-1-mediated effects on programmed cell death,Homo sapiens,reactome | |
| 2236,R-HSA-9694682,,SARS-CoV-2 Genome Replication and Transcription,Homo sapiens,reactome | |
| 2237,R-HSA-9694516,,SARS-CoV-2 Infection,Homo sapiens,reactome | |
| 2238,R-HSA-9705671,,SARS-CoV-2 activates/modulates innate and adaptive immune responses,Homo sapiens,reactome | |
| 2239,R-HSA-9754560,,SARS-CoV-2 modulates autophagy,Homo sapiens,reactome | |
| 2240,R-HSA-9754678,,SARS-CoV-2 modulates host translation machinery,Homo sapiens,reactome | |
| 2241,R-HSA-9705677,,SARS-CoV-2 targets PDZ proteins in cell-cell junction,Homo sapiens,reactome | |
| 2242,R-HSA-9755779,,SARS-CoV-2 targets host intracellular signalling and regulatory pathways,Homo sapiens,reactome | |
| 2243,R-HSA-9705683,,SARS-CoV-2-host interactions,Homo sapiens,reactome | |
| 2244,R-HSA-187577,,SCF(Skp2)-mediated degradation of p27/p21,Homo sapiens,reactome | |
| 2245,R-HSA-174113,,SCF-beta-TrCP mediated degradation of Emi1,Homo sapiens,reactome | |
| 2246,R-HSA-373756,,SDK interactions,Homo sapiens,reactome | |
| 2247,R-HSA-399955,,SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion,Homo sapiens,reactome | |
| 2248,R-HSA-5654688,,SHC-mediated cascade:FGFR1,Homo sapiens,reactome | |
| 2249,R-HSA-5654699,,SHC-mediated cascade:FGFR2,Homo sapiens,reactome | |
| 2250,R-HSA-5654704,,SHC-mediated cascade:FGFR3,Homo sapiens,reactome | |
| 2251,R-HSA-5654719,,SHC-mediated cascade:FGFR4,Homo sapiens,reactome | |
| 2252,R-HSA-2428933,,SHC-related events triggered by IGF1R,Homo sapiens,reactome | |
| 2253,R-HSA-180336,,SHC1 events in EGFR signaling,Homo sapiens,reactome | |
| 2254,R-HSA-1250196,,SHC1 events in ERBB2 signaling,Homo sapiens,reactome | |
| 2255,R-HSA-1250347,,SHC1 events in ERBB4 signaling,Homo sapiens,reactome | |
| 2256,R-HSA-9726840,,SHOC2 M1731 mutant abolishes MRAS complex function,Homo sapiens,reactome | |
| 2257,R-HSA-427359,,SIRT1 negatively regulates rRNA expression,Homo sapiens,reactome | |
| 2258,R-HSA-77588,,SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs,Homo sapiens,reactome | |
| 2259,R-HSA-111367,,SLBP independent Processing of Histone Pre-mRNAs,Homo sapiens,reactome | |
| 2260,R-HSA-5619102,,SLC transporter disorders,Homo sapiens,reactome | |
| 2261,R-HSA-9958517,,SLC-mediated bile acid transport,Homo sapiens,reactome | |
| 2262,R-HSA-425407,,SLC-mediated transmembrane transport,Homo sapiens,reactome | |
| 2263,R-HSA-9958863,,SLC-mediated transport of amino acids,Homo sapiens,reactome | |
| 2264,R-HSA-9958790,,SLC-mediated transport of inorganic anions,Homo sapiens,reactome | |
| 2265,R-HSA-442660,,SLC-mediated transport of neurotransmitters,Homo sapiens,reactome | |
| 2266,R-HSA-9959399,,SLC-mediated transport of oligopeptides,Homo sapiens,reactome | |
| 2267,R-HSA-9955298,,SLC-mediated transport of organic anions,Homo sapiens,reactome | |
| 2268,R-HSA-549127,,SLC-mediated transport of organic cations,Homo sapiens,reactome | |
| 2269,R-HSA-9860276,,SLC15A4:TASL-dependent IRF5 activation,Homo sapiens,reactome | |
| 2270,R-HSA-9956508,,SLC25A15 variants cause hyperornithinemia-hyperammonemia-homocitrullinemia syndrome,Homo sapiens,reactome | |
| 2271,R-HSA-8985586,,SLIT2:ROBO1 increases RHOA activity,Homo sapiens,reactome | |
| 2272,R-HSA-111463,,SMAC (DIABLO) binds to IAPs,Homo sapiens,reactome | |
| 2273,R-HSA-111464,,SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes,Homo sapiens,reactome | |
| 2274,R-HSA-111469,,"SMAC, XIAP-regulated apoptotic response",Homo sapiens,reactome | |
| 2275,R-HSA-3315487,,SMAD2/3 MH2 Domain Mutants in Cancer,Homo sapiens,reactome | |
| 2276,R-HSA-3304356,,SMAD2/3 Phosphorylation Motif Mutants in Cancer,Homo sapiens,reactome | |
| 2277,R-HSA-2173796,,SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription,Homo sapiens,reactome | |
| 2278,R-HSA-3311021,,SMAD4 MH2 Domain Mutants in Cancer,Homo sapiens,reactome | |
| 2279,R-HSA-112412,,SOS-mediated signalling,Homo sapiens,reactome | |
| 2280,R-HSA-9929491,,SPOP-mediated proteasomal degradation of PD-L1(CD274),Homo sapiens,reactome | |
| 2281,R-HSA-9958810,,"SRC activates STAT3 in a quantitative manner, through Cadherin-11 (CDH11), RAC1 and gp130 (IL6ST)",Homo sapiens,reactome | |
| 2282,R-HSA-1799339,,SRP-dependent cotranslational protein targeting to membrane,Homo sapiens,reactome | |
| 2283,R-HSA-9701898,,STAT3 nuclear events downstream of ALK signaling,Homo sapiens,reactome | |
| 2284,R-HSA-9645135,,STAT5 Activation,Homo sapiens,reactome | |
| 2285,R-HSA-9702518,,STAT5 activation downstream of FLT3 ITD mutants,Homo sapiens,reactome | |
| 2286,R-HSA-3249367,,STAT6-mediated induction of chemokines,Homo sapiens,reactome | |
| 2287,R-HSA-1834941,,STING mediated induction of host immune responses,Homo sapiens,reactome | |
| 2288,R-HSA-3108232,,SUMO E3 ligases SUMOylate target proteins,Homo sapiens,reactome | |
| 2289,R-HSA-3065676,,SUMO is conjugated to E1 (UBA2:SAE1),Homo sapiens,reactome | |
| 2290,R-HSA-3065679,,SUMO is proteolytically processed,Homo sapiens,reactome | |
| 2291,R-HSA-3065678,,"SUMO is transferred from E1 to E2 (UBE2I, UBC9)",Homo sapiens,reactome | |
| 2292,R-HSA-2990846,,SUMOylation,Homo sapiens,reactome | |
| 2293,R-HSA-3108214,,SUMOylation of DNA damage response and repair proteins,Homo sapiens,reactome | |
| 2294,R-HSA-4655427,,SUMOylation of DNA methylation proteins,Homo sapiens,reactome | |
| 2295,R-HSA-4615885,,SUMOylation of DNA replication proteins,Homo sapiens,reactome | |
| 2296,R-HSA-4570464,,SUMOylation of RNA binding proteins,Homo sapiens,reactome | |
| 2297,R-HSA-4085377,,SUMOylation of SUMOylation proteins,Homo sapiens,reactome | |
| 2298,R-HSA-4551638,,SUMOylation of chromatin organization proteins,Homo sapiens,reactome | |
| 2299,R-HSA-4755510,,SUMOylation of immune response proteins,Homo sapiens,reactome | |
| 2300,R-HSA-4090294,,SUMOylation of intracellular receptors,Homo sapiens,reactome | |
| 2301,R-HSA-9793242,,SUMOylation of nuclear envelope proteins,Homo sapiens,reactome | |
| 2302,R-HSA-3899300,,SUMOylation of transcription cofactors,Homo sapiens,reactome | |
| 2303,R-HSA-3232118,,SUMOylation of transcription factors,Homo sapiens,reactome | |
| 2304,R-HSA-3232142,,SUMOylation of ubiquitinylation proteins,Homo sapiens,reactome | |
| 2305,R-HSA-9932451,,SWI/SNF chromatin remodelers,Homo sapiens,reactome | |
| 2306,R-HSA-3000480,,Scavenging by Class A Receptors,Homo sapiens,reactome | |
| 2307,R-HSA-3000471,,Scavenging by Class B Receptors,Homo sapiens,reactome | |
| 2308,R-HSA-3000484,,Scavenging by Class F Receptors,Homo sapiens,reactome | |
| 2309,R-HSA-3000497,,Scavenging by Class H Receptors,Homo sapiens,reactome | |
| 2310,R-HSA-2168880,,Scavenging of heme from plasma,Homo sapiens,reactome | |
| 2311,R-HSA-9668328,,Sealing of the nuclear envelope (NE) by ESCRT-III,Homo sapiens,reactome | |
| 2312,R-HSA-9760173,,Secretion of toxins,Homo sapiens,reactome | |
| 2313,R-HSA-9663891,,Selective autophagy,Homo sapiens,reactome | |
| 2314,R-HSA-2408522,,Selenoamino acid metabolism,Homo sapiens,reactome | |
| 2315,R-HSA-2408557,,Selenocysteine synthesis,Homo sapiens,reactome | |
| 2316,R-HSA-399954,,Sema3A PAK dependent Axon repulsion,Homo sapiens,reactome | |
| 2317,R-HSA-400685,,Sema4D in semaphorin signaling,Homo sapiens,reactome | |
| 2318,R-HSA-416572,,Sema4D induced cell migration and growth-cone collapse,Homo sapiens,reactome | |
| 2319,R-HSA-416550,,Sema4D mediated inhibition of cell attachment and migration,Homo sapiens,reactome | |
| 2320,R-HSA-373755,,Semaphorin interactions,Homo sapiens,reactome | |
| 2321,R-HSA-2559582,,Senescence-Associated Secretory Phenotype (SASP),Homo sapiens,reactome | |
| 2322,R-HSA-5693548,,Sensing of DNA Double Strand Breaks,Homo sapiens,reactome | |
| 2323,R-HSA-9709957,,Sensory Perception,Homo sapiens,reactome | |
| 2324,R-HSA-9730628,,Sensory perception of salty taste,Homo sapiens,reactome | |
| 2325,R-HSA-9729555,,Sensory perception of sour taste,Homo sapiens,reactome | |
| 2326,R-HSA-9717207,,"Sensory perception of sweet, bitter, and umami (glutamate) taste",Homo sapiens,reactome | |
| 2327,R-HSA-9717189,,Sensory perception of taste,Homo sapiens,reactome | |
| 2328,R-HSA-9659379,,Sensory processing of sound,Homo sapiens,reactome | |
| 2329,R-HSA-9662360,,Sensory processing of sound by inner hair cells of the cochlea,Homo sapiens,reactome | |
| 2330,R-HSA-9662361,,Sensory processing of sound by outer hair cells of the cochlea,Homo sapiens,reactome | |
| 2331,R-HSA-2467813,,Separation of Sister Chromatids,Homo sapiens,reactome | |
| 2332,R-HSA-977347,,Serine metabolism,Homo sapiens,reactome | |
| 2333,R-HSA-181429,,Serotonin Neurotransmitter Release Cycle,Homo sapiens,reactome | |
| 2334,R-HSA-209931,,Serotonin and melatonin biosynthesis,Homo sapiens,reactome | |
| 2335,R-HSA-380615,,Serotonin clearance from the synaptic cleft,Homo sapiens,reactome | |
| 2336,R-HSA-390666,,Serotonin receptors,Homo sapiens,reactome | |
| 2337,R-HSA-3282872,,Severe congenital neutropenia type 4 (G6PC3),Homo sapiens,reactome | |
| 2338,R-HSA-4085001,,Sialic acid metabolism,Homo sapiens,reactome | |
| 2339,R-HSA-162582,,Signal Transduction,Homo sapiens,reactome | |
| 2340,R-HSA-392518,,Signal amplification,Homo sapiens,reactome | |
| 2341,R-HSA-74749,,Signal attenuation,Homo sapiens,reactome | |
| 2342,R-HSA-391160,,Signal regulatory protein family interactions,Homo sapiens,reactome | |
| 2343,R-HSA-445144,,Signal transduction by L1,Homo sapiens,reactome | |
| 2344,R-HSA-201556,,Signaling by ALK,Homo sapiens,reactome | |
| 2345,R-HSA-9725370,,Signaling by ALK fusions and activated point mutants,Homo sapiens,reactome | |
| 2346,R-HSA-9700206,,Signaling by ALK in cancer,Homo sapiens,reactome | |
| 2347,R-HSA-4839748,,Signaling by AMER1 mutants,Homo sapiens,reactome | |
| 2348,R-HSA-4839744,,Signaling by APC mutants,Homo sapiens,reactome | |
| 2349,R-HSA-4839735,,Signaling by AXIN mutants,Homo sapiens,reactome | |
| 2350,R-HSA-1502540,,Signaling by Activin,Homo sapiens,reactome | |
| 2351,R-HSA-201451,,Signaling by BMP,Homo sapiens,reactome | |
| 2352,R-HSA-6802952,,Signaling by BRAF and RAF1 fusions,Homo sapiens,reactome | |
| 2353,R-HSA-9680350,,Signaling by CSF1 (M-CSF) in myeloid cells,Homo sapiens,reactome | |
| 2354,R-HSA-9674555,,Signaling by CSF3 (G-CSF),Homo sapiens,reactome | |
| 2355,R-HSA-4839743,,Signaling by CTNNB1 phospho-site mutants,Homo sapiens,reactome | |
| 2356,R-HSA-177929,,Signaling by EGFR,Homo sapiens,reactome | |
| 2357,R-HSA-1643713,,Signaling by EGFR in Cancer,Homo sapiens,reactome | |
| 2358,R-HSA-5637812,,Signaling by EGFRvIII in Cancer,Homo sapiens,reactome | |
| 2359,R-HSA-1227986,,Signaling by ERBB2,Homo sapiens,reactome | |
| 2360,R-HSA-9665348,,Signaling by ERBB2 ECD mutants,Homo sapiens,reactome | |
| 2361,R-HSA-9664565,,Signaling by ERBB2 KD Mutants,Homo sapiens,reactome | |
| 2362,R-HSA-9665686,,Signaling by ERBB2 TMD/JMD mutants,Homo sapiens,reactome | |
| 2363,R-HSA-1227990,,Signaling by ERBB2 in Cancer,Homo sapiens,reactome | |
| 2364,R-HSA-1236394,,Signaling by ERBB4,Homo sapiens,reactome | |
| 2365,R-HSA-9006335,,Signaling by Erythropoietin,Homo sapiens,reactome | |
| 2366,R-HSA-190236,,Signaling by FGFR,Homo sapiens,reactome | |
| 2367,R-HSA-1226099,,Signaling by FGFR in disease,Homo sapiens,reactome | |
| 2368,R-HSA-5654736,,Signaling by FGFR1,Homo sapiens,reactome | |
| 2369,R-HSA-1839120,,Signaling by FGFR1 amplification mutants,Homo sapiens,reactome | |
| 2370,R-HSA-5655302,,Signaling by FGFR1 in disease,Homo sapiens,reactome | |
| 2371,R-HSA-5654738,,Signaling by FGFR2,Homo sapiens,reactome | |
| 2372,R-HSA-8851708,,Signaling by FGFR2 IIIa TM,Homo sapiens,reactome | |
| 2373,R-HSA-2023837,,Signaling by FGFR2 amplification mutants,Homo sapiens,reactome | |
| 2374,R-HSA-8853333,,Signaling by FGFR2 fusions,Homo sapiens,reactome | |
| 2375,R-HSA-5655253,,Signaling by FGFR2 in disease,Homo sapiens,reactome | |
| 2376,R-HSA-5654741,,Signaling by FGFR3,Homo sapiens,reactome | |
| 2377,R-HSA-8853334,,Signaling by FGFR3 fusions in cancer,Homo sapiens,reactome | |
| 2378,R-HSA-5655332,,Signaling by FGFR3 in disease,Homo sapiens,reactome | |
| 2379,R-HSA-5654743,,Signaling by FGFR4,Homo sapiens,reactome | |
| 2380,R-HSA-5655291,,Signaling by FGFR4 in disease,Homo sapiens,reactome | |
| 2381,R-HSA-9703648,,Signaling by FLT3 ITD and TKD mutants,Homo sapiens,reactome | |
| 2382,R-HSA-9703465,,Signaling by FLT3 fusion proteins,Homo sapiens,reactome | |
| 2383,R-HSA-372790,,Signaling by GPCR,Homo sapiens,reactome | |
| 2384,R-HSA-5339716,,Signaling by GSK3beta mutants,Homo sapiens,reactome | |
| 2385,R-HSA-5358351,,Signaling by Hedgehog,Homo sapiens,reactome | |
| 2386,R-HSA-2028269,,Signaling by Hippo,Homo sapiens,reactome | |
| 2387,R-HSA-74752,,Signaling by Insulin receptor,Homo sapiens,reactome | |
| 2388,R-HSA-449147,,Signaling by Interleukins,Homo sapiens,reactome | |
| 2389,R-HSA-9669938,,Signaling by KIT in disease,Homo sapiens,reactome | |
| 2390,R-HSA-5339717,,Signaling by LRP5 mutants,Homo sapiens,reactome | |
| 2391,R-HSA-9842663,,Signaling by LTK,Homo sapiens,reactome | |
| 2392,R-HSA-9842640,,Signaling by LTK in cancer,Homo sapiens,reactome | |
| 2393,R-HSA-2586552,,Signaling by Leptin,Homo sapiens,reactome | |
| 2394,R-HSA-5637815,,Signaling by Ligand-Responsive EGFR Variants in Cancer,Homo sapiens,reactome | |
| 2395,R-HSA-9652169,,Signaling by MAP2K mutants,Homo sapiens,reactome | |
| 2396,R-HSA-9652817,,Signaling by MAPK mutants,Homo sapiens,reactome | |
| 2397,R-HSA-6806834,,Signaling by MET,Homo sapiens,reactome | |
| 2398,R-HSA-9660537,,Signaling by MRAS-complex mutants,Homo sapiens,reactome | |
| 2399,R-HSA-8852405,,Signaling by MST1,Homo sapiens,reactome | |
| 2400,R-HSA-1181150,,Signaling by NODAL,Homo sapiens,reactome | |
| 2401,R-HSA-157118,,Signaling by NOTCH,Homo sapiens,reactome | |
| 2402,R-HSA-1980143,,Signaling by NOTCH1,Homo sapiens,reactome | |
| 2403,R-HSA-2691230,,Signaling by NOTCH1 HD Domain Mutants in Cancer,Homo sapiens,reactome | |
| 2404,R-HSA-2894858,,Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer,Homo sapiens,reactome | |
| 2405,R-HSA-2644602,,Signaling by NOTCH1 PEST Domain Mutants in Cancer,Homo sapiens,reactome | |
| 2406,R-HSA-2644603,,Signaling by NOTCH1 in Cancer,Homo sapiens,reactome | |
| 2407,R-HSA-2660825,,Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant,Homo sapiens,reactome | |
| 2408,R-HSA-1980145,,Signaling by NOTCH2,Homo sapiens,reactome | |
| 2409,R-HSA-9012852,,Signaling by NOTCH3,Homo sapiens,reactome | |
| 2410,R-HSA-9013694,,Signaling by NOTCH4,Homo sapiens,reactome | |
| 2411,R-HSA-187037,,Signaling by NTRK1 (TRKA),Homo sapiens,reactome | |
| 2412,R-HSA-9006115,,Signaling by NTRK2 (TRKB),Homo sapiens,reactome | |
| 2413,R-HSA-9034015,,Signaling by NTRK3 (TRKC),Homo sapiens,reactome | |
| 2414,R-HSA-166520,,Signaling by NTRKs,Homo sapiens,reactome | |
| 2415,R-HSA-9006927,,Signaling by Non-Receptor Tyrosine Kinases,Homo sapiens,reactome | |
| 2416,R-HSA-9006931,,Signaling by Nuclear Receptors,Homo sapiens,reactome | |
| 2417,R-HSA-5638302,,Signaling by Overexpressed Wild-Type EGFR in Cancer,Homo sapiens,reactome | |
| 2418,R-HSA-186797,,Signaling by PDGF,Homo sapiens,reactome | |
| 2419,R-HSA-9671555,,Signaling by PDGFR in disease,Homo sapiens,reactome | |
| 2420,R-HSA-9673770,,Signaling by PDGFRA extracellular domain mutants,Homo sapiens,reactome | |
| 2421,R-HSA-9673767,,"Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants",Homo sapiens,reactome | |
| 2422,R-HSA-8848021,,Signaling by PTK6,Homo sapiens,reactome | |
| 2423,R-HSA-9656223,,Signaling by RAF1 mutants,Homo sapiens,reactome | |
| 2424,R-HSA-9753510,,Signaling by RAS GAP mutants,Homo sapiens,reactome | |
| 2425,R-HSA-9753512,,Signaling by RAS GTPase mutants,Homo sapiens,reactome | |
| 2426,R-HSA-6802949,,Signaling by RAS mutants,Homo sapiens,reactome | |
| 2427,R-HSA-5340588,,Signaling by RNF43 mutants,Homo sapiens,reactome | |
| 2428,R-HSA-376176,,Signaling by ROBO receptors,Homo sapiens,reactome | |
| 2429,R-HSA-9006934,,Signaling by Receptor Tyrosine Kinases,Homo sapiens,reactome | |
| 2430,R-HSA-5362517,,Signaling by Retinoic Acid,Homo sapiens,reactome | |
| 2431,R-HSA-194315,,Signaling by Rho GTPases,Homo sapiens,reactome | |
| 2432,R-HSA-9716542,,"Signaling by Rho GTPases, Miro GTPases and RHOBTB3",Homo sapiens,reactome | |
| 2433,R-HSA-1433557,,Signaling by SCF-KIT,Homo sapiens,reactome | |
| 2434,R-HSA-5339700,,Signaling by TCF7L2 mutants,Homo sapiens,reactome | |
| 2435,R-HSA-170834,,Signaling by TGF-beta Receptor Complex,Homo sapiens,reactome | |
| 2436,R-HSA-3304351,,Signaling by TGF-beta Receptor Complex in Cancer,Homo sapiens,reactome | |
| 2437,R-HSA-9006936,,Signaling by TGFB family members,Homo sapiens,reactome | |
| 2438,R-HSA-9839373,,Signaling by TGFBR3,Homo sapiens,reactome | |
| 2439,R-HSA-2404192,,Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R),Homo sapiens,reactome | |
| 2440,R-HSA-194138,,Signaling by VEGF,Homo sapiens,reactome | |
| 2441,R-HSA-195721,,Signaling by WNT,Homo sapiens,reactome | |
| 2442,R-HSA-4791275,,Signaling by WNT in cancer,Homo sapiens,reactome | |
| 2443,R-HSA-1839122,,Signaling by activated point mutants of FGFR1,Homo sapiens,reactome | |
| 2444,R-HSA-1839130,,Signaling by activated point mutants of FGFR3,Homo sapiens,reactome | |
| 2445,R-HSA-1839117,,Signaling by cytosolic FGFR1 fusion mutants,Homo sapiens,reactome | |
| 2446,R-HSA-9673766,,Signaling by cytosolic PDGFRA and PDGFRB fusion proteins,Homo sapiens,reactome | |
| 2447,R-HSA-9680187,,Signaling by extracellular domain mutants of KIT,Homo sapiens,reactome | |
| 2448,R-HSA-6802948,,Signaling by high-kinase activity BRAF mutants,Homo sapiens,reactome | |
| 2449,R-HSA-9669935,,Signaling by juxtamembrane domain KIT mutants,Homo sapiens,reactome | |
| 2450,R-HSA-9669933,,Signaling by kinase domain mutants of KIT,Homo sapiens,reactome | |
| 2451,R-HSA-9673768,,Signaling by membrane-tethered fusions of PDGFRA or PDGFRB,Homo sapiens,reactome | |
| 2452,R-HSA-6802946,,Signaling by moderate kinase activity BRAF mutants,Homo sapiens,reactome | |
| 2453,R-HSA-9670439,,"Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants",Homo sapiens,reactome | |
| 2454,R-HSA-8853336,,Signaling by plasma membrane FGFR1 fusions,Homo sapiens,reactome | |
| 2455,R-HSA-983705,,Signaling by the B Cell Receptor (BCR),Homo sapiens,reactome | |
| 2456,R-HSA-9649948,,Signaling downstream of RAS mutants,Homo sapiens,reactome | |
| 2457,R-HSA-198765,,Signalling to ERK5,Homo sapiens,reactome | |
| 2458,R-HSA-187687,,Signalling to ERKs,Homo sapiens,reactome | |
| 2459,R-HSA-167044,,Signalling to RAS,Homo sapiens,reactome | |
| 2460,R-HSA-198745,,Signalling to STAT3,Homo sapiens,reactome | |
| 2461,R-HSA-187706,,Signalling to p38 via RIT and RIN,Homo sapiens,reactome | |
| 2462,R-HSA-426486,,Small interfering RNA (siRNA) biogenesis,Homo sapiens,reactome | |
| 2463,R-HSA-445355,,Smooth Muscle Contraction,Homo sapiens,reactome | |
| 2464,R-HSA-427652,,Sodium-coupled phosphate cotransporters,Homo sapiens,reactome | |
| 2465,R-HSA-433137,,"Sodium-coupled sulphate, di- and tri-carboxylate transporters",Homo sapiens,reactome | |
| 2466,R-HSA-425561,,Sodium/Calcium exchangers,Homo sapiens,reactome | |
| 2467,R-HSA-425986,,Sodium/Proton exchangers,Homo sapiens,reactome | |
| 2468,R-HSA-9938024,,Somatic hypermutation of immunoglobulin genes,Homo sapiens,reactome | |
| 2469,R-HSA-9968297,,Somatic hypermutation of immunoglobulin genes by error-prone base excision repair (BER),Homo sapiens,reactome | |
| 2470,R-HSA-9968295,,Somatic hypermutation of immunoglobulin genes by error-prone mismatch repair (MMR),Homo sapiens,reactome | |
| 2471,R-HSA-9824272,,Somitogenesis,Homo sapiens,reactome | |
| 2472,R-HSA-9669936,,Sorafenib-resistant KIT mutants,Homo sapiens,reactome | |
| 2473,R-HSA-9674404,,Sorafenib-resistant PDGFR mutants,Homo sapiens,reactome | |
| 2474,R-HSA-9827857,,Specification of primordial germ cells,Homo sapiens,reactome | |
| 2475,R-HSA-9834899,,Specification of the neural plate border,Homo sapiens,reactome | |
| 2476,R-HSA-1300642,,Sperm Motility And Taxes,Homo sapiens,reactome | |
| 2477,R-HSA-9845614,,Sphingolipid catabolism,Homo sapiens,reactome | |
| 2478,R-HSA-1660661,,Sphingolipid de novo biosynthesis,Homo sapiens,reactome | |
| 2479,R-HSA-428157,,Sphingolipid metabolism,Homo sapiens,reactome | |
| 2480,R-HSA-1295596,,Spry regulation of FGF signaling,Homo sapiens,reactome | |
| 2481,R-HSA-69541,,Stabilization of p53,Homo sapiens,reactome | |
| 2482,R-HSA-211994,,Sterols are 12-hydroxylated by CYP8B1,Homo sapiens,reactome | |
| 2483,R-HSA-211736,,Stimulation of the cell death response by PAK-2p34,Homo sapiens,reactome | |
| 2484,R-HSA-2672351,,Stimuli-sensing channels,Homo sapiens,reactome | |
| 2485,R-HSA-9913635,,Strand-asynchronous mitochondrial DNA replication,Homo sapiens,reactome | |
| 2486,R-HSA-390522,,Striated Muscle Contraction,Homo sapiens,reactome | |
| 2487,R-HSA-1614517,,Sulfide oxidation to sulfate,Homo sapiens,reactome | |
| 2488,R-HSA-1614635,,Sulfur amino acid metabolism,Homo sapiens,reactome | |
| 2489,R-HSA-9669934,,Sunitinib-resistant KIT mutants,Homo sapiens,reactome | |
| 2490,R-HSA-9674401,,Sunitinib-resistant PDGFR mutants,Homo sapiens,reactome | |
| 2491,R-HSA-9635465,,Suppression of apoptosis,Homo sapiens,reactome | |
| 2492,R-HSA-9636569,,Suppression of autophagy,Homo sapiens,reactome | |
| 2493,R-HSA-9637687,,Suppression of phagosomal maturation,Homo sapiens,reactome | |
| 2494,R-HSA-5683826,,Surfactant metabolism,Homo sapiens,reactome | |
| 2495,R-HSA-69052,,Switching of origins to a post-replicative state,Homo sapiens,reactome | |
| 2496,R-HSA-8849932,,Synaptic adhesion-like molecules,Homo sapiens,reactome | |
| 2497,R-HSA-3000170,,Syndecan interactions,Homo sapiens,reactome | |
| 2498,R-HSA-174495,,"Synthesis And Processing Of GAG, GAGPOL Polyproteins",Homo sapiens,reactome | |
| 2499,R-HSA-171286,,Synthesis and processing of ENV and VPU,Homo sapiens,reactome | |
| 2500,R-HSA-2142816,,Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE),Homo sapiens,reactome | |
| 2501,R-HSA-2142712,,Synthesis of 12-eicosatetraenoic acid derivatives,Homo sapiens,reactome | |
| 2502,R-HSA-2142770,,Synthesis of 15-eicosatetraenoic acid derivatives,Homo sapiens,reactome | |
| 2503,R-HSA-2142688,,Synthesis of 5-eicosatetraenoic acids,Homo sapiens,reactome | |
| 2504,R-HSA-1483171,,Synthesis of BMP,Homo sapiens,reactome | |
| 2505,R-HSA-1483076,,Synthesis of CL,Homo sapiens,reactome | |
| 2506,R-HSA-69239,,Synthesis of DNA,Homo sapiens,reactome | |
| 2507,R-HSA-446205,,Synthesis of GDP-mannose,Homo sapiens,reactome | |
| 2508,R-HSA-2142696,,Synthesis of Hepoxilins (HX) and Trioxilins (TrX),Homo sapiens,reactome | |
| 2509,R-HSA-1855183,,"Synthesis of IP2, IP, and Ins in the cytosol",Homo sapiens,reactome | |
| 2510,R-HSA-1855204,,Synthesis of IP3 and IP4 in the cytosol,Homo sapiens,reactome | |
| 2511,R-HSA-1855231,,Synthesis of IPs in the ER lumen,Homo sapiens,reactome | |
| 2512,R-HSA-1855191,,Synthesis of IPs in the nucleus,Homo sapiens,reactome | |
| 2513,R-HSA-77111,,Synthesis of Ketone Bodies,Homo sapiens,reactome | |
| 2514,R-HSA-2142691,,Synthesis of Leukotrienes (LT) and Eoxins (EX),Homo sapiens,reactome | |
| 2515,R-HSA-1483166,,Synthesis of PA,Homo sapiens,reactome | |
| 2516,R-HSA-1483191,,Synthesis of PC,Homo sapiens,reactome | |
| 2517,R-HSA-1483213,,Synthesis of PE,Homo sapiens,reactome | |
| 2518,R-HSA-1483148,,Synthesis of PG,Homo sapiens,reactome | |
| 2519,R-HSA-1483226,,Synthesis of PI,Homo sapiens,reactome | |
| 2520,R-HSA-1483248,,Synthesis of PIPs at the ER membrane,Homo sapiens,reactome | |
| 2521,R-HSA-1660514,,Synthesis of PIPs at the Golgi membrane,Homo sapiens,reactome | |
| 2522,R-HSA-1660516,,Synthesis of PIPs at the early endosome membrane,Homo sapiens,reactome | |
| 2523,R-HSA-1660517,,Synthesis of PIPs at the late endosome membrane,Homo sapiens,reactome | |
| 2524,R-HSA-1660499,,Synthesis of PIPs at the plasma membrane,Homo sapiens,reactome | |
| 2525,R-HSA-8847453,,Synthesis of PIPs in the nucleus,Homo sapiens,reactome | |
| 2526,R-HSA-1483101,,Synthesis of PS,Homo sapiens,reactome | |
| 2527,R-HSA-2162123,,Synthesis of Prostaglandins (PG) and Thromboxanes (TX),Homo sapiens,reactome | |
| 2528,R-HSA-446210,,Synthesis of UDP-N-acetyl-glucosamine,Homo sapiens,reactome | |
| 2529,R-HSA-8866652,,Synthesis of active ubiquitin: roles of E1 and E2 enzymes,Homo sapiens,reactome | |
| 2530,R-HSA-192105,,Synthesis of bile acids and bile salts,Homo sapiens,reactome | |
| 2531,R-HSA-193775,,Synthesis of bile acids and bile salts via 24-hydroxycholesterol,Homo sapiens,reactome | |
| 2532,R-HSA-193807,,Synthesis of bile acids and bile salts via 27-hydroxycholesterol,Homo sapiens,reactome | |
| 2533,R-HSA-193368,,Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol,Homo sapiens,reactome | |
| 2534,R-HSA-5358493,,Synthesis of diphthamide-EEF2,Homo sapiens,reactome | |
| 2535,R-HSA-446199,,Synthesis of dolichyl-phosphate,Homo sapiens,reactome | |
| 2536,R-HSA-162699,,Synthesis of dolichyl-phosphate mannose,Homo sapiens,reactome | |
| 2537,R-HSA-480985,,Synthesis of dolichyl-phosphate-glucose,Homo sapiens,reactome | |
| 2538,R-HSA-2142670,,Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET),Homo sapiens,reactome | |
| 2539,R-HSA-162710,,Synthesis of glycosylphosphatidylinositol (GPI),Homo sapiens,reactome | |
| 2540,R-HSA-1855167,,Synthesis of pyrophosphates in the cytosol,Homo sapiens,reactome | |
| 2541,R-HSA-446219,,Synthesis of substrates in N-glycan biosythesis,Homo sapiens,reactome | |
| 2542,R-HSA-75876,,Synthesis of very long-chain fatty acyl-CoAs,Homo sapiens,reactome | |
| 2543,R-HSA-6782861,,Synthesis of wybutosine at G37 of tRNA(Phe),Homo sapiens,reactome | |
| 2544,R-HSA-422085,,"Synthesis, secretion, and deacylation of Ghrelin",Homo sapiens,reactome | |
| 2545,R-HSA-381771,,"Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)",Homo sapiens,reactome | |
| 2546,R-HSA-400511,,"Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)",Homo sapiens,reactome | |
| 2547,R-HSA-445989,,TAK1-dependent IKK and NF-kappa-B activation,Homo sapiens,reactome | |
| 2548,R-HSA-6791462,,"TALDO1 deficiency: failed conversion of Fru(6)P, E4P to SH7P, GA3P",Homo sapiens,reactome | |
| 2549,R-HSA-6791055,,"TALDO1 deficiency: failed conversion of SH7P, GA3P to Fru(6)P, E4P",Homo sapiens,reactome | |
| 2550,R-HSA-8854214,,TBC/RABGAPs,Homo sapiens,reactome | |
| 2551,R-HSA-201681,,TCF dependent signaling in response to WNT,Homo sapiens,reactome | |
| 2552,R-HSA-202403,,TCR signaling,Homo sapiens,reactome | |
| 2553,R-HSA-5221030,,"TET1,2,3 and TDG demethylate DNA",Homo sapiens,reactome | |
| 2554,R-HSA-8866911,,TFAP2 (AP-2) family regulates transcription of cell cycle factors,Homo sapiens,reactome | |
| 2555,R-HSA-8866910,,TFAP2 (AP-2) family regulates transcription of growth factors and their receptors,Homo sapiens,reactome | |
| 2556,R-HSA-8866906,,TFAP2 (AP-2) family regulates transcription of other transcription factors,Homo sapiens,reactome | |
| 2557,R-HSA-8869496,,TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation,Homo sapiens,reactome | |
| 2558,R-HSA-2173789,,TGF-beta receptor signaling activates SMADs,Homo sapiens,reactome | |
| 2559,R-HSA-2173791,,TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition),Homo sapiens,reactome | |
| 2560,R-HSA-3656532,,TGFBR1 KD Mutants in Cancer,Homo sapiens,reactome | |
| 2561,R-HSA-3656535,,TGFBR1 LBD Mutants in Cancer,Homo sapiens,reactome | |
| 2562,R-HSA-3645790,,TGFBR2 Kinase Domain Mutants in Cancer,Homo sapiens,reactome | |
| 2563,R-HSA-3642279,,TGFBR2 MSI Frameshift Mutants in Cancer,Homo sapiens,reactome | |
| 2564,R-HSA-9839383,,TGFBR3 PTM regulation,Homo sapiens,reactome | |
| 2565,R-HSA-9839394,,TGFBR3 expression,Homo sapiens,reactome | |
| 2566,R-HSA-9839397,,TGFBR3 regulates FGF2 signaling,Homo sapiens,reactome | |
| 2567,R-HSA-9839389,,TGFBR3 regulates TGF-beta signaling,Homo sapiens,reactome | |
| 2568,R-HSA-9839406,,TGFBR3 regulates activin signaling,Homo sapiens,reactome | |
| 2569,R-HSA-5602566,,TICAM1 deficiency - HSE,Homo sapiens,reactome | |
| 2570,R-HSA-168927,,"TICAM1, RIP1-mediated IKK complex recruitment",Homo sapiens,reactome | |
| 2571,R-HSA-9014325,,"TICAM1,TRAF6-dependent induction of TAK1 complex",Homo sapiens,reactome | |
| 2572,R-HSA-9013973,,TICAM1-dependent activation of IRF3/IRF7,Homo sapiens,reactome | |
| 2573,R-HSA-5602410,,TLR3 deficiency - HSE,Homo sapiens,reactome | |
| 2574,R-HSA-9013957,,TLR3-mediated TICAM1-dependent programmed cell death,Homo sapiens,reactome | |
| 2575,R-HSA-5676594,,TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway,Homo sapiens,reactome | |
| 2576,R-HSA-75893,,TNF signaling,Homo sapiens,reactome | |
| 2577,R-HSA-5357956,,TNFR1-induced NF-kappa-B signaling pathway,Homo sapiens,reactome | |
| 2578,R-HSA-5357786,,TNFR1-induced proapoptotic signaling,Homo sapiens,reactome | |
| 2579,R-HSA-5626978,,TNFR1-mediated ceramide production,Homo sapiens,reactome | |
| 2580,R-HSA-5668541,,TNFR2 non-canonical NF-kB pathway,Homo sapiens,reactome | |
| 2581,R-HSA-5669034,,TNFs bind their physiological receptors,Homo sapiens,reactome | |
| 2582,R-HSA-5628897,,TP53 Regulates Metabolic Genes,Homo sapiens,reactome | |
| 2583,R-HSA-6803207,,TP53 Regulates Transcription of Caspase Activators and Caspases,Homo sapiens,reactome | |
| 2584,R-HSA-6791312,,TP53 Regulates Transcription of Cell Cycle Genes,Homo sapiens,reactome | |
| 2585,R-HSA-5633008,,TP53 Regulates Transcription of Cell Death Genes,Homo sapiens,reactome | |
| 2586,R-HSA-6796648,,TP53 Regulates Transcription of DNA Repair Genes,Homo sapiens,reactome | |
| 2587,R-HSA-6803211,,TP53 Regulates Transcription of Death Receptors and Ligands,Homo sapiens,reactome | |
| 2588,R-HSA-6803204,,TP53 Regulates Transcription of Genes Involved in Cytochrome C Release,Homo sapiens,reactome | |
| 2589,R-HSA-6804116,,TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest,Homo sapiens,reactome | |
| 2590,R-HSA-6804114,,TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest,Homo sapiens,reactome | |
| 2591,R-HSA-6804115,,TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain,Homo sapiens,reactome | |
| 2592,R-HSA-6803205,,TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain,Homo sapiens,reactome | |
| 2593,R-HSA-5602571,,TRAF3 deficiency - HSE,Homo sapiens,reactome | |
| 2594,R-HSA-918233,,TRAF3-dependent IRF activation pathway,Homo sapiens,reactome | |
| 2595,R-HSA-933541,,TRAF6 mediated IRF7 activation,Homo sapiens,reactome | |
| 2596,R-HSA-975110,,TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling,Homo sapiens,reactome | |
| 2597,R-HSA-933542,,TRAF6 mediated NF-kB activation,Homo sapiens,reactome | |
| 2598,R-HSA-975138,,TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation,Homo sapiens,reactome | |
| 2599,R-HSA-937072,,TRAF6-mediated induction of TAK1 complex within TLR4 complex,Homo sapiens,reactome | |
| 2600,R-HSA-75158,,TRAIL signaling,Homo sapiens,reactome | |
| 2601,R-HSA-937061,,TRIF (TICAM1)-mediated TLR4 signaling,Homo sapiens,reactome | |
| 2602,R-HSA-2562578,,TRIF-mediated programmed cell death,Homo sapiens,reactome | |
| 2603,R-HSA-187042,,TRKA activation by NGF,Homo sapiens,reactome | |
| 2604,R-HSA-3295583,,TRP channels,Homo sapiens,reactome | |
| 2605,R-HSA-1299503,,TWIK related potassium channel (TREK),Homo sapiens,reactome | |
| 2606,R-HSA-1299361,,TWIK-related alkaline pH activated K+ channel (TALK),Homo sapiens,reactome | |
| 2607,R-HSA-1299344,,TWIK-related spinal cord K+ channel (TRESK),Homo sapiens,reactome | |
| 2608,R-HSA-1299316,,TWIK-releated acid-sensitive K+ channel (TASK),Homo sapiens,reactome | |
| 2609,R-HSA-9033500,,TYSND1 cleaves peroxisomal proteins,Homo sapiens,reactome | |
| 2610,R-HSA-380095,,Tachykinin receptors bind tachykinins,Homo sapiens,reactome | |
| 2611,R-HSA-1299308,,Tandem of pore domain in a weak inwardly rectifying K+ channels (TWIK),Homo sapiens,reactome | |
| 2612,R-HSA-1299287,,Tandem pore domain halothane-inhibited K+ channel (THIK),Homo sapiens,reactome | |
| 2613,R-HSA-1296346,,Tandem pore domain potassium channels,Homo sapiens,reactome | |
| 2614,R-HSA-167243,,Tat-mediated HIV elongation arrest and recovery,Homo sapiens,reactome | |
| 2615,R-HSA-167246,,Tat-mediated elongation of the HIV-1 transcript,Homo sapiens,reactome | |
| 2616,R-HSA-174417,,Telomere C-strand (Lagging Strand) Synthesis,Homo sapiens,reactome | |
| 2617,R-HSA-174430,,Telomere C-strand synthesis initiation,Homo sapiens,reactome | |
| 2618,R-HSA-171319,,Telomere Extension By Telomerase,Homo sapiens,reactome | |
| 2619,R-HSA-157579,,Telomere Maintenance,Homo sapiens,reactome | |
| 2620,R-HSA-166665,,Terminal pathway of complement,Homo sapiens,reactome | |
| 2621,R-HSA-977068,,Termination of O-glycan biosynthesis,Homo sapiens,reactome | |
| 2622,R-HSA-5656169,,Termination of translesion DNA synthesis,Homo sapiens,reactome | |
| 2623,R-HSA-1474151,,"Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation",Homo sapiens,reactome | |
| 2624,R-HSA-844615,,The AIM2 inflammasome,Homo sapiens,reactome | |
| 2625,R-HSA-9931521,,The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex,Homo sapiens,reactome | |
| 2626,R-HSA-844623,,The IPAF inflammasome,Homo sapiens,reactome | |
| 2627,R-HSA-844455,,The NLRP1 inflammasome,Homo sapiens,reactome | |
| 2628,R-HSA-844456,,The NLRP3 inflammasome,Homo sapiens,reactome | |
| 2629,R-HSA-1663150,,The activation of arylsulfatases,Homo sapiens,reactome | |
| 2630,R-HSA-2453902,,The canonical retinoid cycle in rods (twilight vision),Homo sapiens,reactome | |
| 2631,R-HSA-167826,,The fatty acid cycling model,Homo sapiens,reactome | |
| 2632,R-HSA-2514856,,The phototransduction cascade,Homo sapiens,reactome | |
| 2633,R-HSA-2187335,,The retinoid cycle in cones (daylight vision),Homo sapiens,reactome | |
| 2634,R-HSA-8852276,,The role of GTSE1 in G2/M progression after G2 checkpoint,Homo sapiens,reactome | |
| 2635,R-HSA-164952,,The role of Nef in HIV-1 replication and disease pathogenesis,Homo sapiens,reactome | |
| 2636,R-HSA-8849175,,Threonine catabolism,Homo sapiens,reactome | |
| 2637,R-HSA-456926,,Thrombin signalling through proteinase activated receptors (PARs),Homo sapiens,reactome | |
| 2638,R-HSA-428930,,Thromboxane signalling through TP receptor,Homo sapiens,reactome | |
| 2639,R-HSA-209968,,Thyroxine biosynthesis,Homo sapiens,reactome | |
| 2640,R-HSA-210993,,Tie2 Signaling,Homo sapiens,reactome | |
| 2641,R-HSA-420029,,Tight junction interactions,Homo sapiens,reactome | |
| 2642,R-HSA-1222538,,Tolerance by Mtb to nitric oxide produced by macrophages,Homo sapiens,reactome | |
| 2643,R-HSA-1222387,,Tolerance of reactive oxygen produced by macrophages,Homo sapiens,reactome | |
| 2644,R-HSA-168142,,Toll Like Receptor 10 (TLR10) Cascade,Homo sapiens,reactome | |
| 2645,R-HSA-181438,,Toll Like Receptor 2 (TLR2) Cascade,Homo sapiens,reactome | |
| 2646,R-HSA-168164,,Toll Like Receptor 3 (TLR3) Cascade,Homo sapiens,reactome | |
| 2647,R-HSA-166016,,Toll Like Receptor 4 (TLR4) Cascade,Homo sapiens,reactome | |
| 2648,R-HSA-168176,,Toll Like Receptor 5 (TLR5) Cascade,Homo sapiens,reactome | |
| 2649,R-HSA-168181,,Toll Like Receptor 7/8 (TLR7/8) Cascade,Homo sapiens,reactome | |
| 2650,R-HSA-168138,,Toll Like Receptor 9 (TLR9) Cascade,Homo sapiens,reactome | |
| 2651,R-HSA-168179,,Toll Like Receptor TLR1:TLR2 Cascade,Homo sapiens,reactome | |
| 2652,R-HSA-168188,,Toll Like Receptor TLR6:TLR2 Cascade,Homo sapiens,reactome | |
| 2653,R-HSA-168898,,Toll-like Receptor Cascades,Homo sapiens,reactome | |
| 2654,R-HSA-5250968,,Toxicity of botulinum toxin type A (botA),Homo sapiens,reactome | |
| 2655,R-HSA-5250958,,Toxicity of botulinum toxin type B (botB),Homo sapiens,reactome | |
| 2656,R-HSA-5250971,,Toxicity of botulinum toxin type C (botC),Homo sapiens,reactome | |
| 2657,R-HSA-5250955,,Toxicity of botulinum toxin type D (botD),Homo sapiens,reactome | |
| 2658,R-HSA-5250992,,Toxicity of botulinum toxin type E (botE),Homo sapiens,reactome | |
| 2659,R-HSA-5250981,,Toxicity of botulinum toxin type F (botF),Homo sapiens,reactome | |
| 2660,R-HSA-5250989,,Toxicity of botulinum toxin type G (botG),Homo sapiens,reactome | |
| 2661,R-HSA-5250982,,Toxicity of tetanus toxin (tetX),Homo sapiens,reactome | |
| 2662,R-HSA-1679131,,Trafficking and processing of endosomal TLR,Homo sapiens,reactome | |
| 2663,R-HSA-399719,,Trafficking of AMPA receptors,Homo sapiens,reactome | |
| 2664,R-HSA-416993,,Trafficking of GluR2-containing AMPA receptors,Homo sapiens,reactome | |
| 2665,R-HSA-5624138,,Trafficking of myristoylated proteins to the cilium,Homo sapiens,reactome | |
| 2666,R-HSA-75944,,Transcription from mitochondrial promoters,Homo sapiens,reactome | |
| 2667,R-HSA-1362277,,Transcription of E2F targets under negative control by DREAM complex,Homo sapiens,reactome | |
| 2668,R-HSA-1362300,,Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1,Homo sapiens,reactome | |
| 2669,R-HSA-9682708,,Transcription of SARS-CoV-1 sgRNAs,Homo sapiens,reactome | |
| 2670,R-HSA-9694786,,Transcription of SARS-CoV-2 sgRNAs,Homo sapiens,reactome | |
| 2671,R-HSA-167172,,Transcription of the HIV genome,Homo sapiens,reactome | |
| 2672,R-HSA-6781827,,Transcription-Coupled Nucleotide Excision Repair (TC-NER),Homo sapiens,reactome | |
| 2673,R-HSA-69895,,Transcriptional activation of cell cycle inhibitor p21,Homo sapiens,reactome | |
| 2674,R-HSA-8953750,,Transcriptional Regulation by E2F6,Homo sapiens,reactome | |
| 2675,R-HSA-8986944,,Transcriptional Regulation by MECP2,Homo sapiens,reactome | |
| 2676,R-HSA-9634815,,Transcriptional Regulation by NPAS4,Homo sapiens,reactome | |
| 2677,R-HSA-3700989,,Transcriptional Regulation by TP53,Homo sapiens,reactome | |
| 2678,R-HSA-8853884,,Transcriptional Regulation by VENTX,Homo sapiens,reactome | |
| 2679,R-HSA-2151201,,Transcriptional activation of mitochondrial biogenesis,Homo sapiens,reactome | |
| 2680,R-HSA-69560,,Transcriptional activation of p53 responsive genes,Homo sapiens,reactome | |
| 2681,R-HSA-2173793,,Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer,Homo sapiens,reactome | |
| 2682,R-HSA-9856649,,Transcriptional and post-translational regulation of MITF-M expression and activity,Homo sapiens,reactome | |
| 2683,R-HSA-8878171,,Transcriptional regulation by RUNX1,Homo sapiens,reactome | |
| 2684,R-HSA-8878166,,Transcriptional regulation by RUNX2,Homo sapiens,reactome | |
| 2685,R-HSA-8878159,,Transcriptional regulation by RUNX3,Homo sapiens,reactome | |
| 2686,R-HSA-5578749,,Transcriptional regulation by small RNAs,Homo sapiens,reactome | |
| 2687,R-HSA-8864260,,Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors,Homo sapiens,reactome | |
| 2688,R-HSA-9843743,,Transcriptional regulation of brown and beige adipocyte differentiation,Homo sapiens,reactome | |
| 2689,R-HSA-9844594,,Transcriptional regulation of brown and beige adipocyte differentiation by EBF2,Homo sapiens,reactome | |
| 2690,R-HSA-9616222,,Transcriptional regulation of granulopoiesis,Homo sapiens,reactome | |
| 2691,R-HSA-9945556,,Transcriptional regulation of multiciliogenesis,Homo sapiens,reactome | |
| 2692,R-HSA-452723,,Transcriptional regulation of pluripotent stem cells,Homo sapiens,reactome | |
| 2693,R-HSA-9690406,,Transcriptional regulation of testis differentiation,Homo sapiens,reactome | |
| 2694,R-HSA-381340,,Transcriptional regulation of white adipocyte differentiation,Homo sapiens,reactome | |
| 2695,R-HSA-166020,,Transfer of LPS from LBP carrier to CD14,Homo sapiens,reactome | |
| 2696,R-HSA-917977,,Transferrin endocytosis and recycling,Homo sapiens,reactome | |
| 2697,R-HSA-72766,,Translation,Homo sapiens,reactome | |
| 2698,R-HSA-72649,,Translation initiation complex formation,Homo sapiens,reactome | |
| 2699,R-HSA-9727281,,Translation of Accessory Proteins,Homo sapiens,reactome | |
| 2700,R-HSA-9679504,,Translation of Replicase and Assembly of the Replication Transcription Complex,Homo sapiens,reactome | |
| 2701,R-HSA-9694676,,Translation of Replicase and Assembly of the Replication Transcription Complex,Homo sapiens,reactome | |
| 2702,R-HSA-9683701,,Translation of Structural Proteins,Homo sapiens,reactome | |
| 2703,R-HSA-9694635,,Translation of Structural Proteins,Homo sapiens,reactome | |
| 2704,R-HSA-9828721,,Translation of respiratory syncytial virus mRNAs,Homo sapiens,reactome | |
| 2705,R-HSA-110320,,Translesion Synthesis by POLH,Homo sapiens,reactome | |
| 2706,R-HSA-5656121,,Translesion synthesis by POLI,Homo sapiens,reactome | |
| 2707,R-HSA-5655862,,Translesion synthesis by POLK,Homo sapiens,reactome | |
| 2708,R-HSA-110312,,Translesion synthesis by REV1,Homo sapiens,reactome | |
| 2709,R-HSA-110313,,Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template,Homo sapiens,reactome | |
| 2710,R-HSA-1445148,,Translocation of SLC2A4 (GLUT4) to the plasma membrane,Homo sapiens,reactome | |
| 2711,R-HSA-202430,,Translocation of ZAP-70 to Immunological synapse,Homo sapiens,reactome | |
| 2712,R-HSA-112315,,Transmission across Chemical Synapses,Homo sapiens,reactome | |
| 2713,R-HSA-112307,,Transmission across Electrical Synapses,Homo sapiens,reactome | |
| 2714,R-HSA-174362,,Transport and metabolism of PAPS,Homo sapiens,reactome | |
| 2715,R-HSA-168874,,"Transport of HA trimer, NA tetramer and M2 tetramer from the endoplasmic reticulum to the Golgi Apparatus",Homo sapiens,reactome | |
| 2716,R-HSA-72202,,Transport of Mature Transcript to Cytoplasm,Homo sapiens,reactome | |
| 2717,R-HSA-159231,,Transport of Mature mRNA Derived from an Intronless Transcript,Homo sapiens,reactome | |
| 2718,R-HSA-159236,,Transport of Mature mRNA derived from an Intron-Containing Transcript,Homo sapiens,reactome | |
| 2719,R-HSA-159234,,Transport of Mature mRNAs Derived from Intronless Transcripts,Homo sapiens,reactome | |
| 2720,R-HSA-9758890,,Transport of RCbl within the body,Homo sapiens,reactome | |
| 2721,R-HSA-168271,,Transport of Ribonucleoproteins into the Host Nucleus,Homo sapiens,reactome | |
| 2722,R-HSA-190827,,Transport of connexins along the secretory pathway,Homo sapiens,reactome | |
| 2723,R-HSA-190872,,Transport of connexons to the plasma membrane,Homo sapiens,reactome | |
| 2724,R-HSA-804914,,Transport of fatty acids,Homo sapiens,reactome | |
| 2725,R-HSA-159763,,Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus,Homo sapiens,reactome | |
| 2726,R-HSA-432030,,Transport of glycerol from adipocytes to the liver by Aquaporins,Homo sapiens,reactome | |
| 2727,R-HSA-83936,,Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane,Homo sapiens,reactome | |
| 2728,R-HSA-727802,,Transport of nucleotide sugars,Homo sapiens,reactome | |
| 2729,R-HSA-382551,,Transport of small molecules,Homo sapiens,reactome | |
| 2730,R-HSA-159230,,Transport of the SLBP Dependant Mature mRNA,Homo sapiens,reactome | |
| 2731,R-HSA-159227,,Transport of the SLBP independent Mature mRNA,Homo sapiens,reactome | |
| 2732,R-HSA-425397,,"Transport of vitamins, nucleosides, and related molecules",Homo sapiens,reactome | |
| 2733,R-HSA-948021,,Transport to the Golgi and subsequent modification,Homo sapiens,reactome | |
| 2734,R-HSA-75109,,Triglyceride biosynthesis,Homo sapiens,reactome | |
| 2735,R-HSA-163560,,Triglyceride catabolism,Homo sapiens,reactome | |
| 2736,R-HSA-8979227,,Triglyceride metabolism,Homo sapiens,reactome | |
| 2737,R-HSA-450513,,"Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA",Homo sapiens,reactome | |
| 2738,R-HSA-5467348,,Truncations of AMER1 destabilize the destruction complex,Homo sapiens,reactome | |
| 2739,R-HSA-71240,,Tryptophan catabolism,Homo sapiens,reactome | |
| 2740,R-HSA-9860927,,"Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells",Homo sapiens,reactome | |
| 2741,R-HSA-446107,,Type I hemidesmosome assembly,Homo sapiens,reactome | |
| 2742,R-HSA-427589,,Type II Na+/Pi cotransporters,Homo sapiens,reactome | |
| 2743,R-HSA-8963684,,Tyrosine catabolism,Homo sapiens,reactome | |
| 2744,R-HSA-5689603,,UCH proteinases,Homo sapiens,reactome | |
| 2745,R-HSA-5602415,,UNC93B1 deficiency - HSE,Homo sapiens,reactome | |
| 2746,R-HSA-5689880,,Ub-specific processing proteases,Homo sapiens,reactome | |
| 2747,R-HSA-2142789,,Ubiquinol biosynthesis,Homo sapiens,reactome | |
| 2748,R-HSA-69601,,Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A,Homo sapiens,reactome | |
| 2749,R-HSA-75815,,Ubiquitin-dependent degradation of Cyclin D,Homo sapiens,reactome | |
| 2750,R-HSA-438066,,"Unblocking of NMDA receptors, glutamate binding and activation",Homo sapiens,reactome | |
| 2751,R-HSA-162585,,Uncoating of the HIV Virion,Homo sapiens,reactome | |
| 2752,R-HSA-168336,,Uncoating of the Influenza Virion,Homo sapiens,reactome | |
| 2753,R-HSA-381119,,Unfolded Protein Response (UPR),Homo sapiens,reactome | |
| 2754,R-HSA-176974,,Unwinding of DNA,Homo sapiens,reactome | |
| 2755,R-HSA-5339562,,Uptake and actions of bacterial toxins,Homo sapiens,reactome | |
| 2756,R-HSA-5210891,,Uptake and function of anthrax toxins,Homo sapiens,reactome | |
| 2757,R-HSA-5336415,,Uptake and function of diphtheria toxin,Homo sapiens,reactome | |
| 2758,R-HSA-9758881,,Uptake of dietary cobalamins into enterocytes,Homo sapiens,reactome | |
| 2759,R-HSA-70635,,Urea cycle,Homo sapiens,reactome | |
| 2760,R-HSA-77108,,Utilization of Ketone Bodies,Homo sapiens,reactome | |
| 2761,R-HSA-195399,,VEGF binds to VEGFR leading to receptor dimerization,Homo sapiens,reactome | |
| 2762,R-HSA-194313,,VEGF ligand-receptor interactions,Homo sapiens,reactome | |
| 2763,R-HSA-4420097,,VEGFA-VEGFR2 Pathway,Homo sapiens,reactome | |
| 2764,R-HSA-5218921,,VEGFR2 mediated cell proliferation,Homo sapiens,reactome | |
| 2765,R-HSA-5218920,,VEGFR2 mediated vascular permeability,Homo sapiens,reactome | |
| 2766,R-HSA-8866423,,VLDL assembly,Homo sapiens,reactome | |
| 2767,R-HSA-8964046,,VLDL clearance,Homo sapiens,reactome | |
| 2768,R-HSA-8866427,,VLDLR internalisation and degradation,Homo sapiens,reactome | |
| 2769,R-HSA-5619094,,Variant SLC6A14 may confer susceptibility towards obesity,Homo sapiens,reactome | |
| 2770,R-HSA-5660686,,Variant SLC6A20 affecting amino acid transport contributes towards hyperglycinuria (HG) and iminoglycinuria (IG),Homo sapiens,reactome | |
| 2771,R-HSA-5619101,,Variant SLC6A20 affecting neurotransmitter transport contributes towards hyperglycinuria (HG) and iminoglycinuria (IG),Homo sapiens,reactome | |
| 2772,R-HSA-432040,,Vasopressin regulates renal water homeostasis via Aquaporins,Homo sapiens,reactome | |
| 2773,R-HSA-388479,,Vasopressin-like receptors,Homo sapiens,reactome | |
| 2774,R-HSA-5653656,,Vesicle-mediated transport,Homo sapiens,reactome | |
| 2775,R-HSA-180585,,Vif-mediated degradation of APOBEC3G,Homo sapiens,reactome | |
| 2776,R-HSA-9824446,,Viral Infection Pathways,Homo sapiens,reactome | |
| 2777,R-HSA-168325,,Viral Messenger RNA Synthesis,Homo sapiens,reactome | |
| 2778,R-HSA-168330,,Viral RNP Complexes in the Host Cell Nucleus,Homo sapiens,reactome | |
| 2779,R-HSA-192823,,Viral mRNA Translation,Homo sapiens,reactome | |
| 2780,R-HSA-9690722,,Viral strategies to evade IFIT action,Homo sapiens,reactome | |
| 2781,R-HSA-9694322,,Virion Assembly and Release,Homo sapiens,reactome | |
| 2782,R-HSA-9679509,,Virion Assembly and Release,Homo sapiens,reactome | |
| 2783,R-HSA-168268,,Virus Assembly and Release,Homo sapiens,reactome | |
| 2784,R-HSA-2187338,,Visual phototransduction,Homo sapiens,reactome | |
| 2785,R-HSA-196819,,Vitamin B1 (thiamin) metabolism,Homo sapiens,reactome | |
| 2786,R-HSA-196843,,Vitamin B2 (riboflavin) metabolism,Homo sapiens,reactome | |
| 2787,R-HSA-199220,,Vitamin B5 (pantothenate) metabolism,Homo sapiens,reactome | |
| 2788,R-HSA-964975,,Vitamin B6 activation to pyridoxal phosphate,Homo sapiens,reactome | |
| 2789,R-HSA-196836,,Vitamin C (ascorbate) metabolism,Homo sapiens,reactome | |
| 2790,R-HSA-196791,,Vitamin D (calciferol) metabolism,Homo sapiens,reactome | |
| 2791,R-HSA-8877627,,Vitamin E transport,Homo sapiens,reactome | |
| 2792,R-HSA-211916,,Vitamins,Homo sapiens,reactome | |
| 2793,R-HSA-1296072,,Voltage gated Potassium channels,Homo sapiens,reactome | |
| 2794,R-HSA-180897,,Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization,Homo sapiens,reactome | |
| 2795,R-HSA-180910,,Vpr-mediated nuclear import of PICs,Homo sapiens,reactome | |
| 2796,R-HSA-180534,,Vpu mediated degradation of CD4,Homo sapiens,reactome | |
| 2797,R-HSA-5620916,,VxPx cargo-targeting to cilium,Homo sapiens,reactome | |
| 2798,R-HSA-3238698,,WNT ligand biogenesis and trafficking,Homo sapiens,reactome | |
| 2799,R-HSA-201688,,WNT mediated activation of DVL,Homo sapiens,reactome | |
| 2800,R-HSA-9673324,,WNT5:FZD7-mediated leishmania damping,Homo sapiens,reactome | |
| 2801,R-HSA-5140745,,"WNT5A-dependent internalization of FZD2, FZD5 and ROR2",Homo sapiens,reactome | |
| 2802,R-HSA-5099900,,WNT5A-dependent internalization of FZD4,Homo sapiens,reactome | |
| 2803,R-HSA-8848584,,Wax and plasmalogen biosynthesis,Homo sapiens,reactome | |
| 2804,R-HSA-9640463,,Wax biosynthesis,Homo sapiens,reactome | |
| 2805,R-HSA-5545619,,XAV939 stabilizes AXIN,Homo sapiens,reactome | |
| 2806,R-HSA-381038,,XBP1(S) activates chaperone genes,Homo sapiens,reactome | |
| 2807,R-HSA-211981,,Xenobiotics,Homo sapiens,reactome | |
| 2808,R-HSA-2032785,,YAP1- and WWTR1 (TAZ)-stimulated gene expression,Homo sapiens,reactome | |
| 2809,R-HSA-9820865,,Z-decay: degradation of maternal mRNAs by zygotically expressed factors,Homo sapiens,reactome | |
| 2810,R-HSA-1606322,,ZBP1(DAI) mediated induction of type I IFNs,Homo sapiens,reactome | |
| 2811,R-HSA-9954716,,ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA,Homo sapiens,reactome | |
| 2812,R-HSA-435368,,Zinc efflux and compartmentalization by the SLC30 family,Homo sapiens,reactome | |
| 2813,R-HSA-442380,,Zinc influx into cells by the SLC39 gene family,Homo sapiens,reactome | |
| 2814,R-HSA-435354,,Zinc transporters,Homo sapiens,reactome | |
| 2815,R-HSA-9819196,,Zygotic genome activation (ZGA),Homo sapiens,reactome | |
| 2816,R-HSA-6807062,,Zymostenol biosynthesis via lathosterol (Kandutsch-Russell pathway),Homo sapiens,reactome | |
| 2817,R-HSA-450302,,activated TAK1 mediates p38 MAPK activation,Homo sapiens,reactome | |
| 2818,R-HSA-9717316,,alectinib-resistant ALK mutants,Homo sapiens,reactome | |
| 2819,R-HSA-2046104,,alpha-linolenic (omega3) and linoleic (omega6) acid metabolism,Homo sapiens,reactome | |
| 2820,R-HSA-2046106,,alpha-linolenic acid (ALA) metabolism,Homo sapiens,reactome | |
| 2821,R-HSA-1307965,,betaKlotho-mediated ligand binding,Homo sapiens,reactome | |
| 2822,R-HSA-9717319,,brigatinib-resistant ALK mutants,Homo sapiens,reactome | |
| 2823,R-HSA-418457,,cGMP effects,Homo sapiens,reactome | |
| 2824,R-HSA-192869,,cRNA Synthesis,Homo sapiens,reactome | |
| 2825,R-HSA-9717323,,ceritinib-resistant ALK mutants,Homo sapiens,reactome | |
| 2826,R-HSA-9702581,,crenolanib-resistant FLT3 mutants,Homo sapiens,reactome | |
| 2827,R-HSA-9717326,,crizotinib-resistant ALK mutants,Homo sapiens,reactome | |
| 2828,R-HSA-203615,,eNOS activation,Homo sapiens,reactome | |
| 2829,R-HSA-9702590,,gilteritinib-resistant FLT3 mutants,Homo sapiens,reactome | |
| 2830,R-HSA-9702596,,lestaurtinib-resistant FLT3 mutants,Homo sapiens,reactome | |
| 2831,R-HSA-9702998,,linifanib-resistant FLT3 mutants,Homo sapiens,reactome | |
| 2832,R-HSA-9717329,,lorlatinib-resistant ALK mutants,Homo sapiens,reactome | |
| 2833,R-HSA-72187,,mRNA 3'-end processing,Homo sapiens,reactome | |
| 2834,R-HSA-72086,,mRNA Capping,Homo sapiens,reactome | |
| 2835,R-HSA-75072,,mRNA Editing,Homo sapiens,reactome | |
| 2836,R-HSA-75064,,mRNA Editing: A to I Conversion,Homo sapiens,reactome | |
| 2837,R-HSA-72200,,mRNA Editing: C to U Conversion,Homo sapiens,reactome | |
| 2838,R-HSA-9770562,,mRNA Polyadenylation,Homo sapiens,reactome | |
| 2839,R-HSA-72172,,mRNA Splicing,Homo sapiens,reactome | |
| 2840,R-HSA-72163,,mRNA Splicing - Major Pathway,Homo sapiens,reactome | |
| 2841,R-HSA-72165,,mRNA Splicing - Minor Pathway,Homo sapiens,reactome | |
| 2842,R-HSA-429958,,mRNA decay by 3' to 5' exoribonuclease,Homo sapiens,reactome | |
| 2843,R-HSA-430039,,mRNA decay by 5' to 3' exoribonuclease,Homo sapiens,reactome | |
| 2844,R-HSA-166208,,mTORC1-mediated signalling,Homo sapiens,reactome | |
| 2845,R-HSA-9702600,,midostaurin-resistant FLT3 mutants,Homo sapiens,reactome | |
| 2846,R-HSA-77286,,mitochondrial fatty acid beta-oxidation of saturated fatty acids,Homo sapiens,reactome | |
| 2847,R-HSA-77288,,mitochondrial fatty acid beta-oxidation of unsaturated fatty acids,Homo sapiens,reactome | |
| 2848,R-HSA-372708,,p130Cas linkage to MAPK signaling for integrins,Homo sapiens,reactome | |
| 2849,R-HSA-171007,,p38MAPK events,Homo sapiens,reactome | |
| 2850,R-HSA-69563,,p53-Dependent G1 DNA Damage Response,Homo sapiens,reactome | |
| 2851,R-HSA-69580,,p53-Dependent G1/S DNA damage checkpoint,Homo sapiens,reactome | |
| 2852,R-HSA-69613,,p53-Independent G1/S DNA Damage Checkpoint,Homo sapiens,reactome | |
| 2853,R-HSA-193704,,p75 NTR receptor-mediated signalling,Homo sapiens,reactome | |
| 2854,R-HSA-193670,,p75NTR negatively regulates cell cycle via SC1,Homo sapiens,reactome | |
| 2855,R-HSA-209543,,p75NTR recruits signalling complexes,Homo sapiens,reactome | |
| 2856,R-HSA-193697,,p75NTR regulates axonogenesis,Homo sapiens,reactome | |
| 2857,R-HSA-193639,,p75NTR signals via NF-kB,Homo sapiens,reactome | |
| 2858,R-HSA-9702605,,pexidartinib-resistant FLT3 mutants,Homo sapiens,reactome | |
| 2859,R-HSA-111995,,phospho-PLA2 pathway,Homo sapiens,reactome | |
| 2860,R-HSA-9702614,,ponatinib-resistant FLT3 mutants,Homo sapiens,reactome | |
| 2861,R-HSA-9702620,,quizartinib-resistant FLT3 mutants,Homo sapiens,reactome | |
| 2862,R-HSA-6793080,,rRNA modification in the mitochondrion,Homo sapiens,reactome | |
| 2863,R-HSA-6790901,,rRNA modification in the nucleus and cytosol,Homo sapiens,reactome | |
| 2864,R-HSA-72312,,rRNA processing,Homo sapiens,reactome | |
| 2865,R-HSA-8868766,,rRNA processing in the mitochondrion,Homo sapiens,reactome | |
| 2866,R-HSA-8868773,,rRNA processing in the nucleus and cytosol,Homo sapiens,reactome | |
| 2867,R-HSA-9702577,,semaxanib-resistant FLT3 mutants,Homo sapiens,reactome | |
| 2868,R-HSA-191859,,snRNP Assembly,Homo sapiens,reactome | |
| 2869,R-HSA-9702624,,sorafenib-resistant FLT3 mutants,Homo sapiens,reactome | |
| 2870,R-HSA-9702632,,sunitinib-resistant FLT3 mutants,Homo sapiens,reactome | |
| 2871,R-HSA-2033515,,t(4;14) translocations of FGFR3,Homo sapiens,reactome | |
| 2872,R-HSA-379724,,tRNA Aminoacylation,Homo sapiens,reactome | |
| 2873,R-HSA-6787450,,tRNA modification in the mitochondrion,Homo sapiens,reactome | |
| 2874,R-HSA-6782315,,tRNA modification in the nucleus and cytosol,Homo sapiens,reactome | |
| 2875,R-HSA-72306,,tRNA processing,Homo sapiens,reactome | |
| 2876,R-HSA-6785470,,tRNA processing in the mitochondrion,Homo sapiens,reactome | |
| 2877,R-HSA-6784531,,tRNA processing in the nucleus,Homo sapiens,reactome | |
| 2878,R-HSA-9708296,,"tRNA-derived small RNA (tsRNA or tRNA-related fragment, tRF) biogenesis",Homo sapiens,reactome | |
| 2879,R-HSA-9703009,,tamatinib-resistant FLT3 mutants,Homo sapiens,reactome | |
| 2880,R-HSA-9702636,,tandutinib-resistant FLT3 mutants,Homo sapiens,reactome | |
| 2881,R-HSA-199992,,trans-Golgi Network Vesicle Budding,Homo sapiens,reactome | |
| 2882,R-HSA-192814,,vRNA Synthesis,Homo sapiens,reactome | |
| 2883,R-HSA-192905,,vRNP Assembly,Homo sapiens,reactome | |
| 95487,,WP100,Glutathione metabolism,Homo sapiens,WikiPathways | |
| 95488,,WP106,Alanine and aspartate metabolism,Homo sapiens,WikiPathways | |
| 95489,,WP107,Translation factors,Homo sapiens,WikiPathways | |
| 95490,,WP111,Electron transport chain OXPHOS system in mitochondria,Homo sapiens,WikiPathways | |
| 95491,,WP117,GPCRs other,Homo sapiens,WikiPathways | |
| 95492,,WP12,Osteoclast signaling,Homo sapiens,WikiPathways | |
| 95493,,WP127,IL5 signaling,Homo sapiens,WikiPathways | |
| 95494,,WP129,Matrix metalloproteinases,Homo sapiens,WikiPathways | |
| 95495,,WP134,Pentose phosphate metabolism,Homo sapiens,WikiPathways | |
| 95496,,WP136,Phase I biotransformations non P450,Homo sapiens,WikiPathways | |
| 95497,,WP138,Androgen receptor signaling,Homo sapiens,WikiPathways | |
| 95498,,WP1403,AMP activated protein kinase signaling,Homo sapiens,WikiPathways | |
| 95499,,WP1422,Sphingolipid pathway,Homo sapiens,WikiPathways | |
| 95500,,WP1423,Ganglio sphingolipid metabolism,Homo sapiens,WikiPathways | |
| 95501,,WP1425,Bone morphogenic protein signaling and regulation,Homo sapiens,WikiPathways | |
| 95502,,WP143,Fatty acid beta oxidation,Homo sapiens,WikiPathways | |
| 95503,,WP1433,Nucleotide binding oligomerization domain NOD pathway,Homo sapiens,WikiPathways | |
| 95504,,WP1434,Osteopontin signaling,Homo sapiens,WikiPathways | |
| 95505,,WP1438,Influenza A virus infection,Homo sapiens,WikiPathways | |
| 95506,,WP1449,Regulation of toll like receptor signaling,Homo sapiens,WikiPathways | |
| 95507,,WP1455,Serotonin transporter activity,Homo sapiens,WikiPathways | |
| 95508,,WP1471,Target of rapamycin signaling,Homo sapiens,WikiPathways | |
| 95509,,WP1495,Glycine metabolism,Homo sapiens,WikiPathways | |
| 95510,,WP15,Selenium micronutrient network,Homo sapiens,WikiPathways | |
| 95511,,WP1528,Physiological and pathological hypertrophy of the heart,Homo sapiens,WikiPathways | |
| 95512,,WP1530,miRNA regulation of DNA damage response,Homo sapiens,WikiPathways | |
| 95513,,WP1531,Vitamin D metabolism,Homo sapiens,WikiPathways | |
| 95514,,WP1533,Vitamin B12 metabolism,Homo sapiens,WikiPathways | |
| 95515,,WP1539,Angiogenesis,Homo sapiens,WikiPathways | |
| 95516,,WP1541,Energy metabolism,Homo sapiens,WikiPathways | |
| 95517,,WP1544,MicroRNAs in cardiomyocyte hypertrophy,Homo sapiens,WikiPathways | |
| 95518,,WP1545,miRNAs involved in DNA damage response,Homo sapiens,WikiPathways | |
| 95519,,WP1559,Transcription factors regulate miRNAs related to cardiac hypertrophy,Homo sapiens,WikiPathways | |
| 95520,,WP1584,Type II diabetes mellitus,Homo sapiens,WikiPathways | |
| 95521,,WP1589,Folate alcohol and cancer pathway hypotheses,Homo sapiens,WikiPathways | |
| 95522,,WP1591,Heart development,Homo sapiens,WikiPathways | |
| 95523,,WP1600,Nicotine metabolism in liver cells,Homo sapiens,WikiPathways | |
| 95524,,WP1601,Fluoropyrimidine activity,Homo sapiens,WikiPathways | |
| 95525,,WP1602,Nicotine effect on dopaminergic neurons,Homo sapiens,WikiPathways | |
| 95526,,WP1603,Nicotine effect on chromaffin cells,Homo sapiens,WikiPathways | |
| 95527,,WP1604,Codeine and morphine metabolism,Homo sapiens,WikiPathways | |
| 95528,,WP167,Eicosanoid synthesis,Homo sapiens,WikiPathways | |
| 95529,,WP170,Nuclear receptors,Homo sapiens,WikiPathways | |
| 95530,,WP1742,TP53 network,Homo sapiens,WikiPathways | |
| 95531,,WP176,Folate metabolism,Homo sapiens,WikiPathways | |
| 95532,,WP1772,Apoptosis modulation and signaling,Homo sapiens,WikiPathways | |
| 95533,,WP179,Cell cycle,Homo sapiens,WikiPathways | |
| 95534,,WP183,Proteasome degradation,Homo sapiens,WikiPathways | |
| 95535,,WP185,Integrin mediated cell adhesion,Homo sapiens,WikiPathways | |
| 95536,,WP186,Homologous recombination,Homo sapiens,WikiPathways | |
| 95537,,WP1941,Peroxisomal beta oxidation of tetracosanoyl CoA,Homo sapiens,WikiPathways | |
| 95538,,WP1946,Cori cycle,Homo sapiens,WikiPathways | |
| 95539,,WP195,IL1 signaling,Homo sapiens,WikiPathways | |
| 95540,,WP197,Cholesterol biosynthesis pathway,Homo sapiens,WikiPathways | |
| 95541,,WP1971,Integrated cancer pathway,Homo sapiens,WikiPathways | |
| 95542,,WP1981,Thyroxine thyroid hormone production,Homo sapiens,WikiPathways | |
| 95543,,WP1982,Sterol regulatory element binding proteins SREBP signaling,Homo sapiens,WikiPathways | |
| 95544,,WP1984,Integrated breast cancer pathway,Homo sapiens,WikiPathways | |
| 95545,,WP1991,SRF and miRs in smooth muscle differentiation and proliferation,Homo sapiens,WikiPathways | |
| 95546,,WP1992,Genes targeted by miRNAs in adipocytes,Homo sapiens,WikiPathways | |
| 95547,,WP1993,Angiogenesis overview,Homo sapiens,WikiPathways | |
| 95548,,WP1995,Effects of nitric oxide,Homo sapiens,WikiPathways | |
| 95549,,WP2001,miR targeted genes in adipocytes,Homo sapiens,WikiPathways | |
| 95550,,WP2003,miR targeted genes in leukocytes,Homo sapiens,WikiPathways | |
| 95551,,WP2004,miR targeted genes in lymphocytes,Homo sapiens,WikiPathways | |
| 95552,,WP2005,miR targeted genes in muscle cell,Homo sapiens,WikiPathways | |
| 95553,,WP2006,miR targeted genes in squamous cell,Homo sapiens,WikiPathways | |
| 95554,,WP2007,Iron metabolism in placenta,Homo sapiens,WikiPathways | |
| 95555,,WP2011,SREBF and miR33 in cholesterol and lipid homeostasis,Homo sapiens,WikiPathways | |
| 95556,,WP2018,RANKL RANK signaling,Homo sapiens,WikiPathways | |
| 95557,,WP2023,Cell differentiation expanded index,Homo sapiens,WikiPathways | |
| 95558,,WP2029,Cell differentiation index,Homo sapiens,WikiPathways | |
| 95559,,WP2032,Thyroid stimulating hormone TSH signaling,Homo sapiens,WikiPathways | |
| 95560,,WP2034,Leptin signaling,Homo sapiens,WikiPathways | |
| 95561,,WP2035,Follicle stimulating hormone FSH signaling,Homo sapiens,WikiPathways | |
| 95562,,WP2036,TNF related weak inducer of apoptosis TWEAK signaling,Homo sapiens,WikiPathways | |
| 95563,,WP2037,Prolactin signaling,Homo sapiens,WikiPathways | |
| 95564,,WP2038,Microtubule cytoskeleton regulation,Homo sapiens,WikiPathways | |
| 95565,,WP205,IL7 signaling,Homo sapiens,WikiPathways | |
| 95566,,WP2059,Alzheimer 39 s disease and miRNA effects,Homo sapiens,WikiPathways | |
| 95567,,WP206,Fatty acid omega oxidation,Homo sapiens,WikiPathways | |
| 95568,,WP2064,Neural crest differentiation,Homo sapiens,WikiPathways | |
| 95569,,WP2112,IL17 signaling,Homo sapiens,WikiPathways | |
| 95570,,WP2113,Type III interferon signaling,Homo sapiens,WikiPathways | |
| 95571,,WP2118,Arrhythmogenic right ventricular cardiomyopathy,Homo sapiens,WikiPathways | |
| 95572,,WP2197,Endothelin pathways,Homo sapiens,WikiPathways | |
| 95573,,WP22,IL9 signaling,Homo sapiens,WikiPathways | |
| 95574,,WP2203,Thymic stromal lymphopoietin TSLP signaling,Homo sapiens,WikiPathways | |
| 95575,,WP2249,Metastatic brain tumor,Homo sapiens,WikiPathways | |
| 95576,,WP2253,Pilocytic astrocytoma,Homo sapiens,WikiPathways | |
| 95577,,WP2261,Glioblastoma signaling,Homo sapiens,WikiPathways | |
| 95578,,WP2263,Androgen receptor network in prostate cancer,Homo sapiens,WikiPathways | |
| 95579,,WP2267,Synaptic vesicle pathway,Homo sapiens,WikiPathways | |
| 95580,,WP2272,Pathogenic Escherichia coli infection,Homo sapiens,WikiPathways | |
| 95581,,WP2276,Glial cell differentiation,Homo sapiens,WikiPathways | |
| 95582,,WP2289,Drug induction of bile acid pathway,Homo sapiens,WikiPathways | |
| 95583,,WP229,Irinotecan pathway,Homo sapiens,WikiPathways | |
| 95584,,WP2290,RalA downstream regulated genes,Homo sapiens,WikiPathways | |
| 95585,,WP2291,Deregulation of Rab and Rab effector genes in bladder cancer,Homo sapiens,WikiPathways | |
| 95586,,WP23,B cell receptor signaling,Homo sapiens,WikiPathways | |
| 95587,,WP231,TNF alpha signaling,Homo sapiens,WikiPathways | |
| 95588,,WP2324,AGE RAGE pathway,Homo sapiens,WikiPathways | |
| 95589,,WP2328,Allograft rejection,Homo sapiens,WikiPathways | |
| 95590,,WP2332,IL11 signaling,Homo sapiens,WikiPathways | |
| 95591,,WP2333,Trans sulfuration pathway,Homo sapiens,WikiPathways | |
| 95592,,WP2338,miRNA biogenesis,Homo sapiens,WikiPathways | |
| 95593,,WP2355,Corticotropin releasing hormone signaling,Homo sapiens,WikiPathways | |
| 95594,,WP2359,Parkin ubiquitin proteasomal system pathway,Homo sapiens,WikiPathways | |
| 95595,,WP236,Adipogenesis,Homo sapiens,WikiPathways | |
| 95596,,WP2361,Gastric cancer network 1,Homo sapiens,WikiPathways | |
| 95597,,WP2363,Gastric cancer network 2,Homo sapiens,WikiPathways | |
| 95598,,WP2366,Butyrate induced histone acetylation,Homo sapiens,WikiPathways | |
| 95599,,WP2369,Histone modifications,Homo sapiens,WikiPathways | |
| 95600,,WP2371,Parkinson 39 s disease pathway,Homo sapiens,WikiPathways | |
| 95601,,WP2374,Oncostatin M signaling,Homo sapiens,WikiPathways | |
| 95602,,WP2380,Brain derived neurotrophic factor BDNF signaling,Homo sapiens,WikiPathways | |
| 95603,,WP24,Peptide GPCRs,Homo sapiens,WikiPathways | |
| 95604,,WP2406,Cardiac progenitor differentiation,Homo sapiens,WikiPathways | |
| 95605,,WP241,One carbon metabolism,Homo sapiens,WikiPathways | |
| 95606,,WP2431,Spinal cord injury,Homo sapiens,WikiPathways | |
| 95607,,WP2435,Quercetin and Nf kB AP 1 induced apoptosis,Homo sapiens,WikiPathways | |
| 95608,,WP2436,Dopamine metabolism,Homo sapiens,WikiPathways | |
| 95609,,WP244,Alpha 6 beta 4 signaling,Homo sapiens,WikiPathways | |
| 95610,,WP2446,Retinoblastoma gene in cancer,Homo sapiens,WikiPathways | |
| 95611,,WP2447,Amyotrophic lateral sclerosis ALS,Homo sapiens,WikiPathways | |
| 95612,,WP2453,TCA cycle and deficiency of pyruvate dehydrogenase complex PDHc,Homo sapiens,WikiPathways | |
| 95613,,WP2456,HIF1A and PPARG in hypertrophic cardiomyopathy,Homo sapiens,WikiPathways | |
| 95614,,WP247,Small ligand GPCRs,Homo sapiens,WikiPathways | |
| 95615,,WP2485,NAD biosynthesis II from tryptophan,Homo sapiens,WikiPathways | |
| 95616,,WP2491,Diclofenac metabolic pathway,Homo sapiens,WikiPathways | |
| 95617,,WP2507,Nanomaterial induced apoptosis,Homo sapiens,WikiPathways | |
| 95618,,WP2509,Nanoparticle triggered autophagic cell death,Homo sapiens,WikiPathways | |
| 95619,,WP2513,Nanoparticle triggered regulated necrosis,Homo sapiens,WikiPathways | |
| 95620,,WP2516,ATM signaling,Homo sapiens,WikiPathways | |
| 95621,,WP2525,Trans sulfuration one carbon metabolism and related pathways,Homo sapiens,WikiPathways | |
| 95622,,WP2526,PDGF pathway,Homo sapiens,WikiPathways | |
| 95623,,WP2533,Glycerophospholipid biosynthetic pathway,Homo sapiens,WikiPathways | |
| 95624,,WP2536,Colchicine metabolic pathway,Homo sapiens,WikiPathways | |
| 95625,,WP254,Apoptosis,Homo sapiens,WikiPathways | |
| 95626,,WP2542,Sulindac metabolic pathway,Homo sapiens,WikiPathways | |
| 95627,,WP2571,Polycystic kidney disease pathway,Homo sapiens,WikiPathways | |
| 95628,,WP2572,Primary focal segmental glomerulosclerosis FSGS,Homo sapiens,WikiPathways | |
| 95629,,WP2583,T cell receptor and co stimulatory signaling,Homo sapiens,WikiPathways | |
| 95630,,WP2586,Aryl hydrocarbon receptor response to main mediators PAH and TCDD,Homo sapiens,WikiPathways | |
| 95631,,WP259,Nifedipine activity,Homo sapiens,WikiPathways | |
| 95632,,WP2596,Gastric acid production,Homo sapiens,WikiPathways | |
| 95633,,WP26,S1P receptor signal transduction,Homo sapiens,WikiPathways | |
| 95634,,WP262,Ebstein Barr virus LMP1 signaling,Homo sapiens,WikiPathways | |
| 95635,,WP2636,Common pathways underlying drug addiction,Homo sapiens,WikiPathways | |
| 95636,,WP2637,Interleukin 1 IL 1 structural pathway,Homo sapiens,WikiPathways | |
| 95637,,WP2640,Aripiprazole metabolic pathway,Homo sapiens,WikiPathways | |
| 95638,,WP2643,Nanoparticle mediated activation of receptor signaling,Homo sapiens,WikiPathways | |
| 95639,,WP2645,Heroin metabolism,Homo sapiens,WikiPathways | |
| 95640,,WP2646,Lidocaine metabolism,Homo sapiens,WikiPathways | |
| 95641,,WP268,Notch signaling,Homo sapiens,WikiPathways | |
| 95642,,WP272,Blood clotting cascade,Homo sapiens,WikiPathways | |
| 95643,,WP2795,Cardiac hypertrophic response,Homo sapiens,WikiPathways | |
| 95644,,WP28,Selenium metabolism and selenoproteins,Homo sapiens,WikiPathways | |
| 95645,,WP2805,exRNA mechanism of action and biogenesis,Homo sapiens,WikiPathways | |
| 95646,,WP2806,Complement system,Homo sapiens,WikiPathways | |
| 95647,,WP2813,Mammary gland development embryonic development stage 1 of 4,Homo sapiens,WikiPathways | |
| 95648,,WP2814,Mammary gland development puberty stage 2 of 4,Homo sapiens,WikiPathways | |
| 95649,,WP2815,Mammary gland development involution stage 4 of 4,Homo sapiens,WikiPathways | |
| 95650,,WP2816,Felbamate metabolism,Homo sapiens,WikiPathways | |
| 95651,,WP2817,Mammary gland development pregnancy and lactation stage 3 of 4,Homo sapiens,WikiPathways | |
| 95652,,WP2826,Cocaine metabolism,Homo sapiens,WikiPathways | |
| 95653,,WP2828,Bladder cancer,Homo sapiens,WikiPathways | |
| 95654,,WP2839,Hair follicle development organogenesis stage 2 of 3,Homo sapiens,WikiPathways | |
| 95655,,WP2840,Hair follicle development cytodifferentiation stage 3 of 3,Homo sapiens,WikiPathways | |
| 95656,,WP2846,PCSK9 mediated LDL receptor degradation,Homo sapiens,WikiPathways | |
| 95657,,WP2848,Pluripotent stem cell differentiation pathway,Homo sapiens,WikiPathways | |
| 95658,,WP2849,Hematopoietic stem cell differentiation,Homo sapiens,WikiPathways | |
| 95659,,WP2853,Endoderm differentiation,Homo sapiens,WikiPathways | |
| 95660,,WP2854,Gene regulatory network modeling somitogenesis,Homo sapiens,WikiPathways | |
| 95661,,WP2855,Dopaminergic neurogenesis,Homo sapiens,WikiPathways | |
| 95662,,WP2857,Mesodermal commitment pathway,Homo sapiens,WikiPathways | |
| 95663,,WP2858,Ectoderm differentiation,Homo sapiens,WikiPathways | |
| 95664,,WP286,IL3 signaling,Homo sapiens,WikiPathways | |
| 95665,,WP2864,Apoptosis related network due to altered Notch3 in ovarian cancer,Homo sapiens,WikiPathways | |
| 95666,,WP2865,IL1 and megakaryocytes in obesity,Homo sapiens,WikiPathways | |
| 95667,,WP2868,TCA cycle nutrient use and invasiveness of ovarian cancer,Homo sapiens,WikiPathways | |
| 95668,,WP2870,Extracellular vesicle mediated signaling in recipient cells,Homo sapiens,WikiPathways | |
| 95669,,WP2873,Aryl hydrocarbon receptor pathway,Homo sapiens,WikiPathways | |
| 95670,,WP2874,Liver X receptor pathway,Homo sapiens,WikiPathways | |
| 95671,,WP2875,Constitutive androstane receptor pathway,Homo sapiens,WikiPathways | |
| 95672,,WP2876,Pregnane X receptor pathway,Homo sapiens,WikiPathways | |
| 95673,,WP2877,Vitamin D receptor pathway,Homo sapiens,WikiPathways | |
| 95674,,WP2878,PPAR alpha pathway,Homo sapiens,WikiPathways | |
| 95675,,WP2879,Farnesoid X receptor pathway,Homo sapiens,WikiPathways | |
| 95676,,WP288,Nod like receptor NLR signaling,Homo sapiens,WikiPathways | |
| 95677,,WP2880,Glucocorticoid receptor pathway,Homo sapiens,WikiPathways | |
| 95678,,WP2881,Estrogen receptor pathway,Homo sapiens,WikiPathways | |
| 95679,,WP2882,Nuclear receptors meta pathway,Homo sapiens,WikiPathways | |
| 95680,,WP2884,NRF2 pathway,Homo sapiens,WikiPathways | |
| 95681,,WP2889,Oxytocin signaling,Homo sapiens,WikiPathways | |
| 95682,,WP289,Myometrial relaxation and contraction pathways,Homo sapiens,WikiPathways | |
| 95683,,WP2895,Differentiation of white and brown adipocyte,Homo sapiens,WikiPathways | |
| 95684,,WP2911,miRNA targets in ECM and membrane receptors,Homo sapiens,WikiPathways | |
| 95685,,WP2916,Interactome of polycomb repressive complex 2 PRC2,Homo sapiens,WikiPathways | |
| 95686,,WP2942,DDX1 as a regulatory component of the Drosha microprocessor,Homo sapiens,WikiPathways | |
| 95687,,WP2943,Hypoxia mediated EMT and stemness,Homo sapiens,WikiPathways | |
| 95688,,WP299,Nuclear receptors in lipid metabolism and toxicity,Homo sapiens,WikiPathways | |
| 95689,,WP3,Transcriptional activation by NRF2 in response to phytochemicals,Homo sapiens,WikiPathways | |
| 95690,,WP304,Kit receptor signaling,Homo sapiens,WikiPathways | |
| 95691,,WP306,Focal adhesion,Homo sapiens,WikiPathways | |
| 95692,,WP313,Hepatocyte growth factor receptor signaling,Homo sapiens,WikiPathways | |
| 95693,,WP314,Fas ligand pathway and stress induction of heat shock proteins,Homo sapiens,WikiPathways | |
| 95694,,WP322,Osteoblast signaling,Homo sapiens,WikiPathways | |
| 95695,,WP325,Triacylglyceride synthesis,Homo sapiens,WikiPathways | |
| 95696,,WP3286,Copper homeostasis,Homo sapiens,WikiPathways | |
| 95697,,WP3287,Overview of nanoparticle effects,Homo sapiens,WikiPathways | |
| 95698,,WP3297,EV release from cardiac cells and their functional effects,Homo sapiens,WikiPathways | |
| 95699,,WP3298,Melatonin metabolism and effects,Homo sapiens,WikiPathways | |
| 95700,,WP3299,let 7 inhibition of ES cell reprogramming,Homo sapiens,WikiPathways | |
| 95701,,WP3300,Dual hijack model of Vif in HIV infection,Homo sapiens,WikiPathways | |
| 95702,,WP3301,MFAP5 mediated ovarian cancer cell motility and invasiveness,Homo sapiens,WikiPathways | |
| 95703,,WP3302,eIF5A regulation in response to inhibition of the nuclear export system,Homo sapiens,WikiPathways | |
| 95704,,WP3303,RAC1 PAK1 p38 MMP2 pathway,Homo sapiens,WikiPathways | |
| 95705,,WP334,GPCRs class B secretin like,Homo sapiens,WikiPathways | |
| 95706,,WP3391,Senescence associated secretory phenotype SASP,Homo sapiens,WikiPathways | |
| 95707,,WP34,Ovarian infertility,Homo sapiens,WikiPathways | |
| 95708,,WP3407,FTO obesity variant mechanism,Homo sapiens,WikiPathways | |
| 95709,,WP3408,Evolocumab mechanism to reduce LDL cholesterol,Homo sapiens,WikiPathways | |
| 95710,,WP3413,NOTCH1 regulation of endothelial cell calcification,Homo sapiens,WikiPathways | |
| 95711,,WP3414,Initiation of transcription and translation elongation at the HIV 1 LTR,Homo sapiens,WikiPathways | |
| 95712,,WP35,G protein signaling,Homo sapiens,WikiPathways | |
| 95713,,WP3527,Pre implantation embryo,Homo sapiens,WikiPathways | |
| 95714,,WP3529,Zinc homeostasis,Homo sapiens,WikiPathways | |
| 95715,,WP357,Fatty acid biosynthesis,Homo sapiens,WikiPathways | |
| 95716,,WP3580,Methionine de novo and salvage pathway,Homo sapiens,WikiPathways | |
| 95717,,WP3584,MECP2 and associated Rett syndrome,Homo sapiens,WikiPathways | |
| 95718,,WP3585,Cytosine methylation,Homo sapiens,WikiPathways | |
| 95719,,WP3591,Sleep regulation,Homo sapiens,WikiPathways | |
| 95720,,WP3593,MicroRNA for targeting cancer growth and vascularization in glioblastoma,Homo sapiens,WikiPathways | |
| 95721,,WP3594,Circadian rhythm genes,Homo sapiens,WikiPathways | |
| 95722,,WP3595,mir 124 predicted interactions with cell cycle and differentiation,Homo sapiens,WikiPathways | |
| 95723,,WP3596,miR 517 relationship with ARCN1 and USP1,Homo sapiens,WikiPathways | |
| 95724,,WP3599,Transcription factor regulation in adipogenesis,Homo sapiens,WikiPathways | |
| 95725,,WP3601,Lipid particles composition,Homo sapiens,WikiPathways | |
| 95726,,WP3611,Photodynamic therapy induced AP 1 survival signaling,Homo sapiens,WikiPathways | |
| 95727,,WP3612,Photodynamic therapy induced NFE2L2 NRF2 survival signaling,Homo sapiens,WikiPathways | |
| 95728,,WP3613,Photodynamic therapy induced unfolded protein response,Homo sapiens,WikiPathways | |
| 95729,,WP3614,Photodynamic therapy induced HIF 1 survival signaling,Homo sapiens,WikiPathways | |
| 95730,,WP3617,Photodynamic therapy induced NF kB survival signaling,Homo sapiens,WikiPathways | |
| 95731,,WP3624,Lung fibrosis,Homo sapiens,WikiPathways | |
| 95732,,WP3627,Gut liver indole metabolism,Homo sapiens,WikiPathways | |
| 95733,,WP363,Wnt signaling NetPath,Homo sapiens,WikiPathways | |
| 95734,,WP3630,NAD metabolism sirtuins and aging,Homo sapiens,WikiPathways | |
| 95735,,WP3633,Caffeine and theobromine metabolism,Homo sapiens,WikiPathways | |
| 95736,,WP3634,Insulin signaling in adipocytes normal condition,Homo sapiens,WikiPathways | |
| 95737,,WP3635,Insulin signaling in adipocytes diabetic condition,Homo sapiens,WikiPathways | |
| 95738,,WP364,IL6 signaling,Homo sapiens,WikiPathways | |
| 95739,,WP3640,Imatinib and chronic myeloid leukemia,Homo sapiens,WikiPathways | |
| 95740,,WP3644,NAD metabolism,Homo sapiens,WikiPathways | |
| 95741,,WP3645,NAD biosynthetic pathways,Homo sapiens,WikiPathways | |
| 95742,,WP3646,Hepatitis C and hepatocellular carcinoma,Homo sapiens,WikiPathways | |
| 95743,,WP3651,Pathways affected in adenoid cystic carcinoma,Homo sapiens,WikiPathways | |
| 95744,,WP3655,Hypothetical craniofacial development pathway,Homo sapiens,WikiPathways | |
| 95745,,WP3656,Interleukin 1 induced activation of NF kB,Homo sapiens,WikiPathways | |
| 95746,,WP3657,Hematopoietic stem cell gene regulation by GABP alpha beta complex,Homo sapiens,WikiPathways | |
| 95747,,WP3658,Wnt beta catenin signaling in leukemia,Homo sapiens,WikiPathways | |
| 95748,,WP3664,Regulation of Wnt B catenin signaling by small molecule compounds,Homo sapiens,WikiPathways | |
| 95749,,WP3666,Metabolism of dichloroethylene by CYP450,Homo sapiens,WikiPathways | |
| 95750,,WP3668,Hypothesized pathways in pathogenesis of cardiovascular disease,Homo sapiens,WikiPathways | |
| 95751,,WP3670,Interactions between LOXL4 and oxidative stress pathway,Homo sapiens,WikiPathways | |
| 95752,,WP3672,lncRNA mediated mechanisms of therapeutic resistance,Homo sapiens,WikiPathways | |
| 95753,,WP3674,Tgif disruption of Shh signaling,Homo sapiens,WikiPathways | |
| 95754,,WP3676,BDNF TrkB signaling,Homo sapiens,WikiPathways | |
| 95755,,WP3678,Amplification and expansion of oncogenic pathways as metastatic traits,Homo sapiens,WikiPathways | |
| 95756,,WP3679,Cell type dependent selectivity of CCK2R signaling,Homo sapiens,WikiPathways | |
| 95757,,WP368,Mitochondrial long chain fatty acid beta oxidation,Homo sapiens,WikiPathways | |
| 95758,,WP3680,Physico chemical features and toxicity associated pathways,Homo sapiens,WikiPathways | |
| 95759,,WP382,MAPK signaling,Homo sapiens,WikiPathways | |
| 95760,,WP383,Striated muscle contraction pathway,Homo sapiens,WikiPathways | |
| 95761,,WP384,Apoptosis modulation by HSP70,Homo sapiens,WikiPathways | |
| 95762,,WP3844,PI3K AKT mTOR signaling and therapeutic opportunities in prostate cancer,Homo sapiens,WikiPathways | |
| 95763,,WP3845,Canonical and non canonical Notch signaling,Homo sapiens,WikiPathways | |
| 95764,,WP3849,MAPK and NFkB signaling inhibited by Yersinia YopJ,Homo sapiens,WikiPathways | |
| 95765,,WP3850,Factors and pathways affecting insulin like growth factor IGF1 Akt signaling,Homo sapiens,WikiPathways | |
| 95766,,WP3851,TLR4 signaling and tolerance,Homo sapiens,WikiPathways | |
| 95767,,WP3853,ERK pathway in Huntington 39 s disease,Homo sapiens,WikiPathways | |
| 95768,,WP3858,Toll like receptor signaling related to MyD88,Homo sapiens,WikiPathways | |
| 95769,,WP3859,TGF beta signaling in thyroid cells for epithelial mesenchymal transition,Homo sapiens,WikiPathways | |
| 95770,,WP3863,T cell antigen receptor TCR pathway during Staphylococcus aureus infection,Homo sapiens,WikiPathways | |
| 95771,,WP3865,Novel intracellular components of RIG I like receptor pathway,Homo sapiens,WikiPathways | |
| 95772,,WP3869,Cannabinoid receptor signaling,Homo sapiens,WikiPathways | |
| 95773,,WP3871,Valproic acid pathway,Homo sapiens,WikiPathways | |
| 95774,,WP3872,Apoptosis regulation by parathyroid hormone related protein,Homo sapiens,WikiPathways | |
| 95775,,WP3873,RIOK1 and RIOK2 in EGFR and PI3K mediated tumorigenesis,Homo sapiens,WikiPathways | |
| 95776,,WP3874,Canonical and non canonical TGF B signaling,Homo sapiens,WikiPathways | |
| 95777,,WP3875,ATR signaling,Homo sapiens,WikiPathways | |
| 95778,,WP3876,BMP2 WNT4 FOXO1 pathway in primary endometrial stromal cell differentiation,Homo sapiens,WikiPathways | |
| 95779,,WP3877,MYD88 distinct input output pathway,Homo sapiens,WikiPathways | |
| 95780,,WP3878,ATM signaling in development and disease,Homo sapiens,WikiPathways | |
| 95781,,WP3879,4 hydroxytamoxifen dexamethasone and retinoic acids regulation of p27 expression,Homo sapiens,WikiPathways | |
| 95782,,WP3888,VEGFA VEGFR2 signaling,Homo sapiens,WikiPathways | |
| 95783,,WP3890,Nanomaterial induced inflammasome activation,Homo sapiens,WikiPathways | |
| 95784,,WP3891,Benzene metabolism,Homo sapiens,WikiPathways | |
| 95785,,WP3892,Development of pulmonary dendritic cells and macrophage subsets,Homo sapiens,WikiPathways | |
| 95786,,WP3893,Development and heterogeneity of the ILC family,Homo sapiens,WikiPathways | |
| 95787,,WP3896,Dengue 2 interactions with complement and coagulation cascades,Homo sapiens,WikiPathways | |
| 95788,,WP391,Mitochondrial gene expression,Homo sapiens,WikiPathways | |
| 95789,,WP3915,Angiopoietin like protein 8 regulatory pathway,Homo sapiens,WikiPathways | |
| 95790,,WP3924,Hfe effect on hepcidin production,Homo sapiens,WikiPathways | |
| 95791,,WP3925,Amino acid metabolism,Homo sapiens,WikiPathways | |
| 95792,,WP3926,ApoE and miR 146 in inflammation and atherosclerosis,Homo sapiens,WikiPathways | |
| 95793,,WP3927,BMP signaling in eyelid development,Homo sapiens,WikiPathways | |
| 95794,,WP3929,Chemokine signaling,Homo sapiens,WikiPathways | |
| 95795,,WP3930,EDA signaling in hair follicle development,Homo sapiens,WikiPathways | |
| 95796,,WP3931,Embryonic stem cell pluripotency pathways,Homo sapiens,WikiPathways | |
| 95797,,WP3932,Focal adhesion PI3K Akt mTOR signaling,Homo sapiens,WikiPathways | |
| 95798,,WP3933,Kennedy pathway from sphingolipids,Homo sapiens,WikiPathways | |
| 95799,,WP3934,Leptin and adiponectin,Homo sapiens,WikiPathways | |
| 95800,,WP3935,Leptin insulin signaling overlap,Homo sapiens,WikiPathways | |
| 95801,,WP3937,Microglia pathogen phagocytosis pathway,Homo sapiens,WikiPathways | |
| 95802,,WP3938,miR 222 in exercise induced cardiac growth,Homo sapiens,WikiPathways | |
| 95803,,WP3941,Oxidative damage response,Homo sapiens,WikiPathways | |
| 95804,,WP3942,PPAR signaling,Homo sapiens,WikiPathways | |
| 95805,,WP3943,ROBO4 and VEGF signaling crosstalk,Homo sapiens,WikiPathways | |
| 95806,,WP3944,Serotonin and anxiety related events,Homo sapiens,WikiPathways | |
| 95807,,WP3945,TYROBP causal network in microglia,Homo sapiens,WikiPathways | |
| 95808,,WP3947,Serotonin and anxiety,Homo sapiens,WikiPathways | |
| 95809,,WP395,IL4 signaling,Homo sapiens,WikiPathways | |
| 95810,,WP3953,mRNA protein and metabolite induced stress pathway by cyclosporin A,Homo sapiens,WikiPathways | |
| 95811,,WP3958,GPR40 role in insulin secretion,Homo sapiens,WikiPathways | |
| 95812,,WP3959,DNA IR double strand breaks and cellular response via ATM,Homo sapiens,WikiPathways | |
| 95813,,WP3963,Mevalonate pathway,Homo sapiens,WikiPathways | |
| 95814,,WP3965,Lipid metabolism pathway,Homo sapiens,WikiPathways | |
| 95815,,WP3967,miR 509 3p alteration of YAP1 ECM axis,Homo sapiens,WikiPathways | |
| 95816,,WP3969,H19 Rb E2F1 and CDK beta catenin in colorectal cancer,Homo sapiens,WikiPathways | |
| 95817,,WP3971,OSX and miRNAs in tooth development,Homo sapiens,WikiPathways | |
| 95818,,WP3972,PDGFR beta pathway,Homo sapiens,WikiPathways | |
| 95819,,WP3981,miRNA regulation of prostate cancer signaling,Homo sapiens,WikiPathways | |
| 95820,,WP3982,miRNA regulation of p53 pathway in prostate cancer,Homo sapiens,WikiPathways | |
| 95821,,WP399,Wnt signaling and pluripotency,Homo sapiens,WikiPathways | |
| 95822,,WP3995,Prion disease pathway,Homo sapiens,WikiPathways | |
| 95823,,WP3996,Ethanol effects on histone modifications,Homo sapiens,WikiPathways | |
| 95824,,WP3998,Prader Willi and Angelman syndrome,Homo sapiens,WikiPathways | |
| 95825,,WP400,p38 MAPK signaling,Homo sapiens,WikiPathways | |
| 95826,,WP4008,NO cGMP PKG mediated neuroprotection,Homo sapiens,WikiPathways | |
| 95827,,WP4016,DNA IR damage and cellular response via ATR,Homo sapiens,WikiPathways | |
| 95828,,WP4018,Clear cell renal cell carcinoma pathways,Homo sapiens,WikiPathways | |
| 95829,,WP4022,Pyrimidine metabolism,Homo sapiens,WikiPathways | |
| 95830,,WP4030,SCFA and skeletal muscle substrate metabolism,Homo sapiens,WikiPathways | |
| 95831,,WP404,Nucleotide metabolism,Homo sapiens,WikiPathways | |
| 95832,,WP405,Eukaryotic transcription initiation,Homo sapiens,WikiPathways | |
| 95833,,WP408,Oxidative stress response,Homo sapiens,WikiPathways | |
| 95834,,WP410,Exercise induced circadian regulation,Homo sapiens,WikiPathways | |
| 95835,,WP411,mRNA processing,Homo sapiens,WikiPathways | |
| 95836,,WP4136,Fibrin complement receptor 3 signaling,Homo sapiens,WikiPathways | |
| 95837,,WP4141,PI3K AKT mTOR vitamin D3 signaling,Homo sapiens,WikiPathways | |
| 95838,,WP4142,Metabolism of sphingolipids in ER and Golgi apparatus,Homo sapiens,WikiPathways | |
| 95839,,WP4146,Macrophage markers,Homo sapiens,WikiPathways | |
| 95840,,WP4147,PTF1A related regulatory pathway,Homo sapiens,WikiPathways | |
| 95841,,WP4148,Splicing factor NOVA regulated synaptic proteins,Homo sapiens,WikiPathways | |
| 95842,,WP4149,White fat cell differentiation,Homo sapiens,WikiPathways | |
| 95843,,WP4150,Wnt signaling in kidney disease,Homo sapiens,WikiPathways | |
| 95844,,WP4153,Degradation pathway of sphingolipids including diseases,Homo sapiens,WikiPathways | |
| 95845,,WP4155,Endometrial cancer,Homo sapiens,WikiPathways | |
| 95846,,WP4156,Biosynthesis and regeneration of tetrahydrobiopterin and catabolism of phenylalanine,Homo sapiens,WikiPathways | |
| 95847,,WP4157,GABA metabolism aka GHB,Homo sapiens,WikiPathways | |
| 95848,,WP4159,GABA receptor signaling,Homo sapiens,WikiPathways | |
| 95849,,WP4172,PI3K Akt signaling,Homo sapiens,WikiPathways | |
| 95850,,WP4174,Metabolism of tetrahydrocannabinol THC,Homo sapiens,WikiPathways | |
| 95851,,WP4186,Somatroph axis GH and its relationship to dietary restriction and aging,Homo sapiens,WikiPathways | |
| 95852,,WP4189,Mevalonate arm of cholesterol biosynthesis pathway with inhibitors,Homo sapiens,WikiPathways | |
| 95853,,WP4190,Mevalonate arm of cholesterol biosynthesis pathway,Homo sapiens,WikiPathways | |
| 95854,,WP4191,Caloric restriction and aging,Homo sapiens,WikiPathways | |
| 95855,,WP4194,Hormonal control of pubertal growth spurt,Homo sapiens,WikiPathways | |
| 95856,,WP4197,Interferon signaling in tuberculosis,Homo sapiens,WikiPathways | |
| 95857,,WP4204,Tumor suppressor activity of SMARCB1,Homo sapiens,WikiPathways | |
| 95858,,WP4205,MET in type 1 papillary renal cell carcinoma,Homo sapiens,WikiPathways | |
| 95859,,WP4206,Hereditary leiomyomatosis and renal cell carcinoma pathway,Homo sapiens,WikiPathways | |
| 95860,,WP4210,Tryptophan catabolism leading to NAD production,Homo sapiens,WikiPathways | |
| 95861,,WP4211,Transcriptional cascade regulating adipogenesis,Homo sapiens,WikiPathways | |
| 95862,,WP4216,Chromosomal and microsatellite instability in colorectal cancer,Homo sapiens,WikiPathways | |
| 95863,,WP4217,Ebola virus infection in host,Homo sapiens,WikiPathways | |
| 95864,,WP422,MAPK cascade,Homo sapiens,WikiPathways | |
| 95865,,WP4220,Neurotransmitter disorders,Homo sapiens,WikiPathways | |
| 95866,,WP4222,Phosphodiesterases in neuronal function,Homo sapiens,WikiPathways | |
| 95867,,WP4223,Ras signaling,Homo sapiens,WikiPathways | |
| 95868,,WP4224,Purine metabolism and related disorders,Homo sapiens,WikiPathways | |
| 95869,,WP4225,Pyrimidine metabolism and related diseases,Homo sapiens,WikiPathways | |
| 95870,,WP4228,Vitamin B6 dependent and responsive disorders,Homo sapiens,WikiPathways | |
| 95871,,WP4233,Acrylamide biotransformation and exposure biomarkers,Homo sapiens,WikiPathways | |
| 95872,,WP4236,Krebs cycle disorders,Homo sapiens,WikiPathways | |
| 95873,,WP4238,Flavan 3 ol metabolic pathway,Homo sapiens,WikiPathways | |
| 95874,,WP4239,Epithelial to mesenchymal transition in colorectal cancer,Homo sapiens,WikiPathways | |
| 95875,,WP4240,Regulation of sister chromatid separation at the metaphase anaphase transition,Homo sapiens,WikiPathways | |
| 95876,,WP4241,Fumarate hydratase deficient papillary renal cell carcinoma,Homo sapiens,WikiPathways | |
| 95877,,WP4249,Hedgehog signaling,Homo sapiens,WikiPathways | |
| 95878,,WP4255,Non small cell lung cancer,Homo sapiens,WikiPathways | |
| 95879,,WP4258,lncRNA in canonical Wnt signaling and colorectal cancer,Homo sapiens,WikiPathways | |
| 95880,,WP4259,Disorders of folate metabolism and transport,Homo sapiens,WikiPathways | |
| 95881,,WP4262,Breast cancer pathway,Homo sapiens,WikiPathways | |
| 95882,,WP4263,Pancreatic adenocarcinoma pathway,Homo sapiens,WikiPathways | |
| 95883,,WP4269,Ethanol metabolism production of ROS by CYP2E1,Homo sapiens,WikiPathways | |
| 95884,,WP4271,Vitamin B12 disorders,Homo sapiens,WikiPathways | |
| 95885,,WP428,Wnt signaling,Homo sapiens,WikiPathways | |
| 95886,,WP4284,Ultraconserved region 339 modulation of tumor suppressor microRNAs in cancer,Homo sapiens,WikiPathways | |
| 95887,,WP4288,MTHFR deficiency,Homo sapiens,WikiPathways | |
| 95888,,WP4290,Metabolic reprogramming in colon cancer,Homo sapiens,WikiPathways | |
| 95889,,WP4292,Methionine metabolism leading to sulfur amino acids and related disorders,Homo sapiens,WikiPathways | |
| 95890,,WP4297,Thiamine metabolic pathways,Homo sapiens,WikiPathways | |
| 95891,,WP4298,Acute viral myocarditis,Homo sapiens,WikiPathways | |
| 95892,,WP4299,Lamin A processing pathway,Homo sapiens,WikiPathways | |
| 95893,,WP43,Oxidation by cytochrome P450,Homo sapiens,WikiPathways | |
| 95894,,WP430,Statin inhibition of cholesterol production,Homo sapiens,WikiPathways | |
| 95895,,WP4300,Extracellular vesicles in the crosstalk of cardiac cells,Homo sapiens,WikiPathways | |
| 95896,,WP4301,Inhibition of exosome biogenesis and secretion by manumycin A in CRPC cells,Homo sapiens,WikiPathways | |
| 95897,,WP4304,Oligodendrocyte specification and differentiation leading to myelin components for CNS,Homo sapiens,WikiPathways | |
| 95898,,WP4312,Rett syndrome,Homo sapiens,WikiPathways | |
| 95899,,WP4313,Ferroptosis,Homo sapiens,WikiPathways | |
| 95900,,WP4315,Malate aspartate shuttle,Homo sapiens,WikiPathways | |
| 95901,,WP4316,miRNA degrading enzymes,Homo sapiens,WikiPathways | |
| 95902,,WP4317,Mitochondrial fatty acid synthesis pathway,Homo sapiens,WikiPathways | |
| 95903,,WP4318,Mitochondrial fission and fusion,Homo sapiens,WikiPathways | |
| 95904,,WP4320,Effect of progerin on genes involved in progeria,Homo sapiens,WikiPathways | |
| 95905,,WP4321,Thermogenesis,Homo sapiens,WikiPathways | |
| 95906,,WP4324,Mitochondrial complex I assembly model OXPHOS system,Homo sapiens,WikiPathways | |
| 95907,,WP4329,miRNA role in immune response in sepsis,Homo sapiens,WikiPathways | |
| 95908,,WP4331,Neovascularization processes,Homo sapiens,WikiPathways | |
| 95909,,WP4336,ncRNAs in Wnt signaling in hepatocellular carcinoma,Homo sapiens,WikiPathways | |
| 95910,,WP4337,ncRNAs involved in STAT3 signaling in hepatocellular carcinoma,Homo sapiens,WikiPathways | |
| 95911,,WP4341,Non genomic actions of 1 25 dihydroxyvitamin D3,Homo sapiens,WikiPathways | |
| 95912,,WP4342,Vitamins A and D action mechanisms,Homo sapiens,WikiPathways | |
| 95913,,WP4352,Ciliary landscape,Homo sapiens,WikiPathways | |
| 95914,,WP4357,NRF2 ARE regulation,Homo sapiens,WikiPathways | |
| 95915,,WP437,EGF EGFR signaling,Homo sapiens,WikiPathways | |
| 95916,,WP438,Non homologous end joining,Homo sapiens,WikiPathways | |
| 95917,,WP4389,Bile acid synthesis and enterohepatic circulation,Homo sapiens,WikiPathways | |
| 95918,,WP4396,Nonalcoholic fatty liver disease,Homo sapiens,WikiPathways | |
| 95919,,WP4397,MSMP expression regulation in cancer cells and its pro angiogenic role in ovarian tumors,Homo sapiens,WikiPathways | |
| 95920,,WP4399,MicroRNA network associated with chronic lymphocytic leukemia,Homo sapiens,WikiPathways | |
| 95921,,WP4400,FABP4 in ovarian cancer,Homo sapiens,WikiPathways | |
| 95922,,WP4462,Platelet mediated interactions with vascular and circulating cells,Homo sapiens,WikiPathways | |
| 95923,,WP4463,Steroidogenic pathway,Homo sapiens,WikiPathways | |
| 95924,,WP4478,LTF danger signal response pathway,Homo sapiens,WikiPathways | |
| 95925,,WP4479,Suppression of HMGB1 mediated inflammation by THBD,Homo sapiens,WikiPathways | |
| 95926,,WP4480,Altered glycosylation of MUC1 in tumor microenvironment,Homo sapiens,WikiPathways | |
| 95927,,WP4481,Resistin as a regulator of inflammation,Homo sapiens,WikiPathways | |
| 95928,,WP4482,Vitamin D in inflammatory diseases,Homo sapiens,WikiPathways | |
| 95929,,WP4483,Relationship between inflammation COX 2 and EGFR,Homo sapiens,WikiPathways | |
| 95930,,WP4484,Control of immune tolerance by vasoactive intestinal peptide,Homo sapiens,WikiPathways | |
| 95931,,WP4493,Cells and molecules involved in local acute inflammatory response,Homo sapiens,WikiPathways | |
| 95932,,WP4494,Selective expression of chemokine receptors during T cell polarization,Homo sapiens,WikiPathways | |
| 95933,,WP4495,IL10 anti inflammatory signaling,Homo sapiens,WikiPathways | |
| 95934,,WP4496,Signal transduction through IL1R,Homo sapiens,WikiPathways | |
| 95935,,WP45,G1 to S cell cycle control,Homo sapiens,WikiPathways | |
| 95936,,WP4504,Cysteine and methionine catabolism,Homo sapiens,WikiPathways | |
| 95937,,WP4506,Tyrosine metabolism and related disorders,Homo sapiens,WikiPathways | |
| 95938,,WP4507,Molybdenum cofactor Moco biosynthesis,Homo sapiens,WikiPathways | |
| 95939,,WP4518,Gamma glutamyl cycle for the biosynthesis and degradation of glutathione,Homo sapiens,WikiPathways | |
| 95940,,WP4519,Cerebral organic acidurias including diseases,Homo sapiens,WikiPathways | |
| 95941,,WP4521,Glycosylation and related congenital defects,Homo sapiens,WikiPathways | |
| 95942,,WP4522,Metabolic pathway of LDL HDL and TG including diseases,Homo sapiens,WikiPathways | |
| 95943,,WP4523,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism,Homo sapiens,WikiPathways | |
| 95944,,WP4524,Alternative pathway of fetal androgen synthesis,Homo sapiens,WikiPathways | |
| 95945,,WP453,Inflammatory response pathway,Homo sapiens,WikiPathways | |
| 95946,,WP4532,Intraflagellar transport proteins binding to dynein,Homo sapiens,WikiPathways | |
| 95947,,WP4533,Transcription co factors SKI and SKIL protein partners,Homo sapiens,WikiPathways | |
| 95948,,WP4534,Mechanoregulation and pathology of YAP TAZ via Hippo and non Hippo mechanisms,Homo sapiens,WikiPathways | |
| 95949,,WP4535,Envelope proteins and their potential roles in EDMD physiopathology,Homo sapiens,WikiPathways | |
| 95950,,WP4536,Genes related to primary cilium development based on CRISPR,Homo sapiens,WikiPathways | |
| 95951,,WP4537,Hippo YAP signaling,Homo sapiens,WikiPathways | |
| 95952,,WP4538,Regulatory circuits of STAT3 signaling,Homo sapiens,WikiPathways | |
| 95953,,WP4539,Synaptic signaling associated with autism spectrum disorder,Homo sapiens,WikiPathways | |
| 95954,,WP4540,Hippo signaling regulation,Homo sapiens,WikiPathways | |
| 95955,,WP4541,Hippo Merlin signaling dysregulation,Homo sapiens,WikiPathways | |
| 95956,,WP4542,Leukocyte intrinsic Hippo pathway functions,Homo sapiens,WikiPathways | |
| 95957,,WP4545,Oxysterols derived from cholesterol,Homo sapiens,WikiPathways | |
| 95958,,WP4549,Fragile X syndrome,Homo sapiens,WikiPathways | |
| 95959,,WP455,GPCRs class A rhodopsin like,Homo sapiens,WikiPathways | |
| 95960,,WP4553,FBXL10 enhancement of MAP ERK signaling in diffuse large B cell lymphoma,Homo sapiens,WikiPathways | |
| 95961,,WP4558,Interferon mediated signaling,Homo sapiens,WikiPathways | |
| 95962,,WP4559,Interactions between immune cells and microRNAs in tumor microenvironment,Homo sapiens,WikiPathways | |
| 95963,,WP4560,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement,Homo sapiens,WikiPathways | |
| 95964,,WP4562,Canonical NF kB pathway,Homo sapiens,WikiPathways | |
| 95965,,WP4564,Neural crest cell migration during development,Homo sapiens,WikiPathways | |
| 95966,,WP4565,Neural crest cell migration in cancer,Homo sapiens,WikiPathways | |
| 95967,,WP4566,Translation inhibitors in chronically activated PDGFRA cells,Homo sapiens,WikiPathways | |
| 95968,,WP4571,Urea cycle and related diseases,Homo sapiens,WikiPathways | |
| 95969,,WP4577,Neurodegeneration with brain iron accumulation NBIA subtypes pathway,Homo sapiens,WikiPathways | |
| 95970,,WP4582,Cancer immunotherapy by CTLA4 blockade,Homo sapiens,WikiPathways | |
| 95971,,WP4583,Biomarkers for urea cycle disorders,Homo sapiens,WikiPathways | |
| 95972,,WP4584,Biomarkers for pyrimidine metabolism disorders,Homo sapiens,WikiPathways | |
| 95973,,WP4585,Cancer immunotherapy by PD 1 blockade,Homo sapiens,WikiPathways | |
| 95974,,WP4586,Metabolism of alpha linolenic acid,Homo sapiens,WikiPathways | |
| 95975,,WP4589,Major receptors targeted by epinephrine and norepinephrine,Homo sapiens,WikiPathways | |
| 95976,,WP4595,Urea cycle and associated pathways,Homo sapiens,WikiPathways | |
| 95977,,WP4628,Aerobic glycolysis augmented,Homo sapiens,WikiPathways | |
| 95978,,WP4630,Measles virus infection,Homo sapiens,WikiPathways | |
| 95979,,WP465,Tryptophan metabolism,Homo sapiens,WikiPathways | |
| 95980,,WP4655,Cytosolic DNA sensing pathway,Homo sapiens,WikiPathways | |
| 95981,,WP4656,Joubert syndrome,Homo sapiens,WikiPathways | |
| 95982,,WP4657,22q11 2 copy number variation syndrome,Homo sapiens,WikiPathways | |
| 95983,,WP4658,Small cell lung cancer,Homo sapiens,WikiPathways | |
| 95984,,WP4659,Gastrin signaling,Homo sapiens,WikiPathways | |
| 95985,,WP466,DNA replication,Homo sapiens,WikiPathways | |
| 95986,,WP4661,Amino acid metabolism pathway excerpt histidine catabolism extension,Homo sapiens,WikiPathways | |
| 95987,,WP4666,Hepatitis B infection,Homo sapiens,WikiPathways | |
| 95988,,WP4673,Male infertility,Homo sapiens,WikiPathways | |
| 95989,,WP4674,Head and neck squamous cell carcinoma,Homo sapiens,WikiPathways | |
| 95990,,WP4685,Melanoma,Homo sapiens,WikiPathways | |
| 95991,,WP4686,Leucine isoleucine and valine metabolism,Homo sapiens,WikiPathways | |
| 95992,,WP4688,Serine metabolism,Homo sapiens,WikiPathways | |
| 95993,,WP4698,Vitamin D sensitive calcium signaling in depression,Homo sapiens,WikiPathways | |
| 95994,,WP4705,Pathways of nucleic acid metabolism and innate immune sensing,Homo sapiens,WikiPathways | |
| 95995,,WP4707,Aspirin and miRNAs,Homo sapiens,WikiPathways | |
| 95996,,WP4718,Cholesterol metabolism with Bloch and Kandutsch Russell pathways,Homo sapiens,WikiPathways | |
| 95997,,WP4719,Eicosanoid metabolism via cyclooxygenases COX,Homo sapiens,WikiPathways | |
| 95998,,WP4720,Eicosanoid metabolism via cytochrome P450 monooxygenases pathway,Homo sapiens,WikiPathways | |
| 95999,,WP4721,Eicosanoid metabolism via lipooxygenases LOX,Homo sapiens,WikiPathways | |
| 96000,,WP4722,Glycerolipids and glycerophospholipids,Homo sapiens,WikiPathways | |
| 96001,,WP4723,Omega 3 omega 6 fatty acid synthesis,Homo sapiens,WikiPathways | |
| 96002,,WP4724,Omega 9 fatty acid synthesis,Homo sapiens,WikiPathways | |
| 96003,,WP4725,Sphingolipid metabolism overview,Homo sapiens,WikiPathways | |
| 96004,,WP4726,Sphingolipid metabolism integrated pathway,Homo sapiens,WikiPathways | |
| 96005,,WP474,Endochondral ossification,Homo sapiens,WikiPathways | |
| 96006,,WP4742,Ketogenesis and ketolysis,Homo sapiens,WikiPathways | |
| 96007,,WP4746,Thyroid hormones production and peripheral downstream signaling effects,Homo sapiens,WikiPathways | |
| 96008,,WP4747,Netrin UNC5B signaling,Homo sapiens,WikiPathways | |
| 96009,,WP4751,HIPK2 in kidney fibrosis,Homo sapiens,WikiPathways | |
| 96010,,WP4752,Base excision repair,Homo sapiens,WikiPathways | |
| 96011,,WP4753,Nucleotide excision repair,Homo sapiens,WikiPathways | |
| 96012,,WP4754,IL18 signaling,Homo sapiens,WikiPathways | |
| 96013,,WP4756,Renin angiotensin aldosterone system RAAS,Homo sapiens,WikiPathways | |
| 96014,,WP4758,Nephrotic syndrome,Homo sapiens,WikiPathways | |
| 96015,,WP4760,PKC gamma calcium signaling in ataxia,Homo sapiens,WikiPathways | |
| 96016,,WP4767,FGFR3 signaling in chondrocyte proliferation and terminal differentiation,Homo sapiens,WikiPathways | |
| 96017,,WP477,Cytoplasmic ribosomal proteins,Homo sapiens,WikiPathways | |
| 96018,,WP4784,Proteoglycan biosynthesis,Homo sapiens,WikiPathways | |
| 96019,,WP4785,Somitogenesis in the context of spondylocostal dysostosis,Homo sapiens,WikiPathways | |
| 96020,,WP4786,Type I collagen synthesis in the context of osteogenesis imperfecta,Homo sapiens,WikiPathways | |
| 96021,,WP4787,Osteoblast differentiation and related diseases,Homo sapiens,WikiPathways | |
| 96022,,WP4788,Autosomal recessive osteopetrosis pathways,Homo sapiens,WikiPathways | |
| 96023,,WP4789,Multiple epiphyseal dysplasia and pseudoachondroplasia genes,Homo sapiens,WikiPathways | |
| 96024,,WP4790,FGF23 signaling in hypophosphatemic rickets and related disorders,Homo sapiens,WikiPathways | |
| 96025,,WP4792,Purine metabolism,Homo sapiens,WikiPathways | |
| 96026,,WP4799,Downregulation of ACE2 by SARS CoV 2 spike protein,Homo sapiens,WikiPathways | |
| 96027,,WP4803,Ciliopathies,Homo sapiens,WikiPathways | |
| 96028,,WP4804,Cholesterol biosynthesis with skeletal dysplasias,Homo sapiens,WikiPathways | |
| 96029,,WP4806,EGFR tyrosine kinase inhibitor resistance,Homo sapiens,WikiPathways | |
| 96030,,WP4808,Endochondral ossification with skeletal dysplasias,Homo sapiens,WikiPathways | |
| 96031,,WP481,Insulin signaling,Homo sapiens,WikiPathways | |
| 96032,,WP4814,Somatic sex determination,Homo sapiens,WikiPathways | |
| 96033,,WP4815,Glycosaminoglycan degradation,Homo sapiens,WikiPathways | |
| 96034,,WP4816,TGF beta receptor signaling in skeletal dysplasias,Homo sapiens,WikiPathways | |
| 96035,,WP4818,Conversion of angiotensinogen to angiotensin II,Homo sapiens,WikiPathways | |
| 96036,,WP4823,Genes controlling nephrogenesis,Homo sapiens,WikiPathways | |
| 96037,,WP4829,mBDNF and proBDNF regulation of GABA neurotransmission,Homo sapiens,WikiPathways | |
| 96038,,WP4830,GDNF RET signaling axis,Homo sapiens,WikiPathways | |
| 96039,,WP4838,Regucalcin in proximal tubule epithelial kidney cells,Homo sapiens,WikiPathways | |
| 96040,,WP4842,Mammalian disorder of sexual development,Homo sapiens,WikiPathways | |
| 96041,,WP4844,Influence of laminopathies on Wnt signaling,Homo sapiens,WikiPathways | |
| 96042,,WP4846,SARS CoV 2 and COVID 19 pathway,Homo sapiens,WikiPathways | |
| 96043,,WP4853,Linoleic acid metabolism affected by SARS CoV 2,Homo sapiens,WikiPathways | |
| 96044,,WP4856,Intracellular trafficking proteins involved in CMT neuropathy,Homo sapiens,WikiPathways | |
| 96045,,WP4860,Hijack of ubiquitination by SARS CoV 2,Homo sapiens,WikiPathways | |
| 96046,,WP4861,Endoplasmic reticulum stress response in coronavirus infection,Homo sapiens,WikiPathways | |
| 96047,,WP4863,Host pathogen interaction of human coronaviruses autophagy,Homo sapiens,WikiPathways | |
| 96048,,WP4864,Host pathogen interaction of human coronaviruses apoptosis,Homo sapiens,WikiPathways | |
| 96049,,WP4868,Type I interferon induction and signaling during SARS CoV 2 infection,Homo sapiens,WikiPathways | |
| 96050,,WP4871,Kisspeptin kisspeptin receptor system in the ovary,Homo sapiens,WikiPathways | |
| 96051,,WP4872,MAP3K1 role in promoting and blocking gonadal determination,Homo sapiens,WikiPathways | |
| 96052,,WP4873,Peroxiredoxin 2 induced ovarian failure,Homo sapiens,WikiPathways | |
| 96053,,WP4874,CAMKK2 pathway,Homo sapiens,WikiPathways | |
| 96054,,WP4875,Disruption of postsynaptic signaling by CNV,Homo sapiens,WikiPathways | |
| 96055,,WP4876,Activation of NLRP3 inflammasome by SARS CoV 2,Homo sapiens,WikiPathways | |
| 96056,,WP4877,Host pathogen interaction of human coronaviruses MAPK signaling,Homo sapiens,WikiPathways | |
| 96057,,WP4879,Overlap between signal transduction pathways contributing to LMNA laminopathies,Homo sapiens,WikiPathways | |
| 96058,,WP4880,Host pathogen interaction of human coronaviruses interferon induction,Homo sapiens,WikiPathways | |
| 96059,,WP4883,SARS CoV 2 and ACE2 receptor molecular mechanisms,Homo sapiens,WikiPathways | |
| 96060,,WP4884,Pathogenesis of SARS CoV 2 mediated by nsp9 nsp10 complex,Homo sapiens,WikiPathways | |
| 96061,,WP4891,COVID 19 adverse outcome pathway,Homo sapiens,WikiPathways | |
| 96062,,WP49,IL2 signaling,Homo sapiens,WikiPathways | |
| 96063,,WP4900,Purinergic signaling,Homo sapiens,WikiPathways | |
| 96064,,WP4904,LDLRAD4 intronic SNP effect on COVID patients,Homo sapiens,WikiPathways | |
| 96065,,WP4905,1q21 1 copy number variation syndrome,Homo sapiens,WikiPathways | |
| 96066,,WP4906,3q29 copy number variation syndrome,Homo sapiens,WikiPathways | |
| 96067,,WP4912,SARS coronavirus and innate immunity,Homo sapiens,WikiPathways | |
| 96068,,WP4917,Proximal tubule transport,Homo sapiens,WikiPathways | |
| 96069,,WP4918,Cellular proteostasis,Homo sapiens,WikiPathways | |
| 96070,,WP4919,Neuroinflammation,Homo sapiens,WikiPathways | |
| 96071,,WP4920,Mitochondrial complex II assembly,Homo sapiens,WikiPathways | |
| 96072,,WP4921,Mitochondrial complex III assembly,Homo sapiens,WikiPathways | |
| 96073,,WP4922,Mitochondrial complex IV assembly,Homo sapiens,WikiPathways | |
| 96074,,WP4923,Autophagy,Homo sapiens,WikiPathways | |
| 96075,,WP4925,Unfolded protein response,Homo sapiens,WikiPathways | |
| 96076,,WP4927,COVID 19 thrombosis and anticoagulation,Homo sapiens,WikiPathways | |
| 96077,,WP4928,MAPK pathway in congenital thyroid cancer,Homo sapiens,WikiPathways | |
| 96078,,WP4931,Direct reversal repair,Homo sapiens,WikiPathways | |
| 96079,,WP4932,7q11 23 copy number variation syndrome,Homo sapiens,WikiPathways | |
| 96080,,WP4936,Perturbations to host cell autophagy induced by SARS CoV 2 proteins,Homo sapiens,WikiPathways | |
| 96081,,WP4940,15q11 2 copy number variation syndrome,Homo sapiens,WikiPathways | |
| 96082,,WP4941,GPR143 in melanocytes and retinal pigment epithelium cells,Homo sapiens,WikiPathways | |
| 96083,,WP4942,15q13 3 copy number variation syndrome,Homo sapiens,WikiPathways | |
| 96084,,WP4946,Genes and complexes involved in the DNA repair pathways,Homo sapiens,WikiPathways | |
| 96085,,WP4947,Nitric oxide metabolism in cystic fibrosis,Homo sapiens,WikiPathways | |
| 96086,,WP4949,16p11 2 proximal deletion syndrome,Homo sapiens,WikiPathways | |
| 96087,,WP4950,16p11 2 distal deletion syndrome,Homo sapiens,WikiPathways | |
| 96088,,WP496,Steroid biosynthesis,Homo sapiens,WikiPathways | |
| 96089,,WP4961,STING pathway in Kawasaki like disease and COVID 19,Homo sapiens,WikiPathways | |
| 96090,,WP4962,Airway smooth muscle cell contraction,Homo sapiens,WikiPathways | |
| 96091,,WP4963,p53 transcriptional gene network,Homo sapiens,WikiPathways | |
| 96092,,WP4966,Fluoroacetic acid toxicity,Homo sapiens,WikiPathways | |
| 96093,,WP4969,Renin Angiotensin System and Bradykinin pathways in COVID 19,Homo sapiens,WikiPathways | |
| 96094,,WP497,Urea cycle and metabolism of amino groups,Homo sapiens,WikiPathways | |
| 96095,,WP4970,Galanin receptor pathway,Homo sapiens,WikiPathways | |
| 96096,,WP4971,Phosphoinositides metabolism,Homo sapiens,WikiPathways | |
| 96097,,WP500,Glycogen synthesis and degradation,Homo sapiens,WikiPathways | |
| 96098,,WP501,GPCRs class C metabotropic glutamate pheromone,Homo sapiens,WikiPathways | |
| 96099,,WP5026,Proline and hydroxyproline pathways,Homo sapiens,WikiPathways | |
| 96100,,WP5027,nsp1 from SARS CoV 2 inhibits translation initiation in the host cell,Homo sapiens,WikiPathways | |
| 96101,,WP5028,Glycine metabolism including IMDs,Homo sapiens,WikiPathways | |
| 96102,,WP5029,Amino acid transport defects IEMs,Homo sapiens,WikiPathways | |
| 96103,,WP5030,Ethylmalonic encephalopathy,Homo sapiens,WikiPathways | |
| 96104,,WP5031,Biotin metabolism including IMDs,Homo sapiens,WikiPathways | |
| 96105,,WP5033,Genes associated with the development of rheumatoid arthritis,Homo sapiens,WikiPathways | |
| 96106,,WP5036,Angiotensin II receptor type 1 pathway,Homo sapiens,WikiPathways | |
| 96107,,WP5037,Riboflavin and CoQ disorders,Homo sapiens,WikiPathways | |
| 96108,,WP5038,Mitochondrial immune response to SARS CoV 2,Homo sapiens,WikiPathways | |
| 96109,,WP5039,SARS CoV 2 innate immunity evasion and cell specific immune response,Homo sapiens,WikiPathways | |
| 96110,,WP5043,Pentose phosphate pathway in senescent cells,Homo sapiens,WikiPathways | |
| 96111,,WP5044,Kynurenine pathway and links to cell senescence,Homo sapiens,WikiPathways | |
| 96112,,WP5046,NAD metabolism in oncogene induced senescence and mitochondrial dysfunction associated senescence,Homo sapiens,WikiPathways | |
| 96113,,WP5049,Glycolysis in senescence,Homo sapiens,WikiPathways | |
| 96114,,WP5050,TCA cycle in senescence,Homo sapiens,WikiPathways | |
| 96115,,WP5052,Nephrogenesis,Homo sapiens,WikiPathways | |
| 96116,,WP5053,Development of ureteric derived collecting system,Homo sapiens,WikiPathways | |
| 96117,,WP5055,Burn wound healing,Homo sapiens,WikiPathways | |
| 96118,,WP5061,Fatty acid transporters,Homo sapiens,WikiPathways | |
| 96119,,WP5063,FOXP3 in COVID 19,Homo sapiens,WikiPathways | |
| 96120,,WP5064,7 oxo C and 7 beta HC pathways,Homo sapiens,WikiPathways | |
| 96121,,WP5065,SARS CoV 2 altering angiogenesis via NRP1,Homo sapiens,WikiPathways | |
| 96122,,WP5066,FOXA2 pathway,Homo sapiens,WikiPathways | |
| 96123,,WP5072,Modulators of TCR signaling and T cell activation,Homo sapiens,WikiPathways | |
| 96124,,WP5074,Kallmann syndrome,Homo sapiens,WikiPathways | |
| 96125,,WP5076,Soluble ACE2 mediated cell entry of SARS CoV 2,Homo sapiens,WikiPathways | |
| 96126,,WP5078,T cell modulation and desmoplasia in pancreatic cancer,Homo sapiens,WikiPathways | |
| 96127,,WP5083,Neuroinflammation and glutamatergic signaling,Homo sapiens,WikiPathways | |
| 96128,,WP5085,Vasopressin regulated water reabsorption,Homo sapiens,WikiPathways | |
| 96129,,WP5087,Pleural mesothelioma,Homo sapiens,WikiPathways | |
| 96130,,WP5088,Prostaglandin signaling,Homo sapiens,WikiPathways | |
| 96131,,WP5089,Kinin Kallikrein pathway,Homo sapiens,WikiPathways | |
| 96132,,WP5090,Complement system in neuronal development and plasticity,Homo sapiens,WikiPathways | |
| 96133,,WP5092,Interactions of natural killer cells in pancreatic cancer,Homo sapiens,WikiPathways | |
| 96134,,WP5093,Opioid receptor pathways,Homo sapiens,WikiPathways | |
| 96135,,WP5094,Orexin receptor pathway,Homo sapiens,WikiPathways | |
| 96136,,WP5095,Overview of proinflammatory and profibrotic mediators,Homo sapiens,WikiPathways | |
| 96137,,WP5097,CCL18 signaling,Homo sapiens,WikiPathways | |
| 96138,,WP5098,T cell activation SARS CoV 2,Homo sapiens,WikiPathways | |
| 96139,,WP51,Regulation of actin cytoskeleton,Homo sapiens,WikiPathways | |
| 96140,,WP5101,Congenital generalized lipodystrophy,Homo sapiens,WikiPathways | |
| 96141,,WP5102,Familial partial lipodystrophy,Homo sapiens,WikiPathways | |
| 96142,,WP5103,Progeria associated lipodystrophy,Homo sapiens,WikiPathways | |
| 96143,,WP5104,Acquired partial lipodystrophy Barraquer Simons syndrome,Homo sapiens,WikiPathways | |
| 96144,,WP5108,Familial hyperlipidemia type 1,Homo sapiens,WikiPathways | |
| 96145,,WP5109,Familial hyperlipidemia type 2,Homo sapiens,WikiPathways | |
| 96146,,WP5110,Familial hyperlipidemia type 3,Homo sapiens,WikiPathways | |
| 96147,,WP5111,Familial hyperlipidemia type 4,Homo sapiens,WikiPathways | |
| 96148,,WP5112,Familial hyperlipidemia type 5,Homo sapiens,WikiPathways | |
| 96149,,WP5113,Antiviral and anti inflammatory effects of Nrf2 on SARS CoV 2 pathway,Homo sapiens,WikiPathways | |
| 96150,,WP5114,Nucleotide excision repair in xeroderma pigmentosum,Homo sapiens,WikiPathways | |
| 96151,,WP5115,Network map of SARS CoV 2 signaling,Homo sapiens,WikiPathways | |
| 96152,,WP5116,SARS CoV 2 B 1 1 7 variant antagonises innate immune activation,Homo sapiens,WikiPathways | |
| 96153,,WP5117,Cohesin complex Cornelia de Lange syndrome,Homo sapiens,WikiPathways | |
| 96154,,WP5118,SMC1 SMC3 role in DNA damage Cornelia de Lange Syndrome,Homo sapiens,WikiPathways | |
| 96155,,WP5119,NIPBL role in DNA damage Cornelia de Lange syndrome,Homo sapiens,WikiPathways | |
| 96156,,WP5120,Inclusion body myositis,Homo sapiens,WikiPathways | |
| 96157,,WP5121,Sphingolipid metabolism in senescence,Homo sapiens,WikiPathways | |
| 96158,,WP5122,Prostaglandin and leukotriene metabolism in senescence,Homo sapiens,WikiPathways | |
| 96159,,WP5123,Mitochondrial fatty acid oxidation disorders,Homo sapiens,WikiPathways | |
| 96160,,WP5124,Alzheimer 39 s disease,Homo sapiens,WikiPathways | |
| 96161,,WP5130,Th17 cell differentiation pathway,Homo sapiens,WikiPathways | |
| 96162,,WP5133,Non classical role of vitamin D,Homo sapiens,WikiPathways | |
| 96163,,WP5136,ALA oxylipin metabolism,Homo sapiens,WikiPathways | |
| 96164,,WP5137,Linoleic acid oxylipin metabolism,Homo sapiens,WikiPathways | |
| 96165,,WP5142,Calcium mediated T cell apoptosis involved in inclusion body myositis,Homo sapiens,WikiPathways | |
| 96166,,WP5143,GDNF signaling,Homo sapiens,WikiPathways | |
| 96167,,WP5144,NRP1 triggered signaling in pancreatic cancer,Homo sapiens,WikiPathways | |
| 96168,,WP5145,COVID 19 structural coverage map,Homo sapiens,WikiPathways | |
| 96169,,WP5146,Lung pathology of COVID 19,Homo sapiens,WikiPathways | |
| 96170,,WP5148,Complement mediated inflammation of pulmonary alveolus in COVID 19 hypothetical pathway,Homo sapiens,WikiPathways | |
| 96171,,WP5149,Lipid metabolism in senescent cells,Homo sapiens,WikiPathways | |
| 96172,,WP5150,Spina bifida,Homo sapiens,WikiPathways | |
| 96173,,WP5152,Iron sulfur cluster biogenesis,Homo sapiens,WikiPathways | |
| 96174,,WP5153,N glycan biosynthesis,Homo sapiens,WikiPathways | |
| 96175,,WP5154,Docosahexaenoic acid oxylipin metabolism,Homo sapiens,WikiPathways | |
| 96176,,WP5155,Arachidonic acid AA ARA oxylipin metabolism,Homo sapiens,WikiPathways | |
| 96177,,WP5156,SARS CoV 2 replication organelle formation,Homo sapiens,WikiPathways | |
| 96178,,WP5158,Urotensin II mediated signaling,Homo sapiens,WikiPathways | |
| 96179,,WP516,Exercise and hypertrophy in skeletal muscle,Homo sapiens,WikiPathways | |
| 96180,,WP5166,Glyoxylate metabolism,Homo sapiens,WikiPathways | |
| 96181,,WP5169,Hemesynthesis defects and porphyrias,Homo sapiens,WikiPathways | |
| 96182,,WP5171,Leukotriene metabolic pathway,Homo sapiens,WikiPathways | |
| 96183,,WP5172,Iron metabolism disorders,Homo sapiens,WikiPathways | |
| 96184,,WP5173,Disorders of galactose metabolism,Homo sapiens,WikiPathways | |
| 96185,,WP5174,Ulcerative colitis signaling,Homo sapiens,WikiPathways | |
| 96186,,WP5175,Disorders in ketone body synthesis,Homo sapiens,WikiPathways | |
| 96187,,WP5176,Disorders of bile acid synthesis and biliary transport,Homo sapiens,WikiPathways | |
| 96188,,WP5178,Disorders of fructose metabolism,Homo sapiens,WikiPathways | |
| 96189,,WP5179,Biosynthesis and turnover of 1 deoxy sphingoid bases,Homo sapiens,WikiPathways | |
| 96190,,WP5180,DYRK1A involvement regarding cell proliferation in brain development,Homo sapiens,WikiPathways | |
| 96191,,WP5181,Roles of ceramides in development of insulin resistance,Homo sapiens,WikiPathways | |
| 96192,,WP5182,Pro survival signaling of neuroprotectin D1,Homo sapiens,WikiPathways | |
| 96193,,WP5183,SARS CoV 2 mitochondrial chronic oxidative stress and endothelial dysfunction,Homo sapiens,WikiPathways | |
| 96194,,WP5186,Vitamin K metabolism and activation of dependent proteins,Homo sapiens,WikiPathways | |
| 96195,,WP5187,mRNA vaccine activation of dendritic cell and induction of IFN 1,Homo sapiens,WikiPathways | |
| 96196,,WP5188,Retinol metabolism,Homo sapiens,WikiPathways | |
| 96197,,WP5189,Copper metabolism,Homo sapiens,WikiPathways | |
| 96198,,WP5190,Creatine pathway,Homo sapiens,WikiPathways | |
| 96199,,WP5191,Resolvin E1 and resolvin D1 signaling decrease inflammation,Homo sapiens,WikiPathways | |
| 96200,,WP5192,Modulation of PI3K Akt mTOR signaling by bioactive sphingolipids,Homo sapiens,WikiPathways | |
| 96201,,WP5193,Cholesterol synthesis disorders,Homo sapiens,WikiPathways | |
| 96202,,WP5194,Synthesis of ceramides and 1 deoxyceramides,Homo sapiens,WikiPathways | |
| 96203,,WP5195,Disorders in ketolysis,Homo sapiens,WikiPathways | |
| 96204,,WP5198,Inflammatory bowel disease signaling,Homo sapiens,WikiPathways | |
| 96205,,WP5199,PtdIns 4 5 P2 in cytokinesis pathway,Homo sapiens,WikiPathways | |
| 96206,,WP5200,Dravet syndrome,Homo sapiens,WikiPathways | |
| 96207,,WP5202,Alstrom syndrome,Homo sapiens,WikiPathways | |
| 96208,,WP5205,Clock controlled autophagy in bone metabolism,Homo sapiens,WikiPathways | |
| 96209,,WP521,Amino acid conjugation of benzoic acid,Homo sapiens,WikiPathways | |
| 96210,,WP5211,Glucose metabolism in triple negative breast cancer cells,Homo sapiens,WikiPathways | |
| 96211,,WP5213,Amino acid metabolism in triple negative breast cancer cells,Homo sapiens,WikiPathways | |
| 96212,,WP5215,Targeted agents in triple negative breast cancer,Homo sapiens,WikiPathways | |
| 96213,,WP5216,Warburg effect modulated by deubiquitinating enzymes and their substrates,Homo sapiens,WikiPathways | |
| 96214,,WP5218,Extrafollicular and follicular B cell activation by SARS CoV 2,Homo sapiens,WikiPathways | |
| 96215,,WP5219,Diet dependent trimethylamine trimethylamine N oxide metabolism,Homo sapiens,WikiPathways | |
| 96216,,WP5220,Metabolic reprogramming in pancreatic cancer,Homo sapiens,WikiPathways | |
| 96217,,WP5221,2q11 2 copy number variation syndrome,Homo sapiens,WikiPathways | |
| 96218,,WP5222,2q13 copy number variation syndrome,Homo sapiens,WikiPathways | |
| 96219,,WP5223,2q21 1 copy number variation syndrome,Homo sapiens,WikiPathways | |
| 96220,,WP5224,2q37 copy number variation syndrome,Homo sapiens,WikiPathways | |
| 96221,,WP5229,Nephrotoxcicity adverse outcome pathway,Homo sapiens,WikiPathways | |
| 96222,,WP5231,Hippocampal synaptogenesis and neurogenesis,Homo sapiens,WikiPathways | |
| 96223,,WP5233,Arsenic metabolism and reactive oxygen species generation,Homo sapiens,WikiPathways | |
| 96224,,WP5234,Bardet Biedl syndrome,Homo sapiens,WikiPathways | |
| 96225,,WP5235,Estradiol regulation in porto sinusoidal vascular disease,Homo sapiens,WikiPathways | |
| 96226,,WP5236,Markers of kidney cell lineage,Homo sapiens,WikiPathways | |
| 96227,,WP5238,Cholestasis,Homo sapiens,WikiPathways | |
| 96228,,WP5239,Lac Phe pathway,Homo sapiens,WikiPathways | |
| 96229,,WP524,G13 signaling,Homo sapiens,WikiPathways | |
| 96230,,WP5241,Mitochondrial beta oxidation,Homo sapiens,WikiPathways | |
| 96231,,WP5256,COVID 19 and endothelial cell senescence,Homo sapiens,WikiPathways | |
| 96232,,WP5258,ROS in COVID 19 endothelial dysfunction,Homo sapiens,WikiPathways | |
| 96233,,WP5265,Neurogenesis regulation in the olfactory epithelium,Homo sapiens,WikiPathways | |
| 96234,,WP5269,Genetic causes of porto sinusoidal vascular disease,Homo sapiens,WikiPathways | |
| 96235,,WP5272,LDL influence on CD14 and TLR4,Homo sapiens,WikiPathways | |
| 96236,,WP5273,Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists,Homo sapiens,WikiPathways | |
| 96237,,WP5275,Ether lipid biosynthesis,Homo sapiens,WikiPathways | |
| 96238,,WP5276,Estrogen synthesis and metabolism,Homo sapiens,WikiPathways | |
| 96239,,WP5277,Steroid hormone precursor biosynthesis,Homo sapiens,WikiPathways | |
| 96240,,WP5279,Mineralocorticoid biosynthesis,Homo sapiens,WikiPathways | |
| 96241,,WP528,Acetylcholine synthesis,Homo sapiens,WikiPathways | |
| 96242,,WP5280,Glucocorticoid biosynthesis,Homo sapiens,WikiPathways | |
| 96243,,WP5283,Chronic hyperglycemia impairment of neuron function,Homo sapiens,WikiPathways | |
| 96244,,WP5284,Cell interactions in pancreatic cancer microenvironment,Homo sapiens,WikiPathways | |
| 96245,,WP5285,Immune infiltration in pancreatic cancer,Homo sapiens,WikiPathways | |
| 96246,,WP5287,17q12 copy number variation syndrome,Homo sapiens,WikiPathways | |
| 96247,,WP5289,Axon guidance,Homo sapiens,WikiPathways | |
| 96248,,WP5292,Glycosphingolipid metabolism,Homo sapiens,WikiPathways | |
| 96249,,WP5293,Acute myeloid leukemia,Homo sapiens,WikiPathways | |
| 96250,,WP5294,Sildenafil treatment,Homo sapiens,WikiPathways | |
| 96251,,WP5299,Ganglio series sphingolipid metabolism,Homo sapiens,WikiPathways | |
| 96252,,WP53,ID signaling,Homo sapiens,WikiPathways | |
| 96253,,WP530,Cytokines and inflammatory response,Homo sapiens,WikiPathways | |
| 96254,,WP5300,TROP2 regulatory signaling,Homo sapiens,WikiPathways | |
| 96255,,WP5302,Neolacto series sphingolipid metabolism,Homo sapiens,WikiPathways | |
| 96256,,WP5303,Lacto series sphingolipid metabolism,Homo sapiens,WikiPathways | |
| 96257,,WP5304,Cholesterol metabolism,Homo sapiens,WikiPathways | |
| 96258,,WP531,DNA mismatch repair,Homo sapiens,WikiPathways | |
| 96259,,WP5311,Isoglobo series sphingolipids,Homo sapiens,WikiPathways | |
| 96260,,WP5312,Metabolic pathways of fibroblasts,Homo sapiens,WikiPathways | |
| 96261,,WP5313,Carnosine metabolism of glial cells,Homo sapiens,WikiPathways | |
| 96262,,WP5314,Lactate shuttle in glial cells,Homo sapiens,WikiPathways | |
| 96263,,WP5315,Sebaleic acid formation and metabolism,Homo sapiens,WikiPathways | |
| 96264,,WP5318,Female steroid hormones in cardiomyocyte energy metabolism,Homo sapiens,WikiPathways | |
| 96265,,WP5320,Male steroid hormones in cardiomyocyte energy metabolism,Homo sapiens,WikiPathways | |
| 96266,,WP5323,Fatty acid and lipoprotein transport in hepatocytes,Homo sapiens,WikiPathways | |
| 96267,,WP5324,Octadecanoid formation from linoleic acid,Homo sapiens,WikiPathways | |
| 96268,,WP5329,Cholesterol biosynthesis pathway in hepatocytes,Homo sapiens,WikiPathways | |
| 96269,,WP5331,Autophagy in pancreatic ductal adenocarcinoma,Homo sapiens,WikiPathways | |
| 96270,,WP5333,Enterocyte cholesterol metabolism,Homo sapiens,WikiPathways | |
| 96271,,WP5336,Induction of autophagy and toll like receptor signaling by graphene oxide,Homo sapiens,WikiPathways | |
| 96272,,WP534,Glycolysis and gluconeogenesis,Homo sapiens,WikiPathways | |
| 96273,,WP5342,Pathophysiological roles of DUX4 in FSHD1,Homo sapiens,WikiPathways | |
| 96274,,WP5344,Cardiomyocyte signaling converging on titin,Homo sapiens,WikiPathways | |
| 96275,,WP5345,1p36 copy number variation syndrome,Homo sapiens,WikiPathways | |
| 96276,,WP5346,8p23 1 copy number variation syndrome,Homo sapiens,WikiPathways | |
| 96277,,WP5347,IL26 signaling,Homo sapiens,WikiPathways | |
| 96278,,WP5348,11p11 2 copy number variation syndrome,Homo sapiens,WikiPathways | |
| 96279,,WP5351,Kleefstra syndrome,Homo sapiens,WikiPathways | |
| 96280,,WP5352,10q11 21q11 23 copy number variation syndrome,Homo sapiens,WikiPathways | |
| 96281,,WP5353,Macrophage stimulating protein MSP signaling,Homo sapiens,WikiPathways | |
| 96282,,WP5355,Metabolic epileptic disorders,Homo sapiens,WikiPathways | |
| 96283,,WP5356,Affected pathways in Duchenne muscular dystrophy,Homo sapiens,WikiPathways | |
| 96284,,WP5358,JAK STAT signaling in the regulation of beta cells,Homo sapiens,WikiPathways | |
| 96285,,WP536,Calcium regulation in cardiac cells,Homo sapiens,WikiPathways | |
| 96286,,WP5360,KCNQ2 related epilepsies,Homo sapiens,WikiPathways | |
| 96287,,WP5362,TAR syndrome,Homo sapiens,WikiPathways | |
| 96288,,WP5365,4p16 3 copy number variation,Homo sapiens,WikiPathways | |
| 96289,,WP5366,NF1 copy number variation syndrome,Homo sapiens,WikiPathways | |
| 96290,,WP5367,Rubinstein Taybi syndrome 1,Homo sapiens,WikiPathways | |
| 96291,,WP5368,Sulfatase and aromatase pathway,Homo sapiens,WikiPathways | |
| 96292,,WP5372,Involvement of secretase in neurodegenerative diseases,Homo sapiens,WikiPathways | |
| 96293,,WP5373,Osteoarthritic chondrocyte hypertrophy,Homo sapiens,WikiPathways | |
| 96294,,WP5376,17p13 3 YWHAE copy number variation,Homo sapiens,WikiPathways | |
| 96295,,WP5380,5q35 copy number variation,Homo sapiens,WikiPathways | |
| 96296,,WP5381,Smith Magenis and Potocki Lupski syndrome copy number variation,Homo sapiens,WikiPathways | |
| 96297,,WP5382,TGFB Smad signaling,Homo sapiens,WikiPathways | |
| 96298,,WP5385,Growth factors and hormones in beta cell proliferation,Homo sapiens,WikiPathways | |
| 96299,,WP5390,Pancreatic cancer subtypes,Homo sapiens,WikiPathways | |
| 96300,,WP5393,Androgen biosynthesis,Homo sapiens,WikiPathways | |
| 96301,,WP5394,UDP derived sugars synthesis in fibroblasts,Homo sapiens,WikiPathways | |
| 96302,,WP5395,Glycosaminoglycan synthesis in fibroblasts,Homo sapiens,WikiPathways | |
| 96303,,WP5396,Enterohepatic circulation of bile acids,Homo sapiens,WikiPathways | |
| 96304,,WP5397,Vitamin A1 and A5 X pathways,Homo sapiens,WikiPathways | |
| 96305,,WP5398,NRXN1 deletion syndrome,Homo sapiens,WikiPathways | |
| 96306,,WP5399,NPHP1 deletion syndrome,Homo sapiens,WikiPathways | |
| 96307,,WP5400,6q16 copy number variation,Homo sapiens,WikiPathways | |
| 96308,,WP5401,7q11 23 distal copy number variation,Homo sapiens,WikiPathways | |
| 96309,,WP5402,10q22q23 copy number variation,Homo sapiens,WikiPathways | |
| 96310,,WP5405,13q12 or CRYL1 copy number variation,Homo sapiens,WikiPathways | |
| 96311,,WP5406,13q12 12 copy number variation,Homo sapiens,WikiPathways | |
| 96312,,WP5407,15q11q13 copy number variation,Homo sapiens,WikiPathways | |
| 96313,,WP5408,15q25 copy number variation,Homo sapiens,WikiPathways | |
| 96314,,WP5409,PAFAH1B1 copy number variation,Homo sapiens,WikiPathways | |
| 96315,,WP5411,Phosphatidyl inositol phosphate pathway,Homo sapiens,WikiPathways | |
| 96316,,WP5412,8q11 23 RB1CC1 copy number variation,Homo sapiens,WikiPathways | |
| 96317,,WP5414,IDO metabolic pathway,Homo sapiens,WikiPathways | |
| 96318,,WP5417,Cell lineage map for neuronal differentiation,Homo sapiens,WikiPathways | |
| 96319,,WP5422,IL19 signaling,Homo sapiens,WikiPathways | |
| 96320,,WP5424,Omega 6 fatty acids in senescence,Homo sapiens,WikiPathways | |
| 96321,,WP5426,HDAC6 interactions in the central nervous system,Homo sapiens,WikiPathways | |
| 96322,,WP5428,FGFR4 p G388R signaling,Homo sapiens,WikiPathways | |
| 96323,,WP5431,FLT3 p Gln640SerfsTer8 signaling,Homo sapiens,WikiPathways | |
| 96324,,WP5432,Omega 3 fatty acids in senescence,Homo sapiens,WikiPathways | |
| 96325,,WP5433,PGK1 PKM2 KHKC KHKA acting as protein kinases,Homo sapiens,WikiPathways | |
| 96326,,WP5434,Cancer pathways,Homo sapiens,WikiPathways | |
| 96327,,WP5437,GNAQ pathways in port wine stain,Homo sapiens,WikiPathways | |
| 96328,,WP5440,EPAC1 and PKA reduction of retinal inflammation,Homo sapiens,WikiPathways | |
| 96329,,WP5441,Artemisinin inhibition of uveal melanoma,Homo sapiens,WikiPathways | |
| 96330,,WP5442,Wnt Beta catenin signaling inhibitors in current and past clinical trials,Homo sapiens,WikiPathways | |
| 96331,,WP5443,Effects of MFN2 mutation,Homo sapiens,WikiPathways | |
| 96332,,WP5444,Acetaminophen in analgesia and antipyresis,Homo sapiens,WikiPathways | |
| 96333,,WP5445,Hunger and satiety,Homo sapiens,WikiPathways | |
| 96334,,WP5446,GLP 1 secretion from intestine to portal vein,Homo sapiens,WikiPathways | |
| 96335,,WP5447,GLP 1 in pancreatic islet cells,Homo sapiens,WikiPathways | |
| 96336,,WP545,Complement activation,Homo sapiens,WikiPathways | |
| 96337,,WP5452,GLP 1 from intestine and pancreas and role in glucose homeostasis,Homo sapiens,WikiPathways | |
| 96338,,WP5461,Primary ovarian insufficiency,Homo sapiens,WikiPathways | |
| 96339,,WP5465,Fanconi anemia,Homo sapiens,WikiPathways | |
| 96340,,WP5469,Hallmark of cancer metastasis and epithelial to mesenchymal transition,Homo sapiens,WikiPathways | |
| 96341,,WP5470,Effect of omega 3 PUFA on Huntington 39 s disease pathways,Homo sapiens,WikiPathways | |
| 96342,,WP5472,Phosphoinositide 3 kinase PI3K family,Homo sapiens,WikiPathways | |
| 96343,,WP5473,Cytokine cytokine receptor interaction,Homo sapiens,WikiPathways | |
| 96344,,WP5474,Catabolism of skeletal muscle in cachexia,Homo sapiens,WikiPathways | |
| 96345,,WP5475,Hallmark of cancer sustaining proliferative signaling,Homo sapiens,WikiPathways | |
| 96346,,WP5477,Molecular pathway for oxidative stress,Homo sapiens,WikiPathways | |
| 96347,,WP5483,Hallmark of cancer non mutational epigenetic reprogramming,Homo sapiens,WikiPathways | |
| 96348,,WP5485,Post COVID neuroinflammation,Homo sapiens,WikiPathways | |
| 96349,,WP5486,Rotenone metabolism,Homo sapiens,WikiPathways | |
| 96350,,WP5489,Regulation of cytotoxic T cell responses by Malat1 miR 15 16 circuit,Homo sapiens,WikiPathways | |
| 96351,,WP5490,Inhibition of GNAQ regulated signaling in uveal melanoma,Homo sapiens,WikiPathways | |
| 96352,,WP5491,Transcriptional regulation of memory B cell differentiation,Homo sapiens,WikiPathways | |
| 96353,,WP5492,AMPK regulation of mammary milk protein synthesis,Homo sapiens,WikiPathways | |
| 96354,,WP5493,Effect of dasatinib on the BCR ABL signaling pathway,Homo sapiens,WikiPathways | |
| 96355,,WP5494,Tyrosine kinase inhibitors in glioblastoma,Homo sapiens,WikiPathways | |
| 96356,,WP5495,Targeting YAP in pancreatic ductal adenocarcinoma PDAC,Homo sapiens,WikiPathways | |
| 96357,,WP5496,Targeted therapy in breast cancer,Homo sapiens,WikiPathways | |
| 96358,,WP5497,Cyclin dependent kinase 4 6 inhibitors in breast cancer,Homo sapiens,WikiPathways | |
| 96359,,WP550,Biogenic amine synthesis,Homo sapiens,WikiPathways | |
| 96360,,WP5500,Bempedoic acid therapy in atherosclerosis and metabolic syndrome,Homo sapiens,WikiPathways | |
| 96361,,WP5501,GNAQ p R183Q drives capillary malformation,Homo sapiens,WikiPathways | |
| 96362,,WP5502,16p13 11 copy number variation syndrome,Homo sapiens,WikiPathways | |
| 96363,,WP5503,Albuterol and budesonide therapy for asthma,Homo sapiens,WikiPathways | |
| 96364,,WP5504,Disorders of mitochondrial homeostatis dynamics protein import and quality control,Homo sapiens,WikiPathways | |
| 96365,,WP5505,Glycosylphosphatidyl inositol anchor pathway,Homo sapiens,WikiPathways | |
| 96366,,WP5506,Disorders of NAD metabolism,Homo sapiens,WikiPathways | |
| 96367,,WP5507,Mitochondrial carrier deficiency associated with shuttle disturbances,Homo sapiens,WikiPathways | |
| 96368,,WP5509,GIP and GLP 1 function by tissue,Homo sapiens,WikiPathways | |
| 96369,,WP5510,16p12 2 copy number variation syndrome 520kb,Homo sapiens,WikiPathways | |
| 96370,,WP5512,Vedolizumab therapy for inflammatory bowel disease,Homo sapiens,WikiPathways | |
| 96371,,WP5513,NSAIDs mechanism of action,Homo sapiens,WikiPathways | |
| 96372,,WP5514,DNAJB1 PRKACA fusion in fibrolamellar liver cancer,Homo sapiens,WikiPathways | |
| 96373,,WP5516,IL23 inhibitors in inflammatory bowel disease,Homo sapiens,WikiPathways | |
| 96374,,WP5517,Perturbed thyroid hormone homeostasis leading to developmental neurotoxicity,Homo sapiens,WikiPathways | |
| 96375,,WP5518,Aspirin prevention of cancer metastasis,Homo sapiens,WikiPathways | |
| 96376,,WP5519,LncRNA like NMRK2 in translocation renal cell carcinoma,Homo sapiens,WikiPathways | |
| 96377,,WP5521,SLC25A46 pathway,Homo sapiens,WikiPathways | |
| 96378,,WP5523,HINT1 pathway,Homo sapiens,WikiPathways | |
| 96379,,WP5524,HSPB3 in Charcot Marie Tooth disease,Homo sapiens,WikiPathways | |
| 96380,,WP5526,Age related macular degeneration,Homo sapiens,WikiPathways | |
| 96381,,WP5527,NF kB signaling and ARTD family members,Homo sapiens,WikiPathways | |
| 96382,,WP5528,JAK STAT signaling and ARTD family members,Homo sapiens,WikiPathways | |
| 96383,,WP5529,Wnt Beta catenin signaling and ARTD family members,Homo sapiens,WikiPathways | |
| 96384,,WP5530,MAPK signaling and ARTD family members,Homo sapiens,WikiPathways | |
| 96385,,WP5531,AKT signaling and ARTD family members,Homo sapiens,WikiPathways | |
| 96386,,WP5532,Retinoid metabolism in retina healthy vs RLBP1 deficient,Homo sapiens,WikiPathways | |
| 96387,,WP5534,Visual cycle,Homo sapiens,WikiPathways | |
| 96388,,WP5536,Wnt signaling in adult hippocampal neurogenesis,Homo sapiens,WikiPathways | |
| 96389,,WP5537,Psoriasis mechanism and therapies,Homo sapiens,WikiPathways | |
| 96390,,WP5538,Atopic dermatitis mechanism and therapies,Homo sapiens,WikiPathways | |
| 96391,,WP554,ACE inhibitor pathway,Homo sapiens,WikiPathways | |
| 96392,,WP5540,Multiple sclerosis mechanism and therapies,Homo sapiens,WikiPathways | |
| 96393,,WP5541,BDNF signaling in neurodevelopment,Homo sapiens,WikiPathways | |
| 96394,,WP5545,Fibrotic response of trabecular meshwork cells to TGFB3 and ENPP2 in aqueous humor,Homo sapiens,WikiPathways | |
| 96395,,WP5546,22q11 2 distal CNV,Homo sapiens,WikiPathways | |
| 96396,,WP5548,Blood based neuroinflammation markers,Homo sapiens,WikiPathways | |
| 96397,,WP5549,Tryptophan kynurenine pathway in post COVID syndrome,Homo sapiens,WikiPathways | |
| 96398,,WP5557,ANK2 pathway in epilepsy development,Homo sapiens,WikiPathways | |
| 96399,,WP5558,Suzetrigine mechanism for pain relief,Homo sapiens,WikiPathways | |
| 96400,,WP5559,Lupus pathogenesis,Homo sapiens,WikiPathways | |
| 96401,,WP5560,Lupus therapies,Homo sapiens,WikiPathways | |
| 96402,,WP5561,Integrative Analysis of Treg Glial Interactions,Homo sapiens,WikiPathways | |
| 96403,,WP5562,Celiac disease mechanism and therapies,Homo sapiens,WikiPathways | |
| 96404,,WP5563,RNA polymerase II transcription the preinitiation complex,Homo sapiens,WikiPathways | |
| 96405,,WP5564,FACT complex and DNA double strand break repair,Homo sapiens,WikiPathways | |
| 96406,,WP5565,Transcription activation RNA polymerase I and KAT2A B and inhibition NuRD complex,Homo sapiens,WikiPathways | |
| 96407,,WP5566,SHANK3 pathway involved in Phelan McDermid syndrome,Homo sapiens,WikiPathways | |
| 96408,,WP5567,Telomere end packaging and neurodevelopmental disorders,Homo sapiens,WikiPathways | |
| 96409,,WP5568,SOX genes and their influence on neurogenesis and neurodevelopmental disorders,Homo sapiens,WikiPathways | |
| 96410,,WP5569,Uterine natural killer cells and progesterone estrogen and chorionic gonadotropin,Homo sapiens,WikiPathways | |
| 96411,,WP5570,Glycerol metabolism including linked IMDs,Homo sapiens,WikiPathways | |
| 96412,,WP5571,Deregulating cellular metabolism through non genotoxic carcinogens,Homo sapiens,WikiPathways | |
| 96413,,WP5572,Nucleosome remodeling complex,Homo sapiens,WikiPathways | |
| 96414,,WP5573,Tessadori Bicknell van Haaften syndrome variants nucleosome assembly,Homo sapiens,WikiPathways | |
| 96415,,WP5574,Oligodendrocyte development,Homo sapiens,WikiPathways | |
| 96416,,WP5575,Tessadori Bicknell van Haaften syndrome 3 overview pathway,Homo sapiens,WikiPathways | |
| 96417,,WP5576,Killer cell immunoglobulin like receptors and human leukocyte antigen C pathway,Homo sapiens,WikiPathways | |
| 96418,,WP558,Complement and coagulation cascades,Homo sapiens,WikiPathways | |
| 96419,,WP5580,HLA C allotypes interactions with KIR on dNK cells,Homo sapiens,WikiPathways | |
| 96420,,WP5584,Signaling lipids,Homo sapiens,WikiPathways | |
| 96421,,WP5585,Parthanatos cell death signaling pathway,Homo sapiens,WikiPathways | |
| 96422,,WP5598,Sodium channel in epilepsy,Homo sapiens,WikiPathways | |
| 96423,,WP5599,KCNQ2 and KCNQ3 related epilepsy,Homo sapiens,WikiPathways | |
| 96424,,WP560,TGF beta receptor signaling,Homo sapiens,WikiPathways | |
| 96425,,WP5600,GABA and glutamate signalling in epileptogenesis,Homo sapiens,WikiPathways | |
| 96426,,WP5601,Caffeine in blood vessels,Homo sapiens,WikiPathways | |
| 96427,,WP5602,Caffeine in neurons,Homo sapiens,WikiPathways | |
| 96428,,WP5603,Caffeine in myocytes,Homo sapiens,WikiPathways | |
| 96429,,WP5604,Sickle cell disease,Homo sapiens,WikiPathways | |
| 96430,,WP5605,Hemoglobin switching embryonic fetal and adult,Homo sapiens,WikiPathways | |
| 96431,,WP5606,Beta globin gene expression regulation,Homo sapiens,WikiPathways | |
| 96432,,WP5607,Erythropoiesis,Homo sapiens,WikiPathways | |
| 96433,,WP5609,Inhibitors of metabolism in melanoma therapy,Homo sapiens,WikiPathways | |
| 96434,,WP561,Heme biosynthesis,Homo sapiens,WikiPathways | |
| 96435,,WP5621,SNARE complex machinery in exocytosis,Homo sapiens,WikiPathways | |
| 96436,,WP5636,Mitophagy,Homo sapiens,WikiPathways | |
| 96437,,WP5637,TGF 1 SMAD2 3 signalling in decidual NK cells at the fetal maternal interface,Homo sapiens,WikiPathways | |
| 96438,,WP5639,Ketogenic diet in epileptogenesis,Homo sapiens,WikiPathways | |
| 96439,,WP58,Monoamine GPCRs,Homo sapiens,WikiPathways | |
| 96440,,WP581,EPO receptor signaling,Homo sapiens,WikiPathways | |
| 96441,,WP585,Interferon type I signaling,Homo sapiens,WikiPathways | |
| 96442,,WP615,Senescence and autophagy in cancer,Homo sapiens,WikiPathways | |
| 96443,,WP619,Type II interferon signaling,Homo sapiens,WikiPathways | |
| 96444,,WP623,Oxidative phosphorylation,Homo sapiens,WikiPathways | |
| 96445,,WP661,Glucose homeostasis,Homo sapiens,WikiPathways | |
| 96446,,WP673,ErbB signaling,Homo sapiens,WikiPathways | |
| 96447,,WP678,Arachidonate epoxygenase epoxide hydrolase,Homo sapiens,WikiPathways | |
| 96448,,WP688,Catalytic cycle of mammalian flavin containing monooxygenases FMOs,Homo sapiens,WikiPathways | |
| 96449,,WP69,T cell receptor signaling,Homo sapiens,WikiPathways | |
| 96450,,WP690,Polyol pathway,Homo sapiens,WikiPathways | |
| 96451,,WP691,Tamoxifen metabolism,Homo sapiens,WikiPathways | |
| 96452,,WP692,Sulfation biotransformation reaction,Homo sapiens,WikiPathways | |
| 96453,,WP694,Arylamine metabolism,Homo sapiens,WikiPathways | |
| 96454,,WP696,Benzo a pyrene metabolism,Homo sapiens,WikiPathways | |
| 96455,,WP697,Estrogen metabolism,Homo sapiens,WikiPathways | |
| 96456,,WP698,Glucuronidation,Homo sapiens,WikiPathways | |
| 96457,,WP699,Aflatoxin B1 metabolism,Homo sapiens,WikiPathways | |
| 96458,,WP702,Metapathway biotransformation Phase I and II,Homo sapiens,WikiPathways | |
| 96459,,WP704,Methylation pathways,Homo sapiens,WikiPathways | |
| 96460,,WP706,Sudden infant death syndrome SIDS susceptibility pathways,Homo sapiens,WikiPathways | |
| 96461,,WP707,DNA damage response,Homo sapiens,WikiPathways | |
| 96462,,WP710,DNA damage response only ATM dependent,Homo sapiens,WikiPathways | |
| 96463,,WP712,Estrogen signaling,Homo sapiens,WikiPathways | |
| 96464,,WP716,Vitamin A and carotenoid metabolism,Homo sapiens,WikiPathways | |
| 96465,,WP722,Serotonin HTR1 group and FOS pathway,Homo sapiens,WikiPathways | |
| 96466,,WP727,Monoamine transport and regulation,Homo sapiens,WikiPathways | |
| 96467,,WP732,Serotonin receptor 2 and ELK SRF GATA4 signaling,Homo sapiens,WikiPathways | |
| 96468,,WP734,Serotonin receptor 4 6 7 and NR3C signaling,Homo sapiens,WikiPathways | |
| 96469,,WP75,Toll like receptor signaling,Homo sapiens,WikiPathways | |
| 96470,,WP78,TCA cycle aka Krebs or citric acid cycle,Homo sapiens,WikiPathways | |
| 96471,,WP80,Nucleotide GPCRs,Homo sapiens,WikiPathways | |
| 96472,,WP98,Prostaglandin synthesis and regulation,Homo sapiens,WikiPathways | |